1	European	JJ	ORGANIZATION	european	amod	2	SENT_1	[p1l725t82r839b108],
2	Journal	NNP	ORGANIZATION	Journal	dep	7	SENT_1	[p1l846t81r934b108],
3	of	IN	ORGANIZATION	of	_	0	SENT_1	[p1l944t81r969b103],
4	Internal	NNP	ORGANIZATION	Internal	nn	5	SENT_1	[p1l975t81r1069b103],
5	Medicine	NNP	ORGANIZATION	Medicine	prep_of	2	SENT_1	[p1l1079t81r1189b103],
6	23	CD	NUMBER	23	dep	7	SENT_1	[p1l1199t82r1227b103],
7	(	CD	NUMBER	(	dep	10	SENT_1	[p1l1239t81r1319b108],
8	2012	CD	DATE	2012	dep	7	SENT_1	[p1l1239t81r1319b108],
9	)	CD	NUMBER	)	num	10	SENT_1	[p1l1239t81r1319b108],
10	245-249	CD	NUMBER	245-249	_	0	SENT_1	[p1l1330t82r1435b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l713t191r847b215],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l861t191r918b215],
3	available	JJ	O	available	amod	2	SENT_2	[p1l931t191r1058b215],
4	at	IN	O	at	_	0	SENT_2	[p1l1071t194r1098b215],
5	SciVerse	NNP	O	SciVerse	nn	6	SENT_2	[p1l1111t191r1241b215],
6	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1254t191r1458b215],

1	European	JJ	ORGANIZATION	european	amod	2	SENT_3	[p1l582t290r830b345],
2	Journal	NNP	ORGANIZATION	Journal	_	0	SENT_3	[p1l844t287r1035b345],
3	of	IN	ORGANIZATION	of	_	0	SENT_3	[p1l1056t287r1110b334],
4	Internal	NNP	ORGANIZATION	Internal	nn	7	SENT_3	[p1l1125t287r1328b334],
5	Medicine	NNP	ORGANIZATION	Medicine	nn	7	SENT_3	[p1l1350t287r1589b334],
6	journal	NN	O	journal	nn	7	SENT_3	[p1l622t422r746b451],
7	homepage	NN	O	homepage	prep_of	2	SENT_3	[p1l764t422r959b451],
8	:	:	O	:	_	0	SENT_3	[p1l764t422r959b451],
9	www	NN	O	www	dep	2	SENT_3	[p1l978t422r1546b451],
10	.	.	O	.	_	0	SENT_3	[p1l978t422r1546b451],

1	e	LS	O	e	dep	2	SENT_4	[p1l978t422r1546b451],
2	|	SYM	O	|	_	0	SENT_4	[p1l978t422r1546b451],
3	sevier.com/locate/ejim	SYM	O	sevier.com/locate/ejim	dep	2	SENT_4	[p1l978t422r1546b451],

1	Original	JJ	O	original	dep	105	SENT_5	[p1l6t541r148b581],
2	article	NN	O	article	dep	105	SENT_5	[p1l163t541r274b573],
3	KCN	NN	O	kcn	dep	105	SENT_5	[p1l6t621r182b675],
4	]	CD	NUMBER	]	dep	105	SENT_5	[p1l6t621r182b675],
5	11	CD	NUMBER	11	dep	105	SENT_5	[p1l6t621r182b675],
6	gene	NN	O	gene	dep	105	SENT_5	[p1l207t632r327b675],
7	E23I	NN	O	e23us	dep	105	SENT_5	[p1l348t621r477b664],
8	(	CD	NUMBER	(	dep	105	SENT_5	[p1l348t621r477b664],
9	variant	NN	O	variant	dep	105	SENT_5	[p1l495t620r675b664],
10	and	CC	O	and	dep	105	SENT_5	[p1l694t619r786b664],
11	therapeutic	JJ	O	therapeutic	dep	105	SENT_5	[p1l806t619r1097b675],
12	response	NN	O	response	dep	105	SENT_5	[p1l1117t632r1342b675],
13	to	TO	O	to	dep	105	SENT_5	[p1l1362t626r1411b664],
14	sulfonylureas	NNS	O	sulfonylurea	dep	105	SENT_5	[p1l1432t619r1769b675],
15	Martin	NNP	PERSON	Martin	dep	105	SENT_5	[p1l6t722r140b757],
16	Javorsky	NNP	PERSON	Javorsky	dep	105	SENT_5	[p1l149t721r322b766],
17	3	CD	NUMBER	3	dep	105	SENT_5	[p1l336t720r359b762],
18	,	,	O	,	_	0	SENT_5	[p1l336t720r359b762],
19	Lucia	NNP	PERSON	Lucia	dep	105	SENT_5	[p1l375t722r475b757],
20	Klimcakova	NNP	PERSON	Klimcakova	dep	105	SENT_5	[p1l490t721r719b757],
21	b	NN	O	b	dep	105	SENT_5	[p1l734t713r760b763],
22	,	,	O	,	_	0	SENT_5	[p1l734t713r760b763],
23	Zbynek	NNP	PERSON	Zbynek	dep	105	SENT_5	[p1l774t721r921b766],
24	Schroner	NNP	PERSON	Schroner	dep	105	SENT_5	[p1l934t721r1113b757],
25	3	CD	NUMBER	3	dep	105	SENT_5	[p1l1126t720r1150b763],
26	,	,	O	,	_	0	SENT_5	[p1l1126t720r1150b763],
27	Jozef	NNP	PERSON	Jozef	dep	105	SENT_5	[p1l1160t721r1264b766],
28	Zidzik	NNP	PERSON	Zidzik	dep	105	SENT_5	[p1l1273t721r1394b757],
29	b	NN	O	b	dep	105	SENT_5	[p1l1407t713r1434b763],
30	,	,	O	,	_	0	SENT_5	[p1l1407t713r1434b763],
31	Eva	NNP	PERSON	Eva	dep	105	SENT_5	[p1l1449t723r1517b757],
32	Babjakova	NNP	PERSON	Babjakova	dep	105	SENT_5	[p1l1532t721r1734b766],
33	3	CD	NUMBER	3	dep	105	SENT_5	[p1l1748t720r1772b763],
34	,	,	O	,	_	0	SENT_5	[p1l1748t720r1772b763],
35	Maria	NNP	PERSON	Maria	dep	105	SENT_5	[p1l1787t722r1901b757],
36	Fabianova	NNP	PERSON	Fabianova	dep	105	SENT_5	[p1l1915t721r2115b757],
37	3	CD	NUMBER	3	dep	105	SENT_5	[p1l2130t720r2153b762],
38	,	,	O	,	_	0	SENT_5	[p1l2130t720r2153b762],
39	Miriam	NNP	PERSON	Miriam	dep	105	SENT_5	[p1l6t775r150b810],
40	Kozarova	NNP	PERSON	Kozarova	dep	105	SENT_5	[p1l166t777r350b810],
41	3	CD	NUMBER	3	dep	105	SENT_5	[p1l364t774r388b816],
42	,	,	O	,	_	0	SENT_5	[p1l364t774r388b816],
43	Ruzena	NNP	PERSON	Ruzena	dep	105	SENT_5	[p1l405t777r549b810],
44	Tkacova	NNP	PERSON	Tkacova	dep	105	SENT_5	[p1l563t775r725b810],
45	C	NNP	O	C	dep	105	SENT_5	[p1l740t774r762b816],
46	,	,	O	,	_	0	SENT_5	[p1l740t774r762b816],
47	Jan	NNP	PERSON	Jan	dep	105	SENT_5	[p1l773t777r838b819],
48	Salagovic	NNP	PERSON	Salagovic	dep	105	SENT_5	[p1l854t775r1038b819],
49	b	NN	O	b	dep	105	SENT_5	[p1l1053t767r1079b816],
50	,	,	O	,	_	0	SENT_5	[p1l1053t767r1079b816],
51	Ivan	NNP	PERSON	Ivan	dep	105	SENT_5	[p1l1096t777r1179b810],
52	Tkac	NNP	PERSON	Tkac	dep	105	SENT_5	[p1l1193t775r1284b810],
53	"	``	O	"	dep	105	SENT_5	[p1l1299t768r1345b794],
54	"	``	O	"	dep	105	SENT_5	[p1l1299t768r1345b794],
55	'	''	O	'	_	0	SENT_5	[p1l1299t768r1345b794],
56	*	CD	NUMBER	*	dep	105	SENT_5	[p1l1299t768r1345b794],
57	3	CD	NUMBER	3	dep	105	SENT_5	[p1l6t849r15b860],
58	Department	NNP	ORGANIZATION	Department	dep	105	SENT_5	[p1l26t851r166b877],
59	of	IN	ORGANIZATION	of	dep	105	SENT_5	[p1l174t850r199b877],
60	Internal	NNP	ORGANIZATION	Internal	dep	105	SENT_5	[p1l203t850r295b872],
61	Medicine	NNP	ORGANIZATION	Medicine	dep	105	SENT_5	[p1l303t850r408b872],
62	4	CD	NUMBER	4	dep	105	SENT_5	[p1l417t851r436b875],
63	,	,	O	,	_	0	SENT_5	[p1l417t851r436b875],
64	Faculty	NNP	ORGANIZATION	Faculty	dep	105	SENT_5	[p1l446t850r529b877],
65	of	IN	ORGANIZATION	of	dep	105	SENT_5	[p1l539t850r564b877],
66	Medicine	NNP	ORGANIZATION	Medicine	dep	105	SENT_5	[p1l568t850r677b875],
67	,	,	O	,	_	0	SENT_5	[p1l568t850r677b875],
68	Safarik	NNP	ORGANIZATION	Safarik	dep	105	SENT_5	[p1l687t850r767b877],
69	University	NNP	ORGANIZATION	University	dep	105	SENT_5	[p1l777t850r898b877],
70	,	,	O	,	_	0	SENT_5	[p1l777t850r898b877],
71	Kosice	NNP	LOCATION	Kosice	dep	105	SENT_5	[p1l908t850r985b875],
72	,	,	O	,	_	0	SENT_5	[p1l908t850r985b875],
73	Slovakia	NNP	LOCATION	Slovakia	dep	105	SENT_5	[p1l995t850r1091b872],
74	b	NN	O	b	dep	105	SENT_5	[p1l6t881r17b895],
75	Department	NNP	ORGANIZATION	Department	dep	105	SENT_5	[p1l27t887r167b913],
76	of	IN	ORGANIZATION	of	dep	105	SENT_5	[p1l176t885r201b913],
77	Medical	NNP	ORGANIZATION	Medical	dep	105	SENT_5	[p1l205t885r296b907],
78	Biology	NNP	ORGANIZATION	Biology	dep	105	SENT_5	[p1l304t886r394b913],
79	,	,	O	,	_	0	SENT_5	[p1l304t886r394b913],
80	Faculty	NNP	O	Faculty	dep	105	SENT_5	[p1l404t886r487b913],
81	of	IN	O	of	dep	105	SENT_5	[p1l497t885r522b913],
82	Medicine	NNP	O	Medicine	dep	105	SENT_5	[p1l526t885r635b911],
83	,	,	O	,	_	0	SENT_5	[p1l526t885r635b911],
84	Safarik	NNP	ORGANIZATION	Safarik	dep	105	SENT_5	[p1l645t885r726b913],
85	University	NNP	ORGANIZATION	University	dep	105	SENT_5	[p1l736t886r856b913],
86	,	,	O	,	_	0	SENT_5	[p1l736t886r856b913],
87	Kosice	NNP	LOCATION	Kosice	dep	105	SENT_5	[p1l866t886r944b911],
88	,	,	O	,	_	0	SENT_5	[p1l866t886r944b911],
89	Slovakia	NNP	ORGANIZATION	Slovakia	dep	105	SENT_5	[p1l953t886r1049b907],
90	C	NNP	ORGANIZATION	C	dep	105	SENT_5	[p1l6t920r15b930],
91	Department	NNP	ORGANIZATION	Department	dep	105	SENT_5	[p1l25t922r165b948],
92	of	IN	ORGANIZATION	of	dep	105	SENT_5	[p1l174t921r199b948],
93	Respiratory	NNP	ORGANIZATION	Respiratory	dep	105	SENT_5	[p1l203t921r335b948],
94	Medicine	NNP	ORGANIZATION	Medicine	dep	105	SENT_5	[p1l344t921r454b946],
95	,	,	O	,	_	0	SENT_5	[p1l344t921r454b946],
96	Faculty	NNP	ORGANIZATION	Faculty	dep	105	SENT_5	[p1l464t921r547b948],
97	of	IN	ORGANIZATION	of	dep	105	SENT_5	[p1l557t921r582b948],
98	Medicine	NNP	ORGANIZATION	Medicine	dep	105	SENT_5	[p1l586t921r695b946],
99	,	,	O	,	_	0	SENT_5	[p1l586t921r695b946],
100	Safarik	NNP	ORGANIZATION	Safarik	dep	105	SENT_5	[p1l705t921r786b948],
101	University	NNP	ORGANIZATION	University	dep	105	SENT_5	[p1l795t921r916b948],
102	,	,	O	,	_	0	SENT_5	[p1l795t921r916b948],
103	Kosice	NNP	LOCATION	Kosice	dep	105	SENT_5	[p1l926t921r1004b946],
104	,	,	O	,	_	0	SENT_5	[p1l926t921r1004b946],
105	Slovakia	NNP	LOCATION	Slovakia	_	0	SENT_5	[p1l1013t921r1110b943],

1	ARTICLE	NN	O	article	_	0	SENT_6	[p1l6t1057r230b1079],
2	INFO	NN	O	info	nn	3	SENT_6	[p1l278t1057r401b1079],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_6	[p1l691t1057r960b1079],

1	Article	NNP	O	Article	nn	2	SENT_7	[p1l6t1134r82b1156],
2	history	NN	O	history	_	0	SENT_7	[p1l92t1134r178b1161],
3	:	:	O	:	_	0	SENT_7	[p1l92t1134r178b1161],
4	Aims	NNS	O	aim	dep	2	SENT_7	[p1l6t1174r80b1198],
5	:	:	O	:	_	0	SENT_7	[p1l6t1174r80b1198],
6	Potassium	NN	O	potassium	dep	4	SENT_7	[p1l98t1174r236b1198],
7	inwardly	RB	O	inwardly	advmod	11	SENT_7	[p1l254t1174r376b1204],
8	rectiﬁer	NN	O	rectiﬁer	nn	11	SENT_7	[p1l393t1173r499b1198],
9	6.2	CD	NUMBER	6.2	num	11	SENT_7	[p1l516t1175r554b1198],
10	subunit	NN	O	subunit	nn	11	SENT_7	[p1l573t1174r675b1198],
11	(	NN	O	(	rcmod	6	SENT_7	[p1l695t1174r797b1204],
12	l	NN	O	l	tmod	32	SENT_7	[p1l695t1174r797b1204],
13	(	CD	NUMBER	(	num	16	SENT_7	[p1l695t1174r797b1204],
14	ir6	NN	O	ir6	nn	16	SENT_7	[p1l695t1174r797b1204],
15	.2	NN	NUMBER	.2	nn	16	SENT_7	[p1l695t1174r797b1204],
16	)	NN	O	)	nsubj	32	SENT_7	[p1l695t1174r797b1204],
17	of	IN	O	of	_	0	SENT_7	[p1l817t1173r845b1198],
18	the	DT	O	the	det	24	SENT_7	[p1l859t1173r902b1198],
19	ATP-sensitive	JJ	O	atp-sensitive	amod	24	SENT_7	[p1l919t1174r1103b1198],
20	potassium	NN	O	potassium	nn	24	SENT_7	[p1l1121t1174r1260b1204],
21	(	CD	NUMBER	(	num	24	SENT_7	[p1l1279t1173r1359b1204],
22	KATP	NN	O	katp	nn	24	SENT_7	[p1l1279t1173r1359b1204],
23	)	NN	O	)	nn	24	SENT_7	[p1l1279t1173r1359b1204],
24	channel	NN	O	channel	prep_of	16	SENT_7	[p1l1379t1173r1484b1198],
25	Received	VBN	O	receive	partmod	24	SENT_7	[p1l6t1215r112b1237],
26	12	CD	DATE	12	num	27	SENT_7	[p1l128t1216r154b1237],
27	August	NNP	DATE	August	dobj	25	SENT_7	[p1l168t1216r253b1242],
28	2011	CD	DATE	2011	num	27	SENT_7	[p1l266t1216r327b1237],
29	encoded	VBN	O	encode	partmod	27	SENT_7	[p1l713t1217r826b1241],
30	by	IN	O	by	_	0	SENT_7	[p1l842t1217r874b1247],
31	I	PRP	O	I	agent	29	SENT_7	[p1l888t1218r965b1247],
32	(	VBP	O	(	rcmod	11	SENT_7	[p1l888t1218r965b1247],
33	CN	NN	O	cn	nn	34	SENT_7	[p1l888t1218r965b1247],
34	]	NN	O	]	dobj	32	SENT_7	[p1l888t1218r965b1247],
35	1	CD	NUMBER	1	number	36	SENT_7	[p1l888t1218r965b1247],
36	1	CD	NUMBER	1	num	37	SENT_7	[p1l977t1218r986b1241],
37	gene	NN	O	gene	nsubj	41	SENT_7	[p1l1004t1224r1068b1247],
38	is	VBZ	O	be	cop	41	SENT_7	[p1l1083t1217r1103b1241],
39	a	DT	O	a	det	41	SENT_7	[p1l1118t1224r1132b1241],
40	therapeutical	JJ	O	therapeutical	amod	41	SENT_7	[p1l1146t1217r1325b1247],
41	target	NN	O	target	rcmod	34	SENT_7	[p1l1340t1220r1420b1247],
42	for	IN	O	for	_	0	SENT_7	[p1l1434t1216r1472b1241],
43	sulfonylureas	NNS	O	sulfonylurea	prep_for	41	SENT_7	[p1l1487t1216r1673b1247],
44	.	.	O	.	_	0	SENT_7	[p1l1487t1216r1673b1247],

1	KCNJZ	NN	ORGANIZATION	kcnjz	nn	4	SENT_8	[p1l1688t1218r1766b1247],
2	1	CD	NUMBER	1	num	4	SENT_8	[p1l1778t1218r1787b1241],
3	E23K	NN	O	e23k	nn	4	SENT_8	[p1l1805t1218r1874b1241],
4	polymorphism	NN	O	polymorphism	_	0	SENT_8	[p1l1888t1217r2088b1247],
5	was	VBD	O	be	auxpass	6	SENT_8	[p1l2102t1224r2154b1241],
6	associReceived	VBN	O	associreceive	rcmod	4	SENT_8	[p1l6t1262r97b1286, p1l7t1290r113b1312],
7	in	IN	O	in	_	0	SENT_8	[p1l124t1291r145b1312],
8	revised	JJ	O	revised	amod	9	SENT_8	[p1l156t1290r241b1312],
9	form	NN	O	form	prep_in	6	SENT_8	[p1l251t1290r308b1312],
10	26	CD	DATE	26	dep	9	SENT_8	[p1l318t1291r347b1312],
11	September	NNP	DATE	September	tmod	9	SENT_8	[p1l357t1290r487b1317],
12	2011	CD	DATE	2011	num	11	SENT_8	[p1l496t1291r552b1312],
13	Accepted	JJ	O	accepted	amod	14	SENT_8	[p1l6t1326r116b1353],
14	22	CD	DATE	22	dep	9	SENT_8	[p1l126t1327r154b1347],
15	October	NNP	DATE	October	tmod	9	SENT_8	[p1l165t1326r260b1348],
16	2011	CD	DATE	2011	num	15	SENT_8	[p1l269t1327r325b1348],
17	Available	JJ	O	available	amod	9	SENT_8	[p1l6t1362r117b1384],
18	online	NN	O	online	prep	9	SENT_8	[p1l126t1362r201b1384],
19	26	CD	DATE	26	dep	18	SENT_8	[p1l211t1363r240b1384],
20	November	NNP	DATE	November	tmod	6	SENT_8	[p1l250t1362r375b1384],
21	2011	CD	DATE	2011	num	20	SENT_8	[p1l384t1363r440b1384],

1	ated	VBN	O	ate	_	0	SENT_9	[p1l7t1446r64b1470],
2	with	IN	O	with	_	0	SENT_9	[p1l72t1446r134b1470],
3	type	NN	O	type	nn	5	SENT_9	[p1l142t1449r201b1476],
4	2	CD	NUMBER	2	num	5	SENT_9	[p1l210t1447r225b1470],
5	diabetes	NN	O	diabetes	prep_with	1	SENT_9	[p1l234t1446r346b1470],
6	in	IN	O	in	_	0	SENT_9	[p1l355t1446r380b1470],
7	genetic	JJ	O	genetic	amod	9	SENT_9	[p1l388t1446r486b1476],
8	association	NN	O	association	nn	9	SENT_9	[p1l494t1446r643b1470],
9	studies	NNS	O	study	prep_in	5	SENT_9	[p1l652t1446r753b1470],
10	.	.	O	.	_	0	SENT_9	[p1l652t1446r753b1470],

1	The	DT	O	the	det	2	SENT_10	[p1l760t1446r810b1470],
2	aim	NN	O	aim	nsubj	8	SENT_10	[p1l818t1446r868b1470],
3	of	IN	O	of	_	0	SENT_10	[p1l877t1446r905b1470],
4	the	DT	O	the	det	7	SENT_10	[p1l910t1446r953b1470],
5	present	JJ	DATE	present	amod	7	SENT_10	[p1l961t1449r1063b1476],
6	pharmacogenetic	JJ	O	pharmacogenetic	amod	7	SENT_10	[p1l1071t1446r1305b1476],
7	study	NN	O	study	prep_of	2	SENT_10	[p1l1314t1446r1388b1476],
8	was	VBD	O	be	dep	11	SENT_10	[p1l1395t1453r1448b1470],
9	to	TO	O	to	_	0	SENT_10	[p1l1456t1449r1482b1470],
10	ggzvgrgzbetes	NNS	O	ggzvgrgzbete	prep_to	8	SENT_10	[p1l1598t1427r1789b1489],
11	examine	VBP	O	examine	_	0	SENT_10	[p1l7t1486r122b1510],
12	the	DT	O	the	det	13	SENT_10	[p1l133t1486r175b1510],
13	effect	NN	O	effect	dobj	11	SENT_10	[p1l186t1486r260b1510],
14	of	IN	O	of	_	0	SENT_10	[p1l271t1486r299b1510],
15	sulfonylurea	NN	O	sulfonylurea	nn	16	SENT_10	[p1l306t1486r474b1516],
16	treatment	NN	O	treatment	prep_of	13	SENT_10	[p1l485t1489r620b1510],
17	on	IN	O	on	_	0	SENT_10	[p1l631t1493r664b1510],
18	glycemic	JJ	O	glycemic	amod	19	SENT_10	[p1l674t1486r794b1516],
19	control	NN	O	control	prep_on	16	SENT_10	[p1l804t1486r900b1510],
20	in	IN	O	in	_	0	SENT_10	[p1l911t1486r936b1510],
21	relationship	NN	O	relationship	prep_in	19	SENT_10	[p1l947t1486r1108b1516],
22	to	TO	O	to	_	0	SENT_10	[p1l1119t1489r1145b1510],
23	KCN	NNP	O	KCN	prep_to	11	SENT_10	[p1l1155t1487r1249b1516],
24	]	CD	NUMBER	]	num	23	SENT_10	[p1l1155t1487r1249b1516],
25	11	CD	NUMBER	11	num	27	SENT_10	[p1l1155t1487r1249b1516],
26	E23K	NN	O	e23k	nn	27	SENT_10	[p1l1263t1487r1332b1510],
27	variant	NN	O	variant	nsubj	11	SENT_10	[p1l1342t1486r1444b1510],
28	.	.	O	.	_	0	SENT_10	[p1l1342t1486r1444b1510],

1	pharmacogeneﬂcs	NNS	O	pharmacogeneﬂcs	nn	2	SENT_11	[p1l1600t1498r1818b1525],
2	Patients	NNS	O	patient	_	0	SENT_11	[p1l6t1526r109b1550],
3	and	CC	O	and	_	0	SENT_11	[p1l118t1526r166b1550],
4	methods	NNS	O	method	conj_and	2	SENT_11	[p1l174t1525r292b1550],
5	:	:	O	:	_	0	SENT_11	[p1l174t1525r292b1550],
6	One	CD	NUMBER	one	num	7	SENT_11	[p1l302t1527r353b1550],
7	hundred	CD	NUMBER	hundred	dep	2	SENT_11	[p1l360t1525r470b1550],
8	and	CC	NUMBER	and	_	0	SENT_11	[p1l478t1526r525b1550],
9	one	CD	NUMBER	one	num	10	SENT_11	[p1l533t1533r580b1550],
10	patients	NNS	O	patient	dep	2	SENT_11	[p1l587t1526r690b1556],
11	with	IN	O	with	_	0	SENT_11	[p1l696t1525r756b1550],
12	type	NN	O	type	nn	14	SENT_11	[p1l763t1529r819b1556],
13	2	CD	NUMBER	2	num	14	SENT_11	[p1l826t1527r841b1549],
14	diabetes	NN	O	diabetes	prep_with	7	SENT_11	[p1l848t1526r955b1550],
15	who	WP	O	who	nsubj	16	SENT_11	[p1l962t1526r1019b1550],
16	failed	VBD	O	fail	rcmod	7	SENT_11	[p1l1026t1525r1096b1550],
17	to	TO	O	to	aux	18	SENT_11	[p1l1103t1529r1128b1550],
18	achieve	VB	O	achieve	xcomp	16	SENT_11	[p1l1135t1525r1232b1550],
19	HbA1c	NN	O	hba1c	nsubjpass	33	SENT_11	[p1l1240t1526r1345b1550],
20	<	JJR	O	<	dep	33	SENT_11	[p1l1240t1526r1345b1550],
21	7	CD	PERCENT	7	num	22	SENT_11	[p1l1350t1527r1383b1550],
22	%	NN	PERCENT	%	nsubjpass	33	SENT_11	[p1l1350t1527r1383b1550],
23	on	IN	O	on	_	0	SENT_11	[p1l1390t1533r1422b1550],
24	pre	JJ	O	pre	amod	31	SENT_11	[p1l1429t1533r1482b1556],
25	—	NN	O	—	nn	31	SENT_11	[p1l1429t1533r1482b1556],
26	5u1f0ny1u	NN	O	5u1f0ny1u	nn	31	SENT_11	[p1l1600t1534r1751b1561],
27	,	,	O	,	_	0	SENT_11	[p1l1600t1534r1751b1561],
28	ea	NN	O	ea	nn	31	SENT_11	[p1l1600t1534r1751b1561],
29	vious	JJ	O	vious	amod	31	SENT_11	[p1l6t1636r75b1660],
30	metformin	NN	O	metformin	nn	31	SENT_11	[p1l84t1636r223b1660],
31	monotherapy	NN	O	monotherapy	prep_on	22	SENT_11	[p1l231t1636r407b1666],
32	were	VBD	O	be	auxpass	33	SENT_11	[p1l415t1643r480b1660],
33	included	VBN	O	include	xcomp	18	SENT_11	[p1l489t1636r600b1660],
34	to	TO	O	to	_	0	SENT_11	[p1l609t1639r634b1660],
35	the	DT	O	the	det	36	SENT_11	[p1l642t1636r684b1660],
36	study	NN	O	study	prep_to	33	SENT_11	[p1l693t1636r769b1666],
37	.	.	O	.	_	0	SENT_11	[p1l693t1636r769b1666],

1	Sulfonylurea	NNP	O	Sulfonylurea	nn	2	SENT_12	[p1l779t1636r941b1666],
2	drug	NN	O	drug	nsubjpass	4	SENT_12	[p1l949t1636r1009b1666],
3	was	VBD	O	be	auxpass	4	SENT_12	[p1l1017t1643r1068b1660],
4	given	VBN	O	give	_	0	SENT_12	[p1l1076t1636r1147b1666],
5	in	IN	O	in	_	0	SENT_12	[p1l1156t1636r1180b1660],
6	addition	NN	O	addition	prep_in	4	SENT_12	[p1l1188t1636r1296b1660],
7	to	TO	O	to	_	0	SENT_12	[p1l1304t1640r1329b1660],
8	metformin	NN	O	metformin	prep_to	4	SENT_12	[p1l1338t1636r1483b1660],
9	.	.	O	.	_	0	SENT_12	[p1l1338t1636r1483b1660],

1	The	DT	O	the	det	3	SENT_13	[p1l6t1676r54b1700],
2	main	JJ	O	main	amod	3	SENT_13	[p1l61t1676r126b1700],
3	outcome	NN	O	outcome	nsubj	8	SENT_13	[p1l133t1680r246b1700],
4	of	IN	O	of	_	0	SENT_13	[p1l253t1676r280b1700],
5	the	DT	O	the	det	6	SENT_13	[p1l283t1676r325b1700],
6	study	NN	O	study	prep_of	3	SENT_13	[p1l332t1676r404b1706],
7	was	VBD	O	be	cop	8	SENT_13	[p1l409t1683r460b1700],
8	reduction	NN	O	reduction	_	0	SENT_13	[p1l467t1676r591b1700],
9	in	IN	O	in	_	0	SENT_13	[p1l598t1676r622b1700],
10	HbA1c	NN	O	hba1c	prep_in	8	SENT_13	[p1l629t1676r714b1700],
11	level	NN	O	level	nn	14	SENT_13	[p1l721t1676r780b1700],
12	(	CD	NUMBER	(	num	14	SENT_13	[p1l789t1676r916b1706],
13	AHbA1c	NN	O	ahba1c	nn	14	SENT_13	[p1l789t1676r916b1706],
14	)	NN	O	)	npadvmod	8	SENT_13	[p1l789t1676r916b1706],
15	after	IN	O	after	_	0	SENT_13	[p1l925t1676r984b1700],
16	6-month	JJ	DURATION	6-month	amod	18	SENT_13	[p1l990t1676r1105b1700],
17	sulfonylurea	NN	O	sulfonylurea	nn	18	SENT_13	[p1l1112t1676r1271b1706],
18	therapy	NN	O	therapy	prep_after	8	SENT_13	[p1l1277t1676r1383b1706],
19	.	.	O	.	_	0	SENT_13	[p1l1277t1676r1383b1706],

1	KCN	NNP	O	KCN	nsubjpass	7	SENT_14	[p1l1389t1677r1464b1706],
2	]	CD	NUMBER	]	num	5	SENT_14	[p1l1389t1677r1464b1706],
3	1	CD	NUMBER	1	num	5	SENT_14	[p1l1389t1677r1464b1706],
4	1	CD	NUMBER	1	num	5	SENT_14	[p1l1471t1677r1480b1700],
5	genotypes	NNS	O	genotype	dep	1	SENT_14	[p1l7t1719r139b1746],
6	were	VBD	O	be	auxpass	7	SENT_14	[p1l148t1723r213b1740],
7	determined	VBN	O	determine	_	0	SENT_14	[p1l223t1716r373b1740],
8	by	IN	O	by	_	0	SENT_14	[p1l382t1716r414b1746],
9	real-time	JJ	O	real-time	amod	10	SENT_14	[p1l423t1716r541b1740],
10	PCR	NN	O	pcr	agent	7	SENT_14	[p1l551t1717r601b1740],
11	with	IN	O	with	_	0	SENT_14	[p1l608t1716r668b1740],
12	melting	JJ	O	melting	amod	14	SENT_14	[p1l678t1716r777b1746],
13	curve	NN	O	curve	nn	14	SENT_14	[p1l786t1723r857b1740],
14	analysis	NN	O	analysis	prep_with	7	SENT_14	[p1l866t1716r973b1746],
15	.	.	O	.	_	0	SENT_14	[p1l866t1716r973b1746],

1	Results	NNS	O	result	_	0	SENT_15	[p1l6t1756r100b1780],
2	:	:	O	:	_	0	SENT_15	[p1l6t1756r100b1780],
3	After	IN	O	after	_	0	SENT_15	[p1l107t1756r173b1780],
4	6-month	JJ	DURATION	6-month	amod	5	SENT_15	[p1l180t1756r294b1780],
5	treatment	NN	O	treatment	prep_after	12	SENT_15	[p1l302t1759r437b1784],
6	,	,	O	,	_	0	SENT_15	[p1l302t1759r437b1784],
7	KCN	NN	O	kcn	nsubj	12	SENT_15	[p1l445t1757r535b1786],
8	]	CD	NUMBER	]	num	7	SENT_15	[p1l445t1757r535b1786],
9	11	CD	NUMBER	11	num	11	SENT_15	[p1l445t1757r535b1786],
10	K-allele	NN	O	k-allele	nn	11	SENT_15	[p1l547t1756r644b1780],
11	carriers	NNS	O	carrier	dep	7	SENT_15	[p1l652t1756r748b1780],
12	had	VBD	O	have	dep	1	SENT_15	[p1l757t1756r804b1780],
13	higher	JJR	O	higher	amod	14	SENT_15	[p1l813t1756r897b1786],
14	decrease	NN	O	decrease	dobj	12	SENT_15	[p1l905t1756r1016b1780],
15	in	IN	O	in	_	0	SENT_15	[p1l1025t1756r1049b1780],
16	HbA1c	NN	O	hba1c	prep_in	14	SENT_15	[p1l1058t1756r1143b1780],
17	compared	VBN	O	compare	_	0	SENT_15	[p1l1151t1756r1281b1786],
18	with	IN	O	with	prepc_compared_with	12	SENT_15	[p1l1289t1756r1349b1780],
19	EE	NN	O	ee	nn	20	SENT_15	[p1l1357t1757r1388b1780],
20	homoKCNJI	NN	O	homokcnjus	pobj	12	SENT_15	[p1l1397t1756r1483b1780, p1l6t1795r75b1821],
21	1	CD	NUMBER	1	num	24	SENT_15	[p1l85t1795r93b1815],
22	E23K	NN	O	e23k	nn	24	SENT_15	[p1l109t1795r170b1816],
23	variant	JJ	O	variant	amod	24	SENT_15	[p1l183t1794r268b1816],
24	zygotes	NNS	O	zygote	dep	20	SENT_15	[p1l706t1793r803b1820],
25	in	IN	O	in	_	0	SENT_15	[p1l816t1790r840b1814],
26	the	DT	O	the	det	29	SENT_15	[p1l851t1790r893b1814],
27	dominant	JJ	O	dominant	amod	29	SENT_15	[p1l905t1790r1032b1814],
28	genetic	JJ	O	genetic	amod	29	SENT_15	[p1l1042t1790r1136b1820],
29	model	NN	O	model	prep_in	24	SENT_15	[p1l1148t1790r1229b1814],
30	(	CD	NUMBER	(	number	31	SENT_15	[p1l1243t1790r1308b1820],
31	1.04	CD	NUMBER	1.04	num	29	SENT_15	[p1l1243t1790r1308b1820],
32	:	:	O	:	_	0	SENT_15	[p1l1318t1793r1340b1816],
33	l	NN	O	l	dep	20	SENT_15	[p1l1318t1793r1340b1816],
34	:	:	O	:	_	0	SENT_15	[p1l1318t1793r1340b1816],
35	0.10	CD	NUMBER	0.10	dep	20	SENT_15	[p1l1350t1791r1405b1814],
36	vs.	CC	O	vs.	prep	35	SENT_15	[p1l1416t1797r1449b1814],
37	0.79	CD	NUMBER	0.79	dep	36	SENT_15	[p1l1461t1791r1515b1814],
38	:	:	O	:	_	0	SENT_15	[p1l1526t1793r1548b1816],
39	l	NN	O	l	dep	20	SENT_15	[p1l1526t1793r1548b1816],
40	:	:	O	:	_	0	SENT_15	[p1l1526t1793r1548b1816],
41	0.12	CD	PERCENT	0.12	num	42	SENT_15	[p1l1558t1791r1636b1818],
42	%	NN	PERCENT	%	dep	20	SENT_15	[p1l1558t1791r1636b1818],
43	,	,	O	,	_	0	SENT_15	[p1l1558t1791r1636b1818],
44	p	NN	O	p	appos	20	SENT_15	[p1l1649t1797r1664b1820],
45	=	JJ	O	=	amod	47	SENT_15	[p1l1674t1800r1698b1809],
46	0.036	CD	NUMBER	0.036	tmod	45	SENT_15	[p1l1709t1790r1798b1820],
47	)	NN	O	)	dep	44	SENT_15	[p1l1709t1790r1798b1820],
48	.	.	O	.	_	0	SENT_15	[p1l1709t1790r1798b1820],

1	In	IN	O	in	dep	8	SENT_16	[p1l1810t1791r1835b1814],
2	the	DT	O	the	det	4	SENT_16	[p1l1847t1790r1888b1814],
3	log-additive	JJ	O	log-additive	amod	4	SENT_16	[p1l1900t1790r2055b1820],
4	model	NN	O	model	pobj	1	SENT_16	[p1l2067t1790r2154b1818],
5	,	,	O	,	_	0	SENT_16	[p1l2067t1790r2154b1818],
6	greater	JJR	O	greater	amod	8	SENT_16	[p1l6t1832r99b1859],
7	mean	JJ	O	mean	amod	8	SENT_16	[p1l6t1875r78b1893],
8	reduction	NN	O	reduction	_	0	SENT_16	[p1l87t1868r211b1893],
9	in	IN	O	in	_	0	SENT_16	[p1l221t1869r245b1893],
10	HbA1c	NN	O	hba1c	prep_in	8	SENT_16	[p1l254t1868r340b1893],
11	by	IN	O	by	_	0	SENT_16	[p1l349t1868r381b1899],
12	0.16	CD	PERCENT	0.16	num	13	SENT_16	[p1l389t1870r461b1893],
13	%	NN	PERCENT	%	prep_by	8	SENT_16	[p1l389t1870r461b1893],
14	(	CD	PERCENT	(	num	17	SENT_16	[p1l473t1869r533b1899],
15	95	CD	PERCENT	95	number	16	SENT_16	[p1l473t1869r533b1899],
16	%	NN	PERCENT	%	amod	17	SENT_16	[p1l473t1869r533b1899],
17	CI	NN	O	ci	dep	13	SENT_16	[p1l542t1870r566b1893],
18	0.01-0	CD	NUMBER	0.01-0	num	19	SENT_16	[p1l576t1870r708b1896],
19	.32	CD	NUMBER	.32	dep	17	SENT_16	[p1l576t1870r708b1896],
20	.	.	O	.	_	0	SENT_16	[p1l576t1870r708b1896],

1	p	NN	O	p	nsubjpass	9	SENT_17	[p1l718t1875r733b1899],
2	=	JJ	O	=	amod	1	SENT_17	[p1l741t1878r765b1888],
3	0.038	CD	NUMBER	0.038	number	4	SENT_17	[p1l773t1868r854b1899],
4	)	CD	NUMBER	)	dep	2	SENT_17	[p1l773t1868r854b1899],
5	per	IN	O	per	_	0	SENT_17	[p1l865t1875r908b1899],
6	each	DT	O	each	det	7	SENT_17	[p1l917t1868r975b1893],
7	K-allele	NN	MISC	k-allele	prep_per	4	SENT_17	[p1l986t1868r1082b1893],
8	was	VBD	O	be	auxpass	9	SENT_17	[p1l1091t1875r1142b1893],
9	observed	VBN	O	observe	_	0	SENT_17	[p1l1152t1868r1275b1893],
10	.	.	O	.	_	0	SENT_17	[p1l1152t1868r1275b1893],

1	The	DT	O	the	det	2	SENT_18	[p1l1283t1868r1331b1893],
2	relationship	NN	O	relationship	nsubj	14	SENT_18	[p1l1341t1868r1495b1899],
3	of	IN	O	of	_	0	SENT_18	[p1l1504t1868r1532b1893],
4	treatment	NN	O	treatment	nn	5	SENT_18	[p1l1537t1872r1667b1893],
5	response	NN	O	response	prep_of	2	SENT_18	[p1l1677t1875r1791b1899],
6	with	IN	O	with	_	0	SENT_18	[p1l1801t1868r1860b1893],
7	KCN	NN	O	kcn	nn	8	SENT_18	[p1l1869t1869r1944b1899],
8	]	NN	O	]	prep_with	5	SENT_18	[p1l1869t1869r1944b1899],
9	1	CD	NUMBER	1	number	10	SENT_18	[p1l1869t1869r1944b1899],
10	1	CD	NUMBER	1	num	11	SENT_18	[p1l1952t1869r1960b1892],
11	genotype	NN	O	genotype	dep	8	SENT_18	[p1l1973t1872r2094b1899],
12	was	VBD	O	be	cop	14	SENT_18	[p1l2103t1875r2154b1893],
13	also	RB	O	also	advmod	14	SENT_18	[p1l1332t1908r1382b1932],
14	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_18	[p1l1391t1908r1525b1938],
15	in	IN	O	in	_	0	SENT_18	[p1l1533t1908r1557b1932],
16	the	DT	O	the	det	18	SENT_18	[p1l1566t1908r1608b1932],
17	biggest	JJS	O	biggest	amod	18	SENT_18	[p1l1616t1908r1709b1938],
18	subgroup	NN	O	subgroup	prep_in	14	SENT_18	[p1l1718t1908r1839b1938],
19	of	IN	O	of	_	0	SENT_18	[p1l1848t1908r1876b1932],
20	patients	NNS	O	patient	prep_of	18	SENT_18	[p1l1882t1908r1984b1938],
21	treated	VBN	O	treat	partmod	20	SENT_18	[p1l1993t1908r2085b1932],
22	with	IN	O	with	_	0	SENT_18	[p1l2094t1908r2154b1932],
23	gliclazide	NN	O	gliclazide	nn	25	SENT_18	[p1l6t1947r126b1977],
24	(	NN	O	(	nn	25	SENT_18	[p1l139t1947r166b1977],
25	n	NN	O	n	prep_with	21	SENT_18	[p1l139t1947r166b1977],
26	=	JJ	O	=	amod	25	SENT_18	[p1l172t1957r196b1966],
27	55	CD	NUMBER	55	num	28	SENT_18	[p1l203t1947r253b1977],
28	)	NN	O	)	dep	26	SENT_18	[p1l203t1947r253b1977],
29	.	.	O	.	_	0	SENT_18	[p1l203t1947r253b1977],

1	Conclusions	NNS	O	conclusion	_	0	SENT_19	[p1l6t1986r159b2011],
2	:	:	O	:	_	0	SENT_19	[p1l6t1986r159b2011],
3	Carriers	NNS	O	carrier	dep	1	SENT_19	[p1l174t1987r273b2011],
4	of	IN	O	of	_	0	SENT_19	[p1l288t1986r315b2011],
5	the	DT	O	the	det	6	SENT_19	[p1l321t1986r362b2011],
6	KCNj1	NN	O	kcnj1	prep_of	3	SENT_19	[p1l377t1988r451b2017],
7	1	CD	NUMBER	1	num	6	SENT_19	[p1l463t1988r471b2011],
8	I	PRP	O	I	dep	6	SENT_19	[p1l489t1986r585b2011],
9	(	SYM	O	(	dep	3	SENT_19	[p1l489t1986r585b2011],
10	-	:	O	-	_	0	SENT_19	[p1l489t1986r585b2011],
11	allele	NN	O	allele	nsubj	12	SENT_19	[p1l489t1986r585b2011],
12	have	VBP	O	have	dep	3	SENT_19	[p1l601t1986r661b2011],
13	better	JJR	O	better	amod	15	SENT_19	[p1l675t1986r753b2011],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_19	[p1l766t1986r915b2017],
15	response	NN	O	response	dobj	12	SENT_19	[p1l929t1993r1044b2017],
16	to	TO	O	to	_	0	SENT_19	[p1l1058t1990r1083b2011],
17	gliclazide	NN	O	gliclazide	prep_to	15	SENT_19	[p1l1098t1986r1224b2017],
18	.	.	O	.	_	0	SENT_19	[p1l1098t1986r1224b2017],

1	This	DT	O	this	det	2	SENT_20	[p1l1237t1986r1290b2011],
2	observation	NN	O	observation	nsubj	4	SENT_20	[p1l1305t1986r1456b2011],
3	might	MD	O	might	aux	4	SENT_20	[p1l1471t1986r1548b2017],
4	help	VB	O	help	_	0	SENT_20	[p1l1561t1986r1617b2017],
5	to	TO	O	to	aux	6	SENT_20	[p1l1632t1990r1657b2011],
6	identify	VB	O	identify	xcomp	4	SENT_20	[p1l1672t1986r1771b2017],
7	patients	NNS	O	patient	dobj	6	SENT_20	[p1l1785t1986r1888b2017],
8	who	WP	O	who	nsubj	10	SENT_20	[p1l1902t1986r1960b2011],
9	will	MD	O	will	aux	10	SENT_20	[p1l1975t1986r2023b2010],
10	have	VB	O	have	rcmod	7	SENT_20	[p1l2037t1986r2098b2011],
11	the	DT	O	the	det	13	SENT_20	[p1l2113t1986r2154b2011],
12	highest	JJS	O	highest	amod	13	SENT_20	[p1l1574t2026r1669b2056],
13	beneﬁt	NN	O	beneﬁt	dobj	10	SENT_20	[p1l1678t2026r1769b2050],
14	from	IN	O	from	_	0	SENT_20	[p1l1778t2026r1840b2050],
15	sulfonylurea	NN	O	sulfonylurea	nn	16	SENT_20	[p1l1850t2026r2010b2056],
16	treatment	NN	O	treatment	prep_from	13	SENT_20	[p1l2019t2030r2154b2050],
17	.	.	O	.	_	0	SENT_20	[p1l2019t2030r2154b2050],

1	©	RB	O	©	_	0	SENT_21	[p1l6t2069r42b2105],
2	2011	CD	DATE	2011	tmod	1	SENT_21	[p1l59t2068r162b2105],
3	European	JJ	ORGANIZATION	european	amod	1	SENT_21	[p1l186t2068r395b2115],
4	Federation	NNP	ORGANIZATION	Federation	dep	1	SENT_21	[p1l413t2066r648b2105],
5	of	IN	ORGANIZATION	of	_	0	SENT_21	[p1l666t2066r712b2105],
6	Internal	NNP	ORGANIZATION	Internal	nn	7	SENT_21	[p1l724t2066r896b2105],
7	Medicine	NNP	ORGANIZATION	Medicine	prep_of	4	SENT_21	[p1l915t2066r1127b2106],
8	.	.	O	.	_	0	SENT_21	[p1l915t2066r1127b2106],

1	Published	VBN	O	publish	csubj	7	SENT_22	[p1l1147t2066r1360b2105],
2	by	IN	O	by	_	0	SENT_22	[p1l1379t2066r1432b2115],
3	Elsevier	NNP	PERSON	Elsevier	nn	6	SENT_22	[p1l1449t2066r1621b2105],
4	B.V.	NNP	O	B.V.	nn	6	SENT_22	[p1l1638t2068r1717b2106],
5	All	NNP	O	All	nn	6	SENT_22	[p1l1734t2066r1792b2105],
6	rights	NNS	O	rights	prep_by	1	SENT_22	[p1l1811t2066r1936b2115],
7	reserved	VBD	O	reserve	_	0	SENT_22	[p1l1955t2066r2154b2106],
8	.	.	O	.	_	0	SENT_22	[p1l1955t2066r2154b2106],

1	1	LS	NUMBER	1	_	0	SENT_23	[p1l11t2352r59b2402],
2	.	.	O	.	_	0	SENT_23	[p1l11t2352r59b2402],

1	Introduction	NN	O	introduction	_	0	SENT_24	[p1l82t2349r478b2402],

1	Type	NN	O	type	nsubj	6	SENT_25	[p1l105t2523r244b2585],
2	2	CD	NUMBER	2	num	3	SENT_25	[p1l263t2523r295b2572],
3	diabetes	NN	O	diabetes	dep	1	SENT_25	[p1l316t2520r553b2572],
4	is	VBZ	O	be	cop	6	SENT_25	[p1l573t2521r615b2572],
5	a	DT	O	a	det	6	SENT_25	[p1l635t2535r664b2572],
6	disorder	NN	O	disorder	_	0	SENT_25	[p1l683t2520r923b2572],
7	characterized	VBN	O	characterize	partmod	6	SENT_25	[p1l940t2520r1326b2572],
8	by	IN	O	by	_	0	SENT_25	[p1l1345t2520r1416b2585],
9	both	DT	O	both	preconj	12	SENT_25	[p1l1432t2520r1563b2572],
10	impaired	JJ	O	impaired	amod	12	SENT_25	[p1l1582t2520r1840b2585],
11	insulin	NN	O	insulin	nn	12	SENT_25	[p1l1860t2520r2053b2572],
12	secretion	NN	O	secretion	agent	7	SENT_25	[p1l11t2605r270b2657],
13	and	CC	O	and	_	0	SENT_25	[p1l289t2604r394b2657],
14	insulin	NN	O	insulin	nn	16	SENT_25	[p1l414t2604r607b2657],
15	sensitivity	NN	O	sensitivity	nn	16	SENT_25	[p1l627t2605r921b2670],
16	[	NN	O	[	conj_and	12	SENT_25	[p1l940t2604r1028b2670],
17	1	CD	NUMBER	1	num	18	SENT_25	[p1l940t2604r1028b2670],
18	]	NN	O	]	dep	12	SENT_25	[p1l940t2604r1028b2670],
19	.	.	O	.	_	0	SENT_25	[p1l940t2604r1028b2670],

1	Sulfonylurea	NNP	O	Sulfonylurea	nn	2	SENT_26	[p1l1048t2604r1410b2670],
2	derivatives	NNS	O	derivative	nsubjpass	6	SENT_26	[p1l1429t2604r1741b2657],
3	have	VBP	O	have	aux	6	SENT_26	[p1l1762t2604r1897b2657],
4	been	VBN	O	be	auxpass	6	SENT_26	[p1l1915t2604r2052b2656],
5	widely	RB	O	widely	advmod	6	SENT_26	[p1l8t2689r204b2755],
6	prescribed	VBN	O	prescribe	_	0	SENT_26	[p1l235t2689r535b2755],
7	oral	JJ	O	oral	amod	9	SENT_26	[p1l569t2689r677b2741],
8	antidiabetic	JJ	O	antidiabetic	amod	9	SENT_26	[p1l709t2689r1047b2742],
9	drugs	NNS	O	drug	dobj	6	SENT_26	[p1l1078t2689r1237b2755],
10	over	IN	O	over	_	0	SENT_26	[p1l1271t2705r1398b2742],
11	the	DT	DATE	the	det	14	SENT_26	[p1l1428t2689r1519b2741],
12	last	JJ	DATE	last	amod	14	SENT_26	[p1l1552t2689r1651b2741],
13	half	JJ	DATE	half	amod	14	SENT_26	[p1l1682t2689r1795b2742],
14	century	NN	DATE	century	prep_over	9	SENT_26	[p1l1820t2697r2052b2755],
15	.	.	O	.	_	0	SENT_26	[p1l1820t2697r2052b2755],

1	While	IN	O	while	mark	5	SENT_27	[p1l7t2775r180b2827],
2	sulfonylureas	NNS	O	sulfonylurea	nsubjpass	5	SENT_27	[p1l198t2774r580b2840],
3	were	VBD	O	be	auxpass	5	SENT_27	[p1l595t2790r740b2827],
4	frequently	RB	O	frequently	advmod	5	SENT_27	[p1l756t2774r1055b2840],
5	prescribed	VBN	O	prescribe	advcl	22	SENT_27	[p1l1069t2775r1370b2840],
6	as	IN	O	as	_	0	SENT_27	[p1l1387t2790r1444b2827],
7	a	DT	O	a	det	9	SENT_27	[p1l1459t2790r1489b2827],
8	ﬁrst-line	JJ	O	ﬁrst-line	amod	9	SENT_27	[p1l1505t2774r1750b2827],
9	treatment	NN	O	treatment	prep_as	5	SENT_27	[p1l1766t2783r2054b2827],
10	of	IN	O	of	_	0	SENT_27	[p1l10t2859r70b2912],
11	type	NN	O	type	nn	13	SENT_27	[p1l83t2867r209b2925],
12	2	CD	NUMBER	2	num	13	SENT_27	[p1l230t2862r261b2911],
13	diabetes	NN	O	diabetes	prep_of	9	SENT_27	[p1l285t2859r523b2912],
14	in	IN	O	in	_	0	SENT_27	[p1l545t2860r598b2911],
15	the	DT	DATE	the	det	16	SENT_27	[p1l619t2859r711b2912],
16	past	NN	DATE	past	prep_in	5	SENT_27	[p1l733t2867r863b2925],
17	,	,	O	,	_	0	SENT_27	[p1l733t2867r863b2925],
18	the	DT	O	the	det	21	SENT_27	[p1l885t2859r976b2912],
19	present	JJ	DATE	present	amod	21	SENT_27	[p1l998t2867r1215b2925],
20	international	JJ	O	international	amod	21	SENT_27	[p1l1235t2859r1605b2912],
21	guidelines	NNS	O	guideline	nsubj	22	SENT_27	[p1l1626t2859r1920b2925],
22	recommend	VBP	O	recommend	_	0	SENT_27	[p1l1942t2875r2052b2912, p1l10t2945r268b2997],
23	sulfonylureas	NNS	O	sulfonylurea	dobj	22	SENT_27	[p1l288t2945r670b3010],
24	as	IN	O	as	_	0	SENT_27	[p1l688t2960r744b2997],
25	an	DT	O	a	det	27	SENT_27	[p1l762t2960r831b2997],
26	add-on	JJ	O	add-on	amod	27	SENT_27	[p1l847t2945r1052b2997],
27	therapy	NN	O	therapy	prep_as	23	SENT_27	[p1l1069t2945r1292b3010],
28	after	IN	O	after	_	0	SENT_27	[p1l1308t2945r1442b2997],
29	lifestyle	NN	O	lifestyle	nn	30	SENT_27	[p1l1457t2945r1679b3010],
30	intervention	NN	O	intervention	prep_after	27	SENT_27	[p1l1698t2946r2053b2997],
31	and	CC	O	and	_	0	SENT_27	[p1l10t3030r114b3082],
32	metformin	NN	O	metformin	prep_after	27	SENT_27	[p1l144t3030r451b3082],
33	monotherapy	JJ	O	monotherapy	amod	35	SENT_27	[p1l480t3030r871b3095],
34	failure	NN	O	failure	nn	35	SENT_27	[p1l898t3030r1079b3082],
35	[	NN	O	[	tmod	22	SENT_27	[p1l1111t3030r1198b3095],
36	2	CD	NUMBER	2	num	37	SENT_27	[p1l1111t3030r1198b3095],
37	]	NN	O	]	dep	35	SENT_27	[p1l1111t3030r1198b3095],
38	.	.	O	.	_	0	SENT_27	[p1l1111t3030r1198b3095],

1	Considerable	JJ	O	considerable	amod	3	SENT_28	[p1l1228t3030r1598b3082],
2	interindividual	JJ	O	interindividual	amod	3	SENT_28	[p1l1627t3030r2052b3082],
3	variability	NN	O	variability	nsubjpass	8	SENT_28	[p1l8t3114r299b3180],
4	to	TO	O	to	_	0	SENT_28	[p1l319t3122r374b3167],
5	sulfonylurea	NN	O	sulfonylurea	nn	6	SENT_28	[p1l397t3114r754b3180],
6	therapy	NN	O	therapy	prep_to	3	SENT_28	[p1l774t3114r997b3180],
7	was	VBD	O	be	auxpass	8	SENT_28	[p1l1016t3130r1129b3167],
8	described	VBN	O	describe	_	0	SENT_28	[p1l1151t3114r1426b3167],
9	in	IN	O	in	_	0	SENT_28	[p1l1449t3115r1501b3166],
10	patients	NNS	O	patient	prep_in	8	SENT_28	[p1l1524t3115r1752b3180],
11	with	IN	O	with	_	0	SENT_28	[p1l1773t3114r1906b3166],
12	type	NN	O	type	nn	14	SENT_28	[p1l1928t3122r2053b3180],
13	2	CD	NUMBER	2	num	14	SENT_28	[p1l10t3202r41b3251],
14	diabetes	NN	O	diabetes	prep_with	10	SENT_28	[p1l82t3199r319b3251],
15	and	CC	O	and	_	0	SENT_28	[p1l358t3199r463b3251],
16	it	PRP	O	it	nsubjpass	23	SENT_28	[p1l503t3200r542b3251],
17	can	MD	O	can	aux	23	SENT_28	[p1l579t3214r676b3251],
18	be	VB	O	be	auxpass	23	SENT_28	[p1l714t3199r781b3251],
19	at	IN	O	at	advmod	23	SENT_28	[p1l820t3207r874b3251],
20	least	JJS	O	least	pobj	19	SENT_28	[p1l911t3199r1043b3251],
21	partially	RB	O	partially	advmod	19	SENT_28	[p1l1080t3199r1318b3265],
22	genetically	RB	O	genetically	advmod	19	SENT_28	[p1l1354t3199r1666b3265],
23	determined	VBN	O	determine	conj_and	8	SENT_28	[p1l1704t3199r2052b3252],
24	.	.	O	.	_	0	SENT_28	[p1l1704t3199r2052b3252],

1	Genes	NNS	O	gene	nsubjpass	16	SENT_29	[p1l10t3287r182b3337],
2	implicated	VBN	O	implicate	partmod	1	SENT_29	[p1l202t3284r504b3350],
3	in	IN	O	in	_	0	SENT_29	[p1l523t3285r577b3336],
4	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	2	SENT_29	[p1l594t3284r1103b3350],
5	[	CD	NUMBER	[	number	6	SENT_29	[p1l1125t3284r1196b3350],
6	3	CD	NUMBER	3	num	7	SENT_29	[p1l1125t3284r1196b3350],
7	]	NN	O	]	dep	4	SENT_29	[p1l1125t3284r1196b3350],
8	or	CC	O	or	_	0	SENT_29	[p1l1218t3300r1278b3337],
9	pharmacodynamics	NNS	O	pharmacodynamic	prep_in	2	SENT_29	[p1l1294t3284r1858b3350],
10	of	IN	O	of	_	0	SENT_29	[p1l1877t3284r1936b3337],
11	sulfonylureas	NN	O	sulfonylurea	prep_of	9	SENT_29	[p1l1947t3284r2052b3337, p1l10t3369r310b3435],
12	[	CD	NUMBER	[	number	13	SENT_29	[p1l337t3369r458b3435],
13	4,5	CD	NUMBER	4,5	num	14	SENT_29	[p1l337t3369r458b3435],
14	]	NN	O	]	dep	9	SENT_29	[p1l337t3369r458b3435],
15	were	VBD	O	be	auxpass	16	SENT_29	[p1l483t3385r627b3422],
16	reported	VBN	O	report	_	0	SENT_29	[p1l652t3369r899b3435],
17	to	TO	O	to	aux	18	SENT_29	[p1l922t3377r978b3422],
18	explain	VB	O	explain	xcomp	16	SENT_29	[p1l1002t3369r1211b3435],
19	at	IN	O	at	advmod	22	SENT_29	[p1l1235t3377r1289b3422],
20	least	JJS	O	least	pobj	19	SENT_29	[p1l1310t3370r1442b3422],
21	a	DT	O	a	det	22	SENT_29	[p1l1464t3385r1494b3422],
22	part	NN	O	part	dobj	18	SENT_29	[p1l1517t3377r1634b3435],
23	of	IN	O	of	_	0	SENT_29	[p1l1656t3369r1716b3422],
24	the	DT	O	the	det	26	SENT_29	[p1l1731t3369r1822b3422],
25	genetic	JJ	O	genetic	amod	26	SENT_29	[p1l1845t3370r2053b3435],
26	variability	NN	O	variability	prep_of	22	SENT_29	[p1l8t3455r299b3520],
27	of	IN	O	of	_	0	SENT_29	[p1l318t3455r379b3507],
28	the	DT	O	the	det	29	SENT_29	[p1l391t3455r482b3507],
29	response	NN	O	response	prep_of	26	SENT_29	[p1l504t3470r759b3520],
30	to	TO	O	to	_	0	SENT_29	[p1l779t3463r835b3507],
31	sulfonylureas	NNS	O	sulfonylurea	prep_to	18	SENT_29	[p1l857t3455r1252b3520],
32	.	.	O	.	_	0	SENT_29	[p1l857t3455r1252b3520],

1	Sulfonylureas	NNP	O	Sulfonylureas	nsubj	4	SENT_30	[p1l108t3540r504b3605],
2	are	VBP	O	be	cop	4	SENT_30	[p1l543t3555r632b3592],
3	insulin	NN	O	insulin	nn	4	SENT_30	[p1l670t3540r868b3592],
4	secretagogues	NNS	O	secretagogue	_	0	SENT_30	[p1l905t3548r1316b3605],
5	which	WDT	O	which	nsubj	6	SENT_30	[p1l1353t3540r1534b3592],
6	act	VBP	O	act	rcmod	4	SENT_30	[p1l1572t3548r1657b3592],
7	by	IN	O	by	_	0	SENT_30	[p1l1692t3540r1762b3605],
8	inducing	VBG	O	induce	prepc_by	6	SENT_30	[p1l1799t3540r2054b3605],
9	closure	NN	O	closure	nsubj	20	SENT_30	[p1l10t3624r218b3677],
10	of	IN	O	of	_	0	SENT_30	[p1l237t3624r298b3676],
11	the	DT	O	the	det	13	SENT_30	[p1l308t3624r401b3677],
12	KATP	NN	ORGANIZATION	katp	nn	13	SENT_30	[p1l420t3628r545b3687],
13	channels	NNS	O	channel	prep_of	9	SENT_30	[p1l562t3624r820b3677],
14	in	IN	O	in	_	0	SENT_30	[p1l839t3625r893b3676],
15	pancreatic	JJ	O	pancreatic	amod	19	SENT_30	[p1l911t3625r1216b3690],
16	[	NN	O	[	nn	19	SENT_30	[p1l1233t3624r1426b3689],
17	3	CD	NUMBER	3	num	19	SENT_30	[p1l1233t3624r1426b3689],
18	—	NN	O	—	nn	19	SENT_30	[p1l1233t3624r1426b3689],
19	cells	NNS	O	cell	prep_in	13	SENT_30	[p1l1233t3624r1426b3689],
20	[	VBP	O	[	ccomp	8	SENT_30	[p1l1448t3624r1538b3690],
21	6	CD	NUMBER	6	num	22	SENT_30	[p1l1448t3624r1538b3690],
22	]	NN	O	]	dobj	20	SENT_30	[p1l1448t3624r1538b3690],
23	.	.	O	.	_	0	SENT_30	[p1l1448t3624r1538b3690],

1	The	DT	O	the	det	5	SENT_31	[p1l1555t3624r1662b3676],
2	I	PRP	O	I	npadvmod	3	SENT_31	[p1l1681t3628r1806b3687],
3	<	JJR	O	<	amod	5	SENT_31	[p1l1681t3628r1806b3687],
4	ATp	NN	O	atp	nn	5	SENT_31	[p1l1681t3628r1806b3687],
5	channel	NN	O	channel	nsubjpass	7	SENT_31	[p1l1823t3624r2053b3676],
6	is	VBZ	O	be	auxpass	7	SENT_31	[p1l10t3710r52b3762],
7	composed	VBN	O	compose	_	0	SENT_31	[p1l74t3710r371b3775],
8	by	IN	O	by	_	0	SENT_31	[p1l392t3710r462b3775],
9	four	CD	NUMBER	four	num	10	SENT_31	[p1l482t3709r602b3762],
10	pore	NN	O	pore	agent	7	SENT_31	[p1l621t3725r751b3775],
11	forming	VBG	O	form	xcomp	7	SENT_31	[p1l773t3709r1006b3775],
12	I	PRP	O	I	nsubj	13	SENT_31	[p1l1026t3710r1196b3762],
13	(	VBP	O	(	ccomp	11	SENT_31	[p1l1026t3710r1196b3762],
14	ir6	JJ	O	ir6	amod	16	SENT_31	[p1l1026t3710r1196b3762],
15	.2	NN	NUMBER	.2	nn	16	SENT_31	[p1l1026t3710r1196b3762],
16	subunits	NNS	O	subunit	dobj	13	SENT_31	[p1l1219t3710r1466b3762],
17	encoded	VBN	O	encode	partmod	16	SENT_31	[p1l1488t3710r1734b3762],
18	by	IN	O	by	_	0	SENT_31	[p1l1755t3710r1825b3775],
19	KCNj11	NN	O	kcnj11	agent	17	SENT_31	[p1l1842t3712r2046b3775],

1	gene	NN	O	gene	_	0	SENT_32	[p2l9t32r162b82],
2	.	.	O	.	_	0	SENT_32	[p2l9t32r162b82],

1	External	JJ	O	external	amod	2	SENT_33	[p2l186t17r428b69],
2	part	NN	O	part	nsubjpass	7	SENT_33	[p2l451t25r570b82],
3	of	IN	O	of	_	0	SENT_33	[p2l592t16r653b69],
4	the	DT	O	the	det	5	SENT_33	[p2l668t17r761b69],
5	channel	NN	O	channel	prep_of	2	SENT_33	[p2l784t17r1014b69],
6	is	VBZ	O	be	auxpass	7	SENT_33	[p2l1037t17r1079b69],
7	constituted	VBN	O	constitute	_	0	SENT_33	[p2l1103t17r1433b69],
8	by	IN	O	by	_	0	SENT_33	[p2l1456t17r1527b82],
9	four	CD	NUMBER	four	num	10	SENT_33	[p2l1548t16r1668b69],
10	sulfonylurea	NN	O	sulfonylurea	agent	7	SENT_33	[p2l1689t16r2053b82],

1	*	NN	O	*	_	0	SENT_34	[p2l52t281r74b306],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_34	[p2l107t281r454b333],
3	author	NN	O	author	dobj	2	SENT_34	[p2l471t281r628b323],
4	at	IN	O	at	_	0	SENT_34	[p2l643t287r700b323],
5	:	:	O	:	_	0	SENT_34	[p2l643t287r700b323],
6	Department	NNP	ORGANIZATION	Department	prep_at	2	SENT_34	[p2l721t284r1006b333],
7	of	IN	ORGANIZATION	of	_	0	SENT_34	[p2l1022t281r1071b323],
8	Internal	NNP	ORGANIZATION	Internal	nn	9	SENT_34	[p2l1082t281r1266b323],
9	Medicine	NNP	ORGANIZATION	Medicine	prep_of	6	SENT_34	[p2l1284t281r1499b323],
10	4	CD	NUMBER	4	num	9	SENT_34	[p2l1516t283r1555b329],
11	,	,	O	,	_	0	SENT_34	[p2l1516t283r1555b329],
12	L.	NNP	ORGANIZATION	L.	nn	15	SENT_34	[p2l1573t284r1607b323],
13	Pasteur	NNP	ORGANIZATION	Pasteur	nn	15	SENT_34	[p2l1625t284r1799b323],
14	University	NNP	ORGANIZATION	University	nn	15	SENT_34	[p2l1815t282r2058b333],
15	Hospital	NNP	ORGANIZATION	Hospital	appos	6	SENT_34	[p2l10t350r214b403],
16	,	,	O	,	_	0	SENT_34	[p2l10t350r214b403],
17	Rastislavova	NNP	PERSON	Rastislavova	appos	6	SENT_34	[p2l236t350r525b392],
18	43	CD	NUMBER	43	num	17	SENT_34	[p2l543t352r612b398],
19	,	,	O	,	_	0	SENT_34	[p2l543t352r612b398],
20	04190	CD	NUMBER	04190	num	17	SENT_34	[p2l634t352r779b392],
21	Kosice	NNP	LOCATION	Kosice	nn	23	SENT_34	[p2l800t351r960b399],
22	,	,	O	,	_	0	SENT_34	[p2l800t351r960b399],
23	Slovakia	NNP	LOCATION	Slovakia	dep	17	SENT_34	[p2l982t350r1186b392],
24	.	.	O	.	_	0	SENT_34	[p2l982t350r1186b392],

1	Te1.	NNP	O	Te1.	_	0	SENT_35	[p2l1206t350r1302b392],
2	:	:	O	:	_	0	SENT_35	[p2l1206t350r1302b392],
3	+421 55 6152230	CD	NUMBER	+421 55 6152230	dep	1	SENT_35	[p2l1565t352r1784b399],[p2l1330t352r1461b395],
4	;	:	O	;	_	0	SENT_35	[p2l1565t352r1784b399],
5	fax	NN	O	fax	dep	1	SENT_35	[p2l1809t350r1891b392],
6	:	:	O	:	_	0	SENT_35	[p2l1809t350r1891b392],
7	+421 55 6152249	CD	NUMBER	+421 55 6152249	dep	5	SENT_35	[p2l85t427r301b467],[p2l1920t352r2051b395],
8	.	.	O	.	_	0	SENT_35	[p2l85t427r301b467],

1	E	NN	O	e	nn	4	SENT_36	[p2l105t494r254b536],
2	—	CD	NUMBER	—	num	4	SENT_36	[p2l105t494r254b536],
3	mail	NN	O	mail	nn	4	SENT_36	[p2l105t494r254b536],
4	address	NN	O	address	_	0	SENT_36	[p2l272t494r456b536],
5	:	:	O	:	_	0	SENT_36	[p2l272t494r456b536],
6	Ivan.Tkac@UP]S.sk	NN	O	ivan.tkac@up]s.sk	nn	8	SENT_36	[p2l477t494r909b546],
7	(	CD	NUMBER	(	num	8	SENT_36	[p2l931t494r974b546],
8	I.	NN	O	i.	dep	4	SENT_36	[p2l931t494r974b546],
9	Tkac	NNP	O	Tkac	dep	8	SENT_36	[p2l992t494r1133b546],
10	)	CD	NUMBER	)	num	9	SENT_36	[p2l992t494r1133b546],
11	.	.	O	.	_	0	SENT_36	[p2l992t494r1133b546],

1	receptor	NN	O	receptor	nsubj	7	SENT_37	[p2l51t857r305b916],
2	1	CD	NUMBER	1	num	6	SENT_37	[p2l335t852r358b902],
3	(	CD	NUMBER	(	num	6	SENT_37	[p2l399t849r606b916],
4	SUR1	NN	O	sur1	nn	6	SENT_37	[p2l399t849r606b916],
5	)	CD	NUMBER	)	num	6	SENT_37	[p2l399t849r606b916],
6	subunits	NNS	O	subunit	dep	1	SENT_37	[p2l640t849r893b903],
7	encoded	VBN	O	encode	_	0	SENT_37	[p2l923t849r1176b903],
8	by	IN	O	by	_	0	SENT_37	[p2l1204t849r1277b916],
9	ATP-binding	JJ	ORGANIZATION	atp-binding	amod	11	SENT_37	[p2l1301t849r1679b916],
10	cassette	NN	O	cassette	nn	11	SENT_37	[p2l1706t857r1943b903],
11	transporter	NN	O	transporter	prep_by	7	SENT_37	[p2l1971t857r2149b903, p2l51t944r251b1002],
12	,	,	O	,	_	0	SENT_37	[p2l1971t857r2149b903, p2l51t944r251b1002],
13	subfamily	NN	O	subfamily	nn	14	SENT_37	[p2l277t936r572b1002],
14	C	NN	O	c	appos	11	SENT_37	[p2l595t939r644b997],
15	,	,	O	,	_	0	SENT_37	[p2l595t939r644b997],
16	member	NN	O	member	appos	14	SENT_37	[p2l670t936r924b989],
17	8	CD	NUMBER	8	number	18	SENT_37	[p2l947t939r978b989],
18	(	CD	NUMBER	(	num	22	SENT_37	[p2l1008t936r1246b1002],
19	ABCC8	NN	O	abcc8	nn	22	SENT_37	[p2l1008t936r1246b1002],
20	)	NN	O	)	nn	22	SENT_37	[p2l1008t936r1246b1002],
21	gene	NN	O	gene	nn	22	SENT_37	[p2l1273t951r1415b1002],
22	[	NN	O	[	dep	16	SENT_37	[p2l1443t936r1536b1002],
23	7	CD	NUMBER	7	num	24	SENT_37	[p2l1443t936r1536b1002],
24	]	NN	O	]	dep	16	SENT_37	[p2l1443t936r1536b1002],
25	.	.	O	.	_	0	SENT_37	[p2l1443t936r1536b1002],

1	Closure	NN	O	closure	nsubj	24	SENT_38	[p2l152t1022r369b1075],
2	of	IN	O	of	_	0	SENT_38	[p2l387t1022r448b1075],
3	the	DT	O	the	det	8	SENT_38	[p2l457t1022r550b1075],
4	[	CD	NUMBER	[	number	5	SENT_38	[p2l568t1025r695b1086],
5	(	CD	NUMBER	(	num	8	SENT_38	[p2l568t1025r695b1086],
6	AT1	NN	O	at1	nn	8	SENT_38	[p2l568t1025r695b1086],
7	)	NN	O	)	nn	8	SENT_38	[p2l568t1025r695b1086],
8	channel	NN	O	channel	prep_of	1	SENT_38	[p2l710t1022r941b1075],
9	plays	VBZ	O	play	rcmod	8	SENT_38	[p2l959t1022r1108b1088],
10	a	DT	O	a	det	12	SENT_38	[p2l1126t1037r1156b1075],
11	critical	JJ	O	critical	amod	12	SENT_38	[p2l1173t1022r1369b1075],
12	role	NN	O	role	nsubj	16	SENT_38	[p2l1386t1022r1498b1075],
13	in	IN	O	in	_	0	SENT_38	[p2l1516t1023r1570b1074],
14	glucose	NN	O	glucose	nn	15	SENT_38	[p2l1586t1022r2150b1088],
15	—	NN	O	—	prep_in	12	SENT_38	[p2l1586t1022r2150b1088],
16	stimulated	VBD	O	stimulate	ccomp	9	SENT_38	[p2l1586t1022r2150b1088],
17	insulin	NN	O	insulin	nn	18	SENT_38	[p2l51t1107r250b1160],
18	secretion	NN	O	secretion	dobj	16	SENT_38	[p2l275t1108r542b1160],
19	by	IN	O	by	_	0	SENT_38	[p2l566t1107r638b1174],
20	pancreatic	JJ	O	pancreatic	amod	23	SENT_38	[p2l661t1108r966b1174],
21	B	NN	O	b	nn	23	SENT_38	[p2l990t1107r1180b1160],
22	—	NN	O	—	nn	23	SENT_38	[p2l990t1107r1180b1160],
23	cells	NNS	O	cell	prep_by	16	SENT_38	[p2l990t1107r1180b1160],
24	[	VBP	O	[	_	0	SENT_38	[p2l1209t1107r1299b1174],
25	8	CD	NUMBER	8	number	26	SENT_38	[p2l1209t1107r1299b1174],
26	]	CD	NUMBER	]	dobj	24	SENT_38	[p2l1209t1107r1299b1174],
27	.	.	O	.	_	0	SENT_38	[p2l1209t1107r1299b1174],

1	Non-synonymous	JJ	O	non-synonymous	amod	3	SENT_39	[p2l1325t1111r1850b1174],
2	polymorphism	NN	O	polymorphism	nn	3	SENT_39	[p2l1874t1107r2149b1174, p2l51t1193r235b1260],
3	E23K	NN	O	e23k	nsubj	7	SENT_39	[p2l265t1196r417b1246],
4	(	CD	NUMBER	(	num	6	SENT_39	[p2l451t1193r701b1259],
5	rs5219	NN	O	rs5219	nn	6	SENT_39	[p2l451t1193r701b1259],
6	)	NN	O	)	dep	3	SENT_39	[p2l451t1193r701b1259],
7	causes	VBZ	O	cause	_	0	SENT_39	[p2l737t1209r926b1246],
8	substitution	NN	O	substitution	dobj	7	SENT_39	[p2l959t1193r1310b1246],
9	of	IN	O	of	_	0	SENT_39	[p2l1342t1193r1403b1246],
10	glutamate	JJ	O	glutamate	amod	12	SENT_39	[p2l1426t1193r1724b1260],
11	(	NN	O	(	nn	12	SENT_39	[p2l1760t1193r1842b1260],
12	E	NN	O	e	prep_of	8	SENT_39	[p2l1760t1193r1842b1260],
13	)	CD	NUMBER	)	dep	17	SENT_39	[p2l1760t1193r1842b1260],
14	by	IN	O	by	_	0	SENT_39	[p2l1877t1193r1949b1260],
15	lysine	NN	O	lysine	prep_by	13	SENT_39	[p2l1979t1193r2149b1260],
16	(	CD	NUMBER	(	dep	17	SENT_39	[p2l55t1280r143b1346],
17	K	NNP	O	K	dep	8	SENT_39	[p2l55t1280r143b1346],
18	)	CD	NUMBER	)	num	17	SENT_39	[p2l55t1280r143b1346],
19	in	IN	O	in	_	0	SENT_39	[p2l171t1280r225b1332],
20	Kir6	NN	O	kir6	nn	22	SENT_39	[p2l248t1280r419b1333],
21	.2	NN	NUMBER	.2	nn	22	SENT_39	[p2l248t1280r419b1333],
22	protein	NN	O	protein	prep_in	17	SENT_39	[p2l444t1280r671b1346],
23	.	.	O	.	_	0	SENT_39	[p2l444t1280r671b1346],

1	It	PRP	O	it	nsubjpass	3	SENT_40	[p2l695t1283r737b1333],
2	was	VBD	O	be	auxpass	3	SENT_40	[p2l755t1295r870b1333],
3	associated	VBN	O	associate	_	0	SENT_40	[p2l894t1279r1195b1333],
4	with	IN	O	with	_	0	SENT_40	[p2l1217t1280r1354b1333],
5	the	DT	O	the	det	6	SENT_40	[p2l1375t1280r1469b1333],
6	risk	NN	O	risk	prep_with	3	SENT_40	[p2l1492t1280r1600b1333],
7	of	IN	O	of	_	0	SENT_40	[p2l1621t1279r1683b1333],
8	type	NN	O	type	nn	10	SENT_40	[p2l1697t1288r1826b1346],
9	2	CD	NUMBER	2	num	10	SENT_40	[p2l1848t1282r1881b1332],
10	diabetes	NN	O	diabetes	prep_of	6	SENT_40	[p2l1905t1280r2148b1333],
11	in	IN	O	in	_	0	SENT_40	[p2l51t1366r106b1418],
12	Caucasian	JJ	LOCATION	caucasian	amod	13	SENT_40	[p2l130t1366r421b1419],
13	population	NN	O	population	prep_in	3	SENT_40	[p2l445t1365r765b1432],
14	based	VBN	O	base	partmod	13	SENT_40	[p2l788t1365r956b1419],
15	on	IN	O	on	_	0	SENT_40	[p2l981t1381r1054b1419],
16	the	DT	O	the	det	19	SENT_40	[p2l1077t1365r1171b1419],
17	candidate	NN	O	candidate	nn	19	SENT_40	[p2l1195t1365r1481b1419],
18	gene	NN	O	gene	nn	19	SENT_40	[p2l1505t1381r1645b1432],
19	approach	NN	O	approach	prep_on	14	SENT_40	[p2l1668t1365r1942b1432],
20	[	CD	NUMBER	[	number	21	SENT_40	[p2l1970t1365r2149b1432],
21	9,10	CD	NUMBER	9,10	num	22	SENT_40	[p2l1970t1365r2149b1432],
22	]	NN	O	]	dep	14	SENT_40	[p2l1970t1365r2149b1432],
23	.	.	O	.	_	0	SENT_40	[p2l1970t1365r2149b1432],

1	This	DT	O	this	det	2	SENT_41	[p2l48t1452r169b1505],
2	polymorphism	NN	O	polymorphism	nsubjpass	4	SENT_41	[p2l195t1452r630b1518],
3	was	VBD	O	be	auxpass	4	SENT_41	[p2l653t1467r769b1505],
4	shown	VBN	O	show	_	0	SENT_41	[p2l795t1452r992b1505],
5	to	TO	O	to	aux	6	SENT_41	[p2l1015t1460r1073b1505],
6	be	VB	O	be	xcomp	4	SENT_41	[p2l1097t1452r1166b1505],
7	in	IN	O	in	_	0	SENT_41	[p2l1192t1453r1246b1504],
8	strong	JJ	O	strong	amod	10	SENT_41	[p2l1272t1460r1459b1518],
9	linkage	NN	O	linkage	nn	10	SENT_41	[p2l1483t1452r1694b1518],
10	disequilibrium	NN	O	disequilibrium	prep_in	6	SENT_41	[p2l1720t1452r2150b1518],
11	with	IN	O	with	_	0	SENT_41	[p2l49t1538r186b1591],
12	A1369S	NN	O	a1369	nn	14	SENT_41	[p2l217t1540r442b1591],
13	gene	NN	O	gene	nn	14	SENT_41	[p2l476t1553r616b1604],
14	variant	NN	O	variant	prep_with	10	SENT_41	[p2l649t1539r860b1591],
15	in	IN	O	in	_	0	SENT_41	[p2l892t1539r947b1590],
16	ABCC8	NN	O	abcc8	prep_in	6	SENT_41	[p2l975t1540r1167b1591],
17	[	CD	NUMBER	[	number	18	SENT_41	[p2l1203t1538r1420b1604],
18	10,11	CD	NUMBER	10,11	num	19	SENT_41	[p2l1203t1538r1420b1604],
19	]	NN	O	]	dep	6	SENT_41	[p2l1203t1538r1420b1604],
20	.	.	O	.	_	0	SENT_41	[p2l1203t1538r1420b1604],

1	Risk	NN	O	risk	nn	2	SENT_42	[p2l1456t1538r1578b1591],
2	variant	NN	O	variant	_	0	SENT_42	[p2l1608t1539r1818b1591],
3	of	IN	O	of	_	0	SENT_42	[p2l1850t1538r1912b1591],
4	KCN	NNP	O	KCN	prep_of	2	SENT_42	[p2l1937t1541r2142b1604],
5	]	CD	NUMBER	]	num	4	SENT_42	[p2l1937t1541r2142b1604],
6	11	CD	NUMBER	11	num	7	SENT_42	[p2l1937t1541r2142b1604],
7	gene	NN	O	gene	nsubjpass	9	SENT_42	[p2l50t1639r190b1690],
8	was	VBD	O	be	auxpass	9	SENT_42	[p2l225t1639r340b1676],
9	shown	VBN	O	show	dep	2	SENT_42	[p2l378t1623r574b1676],
10	to	TO	O	to	aux	12	SENT_42	[p2l610t1631r667b1676],
11	be	VB	O	be	auxpass	12	SENT_42	[p2l702t1623r772b1676],
12	associated	VBN	O	associate	xcomp	9	SENT_42	[p2l807t1623r1109b1676],
13	with	IN	O	with	_	0	SENT_42	[p2l1144t1623r1281b1676],
14	decreased	VBN	O	decrease	amod	17	SENT_42	[p2l1316t1623r1609b1676],
15	insulin	NN	O	insulin	nn	17	SENT_42	[p2l1647t1623r1846b1676],
16	secretion	NN	O	secretion	nn	17	SENT_42	[p2l1882t1624r2150b1676],
17	[	NN	O	[	prep_with	12	SENT_42	[p2l54t1709r271b1776],
18	12,13	CD	NUMBER	12,13	num	19	SENT_42	[p2l54t1709r271b1776],
19	]	NN	O	]	dep	17	SENT_42	[p2l54t1709r271b1776],
20	,	,	O	,	_	0	SENT_42	[p2l54t1709r271b1776],
21	and	CC	O	and	_	0	SENT_42	[p2l294t1709r401b1762],
22	therefore	RB	O	therefore	advmod	25	SENT_42	[p2l424t1709r696b1762],
23	this	DT	O	this	det	24	SENT_42	[p2l718t1709r824b1762],
24	gene	NN	O	gene	nsubj	25	SENT_42	[p2l846t1725r986b1776],
25	appears	VBZ	O	appear	conj_and	9	SENT_42	[p2l1008t1725r1237b1776],
26	to	TO	O	to	aux	30	SENT_42	[p2l1259t1717r1316b1762],
27	be	VB	O	be	cop	30	SENT_42	[p2l1338t1709r1407b1762],
28	a	DT	O	a	det	30	SENT_42	[p2l1429t1725r1460b1762],
29	logical	JJ	O	logical	amod	30	SENT_42	[p2l1482t1709r1669b1776],
30	target	NN	O	target	xcomp	25	SENT_42	[p2l1691t1717r1867b1776],
31	for	IN	O	for	_	0	SENT_42	[p2l1887t1709r1969b1762],
32	pharmacogenetic	JJ	O	pharmacogenetic	amod	33	SENT_42	[p2l1989t1709r2149b1776, p2l51t1796r424b1862],
33	studies	NNS	O	study	prep_for	30	SENT_42	[p2l449t1795r654b1849],
34	with	IN	O	with	_	0	SENT_42	[p2l677t1795r814b1849],
35	insulin	NN	O	insulin	nn	36	SENT_42	[p2l839t1795r1037b1849],
36	secretagogues	NNS	O	secretagogue	prep_with	33	SENT_42	[p2l1062t1803r1490b1862],
37	,	,	O	,	_	0	SENT_42	[p2l1062t1803r1490b1862],
38	such	JJ	O	such	_	0	SENT_42	[p2l1516t1795r1649b1849],
39	as	IN	O	as	_	0	SENT_42	[p2l1673t1811r1732b1849],
40	sulfonylureas	NNS	O	sulfonylurea	prep_such_as	2	SENT_42	[p2l1757t1795r2149b1862],
41	or	CC	O	or	_	0	SENT_42	[p2l51t1897r113b1935],
42	meglitinides	NNS	O	meglitinide	conj_or	40	SENT_42	[p2l132t1881r511b1948],
43	.	.	O	.	_	0	SENT_42	[p2l132t1881r511b1948],

1	Pharmacogenetic	JJ	O	pharmacogenetic	amod	2	SENT_43	[p2l152t1968r671b2034],
2	studies	NNS	O	study	nsubj	39	SENT_43	[p2l705t1968r915b2021],
3	that	WDT	O	that	nsubj	4	SENT_43	[p2l950t1968r1071b2021],
4	studied	VBD	O	study	rcmod	2	SENT_43	[p2l1104t1968r1325b2021],
5	the	DT	O	the	det	6	SENT_43	[p2l1359t1968r1454b2021],
6	effect	NN	O	effect	dobj	4	SENT_43	[p2l1488t1968r1654b2021],
7	of	IN	O	of	_	0	SENT_43	[p2l1686t1968r1749b2021],
8	sulfonylurea	NN	O	sulfonylurea	nn	9	SENT_43	[p2l1777t1968r2150b2034],
9	therapy	NN	O	therapy	prep_of	6	SENT_43	[p2l50t2054r285b2120],
10	with	IN	O	with	_	0	SENT_43	[p2l310t2054r450b2107],
11	respect	NN	O	respect	prep_with	4	SENT_43	[p2l479t2062r697b2120],
12	to	TO	O	to	_	0	SENT_43	[p2l724t2062r782b2107],
13	KCN	NNP	O	KCN	prep_to	4	SENT_43	[p2l810t2057r957b2120],
14	]	CD	NUMBER	]	num	13	SENT_43	[p2l810t2057r957b2120],
15	11	CD	NUMBER	11	num	16	SENT_43	[p2l964t2057r1019b2106],
16	genotype	NN	O	genotype	dep	2	SENT_43	[p2l1054t2062r1334b2120],
17	in	IN	O	in	_	0	SENT_43	[p2l1365t2055r1420b2106],
18	type	NN	O	type	nn	20	SENT_43	[p2l1449t2062r1579b2120],
19	2	CD	NUMBER	2	num	20	SENT_43	[p2l1609t2057r1641b2106],
20	diabetes	NN	O	diabetes	prep_in	16	SENT_43	[p2l1673t2054r1937b2115],
21	,	,	O	,	_	0	SENT_43	[p2l1673t2054r1937b2115],
22	tested	VBN	O	test	partmod	16	SENT_43	[p2l1967t2054r2149b2107],
23	the	DT	O	the	det	24	SENT_43	[p2l50t2139r145b2192],
24	effectiveness	NN	O	effectiveness	dobj	22	SENT_43	[p2l183t2139r560b2192],
25	of	IN	O	of	_	0	SENT_43	[p2l598t2139r661b2192],
26	sulfonylurea	NN	O	sulfonylurea	prep_of	24	SENT_43	[p2l691t2139r1057b2206],
27	as	IN	O	as	_	0	SENT_43	[p2l1094t2155r1152b2192],
28	a	DT	O	a	det	32	SENT_43	[p2l1190t2155r1220b2192],
29	ﬁrst	JJ	O	ﬁrst	amod	32	SENT_43	[p2l1258t2139r1510b2192],
30	—	NN	O	—	nn	32	SENT_43	[p2l1258t2139r1510b2192],
31	line	NN	O	line	nn	32	SENT_43	[p2l1258t2139r1510b2192],
32	therapy	NN	O	therapy	prep_as	26	SENT_43	[p2l1547t2139r1776b2206],
33	so	RB	O	so	advmod	34	SENT_43	[p2l1813t2155r1875b2192],
34	far	RB	O	far	advmod	22	SENT_43	[p2l1913t2139r2002b2201],
35	,	,	O	,	_	0	SENT_43	[p2l1913t2139r2002b2201],
36	and	CC	O	and	_	0	SENT_43	[p2l2041t2139r2149b2192],
37	these	DT	O	these	det	38	SENT_43	[p2l51t2226r207b2279],
38	studies	NNS	O	study	conj_and	2	SENT_43	[p2l225t2226r431b2279],
39	yielded	VBD	O	yield	_	0	SENT_43	[p2l448t2226r664b2292],
40	controversial	JJ	O	controversial	amod	41	SENT_43	[p2l682t2226r1067b2279],
41	results	NNS	O	result	dobj	39	SENT_43	[p2l1084t2226r1292b2279],
42	.	.	O	.	_	0	SENT_43	[p2l1084t2226r1292b2279],

1	Studies	NNS	O	study	nsubj	5	SENT_44	[p2l1311t2226r1522b2279],
2	in	IN	O	in	_	0	SENT_44	[p2l1541t2226r1595b2278],
3	Caucasian	JJ	LOCATION	caucasian	amod	4	SENT_44	[p2l1614t2226r1905b2279],
4	populations	NNS	O	population	prep_in	1	SENT_44	[p2l1923t2226r2150b2292, p2l51t2312r194b2365],
5	showed	VBD	O	show	dep	27	SENT_44	[p2l222t2311r451b2365],
6	either	CC	O	either	preconj	11	SENT_44	[p2l478t2311r652b2365],
7	no	DT	O	no	det	11	SENT_44	[p2l677t2327r750b2365],
8	association	NN	O	association	nn	11	SENT_44	[p2l776t2312r1100b2365],
9	[	CD	NUMBER	[	number	10	SENT_44	[p2l1130t2311r1241b2378],
10	14	CD	NUMBER	14	num	11	SENT_44	[p2l1130t2311r1241b2378],
11	]	NN	O	]	dobj	5	SENT_44	[p2l1130t2311r1241b2378],
12	or	CC	O	or	_	0	SENT_44	[p2l1271t2327r1332b2365],
13	a	DT	O	a	det	15	SENT_44	[p2l1357t2327r1387b2365],
14	higher	JJR	O	higher	amod	15	SENT_44	[p2l1414t2311r1604b2378],
15	rate	NN	O	rate	dobj	5	SENT_44	[p2l1630t2319r1743b2365],
16	of	IN	O	of	_	0	SENT_44	[p2l1770t2311r1831b2365],
17	secondary	JJ	O	secondary	amod	19	SENT_44	[p2l1851t2311r2152b2378],
18	sulfonylurea	NN	O	sulfonylurea	nn	19	SENT_44	[p2l52t2398r418b2464],
19	failure	NN	O	failure	prep_of	15	SENT_44	[p2l448t2398r634b2451],
20	in	IN	O	in	_	0	SENT_44	[p2l666t2399r721b2450],
21	KCNJI	NNP	ORGANIZATION	KCNJI	prep_in	5	SENT_44	[p2l749t2401r919b2464],
22	1	CD	NUMBER	1	num	26	SENT_44	[p2l936t2401r955b2450],
23	K	NNP	O	K	nn	26	SENT_44	[p2l993t2398r1214b2451],
24	—	CD	NUMBER	—	num	26	SENT_44	[p2l993t2398r1214b2451],
25	allele	NN	O	allele	nn	26	SENT_44	[p2l993t2398r1214b2451],
26	carriers	NNS	O	carrier	nsubj	27	SENT_44	[p2l1246t2399r1466b2451],
27	[	VBP	O	[	_	0	SENT_44	[p2l1500t2398r1627b2464],
28	12	CD	NUMBER	12	num	29	SENT_44	[p2l1500t2398r1627b2464],
29	]	CD	NUMBER	]	dobj	27	SENT_44	[p2l1500t2398r1627b2464],
30	.	.	O	.	_	0	SENT_44	[p2l1500t2398r1627b2464],

1	In	IN	O	in	_	0	SENT_45	[p2l1660t2401r1714b2450],
2	opposite	JJ	O	opposite	prep_in	9	SENT_45	[p2l1745t2399r2006b2464],
3	,	,	O	,	_	0	SENT_45	[p2l1745t2399r2006b2464],
4	two	CD	NUMBER	two	num	5	SENT_45	[p2l2037t2406r2149b2451],
5	studies	NNS	O	study	nsubj	9	SENT_45	[p2l52t2484r254b2537],
6	in	IN	O	in	_	0	SENT_45	[p2l284t2485r339b2536],
7	Asian	JJ	LOCATION	asian	amod	8	SENT_45	[p2l366t2485r526b2537],
8	populations	NNS	O	population	prep_in	5	SENT_45	[p2l555t2484r897b2550],
9	showed	VBD	O	show	_	0	SENT_45	[p2l928t2484r1154b2537],
10	associations	NNS	O	association	nsubj	29	SENT_45	[p2l1184t2485r1530b2537],
11	of	IN	O	of	_	0	SENT_45	[p2l1561t2484r1622b2537],
12	both	DT	O	both	det	14	SENT_45	[p2l1643t2484r1776b2537],
13	KCN	NN	O	kcn	nn	14	SENT_45	[p2l1803t2487r2006b2550],
14	]	NN	O	]	prep_of	10	SENT_45	[p2l1803t2487r2006b2550],
15	11	CD	NUMBER	11	dep	14	SENT_45	[p2l1803t2487r2006b2550],
16	and	CC	O	and	_	0	SENT_45	[p2l2042t2484r2149b2537],
17	ABCC8	CD	NUMBER	abcc8	num	18	SENT_45	[p2l45t2572r234b2622],
18	polymorphisms	NNS	O	polymorphism	prep_of	10	SENT_45	[p2l258t2569r714b2636],
19	with	IN	O	with	_	0	SENT_45	[p2l738t2569r873b2622],
20	better	JJR	O	better	amod	21	SENT_45	[p2l897t2569r1072b2622],
21	response	NN	O	response	prep_with	18	SENT_45	[p2l1095t2585r1354b2636],
22	to	TO	O	to	_	0	SENT_45	[p2l1379t2577r1435b2622],
23	sulfonylurea	NN	O	sulfonylurea	nn	24	SENT_45	[p2l1462t2569r1821b2636],
24	therapy	NN	O	therapy	prep_to	21	SENT_45	[p2l1845t2569r2072b2636],
25	in	IN	O	in	_	0	SENT_45	[p2l2095t2570r2149b2622],
26	risk	NN	O	risk	nn	28	SENT_45	[p2l51t2655r157b2708],
27	allele	NN	O	allele	nn	28	SENT_45	[p2l177t2655r327b2708],
28	carriers	NNS	O	carrier	prep_in	24	SENT_45	[p2l349t2656r565b2708],
29	[	VBP	O	[	ccomp	9	SENT_45	[p2l589t2655r802b2722],
30	15,16	CD	NUMBER	15,16	number	31	SENT_45	[p2l589t2655r802b2722],
31	]	CD	NUMBER	]	dobj	29	SENT_45	[p2l589t2655r802b2722],
32	.	.	O	.	_	0	SENT_45	[p2l589t2655r802b2722],

1	The	DT	O	the	det	2	SENT_46	[p2l149t2742r259b2795],
2	aim	NN	O	aim	nsubj	8	SENT_46	[p2l291t2743r402b2795],
3	of	IN	O	of	_	0	SENT_46	[p2l434t2741r496b2795],
4	the	DT	O	the	det	7	SENT_46	[p2l520t2742r615b2795],
5	present	JJ	DATE	present	amod	7	SENT_46	[p2l648t2750r876b2808],
6	pharmacogenetic	JJ	O	pharmacogenetic	amod	7	SENT_46	[p2l906t2742r1428b2808],
7	study	NN	O	study	prep_of	2	SENT_46	[p2l1459t2742r1625b2808],
8	was	VBD	O	be	_	0	SENT_46	[p2l1653t2757r1770b2795],
9	to	TO	O	to	aux	10	SENT_46	[p2l1803t2750r1861b2795],
10	examine	VB	O	examine	xcomp	8	SENT_46	[p2l1893t2742r2150b2795],
11	whether	IN	O	whether	complm	20	SENT_46	[p2l49t2827r308b2881],
12	the	DT	O	the	det	13	SENT_46	[p2l341t2827r436b2881],
13	effect	NN	O	effect	nsubj	20	SENT_46	[p2l473t2827r639b2881],
14	of	IN	O	of	_	0	SENT_46	[p2l674t2827r736b2881],
15	sulfonylurea	NN	O	sulfonylurea	nn	16	SENT_46	[p2l766t2827r1140b2894],
16	therapy	NN	O	therapy	prep_of	13	SENT_46	[p2l1175t2827r1409b2894],
17	on	IN	O	on	_	0	SENT_46	[p2l1444t2843r1518b2881],
18	glycemic	JJ	O	glycemic	amod	19	SENT_46	[p2l1553t2827r1820b2894],
19	control	NN	O	control	prep_on	16	SENT_46	[p2l1855t2828r2069b2881],
20	is	VBZ	O	be	ccomp	10	SENT_46	[p2l2106t2828r2149b2881],

1	0953-6205	CD	DURATION	0953-6205	_	0	SENT_47	[p2l299t2936r453b2962],
2	/	:	O	/	punct	1	SENT_47	[p2l299t2936r453b2962],
3	$	$	MONEY	$	nsubj	5	SENT_47	[p2l299t2936r453b2962],
4	~	CD	MONEY	~	num	3	SENT_47	[p2l463t2949r476b2952],
5	see	VBP	O	see	dep	1	SENT_47	[p2l487t2943r524b2958],
6	front	JJ	O	front	amod	7	SENT_47	[p2l534t2936r593b2958],
7	matter	NN	O	matter	dobj	5	SENT_47	[p2l602t2940r683b2958],
8	©	CD	NUMBER	©	num	9	SENT_47	[p2l692t2938r711b2958],
9	2011	CD	DATE	2011	dep	7	SENT_47	[p2l720t2938r777b2958],
10	European	JJ	ORGANIZATION	european	amod	11	SENT_47	[p2l790t2938r903b2963],
11	Federation	NNP	ORGANIZATION	Federation	tmod	5	SENT_47	[p2l913t2936r1041b2958],
12	of	IN	ORGANIZATION	of	_	0	SENT_47	[p2l1051t2936r1076b2958],
13	Internal	NNP	ORGANIZATION	Internal	nn	14	SENT_47	[p2l1083t2936r1176b2958],
14	Medicine	NNP	ORGANIZATION	Medicine	prep_of	11	SENT_47	[p2l1186t2936r1302b2958],
15	.	.	O	.	_	0	SENT_47	[p2l1186t2936r1302b2958],

1	Published	VBN	O	publish	csubj	7	SENT_48	[p2l1313t2936r1429b2958],
2	by	IN	O	by	_	0	SENT_48	[p2l1439t2936r1468b2963],
3	Elsevier	NNP	PERSON	Elsevier	nn	6	SENT_48	[p2l1477t2936r1571b2958],
4	B.V.	NNP	O	B.V.	nn	6	SENT_48	[p2l1580t2938r1623b2958],
5	All	NNP	O	All	nn	6	SENT_48	[p2l1632t2936r1664b2958],
6	rights	NNS	O	rights	prep_by	1	SENT_48	[p2l1674t2937r1742b2963],
7	reserved	VBD	O	reserve	_	0	SENT_48	[p2l1753t2936r1861b2958],
8	.	.	O	.	_	0	SENT_48	[p2l1753t2936r1861b2958],

1	doi	FW	O	doi	_	0	SENT_49	[p2l299t2972r675b2999],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_49	[p2l299t2972r675b2999],
3	/	:	O	/	punct	1	SENT_49	[p2l299t2972r675b2999],
4	j.	NN	O	j.	nn	5	SENT_49	[p2l299t2972r675b2999],
5	ejim	NN	O	ejim	dep	1	SENT_49	[p2l299t2972r675b2999],
6	.2011.10.018	CD	NUMBER	.2011.10.018	num	9	SENT_49	[p2l299t2972r675b2999],
7	246	CD	NUMBER	246	num	9	SENT_49	[p2l312t3005r356b3026],
8	M.	NNP	NUMBER	M.	nn	9	SENT_49	[p2l937t3006r965b3026],
9	javorsky	NNP	O	javorsky	dep	5	SENT_49	[p2l970t3004r1072b3031],
10	et	FW	O	et	nn	11	SENT_49	[p2l1081t3007r1104b3026],
11	al.	FW	O	al.	dep	9	SENT_49	[p2l1111t3004r1136b3026],
12	/	:	O	/	punct	22	SENT_49	[p2l1145t3005r1155b3029],
13	European	JJ	MISC	european	amod	14	SENT_49	[p2l1162t3006r1272b3031],
14	journal	NN	O	journal	dep	19	SENT_49	[p2l1277t3004r1365b3031],
15	of	IN	O	of	_	0	SENT_49	[p2l1374t3004r1399b3031],
16	Internal	JJ	ORGANIZATION	internal	amod	17	SENT_49	[p2l1403t3004r1494b3026],
17	Medicine	NN	ORGANIZATION	medicine	prep_of	14	SENT_49	[p2l1503t3004r1608b3026],
18	23	CD	NUMBER	23	dep	19	SENT_49	[p2l1616t3005r1645b3026],
19	(	CD	NUMBER	(	dep	22	SENT_49	[p2l1656t3004r1734b3031],
20	2012	CD	DATE	2012	dep	19	SENT_49	[p2l1656t3004r1734b3031],
21	)	CD	NUMBER	)	num	22	SENT_49	[p2l1656t3004r1734b3031],
22	245-249	CD	NUMBER	245-249	dep	9	SENT_49	[p2l1744t3005r1847b3026],

1	related	JJ	O	related	amod	5	SENT_50	[p2l10t3143r222b3198],
2	to	TO	O	to	_	0	SENT_50	[p2l247t3151r306b3198],
3	I	PRP	O	I	prep_to	1	SENT_50	[p2l330t3146r543b3212],
4	<	JJR	O	<	amod	5	SENT_50	[p2l330t3146r543b3212],
5	CN	NN	O	cn	_	0	SENT_50	[p2l330t3146r543b3212],
6	]	CD	NUMBER	]	number	7	SENT_50	[p2l330t3146r543b3212],
7	11	CD	NUMBER	11	num	8	SENT_50	[p2l330t3146r543b3212],
8	E23I	NN	O	e23us	dep	5	SENT_50	[p2l576t3146r733b3198],
9	(	CD	NUMBER	(	num	10	SENT_50	[p2l576t3146r733b3198],
10	genotype	NN	O	genotype	dep	8	SENT_50	[p2l755t3151r1054b3212],
11	.	.	O	.	_	0	SENT_50	[p2l755t3151r1054b3212],

1	We	PRP	O	we	nsubj	2	SENT_51	[p2l1078t3146r1182b3198],
2	chose	VBD	O	choose	_	0	SENT_51	[p2l1208t3143r1380b3198],
3	a	DT	O	a	det	5	SENT_51	[p2l1405t3159r1436b3198],
4	study	NN	O	study	nn	5	SENT_51	[p2l1462t3143r1630b3212],
5	design	NN	O	design	nsubj	29	SENT_51	[p2l1653t3143r1852b3212],
6	in	IN	O	in	_	0	SENT_51	[p2l1878t3144r1934b3197],
7	which	WDT	O	which	rel	10	SENT_51	[p2l1957t3143r2146b3198],
8	sulfonylurea	NN	O	sulfonylurea	nsubjpass	10	SENT_51	[p2l10t3232r391b3301],
9	was	VBD	O	be	auxpass	10	SENT_51	[p2l413t3248r532b3287],
10	added	VBN	O	add	rcmod	5	SENT_51	[p2l558t3232r744b3287],
11	to	TO	O	to	_	0	SENT_51	[p2l768t3240r827b3287],
12	metformin	NN	O	metformin	prep_to	10	SENT_51	[p2l853t3232r1182b3287],
13	as	IN	O	as	_	0	SENT_51	[p2l1206t3248r1265b3287],
14	a	DT	DURATION	a	det	16	SENT_51	[p2l1291t3248r1322b3287],
15	second	JJ	DURATION	second	amod	16	SENT_51	[p2l1347t3232r1558b3287],
16	drug	NN	O	drug	prep_as	12	SENT_51	[p2l1583t3232r1724b3301],
17	after	IN	O	after	_	0	SENT_51	[p2l1749t3232r1890b3287],
18	metformin	JJ	O	metformin	amod	20	SENT_51	[p2l1913t3232r2146b3287, p2l10t3322r129b3376],
19	monotherapy	JJ	O	monotherapy	amod	20	SENT_51	[p2l174t3321r590b3390],
20	failure	NN	O	failure	prep_after	10	SENT_51	[p2l634t3321r843b3385],
21	,	,	O	,	_	0	SENT_51	[p2l634t3321r843b3385],
22	in	IN	O	in	_	0	SENT_51	[p2l890t3322r946b3376],
23	line	NN	O	line	prep_in	10	SENT_51	[p2l991t3321r1102b3376],
24	with	IN	O	with	_	0	SENT_51	[p2l1146t3321r1287b3376],
25	the	DT	O	the	det	28	SENT_51	[p2l1331t3321r1428b3376],
26	present	JJ	DATE	present	amod	28	SENT_51	[p2l1474t3329r1706b3390],
27	international	JJ	O	international	amod	28	SENT_51	[p2l1749t3321r2145b3376],
28	guidelines	NNS	O	guideline	prep_with	23	SENT_51	[p2l8t3410r322b3479],
29	[	VBP	O	[	ccomp	2	SENT_51	[p2l351t3410r445b3479],
30	2	CD	NUMBER	2	number	31	SENT_51	[p2l351t3410r445b3479],
31	]	CD	NUMBER	]	dobj	29	SENT_51	[p2l351t3410r445b3479],
32	.	.	O	.	_	0	SENT_51	[p2l351t3410r445b3479],

1	2	LS	NUMBER	2	_	0	SENT_52	[p2l9t3634r61b3685],
2	.	.	O	.	_	0	SENT_52	[p2l9t3634r61b3685],

1	Materials	NNPS	O	Materials	_	0	SENT_53	[p2l85t3631r386b3685],
2	and	CC	O	and	_	0	SENT_53	[p2l408t3631r529b3685],
3	methods	NNS	O	method	conj_and	1	SENT_53	[p2l551t3631r834b3685],

1	2.1	CD	NUMBER	2.1	_	0	SENT_54	[p3l6t71r107b123],
2	.	.	O	.	_	0	SENT_54	[p3l6t71r107b123],

1	Patients	NNS	O	patient	_	0	SENT_55	[p3l132t69r367b123],
2	a	DT	O	a	det	4	SENT_55	[p3l391t84r423b123],
3	study	NN	O	study	nn	4	SENT_55	[p3l445t68r607b137],
4	design	NN	O	design	dep	1	SENT_55	[p3l630t68r816b137],

1	Type	NN	O	type	nsubjpass	5	SENT_56	[p3l109t250r257b315],
2	2	CD	NUMBER	2	num	3	SENT_56	[p3l292t249r324b301],
3	diabetes	NN	O	diabetes	dep	1	SENT_56	[p3l362t246r615b301],
4	was	VBD	O	be	auxpass	5	SENT_56	[p3l649t262r768b301],
5	diagnosed	VBN	O	diagnose	_	0	SENT_56	[p3l804t246r1114b315],
6	according	VBG	O	accord	_	0	SENT_56	[p3l1149t246r1448b315],
7	to	TO	O	to	prepc_according_to	5	SENT_56	[p3l1481t254r1540b301],
8	the	DT	O	the	det	9	SENT_56	[p3l1575t246r1672b301],
9	criteria	NNS	O	criterion	pobj	5	SENT_56	[p3l1707t247r1924b301],
10	of	IN	O	of	_	0	SENT_56	[p3l1959t246r2022b301],
11	the	DT	O	the	det	17	SENT_56	[p3l2049t246r2146b301],
12	American	JJ	ORGANIZATION	american	amod	17	SENT_56	[p3l7t336r302b390],
13	Diabetes	NNP	ORGANIZATION	Diabetes	nn	17	SENT_56	[p3l335t335r596b390],
14	Association	NNP	ORGANIZATION	Association	nn	17	SENT_56	[p3l627t336r977b390],
15	[	NN	O	[	nn	17	SENT_56	[p3l1014t335r1146b404],
16	17	CD	NUMBER	17	num	17	SENT_56	[p3l1014t335r1146b404],
17	]	NN	O	]	prep_of	9	SENT_56	[p3l1014t335r1146b404],
18	.	.	O	.	_	0	SENT_56	[p3l1014t335r1146b404],

1	The	DT	O	the	det	2	SENT_57	[p3l1177t335r1289b390],
2	study	NN	O	study	nsubjpass	4	SENT_57	[p3l1324t335r1492b404],
3	was	VBD	O	be	auxpass	4	SENT_57	[p3l1522t351r1640b390],
4	conducted	VBN	O	conduct	_	0	SENT_57	[p3l1674t335r1992b390],
5	in	IN	O	in	_	0	SENT_57	[p3l2027t336r2083b390],
6	a	DT	O	a	det	9	SENT_57	[p3l2115t351r2146b390],
7	university	NN	O	university	nn	9	SENT_57	[p3l10t426r319b493],
8	hospital	NN	O	hospital	nn	9	SENT_57	[p3l343t425r585b493],
9	setting	NN	O	setting	prep_in	4	SENT_57	[p3l613t426r834b493],
10	.	.	O	.	_	0	SENT_57	[p3l613t426r834b493],

1	One	CD	NUMBER	one	num	2	SENT_58	[p3l861t428r981b480],
2	hundred	CD	NUMBER	hundred	nsubjpass	19	SENT_58	[p3l1007t425r1268b480],
3	and	CC	NUMBER	and	_	0	SENT_58	[p3l1294t425r1405b480],
4	one	CD	NUMBER	one	num	5	SENT_58	[p3l1431t441r1541b480],
5	patients	NNS	O	patient	nsubjpass	19	SENT_58	[p3l1568t426r1813b493],
6	(	IN	O	(	_	0	SENT_58	[p3l1843t425r1942b493],
7	50	CD	NUMBER	50	num	8	SENT_58	[p3l1843t425r1942b493],
8	males	NNS	O	male	prep_(	19	SENT_58	[p3l1970t425r2146b480],
9	and	CC	O	and	_	0	SENT_58	[p3l9t514r121b569],
10	51	CD	NUMBER	51	num	11	SENT_58	[p3l145t517r210b569],
11	females	NNS	O	female	prep_(	19	SENT_58	[p3l242t513r502b582],
12	)	CD	NUMBER	)	nsubjpass	19	SENT_58	[p3l242t513r502b582],
13	of	IN	O	of	_	0	SENT_58	[p3l529t513r593b569],
14	Central	JJ	MISC	central	amod	17	SENT_58	[p3l608t514r827b569],
15	European	JJ	MISC	european	amod	17	SENT_58	[p3l851t517r1141b582],
16	Caucasian	JJ	MISC	caucasian	amod	17	SENT_58	[p3l1165t514r1468b569],
17	origin	NN	O	origin	prep_of	12	SENT_58	[p3l1491t514r1670b582],
18	were	VBD	O	be	auxpass	19	SENT_58	[p3l1691t529r1845b569],
19	recruited	VBN	O	recruit	_	0	SENT_58	[p3l1868t514r2146b569],
20	from	IN	O	from	_	0	SENT_58	[p3l10t602r156b657],
21	three	CD	NUMBER	three	prep_from	19	SENT_58	[p3l177t602r337b657],
22	out	IN	O	out	_	0	SENT_58	[p3l359t603r707b671],
23	—	CD	NUMBER	—	num	25	SENT_58	[p3l359t603r707b671],
24	patient	NN	O	patient	nn	25	SENT_58	[p3l359t603r707b671],
25	clinics	NNS	O	clinic	prep_out	19	SENT_58	[p3l727t602r931b658],
26	.	.	O	.	_	0	SENT_58	[p3l727t602r931b658],

1	Baseline	NN	O	baseline	nsubjpass	9	SENT_59	[p3l955t602r1206b657],
2	clinical	JJ	O	clinical	amod	1	SENT_59	[p3l1228t602r1442b657],
3	and	CC	O	and	_	0	SENT_59	[p3l1464t602r1575b657],
4	biochemical	JJ	O	biochemical	amod	5	SENT_59	[p3l1596t602r1965b657],
5	characteristics	NNS	O	characteristic	nsubjpass	9	SENT_59	[p3l1988t602r2146b657, p3l9t692r314b746],
6	of	IN	O	of	_	0	SENT_59	[p3l339t691r402b746],
7	patients	NNS	O	patient	prep_of	5	SENT_59	[p3l419t692r664b760],
8	are	VBP	O	be	auxpass	9	SENT_59	[p3l688t707r781b746],
9	shown	VBN	O	show	_	0	SENT_59	[p3l807t691r1010b746],
10	in	IN	O	in	_	0	SENT_59	[p3l1034t692r1090b746],
11	Table	NNP	O	Table	prep_in	9	SENT_59	[p3l1111t691r1275b746],
12	1	CD	NUMBER	1	num	11	SENT_59	[p3l1303t694r1349b747],
13	.	.	O	.	_	0	SENT_59	[p3l1303t694r1349b747],

1	Patients	NNS	O	patient	nsubj	3	SENT_60	[p3l1374t692r1617b746],
2	were	VBD	O	be	cop	3	SENT_60	[p3l1640t707r1793b746],
3	eligible	JJ	O	eligible	_	0	SENT_60	[p3l1818t691r2039b760],
4	for	IN	O	for	_	0	SENT_60	[p3l2063t691r2148b746],
5	the	DT	O	the	det	6	SENT_60	[p3l9t780r106b835],
6	study	NN	O	study	prep_for	3	SENT_60	[p3l140t780r308b849],
7	if	IN	O	if	mark	9	SENT_60	[p3l340t780r385b835],
8	they	PRP	O	they	nsubj	21	SENT_60	[p3l409t780r545b849],
9	were	VBD	O	be	advcl	3	SENT_60	[p3l575t796r729b835],
10	on	IN	O	on	_	0	SENT_60	[p3l761t796r836b835],
11	previous	JJ	O	previous	amod	13	SENT_60	[p3l870t781r1132b849],
12	metformin	JJ	O	metformin	amod	13	SENT_60	[p3l1166t780r1494b835],
13	monotherapy	NN	O	monotherapy	prep_on	9	SENT_60	[p3l1527t780r1943b849],
14	for	IN	O	for	_	0	SENT_60	[p3l1975t780r2060b835],
15	at	IN	DURATION	at	quantmod	17	SENT_60	[p3l2091t788r2148b835],
16	least	JJS	DURATION	least	mwe	15	SENT_60	[p3l10t869r151b923],
17	6	CD	DURATION	6	num	18	SENT_60	[p3l170t872r204b923],
18	months	NNS	NUMBER	month	prep_for	13	SENT_60	[p3l226t869r473b931],
19	,	,	O	,	_	0	SENT_60	[p3l226t869r473b931],
20	and	CC	O	and	_	0	SENT_60	[p3l494t869r605b923],
21	failed	VBD	O	fail	advcl	3	SENT_60	[p3l626t869r793b923],
22	to	TO	O	to	aux	23	SENT_60	[p3l813t877r872b923],
23	maintain	VB	O	maintain	xcomp	21	SENT_60	[p3l893t870r1166b923],
24	HbA1c	NN	O	hba1c	dep	25	SENT_60	[p3l1187t869r1433b923],
25	<	JJR	O	<	dobj	23	SENT_60	[p3l1187t869r1433b923],
26	7.0	CD	PERCENT	7.0	num	27	SENT_60	[p3l1446t872r1576b924],
27	%	NN	PERCENT	%	npadvmod	23	SENT_60	[p3l1446t872r1576b924],
28	on	IN	O	on	_	0	SENT_60	[p3l1596t885r1671b923],
29	maximal	JJ	O	maximal	prep_on	23	SENT_60	[p3l1691t869r1957b923],
30	tolerated	VBN	O	tolerate	partmod	29	SENT_60	[p3l1977t869r2146b923, p3l9t957r139b1011],
31	doses	NNS	O	dose	dobj	30	SENT_60	[p3l178t957r346b1011],
32	of	IN	O	of	_	0	SENT_60	[p3l384t957r448b1011],
33	metformin	NN	O	metformin	prep_of	31	SENT_60	[p3l478t957r807b1011],
34	at	IN	O	at	_	0	SENT_60	[p3l843t965r900b1011],
35	two	CD	NUMBER	two	num	37	SENT_60	[p3l935t965r1052b1011],
36	consecutive	JJ	O	consecutive	amod	37	SENT_60	[p3l1090t958r1449b1011],
37	visits	NNS	O	visit	prep_at	30	SENT_60	[p3l1486t958r1643b1011],
38	within	IN	O	within	_	0	SENT_60	[p3l1680t957r1882b1011],
39	a	DT	O	a	det	42	SENT_60	[p3l1918t973r1950b1011],
40	three	CD	DURATION	three	num	42	SENT_60	[p3l1986t957r2146b1011],
41	month	NN	NUMBER	month	nn	42	SENT_60	[p3l10t1044r213b1099],
42	period	NN	O	period	prep_within	37	SENT_60	[p3l263t1044r474b1113],
43	.	.	O	.	_	0	SENT_60	[p3l263t1044r474b1113],

1	Inclusion	NN	O	inclusion	nn	2	SENT_61	[p3l525t1044r803b1099],
2	criteria	NNS	O	criterion	nsubj	4	SENT_61	[p3l852t1045r1070b1099],
3	were	VBD	O	be	cop	4	SENT_61	[p3l1117t1060r1271b1099],
4	HbA1c	NN	O	hba1c	dep	18	SENT_61	[p3l1322t1044r1523b1099],
5	of	IN	O	of	_	0	SENT_61	[p3l1571t1044r1634b1099],
6	7.0-11	CD	PERCENT	7.0-11	num	8	SENT_61	[p3l1678t1047r1993b1108],
7	.0	CD	PERCENT	.0	num	8	SENT_61	[p3l1678t1047r1993b1108],
8	%	NN	PERCENT	%	prep_of	4	SENT_61	[p3l1678t1047r1993b1108],
9	,	,	O	,	_	0	SENT_61	[p3l1678t1047r1993b1108],
10	age	NN	O	age	prep_of	4	SENT_61	[p3l2044t1060r2146b1113],
11	35-70	CD	NUMBER	35-70	num	12	SENT_61	[p3l8t1135r199b1187],
12	years	NNS	NUMBER	year	dep	10	SENT_61	[p3l219t1148r395b1201],
13	,	,	O	,	_	0	SENT_61	[p3l219t1148r395b1201],
14	and	CC	O	and	_	0	SENT_61	[p3l443t1132r554b1187],
15	body	NN	O	body	nn	17	SENT_61	[p3l601t1132r753b1201],
16	mass	NN	O	mass	nn	17	SENT_61	[p3l799t1148r949b1187],
17	index	NN	O	index	conj_and	8	SENT_61	[p3l998t1132r1169b1187],
18	(	VBD	O	(	_	0	SENT_61	[p3l1218t1132r1389b1200],
19	BMI	NNP	O	BMI	dobj	18	SENT_61	[p3l1218t1132r1389b1200],
20	)	CD	NUMBER	)	num	19	SENT_61	[p3l1218t1132r1389b1200],
21	20-35	CD	NUMBER	20-35	num	22	SENT_61	[p3l1440t1135r1628b1187],
22	kg/m2	NN	O	kg/m2	nsubj	18	SENT_61	[p3l1652t1122r1855b1201],
23	.	.	O	.	_	0	SENT_61	[p3l1652t1122r1855b1201],

1	Patients	NNS	O	patient	nsubjpass	23	SENT_62	[p3l1903t1133r2146b1187],
2	with	IN	O	with	_	0	SENT_62	[p3l8t1221r149b1276],
3	malignancies	NNS	O	malignancy	prep_with	1	SENT_62	[p3l176t1221r592b1290],
4	,	,	O	,	_	0	SENT_62	[p3l176t1221r592b1290],
5	endocrine	JJ	O	endocrine	amod	6	SENT_62	[p3l620t1221r925b1276],
6	disorders	NNS	O	disorder	conj_and	3	SENT_62	[p3l952t1221r1251b1285],
7	,	,	O	,	_	0	SENT_62	[p3l952t1221r1251b1285],
8	chronic	JJ	O	chronic	amod	10	SENT_62	[p3l1279t1221r1507b1276],
9	renal	JJ	O	renal	amod	10	SENT_62	[p3l1533t1221r1686b1276],
10	failure	NN	O	failure	conj_and	3	SENT_62	[p3l1714t1221r1923b1285],
11	,	,	O	,	_	0	SENT_62	[p3l1714t1221r1923b1285],
12	severe	JJ	O	severe	amod	14	SENT_62	[p3l1951t1237r2146b1276],
13	liver	NN	O	liver	nn	14	SENT_62	[p3l10t1310r146b1365],
14	disease	NN	O	disease	conj_and	3	SENT_62	[p3l167t1310r402b1374],
15	,	,	O	,	_	0	SENT_62	[p3l167t1310r402b1374],
16	systemic	JJ	O	systemic	amod	18	SENT_62	[p3l426t1311r692b1379],
17	inﬂammatory	JJ	O	inﬂammatory	amod	18	SENT_62	[p3l713t1310r1134b1379],
18	disease	NN	O	disease	prep_with	1	SENT_62	[p3l1154t1310r1374b1365],
19	and	CC	O	and	_	0	SENT_62	[p3l1397t1310r1507b1365],
20	corticosteroid	NN	O	corticosteroid	nn	21	SENT_62	[p3l1531t1310r1953b1365],
21	treatment	NN	O	treatment	prep_with	1	SENT_62	[p3l1975t1318r2146b1365, p3l10t1408r170b1455],
22	were	VBD	O	be	auxpass	23	SENT_62	[p3l187t1416r341b1455],
23	excluded	VBN	O	exclude	_	0	SENT_62	[p3l362t1400r653b1455],
24	.	.	O	.	_	0	SENT_62	[p3l362t1400r653b1455],

1	The	DT	O	the	det	3	SENT_63	[p3l671t1400r783b1455],
2	ethical	JJ	O	ethical	amod	3	SENT_63	[p3l804t1400r1006b1455],
3	approval	NN	O	approval	nsubjpass	8	SENT_63	[p3l1027t1400r1295b1468],
4	for	IN	O	for	_	0	SENT_63	[p3l1316t1400r1401b1455],
5	this	DT	O	this	det	6	SENT_63	[p3l1419t1400r1530b1455],
6	study	NN	O	study	prep_for	3	SENT_63	[p3l1552t1400r1721b1468],
7	was	VBD	O	be	auxpass	8	SENT_63	[p3l1738t1416r1857b1455],
8	obtained	VBN	O	obtain	_	0	SENT_63	[p3l1878t1400r2146b1455],
9	from	IN	O	from	_	0	SENT_63	[p3l10t1489r156b1544],
10	L.	NNP	ORGANIZATION	L.	nn	15	SENT_63	[p3l189t1492r232b1544],
11	Pasteur	NNP	ORGANIZATION	Pasteur	nn	15	SENT_63	[p3l267t1492r494b1544],
12	University	NNP	ORGANIZATION	University	nn	15	SENT_63	[p3l525t1490r843b1557],
13	Hospital	NNP	ORGANIZATION	Hospital	nn	15	SENT_63	[p3l874t1489r1127b1557],
14	Review	NNP	ORGANIZATION	Review	nn	15	SENT_63	[p3l1161t1490r1384b1544],
15	Board	NNP	ORGANIZATION	Board	prep_from	8	SENT_63	[p3l1417t1489r1608b1544],
16	.	.	O	.	_	0	SENT_63	[p3l1417t1489r1608b1544],

1	All	DT	O	all	det	3	SENT_64	[p3l1639t1489r1721b1543],
2	participating	VBG	O	participate	amod	3	SENT_64	[p3l1755t1490r2148b1557],
3	subjects	NNS	O	subject	nsubj	4	SENT_64	[p3l10t1577r255b1646],
4	gave	VBD	O	give	_	0	SENT_64	[p3l280t1593r420b1646],
5	a	DT	O	a	det	7	SENT_64	[p3l444t1593r475b1632],
6	written	VBN	O	write	amod	7	SENT_64	[p3l498t1578r726b1632],
7	consent	NN	O	consent	dobj	4	SENT_64	[p3l751t1585r990b1632],
8	to	TO	O	to	_	0	SENT_64	[p3l1012t1585r1070b1632],
9	the	DT	O	the	det	10	SENT_64	[p3l1095t1577r1192b1632],
10	study	NN	O	study	prep_to	7	SENT_64	[p3l1217t1577r1399b1646],
11	.	.	O	.	_	0	SENT_64	[p3l1217t1577r1399b1646],

1	At	IN	O	at	_	0	SENT_65	[p3l109t1668r178b1721],
2	the	DT	O	the	det	4	SENT_65	[p3l201t1666r299b1721],
3	baseline	NN	O	baseline	nn	4	SENT_65	[p3l323t1666r574b1721],
4	visit	NN	O	visit	prep_at	20	SENT_65	[p3l597t1667r740b1729],
5	,	,	O	,	_	0	SENT_65	[p3l597t1667r740b1729],
6	anthropometric	NN	O	anthropometric	nn	7	SENT_65	[p3l766t1666r1250b1735],
7	data	NNS	O	datum	nsubjpass	20	SENT_65	[p3l1274t1666r1419b1730],
8	,	,	O	,	_	0	SENT_65	[p3l1274t1666r1419b1730],
9	as	RB	O	as	_	0	SENT_65	[p3l1445t1682r1504b1721],
10	well	RB	O	well	_	0	SENT_65	[p3l1529t1666r1659b1721],
11	as	IN	O	as	_	0	SENT_65	[p3l1684t1682r1744b1721],
12	the	DT	O	the	det	14	SENT_65	[p3l1769t1666r1866b1721],
13	diabetes	NN	O	diabetes	nn	14	SENT_65	[p3l1892t1666r2146b1721],
14	duration	NN	O	duration	nsubjpass	20	SENT_65	[p3l10t1755r272b1810],
15	and	CC	O	and	_	0	SENT_65	[p3l308t1755r419b1810],
16	metformin	NN	O	metformin	nn	18	SENT_65	[p3l457t1755r785b1810],
17	treatment	NN	O	treatment	nn	18	SENT_65	[p3l820t1763r1129b1810],
18	duration	NN	O	duration	conj_and	7	SENT_65	[p3l1163t1755r1426b1810],
19	were	VBD	O	be	auxpass	20	SENT_65	[p3l1460t1771r1613b1810],
20	recorded	VBN	O	record	_	0	SENT_65	[p3l1650t1755r1937b1810],
21	.	.	O	.	_	0	SENT_65	[p3l1650t1755r1937b1810],

1	Blood	NN	O	blood	nn	2	SENT_66	[p3l1974t1755r2146b1810],
2	samples	NNS	O	sample	nsubjpass	4	SENT_66	[p3l10t1843r256b1912],
3	were	VBD	O	be	auxpass	4	SENT_66	[p3l291t1859r444b1898],
4	taken	VBN	O	take	_	0	SENT_66	[p3l480t1843r650b1898],
5	for	IN	O	for	_	0	SENT_66	[p3l686t1843r771b1898],
6	genotyping	VBG	O	genotype	prepc_for	4	SENT_66	[p3l803t1844r1152b1912],
7	and	CC	O	and	_	0	SENT_66	[p3l1186t1843r1297b1898],
8	for	IN	O	for	_	0	SENT_66	[p3l1335t1843r1419b1898],
9	biochemical	JJ	O	biochemical	amod	10	SENT_66	[p3l1453t1843r1822b1898],
10	measurements	NNS	O	measurement	conj_and	6	SENT_66	[p3l1858t1859r2146b1898, p3l10t1941r213b1988],
11	.	.	O	.	_	0	SENT_66	[p3l1858t1859r2146b1898, p3l10t1941r213b1988],

1	Sulfonylurea	NN	O	sulfonylurea	nn	2	SENT_67	[p3l235t1933r621b2001],
2	treatment	NN	O	treatment	nsubj	10	SENT_67	[p3l642t1941r949b1988],
3	was	VBD	O	be	auxpass	4	SENT_67	[p3l968t1949r1087b1988],
4	started	VBN	O	start	rcmod	2	SENT_67	[p3l1109t1933r1320b1988],
5	with	IN	O	with	_	0	SENT_67	[p3l1340t1933r1481b1988],
6	25-50	CD	PERCENT	25-50	num	7	SENT_67	[p3l1502t1936r1734b1988],
7	%	NN	PERCENT	%	prep_with	4	SENT_67	[p3l1502t1936r1734b1988],
8	of	IN	O	of	_	0	SENT_67	[p3l1755t1933r1819b1988],
9	maximum	NN	O	maximum	prep_of	7	SENT_67	[p3l1833t1934r2147b1988],
10	approved	VBD	O	approve	_	0	SENT_67	[p3l9t2022r298b2090],
11	dose	NN	O	dose	dobj	10	SENT_67	[p3l322t2022r461b2077],
12	for	IN	O	for	_	0	SENT_67	[p3l486t2022r571b2077],
13	the	DT	O	the	det	15	SENT_67	[p3l592t2022r690b2077],
14	speciﬁc	NN	O	speciﬁc	nn	15	SENT_67	[p3l715t2022r941b2090],
15	sulfonylurea	NN	O	sulfonylurea	prep_for	10	SENT_67	[p3l965t2022r1359b2090],
16	.	.	O	.	_	0	SENT_67	[p3l965t2022r1359b2090],

1	55	CD	NUMBER	55	num	2	SENT_68	[p3l1385t2025r1456b2077],
2	patients	NNS	O	patient	nsubjpass	4	SENT_68	[p3l1482t2023r1727b2090],
3	were	VBD	O	be	auxpass	4	SENT_68	[p3l1750t2038r1903b2077],
4	treated	VBN	O	treat	_	0	SENT_68	[p3l1927t2022r2146b2077],
5	with	IN	O	with	_	0	SENT_68	[p3l8t2110r149b2165],
6	gliclazide	NN	O	gliclazide	prep_with	4	SENT_68	[p3l170t2110r471b2179],
7	,	,	O	,	_	0	SENT_68	[p3l170t2110r471b2179],
8	29	CD	NUMBER	29	num	9	SENT_68	[p3l494t2113r567b2165],
9	patients	NNS	O	patient	appos	6	SENT_68	[p3l590t2111r835b2179],
10	with	IN	O	with	_	0	SENT_68	[p3l855t2110r997b2165],
11	glimepiride	NN	O	glimepiride	prep_with	9	SENT_68	[p3l1017t2110r1385b2179],
12	,	,	O	,	_	0	SENT_68	[p3l1017t2110r1385b2179],
13	14	CD	NUMBER	14	num	14	SENT_68	[p3l1411t2113r1482b2165],
14	patients	NNS	O	patient	conj_and	6	SENT_68	[p3l1503t2111r1748b2179],
15	with	IN	O	with	_	0	SENT_68	[p3l1769t2110r1910b2165],
16	gliben	NN	O	gliben	nn	18	SENT_68	[p3l1931t2110r2146b2179],
17	—	NN	O	—	nn	18	SENT_68	[p3l1931t2110r2146b2179],
18	clamide	NN	O	clamide	prep_with	14	SENT_68	[p3l10t2199r249b2254],
19	and	CC	O	and	_	0	SENT_68	[p3l288t2199r399b2254],
20	3	CD	NUMBER	3	num	21	SENT_68	[p3l438t2202r471b2254],
21	patients	NNS	O	patient	conj_and	6	SENT_68	[p3l513t2200r758b2268],
22	with	IN	O	with	_	0	SENT_68	[p3l797t2199r937b2254],
23	glipizide	NN	O	glipizide	prep_with	21	SENT_68	[p3l975t2199r1251b2268],
24	.	.	O	.	_	0	SENT_68	[p3l975t2199r1251b2268],

1	Measurements	NNS	O	measurement	nsubjpass	7	SENT_69	[p3l1292t2202r1745b2254],
2	of	IN	O	of	_	0	SENT_69	[p3l1785t2199r1848b2254],
3	FPG	NNP	ORGANIZATION	FPG	prep_of	1	SENT_69	[p3l1881t2202r1996b2254],
4	and	CC	O	and	_	0	SENT_69	[p3l2035t2199r2146b2254],
5	HbA1C	NN	O	hba1c	conj_and	3	SENT_69	[p3l10t2288r193b2354],
6	were	VBD	O	be	auxpass	7	SENT_69	[p3l220t2304r373b2343],
7	repeated	VBN	O	repeat	_	0	SENT_69	[p3l403t2288r671b2357],
8	after	IN	O	after	_	0	SENT_69	[p3l701t2288r843b2343],
9	3	CD	NUMBER	3	nn	12	SENT_69	[p3l870t2291r902b2343],
10	and	CC	O	and	_	0	SENT_69	[p3l934t2288r1045b2343],
11	6	CD	DURATION	6	nn	12	SENT_69	[p3l1076t2291r1110b2343],
12	months	NNS	NUMBER	month	prep_after	7	SENT_69	[p3l1132t2288r1378b2352],
13	,	,	O	,	_	0	SENT_69	[p3l1132t2288r1378b2352],
14	while	IN	O	while	mark	23	SENT_69	[p3l1407t2288r1578b2343],
15	measurements	NNS	O	measurement	nsubjpass	23	SENT_69	[p3l1608t2296r2060b2343],
16	of	IN	O	of	_	0	SENT_69	[p3l2090t2288r2154b2343],
17	body	NN	O	body	nn	18	SENT_69	[p3l9t2377r161b2446],
18	weight	NN	O	weight	prep_of	15	SENT_69	[p3l184t2377r399b2446],
19	and	CC	O	and	_	0	SENT_69	[p3l424t2377r535b2432],
20	serum	NN	O	serum	nn	21	SENT_69	[p3l563t2393r753b2432],
21	lipids	NNS	O	lipid	conj_and	18	SENT_69	[p3l780t2377r944b2446],
22	were	VBD	O	be	auxpass	23	SENT_69	[p3l970t2393r1124b2432],
23	repeated	VBN	O	repeat	dep	12	SENT_69	[p3l1150t2377r1418b2446],
24	after	IN	O	after	_	0	SENT_69	[p3l1446t2377r1588b2432],
25	6	CD	DURATION	6	num	26	SENT_69	[p3l1613t2380r1647b2432],
26	months	NNS	NUMBER	month	prep_after	23	SENT_69	[p3l1669t2377r1900b2432],
27	following	VBG	O	follow	_	0	SENT_69	[p3l1927t2377r2145b2432, p3l10t2468r104b2535],
28	initiation	NN	O	initiation	prep_following	26	SENT_69	[p3l141t2468r420b2522],
29	of	IN	O	of	_	0	SENT_69	[p3l458t2467r522b2522],
30	sulfonylurea	NN	O	sulfonylurea	nn	31	SENT_69	[p3l553t2467r933b2535],
31	therapy	NN	O	therapy	prep_of	28	SENT_69	[p3l970t2467r1221b2535],
32	.	.	O	.	_	0	SENT_69	[p3l970t2467r1221b2535],

1	If	IN	O	if	mark	9	SENT_70	[p3l1261t2467r1306b2521],
2	HbA1c	NN	O	hba1c	nn	3	SENT_70	[p3l1337t2467r1538b2522],
3	level	NN	O	level	dep	4	SENT_70	[p3l1575t2467r1853b2522],
4	<	JJR	O	<	nsubjpass	9	SENT_70	[p3l1575t2467r1853b2522],
5	7	CD	PERCENT	7	number	6	SENT_70	[p3l1575t2467r1853b2522],
6	%	NN	PERCENT	%	amod	4	SENT_70	[p3l1575t2467r1853b2522],
7	was	VBD	O	be	auxpass	9	SENT_70	[p3l1889t2483r2008b2522],
8	not	RB	O	not	neg	9	SENT_70	[p3l2047t2475r2148b2522],
9	reached	VBN	O	reach	advcl	18	SENT_70	[p3l10t2556r251b2611],
10	after	IN	O	after	_	0	SENT_70	[p3l278t2556r420b2611],
11	3-month	JJ	DURATION	3-month	amod	12	SENT_70	[p3l444t2556r714b2611],
12	therapy	NN	O	therapy	prep_after	9	SENT_70	[p3l741t2556r992b2624],
13	,	,	O	,	_	0	SENT_70	[p3l741t2556r992b2624],
14	doses	NNS	O	dose	nsubjpass	18	SENT_70	[p3l1019t2556r1188b2611],
15	could	MD	O	could	aux	18	SENT_70	[p3l1215t2556r1381b2611],
16	have	VB	O	have	aux	18	SENT_70	[p3l1409t2556r1551b2611],
17	been	VBN	O	be	auxpass	18	SENT_70	[p3l1578t2556r1725b2611],
18	increased	VBN	O	increase	_	0	SENT_70	[p3l1753t2556r2042b2611],
19	up	RB	O	up	advmod	18	SENT_70	[p3l2070t2572r2146b2624],
20	to	TO	O	to	_	0	SENT_70	[p3l9t2652r68b2699],
21	100	CD	PERCENT	100	num	22	SENT_70	[p3l93t2647r244b2699],
22	%	NN	PERCENT	%	prep_to	19	SENT_70	[p3l93t2647r244b2699],
23	of	IN	O	of	_	0	SENT_70	[p3l265t2644r329b2699],
24	the	DT	O	the	det	26	SENT_70	[p3l342t2644r439b2699],
25	approved	VBN	O	approve	amod	26	SENT_70	[p3l460t2644r749b2713],
26	dose	NN	O	dose	prep_of	22	SENT_70	[p3l770t2644r910b2699],
27	for	IN	O	for	_	0	SENT_70	[p3l931t2644r1016b2699],
28	the	DT	O	the	det	31	SENT_70	[p3l1035t2644r1132b2699],
29	speciﬁc	NN	O	speciﬁc	nn	31	SENT_70	[p3l1155t2644r1381b2713],
30	sulfonylurea	NN	O	sulfonylurea	nn	31	SENT_70	[p3l1402t2644r1783b2713],
31	compound	NN	O	compound	prep_for	26	SENT_70	[p3l1803t2644r2145b2713],
32	.	.	O	.	_	0	SENT_70	[p3l1803t2644r2145b2713],

1	Mean	NN	O	mean	nn	3	SENT_71	[p3l10t2736r179b2788],
2	sulfonylurea	NN	O	sulfonylurea	nn	3	SENT_71	[p3l203t2733r583b2802],
3	dose	NN	O	dose	nsubj	11	SENT_71	[p3l606t2733r745b2788],
4	prescribed	VBN	O	prescribe	partmod	3	SENT_71	[p3l768t2733r1089b2802],
5	on	IN	O	on	_	0	SENT_71	[p3l1113t2749r1188b2788],
6	the	DT	O	the	det	8	SENT_71	[p3l1210t2733r1307b2788],
7	3-month	JJ	DURATION	3-month	amod	8	SENT_71	[p3l1329t2733r1600b2788],
8	visit	NN	O	visit	prep_on	4	SENT_71	[p3l1621t2734r1751b2788],
9	was	VBD	O	be	cop	11	SENT_71	[p3l1770t2749r1889b2788],
10	47	CD	NUMBER	47	num	11	SENT_71	[p3l1911t2736r1985b2787],
11	j	NN	O	j	_	0	SENT_71	[p3l2002t2741r2053b2791],
12	:	:	O	:	_	0	SENT_71	[p3l2002t2741r2053b2791],
13	2	CD	PERCENT	2	num	14	SENT_71	[p3l2070t2736r2147b2788],
14	%	NN	PERCENT	%	nsubj	17	SENT_71	[p3l2070t2736r2147b2788],
15	of	IN	O	of	_	0	SENT_71	[p3l10t2822r73b2877],
16	maximum	NN	O	maximum	prep_of	14	SENT_71	[p3l97t2823r412b2877],
17	approved	VBD	O	approve	parataxis	11	SENT_71	[p3l443t2822r732b2891],
18	dose	NN	O	dose	dobj	17	SENT_71	[p3l764t2822r903b2877],
19	for	IN	O	for	_	0	SENT_71	[p3l935t2822r1020b2877],
20	speciﬁc	NN	O	speciﬁc	nn	21	SENT_71	[p3l1052t2822r1277b2891],
21	drug	NN	O	drug	prep_for	17	SENT_71	[p3l1308t2822r1463b2891],
22	.	.	O	.	_	0	SENT_71	[p3l1308t2822r1463b2891],

1	Metformin	NNP	O	Metformin	nn	2	SENT_72	[p3l1497t2822r1826b2877],
2	dose	NN	O	dose	nsubjpass	5	SENT_72	[p3l1857t2822r1996b2877],
3	was	VBD	O	be	auxpass	5	SENT_72	[p3l2026t2838r2145b2877],
4	not	RB	O	not	neg	5	SENT_72	[p3l10t2919r111b2966],
5	changed	VBN	O	change	_	0	SENT_72	[p3l135t2911r391b2980],
6	during	IN	O	during	_	0	SENT_72	[p3l417t2911r620b2980],
7	the	DT	O	the	det	10	SENT_72	[p3l643t2911r740b2966],
8	entire	JJ	O	entire	amod	10	SENT_72	[p3l767t2912r946b2966],
9	study	NN	O	study	nn	10	SENT_72	[p3l973t2911r1141b2980],
10	period	NN	O	period	prep_during	5	SENT_72	[p3l1165t2911r1377b2980],
11	.	.	O	.	_	0	SENT_72	[p3l1165t2911r1377b2980],

1	The	DT	O	the	det	3	SENT_73	[p3l1401t2911r1513b2966],
2	participating	VBG	O	participate	amod	3	SENT_73	[p3l1539t2912r1931b2980],
3	physicians	NNS	O	physician	nsubjpass	5	SENT_73	[p3l1956t2911r2146b2980, p3l10t3002r162b3056],
4	were	VBD	O	be	auxpass	5	SENT_73	[p3l185t3017r338b3056],
5	blinded	VBN	O	blind	_	0	SENT_73	[p3l362t3001r593b3056],
6	to	TO	O	to	_	0	SENT_73	[p3l618t3009r677b3056],
7	the	DT	O	the	det	8	SENT_73	[p3l701t3001r798b3056],
8	results	NNS	O	result	prep_to	5	SENT_73	[p3l824t3001r1025b3056],
9	of	IN	O	of	_	0	SENT_73	[p3l1051t3001r1114b3056],
10	genotyping	NN	O	genotyping	prep_of	8	SENT_73	[p3l1129t3002r1491b3069],
11	.	.	O	.	_	0	SENT_73	[p3l1129t3002r1491b3069],

1	2.2	CD	NUMBER	2.2	_	0	SENT_74	[p3l6t3224r107b3276],
2	.	.	O	.	_	0	SENT_74	[p3l6t3224r107b3276],

1	Study	NNP	O	Study	_	0	SENT_75	[p3l132t3221r299b3289],
2	outcome	NN	O	outcome	dep	1	SENT_75	[p3l323t3229r574b3276],

1	The	DT	O	the	det	4	SENT_76	[p3l109t3399r219b3454],
2	main	JJ	O	main	amod	4	SENT_76	[p3l237t3400r388b3454],
3	study	NN	O	study	nn	4	SENT_76	[p3l406t3399r571b3468],
4	outcome	NN	O	outcome	nsubj	7	SENT_76	[p3l586t3407r848b3454],
5	was	VBD	O	be	cop	7	SENT_76	[p3l863t3415r981b3454],
6	the	DT	O	the	det	7	SENT_76	[p3l999t3399r1095b3454],
7	change	NN	O	change	_	0	SENT_76	[p3l1111t3399r1323b3468],
8	in	IN	O	in	_	0	SENT_76	[p3l1341t3400r1397b3453],
9	HbA1c	NN	O	hba1c	nn	10	SENT_76	[p3l1414t3399r1613b3454],
10	level	NN	O	level	prep_in	7	SENT_76	[p3l1629t3399r1767b3454],
11	following	VBG	O	follow	_	0	SENT_76	[p3l1785t3399r2069b3468],
12	6month	JJ	O	6month	amod	13	SENT_76	[p3l2085t3402r2146b3454, p3l10t3488r209b3543],
13	therapy	NN	O	therapy	prep_following	10	SENT_76	[p3l235t3488r468b3557],
14	with	IN	O	with	_	0	SENT_76	[p3l491t3488r629b3543],
15	sulfonylurea	NN	O	sulfonylurea	nn	19	SENT_76	[p3l657t3488r1028b3557],
16	(	CD	NUMBER	(	num	19	SENT_76	[p3l1058t3488r1288b3557],
17	AHbAl	NN	O	ahbal	nn	19	SENT_76	[p3l1058t3488r1288b3557],
18	c	NN	O	c	nn	19	SENT_76	[p3l1301t3489r1371b3557],
19	)	NN	O	)	prep_with	13	SENT_76	[p3l1301t3489r1371b3557],
20	.	.	O	.	_	0	SENT_76	[p3l1301t3489r1371b3557],

1	HbAlc	NN	O	hbalc	nsubjpass	19	SENT_77	[p3l1398t3488r1596b3543],
2	is	VBZ	O	be	auxpass	3	SENT_77	[p3l1621t3489r1664b3543],
3	used	VBN	O	use	_	0	SENT_77	[p3l1690t3488r1829b3543],
4	in	IN	O	in	_	0	SENT_77	[p3l1856t3489r1912b3543],
5	clinical	JJ	O	clinical	amod	6	SENT_77	[p3l1938t3488r2146b3543],
6	practice	NN	O	practice	prep_in	3	SENT_77	[p3l10t3578r246b3646],
7	as	IN	O	as	_	0	SENT_77	[p3l266t3593r325b3632],
8	the	DT	O	the	det	10	SENT_77	[p3l345t3577r440b3632],
9	main	JJ	O	main	amod	10	SENT_77	[p3l461t3578r612b3632],
10	index	NN	O	index	prep_as	3	SENT_77	[p3l632t3577r800b3632],
11	of	IN	O	of	_	0	SENT_77	[p3l818t3577r880b3632],
12	long	JJ	O	long	amod	14	SENT_77	[p3l893t3577r1196b3646],
13	—	NN	O	—	nn	14	SENT_77	[p3l893t3577r1196b3646],
14	term	NN	O	term	prep_of	10	SENT_77	[p3l893t3577r1196b3646],
15	glycemic	JJ	O	glycemic	amod	16	SENT_77	[p3l1214t3577r1481b3646],
16	control	NN	O	control	dep	14	SENT_77	[p3l1500t3577r1712b3632],
17	and	CC	O	and	_	0	SENT_77	[p3l1732t3577r1841b3632],
18	is	VBZ	O	be	auxpass	19	SENT_77	[p3l1863t3578r1906b3632],
19	considered	VBN	O	consider	conj_and	3	SENT_77	[p3l1927t3577r2145b3632, p3l10t3667r140b3722],
20	to	TO	O	to	aux	24	SENT_77	[p3l167t3675r224b3722],
21	be	VB	O	be	cop	24	SENT_77	[p3l249t3667r320b3722],
22	an	DT	O	a	det	24	SENT_77	[p3l345t3683r417b3722],
23	appropriate	JJ	O	appropriate	amod	24	SENT_77	[p3l441t3668r792b3735],
24	endpoint	NN	O	endpoint	xcomp	19	SENT_77	[p3l818t3667r1091b3735],
25	for	IN	O	for	_	0	SENT_77	[p3l1114t3667r1197b3722],
26	a	DT	O	a	det	28	SENT_77	[p3l1222t3683r1253b3722],
27	pharmacogenetic	JJ	O	pharmacogenetic	amod	28	SENT_77	[p3l1277t3667r1798b3735],
28	study	NN	O	study	prep_for	24	SENT_77	[p3l1823t3667r1988b3735],
29	[	CD	NUMBER	[	number	30	SENT_77	[p3l2015t3667r2145b3735],
30	18	CD	NUMBER	18	num	31	SENT_77	[p3l2015t3667r2145b3735],
31	]	NN	O	]	dobj	3	SENT_77	[p3l2015t3667r2145b3735],
32	.	.	O	.	_	0	SENT_77	[p3l2015t3667r2145b3735],

1	We	PRP	O	we	nsubj	2	SENT_78	[p4l7t20r110b72],
2	decided	VBD	O	decide	_	0	SENT_78	[p4l134t17r367b72],
3	to	TO	O	to	aux	4	SENT_78	[p4l391t25r448b72],
4	use	VB	O	use	xcomp	2	SENT_78	[p4l472t33r572b72],
5	the	DT	O	the	det	6	SENT_78	[p4l594t17r690b72],
6	reduction	NN	O	reduction	dobj	4	SENT_78	[p4l714t17r1002b72],
7	of	IN	O	of	_	0	SENT_78	[p4l1025t17r1088b72],
8	HbA1c	NN	O	hba1c	nn	9	SENT_78	[p4l1103t17r1301b72],
9	value	NN	O	value	prep_of	6	SENT_78	[p4l1321t17r1483b72],
10	after	IN	O	after	_	0	SENT_78	[p4l1505t17r1645b72],
11	6-month	JJ	DURATION	6-month	amod	12	SENT_78	[p4l1666t17r1930b72],
12	period	NN	O	period	prep_after	4	SENT_78	[p4l1953t17r2146b85],

1	Table	NNP	O	Table	_	0	SENT_79	[p4l6t239r145b283],
2	1	CD	NUMBER	1	num	4	SENT_79	[p4l166t241r188b282],
3	Baseline	NN	O	baseline	nn	4	SENT_79	[p4l9t309r206b353],
4	characteristics	NNS	O	characteristic	dep	1	SENT_79	[p4l219t310r561b353],
5	of	IN	O	of	_	0	SENT_79	[p4l575t309r625b353],
6	the	DT	O	the	det	7	SENT_79	[p4l631t309r707b353],
7	subjects	NNS	O	subject	prep_of	4	SENT_79	[p4l722t309r913b364],
8	and	CC	O	and	_	0	SENT_79	[p4l927t309r1014b353],
9	the	DT	O	the	det	10	SENT_79	[p4l1028t309r1104b353],
10	effect	NN	O	effect	conj_and	4	SENT_79	[p4l1118t309r1250b353],
11	of	IN	O	of	_	0	SENT_79	[p4l1261t309r1312b353],
12	6-month	JJ	DURATION	6-month	amod	14	SENT_79	[p4l1319t309r1531b353],
13	sulfonylurea	NN	O	sulfonylurea	nn	14	SENT_79	[p4l1544t309r1841b364],
14	treatment	NN	O	treatment	prep_of	10	SENT_79	[p4l1853t316r2095b353],
15	in	IN	O	in	_	0	SENT_79	[p4l2107t310r2152b353],
16	addition	NN	O	addition	_	0	SENT_79	[p4l9t381r208b424],
17	to	TO	O	to	_	0	SENT_79	[p4l225t387r271b424],
18	previous	JJ	O	previous	amod	20	SENT_79	[p4l288t382r494b435],
19	metformin	JJ	O	metformin	amod	20	SENT_79	[p4l512t381r770b424],
20	monotherapy	NN	O	monotherapy	prep_in_addition_to	14	SENT_79	[p4l787t381r1114b435],
21	in	IN	O	in	_	0	SENT_79	[p4l1130t382r1175b424],
22	the	DT	O	the	det	24	SENT_79	[p4l1191t381r1268b424],
23	entire	JJ	O	entire	amod	24	SENT_79	[p4l1285t381r1426b424],
24	group	NN	O	group	prep_in	20	SENT_79	[p4l1442t393r1582b435],
25	of	IN	O	of	_	0	SENT_79	[p4l1600t381r1650b424],
26	patients	NNS	O	patient	prep_of	24	SENT_79	[p4l1662t382r1865b435],
27	.	.	O	.	_	0	SENT_79	[p4l1662t382r1865b435],

1	Before	IN	O	before	mark	2	SENT_80	[p4l841t519r996b563],
2	treatment	NN	O	treatment	_	0	SENT_80	[p4l1015t526r1262b563],
3	After	IN	O	after	dep	2	SENT_80	[p4l1401t519r1525b563],
4	treatment	NN	O	treatment	nn	5	SENT_80	[p4l1542t526r1789b563],
5	p	NN	O	p	pobj	3	SENT_80	[p4l1930t532r1958b574],

1	Weight	NNP	O	Weight	dep	117	SENT_81	[p4l57t657r241b711],
2	(	CD	NUMBER	(	dep	117	SENT_81	[p4l263t657r360b711],
3	kg	NN	O	kg	dep	117	SENT_81	[p4l263t657r360b711],
4	)	NN	O	)	dep	117	SENT_81	[p4l263t657r360b711],
5	84.4	CD	NUMBER	84.4	dep	117	SENT_81	[p4l841t659r943b701],
6	:	:	O	:	_	0	SENT_81	[p4l955t663r996b703],
7	t	NN	O	t	dep	117	SENT_81	[p4l955t663r996b703],
8	1.5	CD	NUMBER	1.5	dep	117	SENT_81	[p4l1013t659r1080b701],
9	84.7	CD	NUMBER	84.7	dep	117	SENT_81	[p4l1403t659r1504b701],
10	:	:	O	:	_	0	SENT_81	[p4l1518t663r1559b703],
11	|	CD	NUMBER	|	dep	117	SENT_81	[p4l1518t663r1559b703],
12	:	:	O	:	_	0	SENT_81	[p4l1518t663r1559b703],
13	1.6	CD	NUMBER	1.6	dep	117	SENT_81	[p4l1575t659r1644b701],
14	0.279	CD	NUMBER	0.279	dep	117	SENT_81	[p4l1966t659r2099b701],
15	BMI	NN	O	bmus	dep	117	SENT_81	[p4l60t730r155b770],
16	(	CD	NUMBER	(	dep	117	SENT_81	[p4l179t719r370b782],
17	kg/m2	NN	O	kg/m2	dep	117	SENT_81	[p4l179t719r370b782],
18	)	CD	NUMBER	)	dep	117	SENT_81	[p4l179t719r370b782],
19	30.3	CD	NUMBER	30.3	dep	117	SENT_81	[p4l839t729r940b771],
20	:	:	O	:	_	0	SENT_81	[p4l956t733r996b773],
21	t	NN	O	t	dep	117	SENT_81	[p4l956t733r996b773],
22	0.4	CD	NUMBER	0.4	dep	117	SENT_81	[p4l1010t729r1082b771],
23	30.4	CD	NUMBER	30.4	dep	117	SENT_81	[p4l1402t729r1506b771],
24	A	DT	O	a	dep	117	SENT_81	[p4l1518t733r1559b773],
25	:	:	O	:	_	0	SENT_81	[p4l1518t733r1559b773],
26	0.4	CD	NUMBER	0.4	dep	117	SENT_81	[p4l1573t729r1644b771],
27	0.684	CD	NUMBER	0.684	dep	117	SENT_81	[p4l1966t729r2100b771],
28	FPG	NNP	O	FPG	dep	117	SENT_81	[p4l60t801r152b842],
29	(	CD	NUMBER	(	dep	117	SENT_81	[p4l175t798r395b853],
30	mmol/1	NN	O	mmol/1	dep	117	SENT_81	[p4l175t798r395b853],
31	)	CD	NUMBER	)	dep	117	SENT_81	[p4l175t798r395b853],
32	8.63	CD	NUMBER	8.63	dep	117	SENT_81	[p4l841t801r940b842],
33	;	:	O	;	_	0	SENT_81	[p4l956t805r996b845],
34	l	NN	O	l	dep	117	SENT_81	[p4l956t805r996b845],
35	:	:	O	:	_	0	SENT_81	[p4l956t805r996b845],
36	0.14	CD	NUMBER	0.14	dep	117	SENT_81	[p4l1010t801r1113b842],
37	7.18	CD	NUMBER	7.18	dep	117	SENT_81	[p4l1404t801r1504b842],
38	:	:	O	:	_	0	SENT_81	[p4l1518t805r1559b845],
39	l	NN	O	l	dep	117	SENT_81	[p4l1518t805r1559b845],
40	:	:	O	:	_	0	SENT_81	[p4l1518t805r1559b845],
41	0.12	CD	NUMBER	0.12	dep	117	SENT_81	[p4l1573t801r1673b842],
42	<	JJR	O	<	dep	117	SENT_81	[p4l1929t801r2093b842],
43	0.001	CD	NUMBER	0.001	dep	117	SENT_81	[p4l1929t801r2093b842],
44	HbA1	NN	O	hba1	dep	117	SENT_81	[p4l60t870r188b913],
45	c	NN	O	c	dep	117	SENT_81	[p4l198t882r221b913],
46	(	CD	PERCENT	(	dep	117	SENT_81	[p4l243t870r315b924],
47	%	NN	PERCENT	%	dep	117	SENT_81	[p4l243t870r315b924],
48	)	CD	NUMBER	)	dep	117	SENT_81	[p4l243t870r315b924],
49	8.04	CD	NUMBER	8.04	dep	117	SENT_81	[p4l841t872r943b914],
50	:	:	O	:	_	0	SENT_81	[p4l956t876r996b916],
51	t	NN	O	t	dep	117	SENT_81	[p4l956t876r996b916],
52	0.09	CD	NUMBER	0.09	dep	117	SENT_81	[p4l1010t872r1112b914],
53	6.99	CD	NUMBER	6.99	dep	117	SENT_81	[p4l1403t872r1504b914],
54	;	:	O	;	_	0	SENT_81	[p4l1518t876r1559b916],
55	l	NN	O	l	dep	117	SENT_81	[p4l1518t876r1559b916],
56	;	:	O	;	_	0	SENT_81	[p4l1518t876r1559b916],
57	0.06	CD	NUMBER	0.06	dep	117	SENT_81	[p4l1573t872r1675b914],
58	<	JJR	O	<	dep	117	SENT_81	[p4l1929t872r2093b914],
59	0.001	CD	NUMBER	0.001	dep	117	SENT_81	[p4l1929t872r2093b914],
60	Cholesterol	NN	O	cholesterol	dep	117	SENT_81	[p4l60t941r337b985],
61	(	CD	NUMBER	(	dep	117	SENT_81	[p4l360t941r579b995],
62	mmol/1	NN	O	mmol/1	dep	117	SENT_81	[p4l360t941r579b995],
63	)	CD	NUMBER	)	dep	117	SENT_81	[p4l360t941r579b995],
64	5.16	CD	NUMBER	5.16	dep	117	SENT_81	[p4l841t943r942b985],
65	i	FW	O	i	dep	117	SENT_81	[p4l956t947r996b987],
66	0.12	CD	NUMBER	0.12	dep	117	SENT_81	[p4l1010t943r1111b985],
67	4.90	CD	NUMBER	4.90	dep	117	SENT_81	[p4l1401t943r1505b985],
68	:	:	O	:	_	0	SENT_81	[p4l1518t947r1559b987],
69	l	NN	O	l	dep	117	SENT_81	[p4l1518t947r1559b987],
70	:	:	O	:	_	0	SENT_81	[p4l1518t947r1559b987],
71	0.12	CD	NUMBER	0.12	dep	117	SENT_81	[p4l1573t943r1673b985],
72	0.057	CD	NUMBER	0.057	dep	117	SENT_81	[p4l1966t943r2098b985],
73	LDL	NN	O	ldl	dep	117	SENT_81	[p4l60t1015r151b1055],
74	cholesterol	NN	O	cholesterol	dep	117	SENT_81	[p4l168t1012r438b1056],
75	(	CD	NUMBER	(	dep	117	SENT_81	[p4l461t1012r681b1066],
76	mmol/1	NN	O	mmol/1	dep	117	SENT_81	[p4l461t1012r681b1066],
77	)	CD	NUMBER	)	dep	117	SENT_81	[p4l461t1012r681b1066],
78	2.84	CD	NUMBER	2.84	dep	117	SENT_81	[p4l840t1014r943b1056],
79	:	:	O	:	_	0	SENT_81	[p4l956t1018r996b1058],
80	l	NN	O	l	dep	117	SENT_81	[p4l956t1018r996b1058],
81	:	:	O	:	_	0	SENT_81	[p4l956t1018r996b1058],
82	0.09	CD	NUMBER	0.09	dep	117	SENT_81	[p4l1010t1014r1112b1056],
83	2.61	CD	NUMBER	2.61	dep	117	SENT_81	[p4l1403t1014r1499b1056],
84	:	:	O	:	_	0	SENT_81	[p4l1518t1018r1559b1058],
85	I	PRP	O	I	dep	117	SENT_81	[p4l1518t1018r1559b1058],
86	:	:	O	:	_	0	SENT_81	[p4l1518t1018r1559b1058],
87	0.06	CD	NUMBER	0.06	dep	117	SENT_81	[p4l1573t1014r1675b1056],
88	0.029	CD	NUMBER	0.029	dep	117	SENT_81	[p4l1966t1014r2099b1056],
89	HDL	NN	O	hdl	dep	117	SENT_81	[p4l60t1086r164b1126],
90	cholesterol	NN	O	cholesterol	dep	117	SENT_81	[p4l182t1083r451b1127],
91	(	CD	NUMBER	(	dep	117	SENT_81	[p4l475t1083r695b1137],
92	mmol/1	NN	O	mmol/1	dep	117	SENT_81	[p4l475t1083r695b1137],
93	)	CD	NUMBER	)	dep	117	SENT_81	[p4l475t1083r695b1137],
94	1.11	CD	NUMBER	1.11	dep	117	SENT_81	[p4l843t1086r936b1127],
95	i	FW	O	i	dep	117	SENT_81	[p4l956t1089r996b1129],
96	0.03	CD	NUMBER	0.03	dep	117	SENT_81	[p4l1010t1085r1110b1127],
97	1.16	CD	NUMBER	1.16	dep	117	SENT_81	[p4l1406t1085r1505b1127],
98	:	:	O	:	_	0	SENT_81	[p4l1518t1089r1559b1129],
99	l	NN	O	l	dep	117	SENT_81	[p4l1518t1089r1559b1129],
100	:	:	O	:	_	0	SENT_81	[p4l1518t1089r1559b1129],
101	0.03	CD	NUMBER	0.03	dep	117	SENT_81	[p4l1573t1085r1672b1127],
102	0.029	CD	NUMBER	0.029	dep	117	SENT_81	[p4l1966t1085r2099b1127],
103	Triglycerides	NNS	MISC	triglyceride	dep	117	SENT_81	[p4l58t1154r375b1208],
104	(	VBP	O	(	dep	117	SENT_81	[p4l399t1154r618b1208],
105	mmol/1	NN	O	mmol/1	dep	117	SENT_81	[p4l399t1154r618b1208],
106	)	CD	NUMBER	)	dep	117	SENT_81	[p4l399t1154r618b1208],
107	2.07	CD	NUMBER	2.07	dep	117	SENT_81	[p4l840t1156r941b1198],
108	:	:	O	:	_	0	SENT_81	[p4l956t1160r996b1200],
109	|	CD	NUMBER	|	dep	117	SENT_81	[p4l956t1160r996b1200],
110	;	:	O	;	_	0	SENT_81	[p4l956t1160r996b1200],
111	0.09	CD	NUMBER	0.09	dep	117	SENT_81	[p4l1010t1156r1112b1198],
112	1.86	CD	NUMBER	1.86	dep	117	SENT_81	[p4l1406t1156r1505b1198],
113	:	:	O	:	_	0	SENT_81	[p4l1518t1160r1559b1200],
114	l	NN	O	l	dep	117	SENT_81	[p4l1518t1160r1559b1200],
115	:	:	O	:	_	0	SENT_81	[p4l1518t1160r1559b1200],
116	0.08	CD	NUMBER	0.08	dep	117	SENT_81	[p4l1573t1156r1673b1198],
117	0.005	CD	NUMBER	0.005	_	0	SENT_81	[p4l1966t1156r2098b1198],

1	Data	NNS	O	datum	nsubjpass	3	SENT_82	[p4l9t1295r116b1336],
2	are	VBP	O	be	auxpass	3	SENT_82	[p4l130t1305r203b1336],
3	expressed	VBN	O	express	_	0	SENT_82	[p4l218t1292r452b1347],
4	as	IN	O	as	_	0	SENT_82	[p4l468t1305r514b1336],
5	mean	NN	O	mean	prep_as	3	SENT_82	[p4l530t1305r661b1336],
6	:	:	O	:	_	0	SENT_82	[p4l673t1298r713b1338],
7	I	PRP	O	I	dep	5	SENT_82	[p4l673t1298r713b1338],
8	;	:	O	;	_	0	SENT_82	[p4l673t1298r713b1338],
9	SEM	NN	O	sem	dep	5	SENT_82	[p4l726t1294r839b1336],
10	.	.	O	.	_	0	SENT_82	[p4l726t1294r839b1336],

1	p-values	NNS	O	p-value	nsubj	2	SENT_83	[p4l855t1292r1054b1347],
2	refer	VBP	O	refer	_	0	SENT_83	[p4l1070t1292r1181b1336],
3	to	TO	O	to	_	0	SENT_83	[p4l1194t1299r1239b1336],
4	paired	JJ	O	paired	amod	5	SENT_83	[p4l1255t1292r1403b1347],
5	Student	NN	O	student	poss	7	SENT_83	[p4l1419t1292r1634b1336],
6	's	POS	O	's	_	0	SENT_83	[p4l1419t1292r1634b1336],
7	tests	NNS	O	test	prep_to	2	SENT_83	[p4l1649t1299r1767b1336],
8	.	.	O	.	_	0	SENT_83	[p4l1649t1299r1767b1336],

1	BMI	NNP	O	BMI	_	0	SENT_84	[p4l1783t1295r1886b1342],
2	,	,	O	,	_	0	SENT_84	[p4l1783t1295r1886b1342],
3	body	NN	O	body	nn	5	SENT_84	[p4l1901t1292r2019b1347],
4	mass	NN	O	mass	nn	5	SENT_84	[p4l2033t1305r2150b1336],
5	index	NN	O	index	appos	1	SENT_84	[p4l9t1363r154b1413],
6	;	:	O	;	_	0	SENT_84	[p4l9t1363r154b1413],
7	FPG	NNP	ORGANIZATION	FPG	dep	1	SENT_84	[p4l192t1365r293b1413],
8	,	,	O	,	_	0	SENT_84	[p4l192t1365r293b1413],
9	fasting	VBG	O	fast	amod	11	SENT_84	[p4l328t1363r486b1417],
10	plasma	NN	O	plasma	nn	11	SENT_84	[p4l518t1363r686b1417],
11	glucose	NN	O	glucose	appos	7	SENT_84	[p4l719t1363r909b1417],
12	;	:	O	;	_	0	SENT_84	[p4l719t1363r909b1417],
13	LDL	NN	O	ldl	dep	7	SENT_84	[p4l947t1365r1043b1413],
14	,	,	O	,	_	0	SENT_84	[p4l947t1365r1043b1413],
15	low-density	JJ	O	low-density	amod	16	SENT_84	[p4l1079t1363r1362b1417],
16	lipoprotein	NN	O	lipoprotein	appos	13	SENT_84	[p4l1395t1363r1669b1417],
17	;	:	O	;	_	0	SENT_84	[p4l1395t1363r1669b1417],
18	HDL	NNP	O	HDL	dep	7	SENT_84	[p4l1707t1365r1817b1413],
19	,	,	O	,	_	0	SENT_84	[p4l1707t1365r1817b1413],
20	high	JJ	O	high	amod	23	SENT_84	[p4l1853t1363r2152b1417],
21	—	NN	O	—	nn	23	SENT_84	[p4l1853t1363r2152b1417],
22	density	NN	O	density	nn	23	SENT_84	[p4l1853t1363r2152b1417],
23	lipoprotein	NN	O	lipoprotein	appos	18	SENT_84	[p4l9t1434r280b1488],
24	.	.	O	.	_	0	SENT_84	[p4l9t1434r280b1488],

1	based	VBN	O	base	_	0	SENT_85	[p4l10t1641r182b1696],
2	on	IN	O	on	prepc_based_on	13	SENT_85	[p4l234t1657r308b1696],
3	the	DT	O	the	det	4	SENT_85	[p4l359t1641r456b1696],
4	results	NNS	O	result	pobj	13	SENT_85	[p4l508t1641r705b1696],
5	of	IN	O	of	_	0	SENT_85	[p4l757t1641r820b1696],
6	A	DT	O	a	det	10	SENT_85	[p4l861t1643r906b1695],
7	Diabetes	NNP	O	Diabetes	nn	10	SENT_85	[p4l956t1641r1211b1696],
8	Outcomes	NNPS	O	Outcomes	nn	10	SENT_85	[p4l1264t1644r1564b1696],
9	Progression	NNP	O	Progression	nn	10	SENT_85	[p4l1617t1642r1967b1710],
10	Trial	NNP	O	Trial	prep_of	4	SENT_85	[p4l2016t1641r2151b1696],
11	(	NNP	O	(	nn	12	SENT_85	[p4l15t1730r275b1798],
12	ADOPT	NNP	O	ADOPT	nsubj	13	SENT_85	[p4l15t1730r275b1798],
13	)	VBD	O	)	_	0	SENT_85	[p4l15t1730r275b1798],
14	which	WDT	O	which	nsubj	15	SENT_85	[p4l306t1730r493b1785],
15	showed	VBD	O	show	ccomp	13	SENT_85	[p4l522t1730r755b1785],
16	that	IN	O	that	complm	24	SENT_85	[p4l785t1730r907b1785],
17	maximal	JJ	O	maximal	amod	18	SENT_85	[p4l934t1730r1195b1785],
18	response	NN	O	response	nsubjpass	24	SENT_85	[p4l1225t1746r1492b1799],
19	to	TO	O	to	_	0	SENT_85	[p4l1522t1738r1580b1785],
20	sulfonylurea	NN	O	sulfonylurea	nn	22	SENT_85	[p4l1611t1730r1984b1799],
21	drug	NN	O	drug	nn	22	SENT_85	[p4l2012t1730r2152b1799],
22	glibenclamide	NN	O	glibenclamide	prep_to	18	SENT_85	[p4l10t1819r432b1888],
23	was	VBD	O	be	auxpass	24	SENT_85	[p4l457t1835r575b1874],
24	recorded	VBN	O	record	ccomp	15	SENT_85	[p4l601t1819r867b1874],
25	after	IN	O	after	_	0	SENT_85	[p4l894t1819r1033b1874],
26	6-month	JJ	DURATION	6-month	amod	27	SENT_85	[p4l1057t1819r1322b1874],
27	treatment	NN	O	treatment	prep_after	24	SENT_85	[p4l1347t1827r1650b1874],
28	[	CD	NUMBER	[	number	29	SENT_85	[p4l1677t1819r1807b1888],
29	19	CD	NUMBER	19	num	30	SENT_85	[p4l1677t1819r1807b1888],
30	]	NN	O	]	dep	24	SENT_85	[p4l1677t1819r1807b1888],
31	.	.	O	.	_	0	SENT_85	[p4l1677t1819r1807b1888],

1	Six	CD	NUMBER	six	num	3	SENT_86	[p4l1833t1819r2150b1874],
2	—	CD	NUMBER	—	num	3	SENT_86	[p4l1833t1819r2150b1874],
3	month	NN	NUMBER	month	nsubj	5	SENT_86	[p4l1833t1819r2150b1874],
4	period	NN	O	period	dep	3	SENT_86	[p4l11t1908r204b1977],
5	enables	VBZ	O	enable	_	0	SENT_86	[p4l237t1908r462b1963],
6	also	RB	O	also	advmod	5	SENT_86	[p4l495t1908r611b1963],
7	adjustments	NNS	O	adjustment	dobj	5	SENT_86	[p4l644t1908r1014b1977],
8	in	IN	O	in	_	0	SENT_86	[p4l1049t1909r1104b1963],
9	the	DT	O	the	det	11	SENT_86	[p4l1136t1908r1233b1963],
10	sulfonylurea	NN	O	sulfonylurea	nn	11	SENT_86	[p4l1265t1908r1638b1977],
11	dose	NN	O	dose	prep_in	7	SENT_86	[p4l1671t1908r1808b1963],
12	needed	VBN	O	need	partmod	11	SENT_86	[p4l1840t1908r2059b1963],
13	to	TO	O	to	aux	14	SENT_86	[p4l2092t1916r2150b1963],
14	achieve	VB	O	achieve	xcomp	12	SENT_86	[p4l11t1997r236b2053],
15	higher	JJR	O	higher	amod	17	SENT_86	[p4l259t1998r454b2066],
16	drug	NN	O	drug	nn	17	SENT_86	[p4l474t1997r614b2066],
17	effect	NN	O	effect	dobj	14	SENT_86	[p4l634t1997r811b2053],
18	.	.	O	.	_	0	SENT_86	[p4l634t1997r811b2053],

1	2.3	CD	NUMBER	2.3	_	0	SENT_87	[p4l7t2179r109b2231],
2	.	.	O	.	_	0	SENT_87	[p4l7t2179r109b2231],

1	Biochemical	JJ	O	biochemical	amod	2	SENT_88	[p4l134t2176r491b2231],
2	analyses	NNS	O	analysis	_	0	SENT_88	[p4l513t2176r762b2245],

1	In	IN	O	in	_	0	SENT_89	[p4l113t2358r170b2409],
2	all	DT	O	all	det	3	SENT_89	[p4l189t2354r259b2409],
3	patients	NNS	O	patient	prep_in	10	SENT_89	[p4l279t2355r540b2423],
4	,	,	O	,	_	0	SENT_89	[p4l279t2355r540b2423],
5	peripheral	JJ	O	peripheral	amod	8	SENT_89	[p4l559t2354r877b2423],
6	venous	JJ	O	venous	amod	8	SENT_89	[p4l894t2370r1113b2409],
7	blood	NN	O	blood	nn	8	SENT_89	[p4l1132t2354r1303b2409],
8	samples	NNS	O	sample	nsubjpass	10	SENT_89	[p4l1324t2354r1570b2423],
9	were	VBD	O	be	auxpass	10	SENT_89	[p4l1588t2370r1741b2409],
10	collected	VBN	O	collect	_	0	SENT_89	[p4l1761t2354r2033b2409],
11	between	IN	O	between	_	0	SENT_89	[p4l2052t2354r2150b2409, p4l10t2452r201b2499],
12	7-8	CD	NUMBER	7-8	prep_between	10	SENT_89	[p4l232t2447r341b2499],
13	a.m.	RB	O	a.m.	advmod	12	SENT_89	[p4l364t2460r487b2499],
14	following	VBG	O	follow	xcomp	10	SENT_89	[p4l519t2444r809b2512],
15	an	DT	O	a	det	18	SENT_89	[p4l837t2460r909b2499],
16	overnight	JJ	TIME	overnight	amod	18	SENT_89	[p4l938t2444r1238b2512],
17	12	CD	NUMBER	12	num	18	SENT_89	[p4l1268t2447r1337b2498],
18	h	NN	O	h	dobj	14	SENT_89	[p4l1361t2444r1397b2498],
19	fast	RB	O	fast	advmod	14	SENT_89	[p4l1427t2444r1548b2499],
20	.	.	O	.	_	0	SENT_89	[p4l1427t2444r1548b2499],

1	Glucose	NN	O	glucose	nsubjpass	3	SENT_90	[p4l1579t2444r1816b2499],
2	was	VBD	O	be	auxpass	3	SENT_90	[p4l1845t2460r1964b2499],
3	measured	VBN	O	measure	ccomp	11	SENT_90	[p4l1995t2460r2150b2499, p4l12t2533r179b2588],
4	by	IN	O	by	_	0	SENT_90	[p4l212t2533r286b2601],
5	glucoseoxidase	NN	O	glucoseoxidase	nn	6	SENT_90	[p4l316t2533r780b2601],
6	method	NN	O	method	agent	3	SENT_90	[p4l814t2533r1066b2596],
7	,	,	O	,	_	0	SENT_90	[p4l814t2533r1066b2596],
8	blood	NN	O	blood	nn	9	SENT_90	[p4l1099t2533r1271b2588],
9	lipids	NNS	O	lipid	nsubjpass	11	SENT_90	[p4l1305t2533r1469b2601],
10	were	VBD	O	be	auxpass	11	SENT_90	[p4l1501t2548r1655b2588],
11	determined	VBN	O	determine	_	0	SENT_90	[p4l1688t2533r2046b2588],
12	by	IN	O	by	_	0	SENT_90	[p4l2078t2533r2152b2601],
13	routine	JJ	O	routine	amod	15	SENT_90	[p4l11t2622r234b2676],
14	enzymatic	JJ	O	enzymatic	amod	15	SENT_90	[p4l256t2622r572b2690],
15	methods	NNS	O	method	agent	11	SENT_90	[p4l594t2621r875b2677],
16	.	.	O	.	_	0	SENT_90	[p4l594t2621r875b2677],

1	HbA1c	NN	O	hba1c	nsubjpass	3	SENT_91	[p4l899t2621r1100b2676],
2	was	VBD	O	be	auxpass	3	SENT_91	[p4l1119t2637r1238b2676],
3	measured	VBN	O	measure	_	0	SENT_91	[p4l1261t2621r1561b2676],
4	using	VBG	O	use	xcomp	3	SENT_91	[p4l1584t2622r1749b2690],
5	an	DT	O	a	det	7	SENT_91	[p4l1770t2637r1841b2676],
6	immunoturbidimetric	JJ	O	immunoturbidimetric	amod	7	SENT_91	[p4l1864t2622r2150b2676, p4l10t2710r420b2765],
7	method	NN	O	method	dobj	4	SENT_91	[p4l445t2710r681b2765],
8	(	CD	NUMBER	(	num	10	SENT_91	[p4l710t2710r920b2778],
9	Roche	NNP	PERSON	Roche	nn	10	SENT_91	[p4l710t2710r920b2778],
10	Diagnostica	NNP	PERSON	Diagnostica	dep	7	SENT_91	[p4l946t2711r1315b2779],
11	,	,	O	,	_	0	SENT_91	[p4l946t2711r1315b2779],
12	France	NNP	LOCATION	France	appos	10	SENT_91	[p4l1341t2710r1585b2778],
13	)	CD	NUMBER	)	num	12	SENT_91	[p4l1341t2710r1585b2778],
14	.	.	O	.	_	0	SENT_91	[p4l1341t2710r1585b2778],

1	2.4	CD	NUMBER	2.4	_	0	SENT_92	[p4l7t2891r109b2944],
2	.	.	O	.	_	0	SENT_92	[p4l7t2891r109b2944],

1	Genotyping	VBG	O	genotype	_	0	SENT_93	[p4l136t2890r476b2957],

1	Genomic	JJ	O	genomic	amod	2	SENT_94	[p4l113t3067r381b3122],
2	DNA	NN	O	dna	nsubjpass	6	SENT_94	[p4l408t3069r546b3121],
3	from	IN	O	from	_	0	SENT_94	[p4l572t3066r715b3122],
4	blood	NN	O	blood	prep_from	2	SENT_94	[p4l742t3067r910b3122],
5	was	VBD	O	be	auxpass	6	SENT_94	[p4l936t3082r1055b3122],
6	extracted	VBN	O	extract	_	0	SENT_94	[p4l1082t3067r1363b3122],
7	using	VBG	O	use	xcomp	6	SENT_94	[p4l1391t3067r1553b3135],
8	a	DT	O	a	det	13	SENT_94	[p4l1579t3082r1610b3122],
9	Wizard	NNP	O	Wizard	nn	13	SENT_94	[p4l1635t3067r1855b3122],
10	Genomic	JJ	O	genomic	amod	13	SENT_94	[p4l1884t3067r2151b3122],
11	DNA	NN	O	dna	nn	13	SENT_94	[p4l11t3157r149b3210],
12	puriﬁcation	NN	O	puriﬁcation	nn	13	SENT_94	[p4l173t3155r521b3224],
13	kit	NN	O	kit	nsubj	14	SENT_94	[p4l547t3155r624b3210],
14	(	CD	NUMBER	(	xcomp	7	SENT_94	[p4l652t3155r942b3224],
15	Promega	NNP	ORGANIZATION	Promega	nn	20	SENT_94	[p4l652t3155r942b3224],
16	Corp.	NNP	ORGANIZATION	Corp.	nn	20	SENT_94	[p4l968t3158r1136b3224],
17	,	,	O	,	_	0	SENT_94	[p4l968t3158r1136b3224],
18	Wisconsin	NNP	LOCATION	Wisconsin	appos	20	SENT_94	[p4l1159t3156r1488b3218],
19	,	,	O	,	_	0	SENT_94	[p4l1159t3156r1488b3218],
20	USA	NNP	LOCATION	USA	dep	14	SENT_94	[p4l1513t3155r1680b3223],
21	)	CD	NUMBER	)	num	20	SENT_94	[p4l1513t3155r1680b3223],
22	.	.	O	.	_	0	SENT_94	[p4l1513t3155r1680b3223],

1	KCN	NN	O	kcn	nsubjpass	7	SENT_95	[p4l1703t3158r1913b3224],
2	]	CD	NUMBER	]	num	1	SENT_95	[p4l1703t3158r1913b3224],
3	11	CD	NUMBER	11	num	5	SENT_95	[p4l1703t3158r1913b3224],
4	rs5219	NN	O	rs5219	nn	5	SENT_95	[p4l1946t3158r2150b3210],
5	polymorphism	NN	O	polymorphism	dep	1	SENT_95	[p4l11t3244r456b3313],
6	was	VBD	O	be	auxpass	7	SENT_95	[p4l477t3260r595b3299],
7	determined	VBN	O	determine	_	0	SENT_95	[p4l621t3244r970b3299],
8	by	IN	O	by	_	0	SENT_95	[p4l996t3244r1069b3313],
9	melting	NN	O	melting	nn	10	SENT_95	[p4l1092t3244r1324b3313],
10	analysis	NN	O	analysis	agent	7	SENT_95	[p4l1347t3244r1583b3313],
11	of	IN	O	of	_	0	SENT_95	[p4l1609t3244r1671b3299],
12	small	JJ	O	small	amod	13	SENT_95	[p4l1689t3244r1847b3299],
13	amplicon	NN	O	amplicon	prep_of	10	SENT_95	[p4l1872t3244r2150b3313],
14	after	IN	O	after	_	0	SENT_95	[p4l11t3333r150b3388],
15	the	DT	O	the	det	19	SENT_95	[p4l170t3333r265b3388],
16	real	JJ	O	real	amod	19	SENT_95	[p4l289t3333r565b3388],
17	—	NN	O	—	nn	19	SENT_95	[p4l289t3333r565b3388],
18	time	NN	O	time	nn	19	SENT_95	[p4l289t3333r565b3388],
19	PCR	NN	O	pcr	prep_after	7	SENT_95	[p4l588t3336r705b3388],
20	on	IN	O	on	_	0	SENT_95	[p4l724t3349r800b3388],
21	LightScanner	NNP	O	LightScanner	nn	23	SENT_95	[p4l822t3333r1213b3402],
22	32	CD	NUMBER	32	num	23	SENT_95	[p4l1233t3336r1305b3388],
23	instrument	NN	O	instrument	prep_on	19	SENT_95	[p4l1330t3334r1666b3388],
24	in	IN	O	in	_	0	SENT_95	[p4l1688t3334r1743b3388],
25	the	DT	O	the	det	26	SENT_95	[p4l1765t3333r1861b3388],
26	presence	NN	O	presence	prep_in	7	SENT_95	[p4l1884t3349r2150b3402],
27	of	IN	O	of	_	0	SENT_95	[p4l11t3422r74b3477],
28	LCGreen	NN	O	lcgreen	prep_of	26	SENT_95	[p4l94t3425r344b3477],
29	Plus	CC	O	plus	_	0	SENT_95	[p4l372t3422r493b3477],
30	dye	VB	O	dye	conj_plus	7	SENT_95	[p4l520t3422r627b3491],
31	(	CD	NUMBER	(	num	34	SENT_95	[p4l658t3422r852b3491],
32	Idaho	NNP	ORGANIZATION	Idaho	nn	34	SENT_95	[p4l658t3422r852b3491],
33	Technology	NNP	ORGANIZATION	Technology	nn	34	SENT_95	[p4l876t3422r1226b3491],
34	Inc.	NNP	ORGANIZATION	Inc.	dobj	30	SENT_95	[p4l1251t3426r1367b3486],
35	,	,	O	,	_	0	SENT_95	[p4l1251t3426r1367b3486],
36	Salt	NNP	LOCATION	Salt	nn	38	SENT_95	[p4l1396t3422r1505b3477],
37	Lake	NNP	LOCATION	Lake	nn	38	SENT_95	[p4l1531t3422r1665b3477],
38	City	NNP	LOCATION	City	appos	34	SENT_95	[p4l1692t3423r1821b3491],
39	,	,	O	,	_	0	SENT_95	[p4l1692t3423r1821b3491],
40	USA	NNP	LOCATION	USA	appos	38	SENT_95	[p4l1848t3422r2014b3491],
41	)	CD	NUMBER	)	num	40	SENT_95	[p4l1848t3422r2014b3491],
42	.	.	O	.	_	0	SENT_95	[p4l1848t3422r2014b3491],

1	The	DT	O	the	det	2	SENT_96	[p4l2040t3422r2150b3477],
2	sequences	NNS	O	sequence	_	0	SENT_96	[p4l12t3528r318b3580],
3	of	IN	O	of	_	0	SENT_96	[p4l351t3512r415b3567],
4	primers	NNS	O	primer	prep_of	2	SENT_96	[p4l439t3513r672b3580],
5	(	CD	NUMBER	(	dep	2	SENT_96	[p4l710t3512r1178b3580],
6	Sigma	NNP	O	Sigma	dep	5	SENT_96	[p4l710t3512r1178b3580],
7	.	.	O	.	_	0	SENT_96	[p4l710t3512r1178b3580],

1	—	NN	O	—	_	0	SENT_97	[p4l710t3512r1178b3580],
2	.	.	O	.	_	0	SENT_97	[p4l710t3512r1178b3580],

1	Aldrich	NNP	PERSON	Aldrich	nn	3	SENT_98	[p4l710t3512r1178b3580],
2	,	,	O	,	_	0	SENT_98	[p4l710t3512r1178b3580],
3	Germany	NNP	LOCATION	Germany	_	0	SENT_98	[p4l1211t3512r1511b3580],
4	)	CD	NUMBER	)	num	3	SENT_98	[p4l1211t3512r1511b3580],
5	were	VBD	O	be	aux	6	SENT_98	[p4l1547t3528r1698b3567],
6	following	VBG	O	follow	partmod	3	SENT_98	[p4l1732t3512r2031b3580],
7	:	:	O	:	_	0	SENT_98	[p4l1732t3512r2031b3580],
8	5	CD	NUMBER	5	num	10	SENT_98	[p4l2070t3515r2150b3567, p4l11t3603r980b3654],
9	’	CD	NUMBER	’	num	10	SENT_98	[p4l2070t3515r2150b3567, p4l11t3603r980b3654],
10	CACGCCTGGCAGAGGACCCTG	NN	O	cacgcctggcagaggaccctg	dep	3	SENT_98	[p4l2070t3515r2150b3567, p4l11t3603r980b3654],
11	—	CD	NUMBER	—	number	12	SENT_98	[p4l2070t3515r2150b3567, p4l11t3603r980b3654],
12	3	CD	NUMBER	3	num	13	SENT_98	[p4l2070t3515r2150b3567, p4l11t3603r980b3654],
13	’	NN	O	’	rcmod	10	SENT_98	[p4l2070t3515r2150b3567, p4l11t3603r980b3654],
14	and	CC	O	and	_	0	SENT_98	[p4l1017t3600r1127b3654],
15	5	CD	NUMBER	5	conj_and	13	SENT_98	[p4l1163t3603r2149b3655],
16	’	SYM	O	’	dep	19	SENT_98	[p4l1163t3603r2149b3655],
17	-	:	O	-	_	0	SENT_98	[p4l1163t3603r2149b3655],
18	CGGGCACGGTACCTGGGCT-3	NN	O	cgggcacggtacctgggct-3	nn	19	SENT_98	[p4l1163t3603r2149b3655],
19	’	NN	O	’	dep	13	SENT_98	[p4l1163t3603r2149b3655],
20	.	.	O	.	_	0	SENT_98	[p4l1163t3603r2149b3655],

1	Genotypes	NNS	O	genotype	nsubj	3	SENT_99	[p5l11t26r329b92],
2	were	VBD	O	be	aux	3	SENT_99	[p5l345t39r496b78],
3	identiﬁed	VBN	O	identiﬁed	_	0	SENT_99	[p5l514t23r801b78],
4	by	IN	O	by	_	0	SENT_99	[p5l818t23r892b92],
5	different	JJ	O	different	amod	7	SENT_99	[p5l907t23r1167b78],
6	melting	JJ	O	melting	amod	7	SENT_99	[p5l1182t23r1414b92],
7	temperatures	NNS	O	temperature	prep_by	3	SENT_99	[p5l1429t31r1834b92],
8	(	VBP	O	(	dep	7	SENT_99	[p5l1857t23r2150b92, p5l10t113r193b181],
9	homozygotes	NNS	O	homozygote	dobj	8	SENT_99	[p5l1857t23r2150b92, p5l10t113r193b181],
10	)	CD	NUMBER	)	dep	9	SENT_99	[p5l1857t23r2150b92, p5l10t113r193b181],
11	or	CC	O	or	_	0	SENT_99	[p5l215t128r277b167],
12	by	IN	O	by	conj_or	10	SENT_99	[p5l292t112r366b181],
13	change	NN	O	change	pobj	12	SENT_99	[p5l381t112r593b181],
14	in	IN	O	in	_	0	SENT_99	[p5l611t113r667b167],
15	the	DT	O	the	det	18	SENT_99	[p5l684t112r780b167],
16	melting	NN	O	melting	nn	18	SENT_99	[p5l797t112r1030b181],
17	curve	NN	O	curve	nn	18	SENT_99	[p5l1045t128r1210b167],
18	shape	NN	O	shape	prep_in	8	SENT_99	[p5l1228t112r1401b181],
19	(	CD	NUMBER	(	num	20	SENT_99	[p5l1422t112r1914b181],
20	heterozygotes	NNS	O	heterozygote	dep	21	SENT_99	[p5l1422t112r1914b181],
21	)	RB	O	)	amod	18	SENT_99	[p5l1422t112r1914b181],
22	,	,	O	,	_	0	SENT_99	[p5l1422t112r1914b181],
23	as	IN	O	as	_	0	SENT_99	[p5l1932t128r1992b167],
24	indicated	VBN	O	indicate	conj_as	3	SENT_99	[p5l2010t112r2150b167, p5l11t201r170b256],
25	on	IN	O	on	_	0	SENT_99	[p5l200t217r274b256],
26	the	DT	O	the	det	28	SENT_99	[p5l302t201r398b256],
27	derivative	JJ	O	derivative	amod	28	SENT_99	[p5l427t201r728b256],
28	plots	NNS	O	plot	prep_on	24	SENT_99	[p5l757t201r902b270],
29	using	VBG	O	use	partmod	28	SENT_99	[p5l931t202r1093b270],
30	Lightscanner	NNP	O	Lightscanner	dobj	29	SENT_99	[p5l1121t201r1512b270],
31	32	CD	NUMBER	32	num	30	SENT_99	[p5l1538t204r1611b256],
32	software	NN	O	software	nn	33	SENT_99	[p5l1642t201r1901b256],
33	version	NN	O	version	dobj	3	SENT_99	[p5l1929t202r2150b256],
34	1.0.0.23	CD	NUMBER	1.0.0.23	num	33	SENT_99	[p5l14t294r256b346],
35	.	.	O	.	_	0	SENT_99	[p5l14t294r256b346],

1	2.5	CD	NUMBER	2.5	_	0	SENT_100	[p5l7t472r109b524],
2	.	.	O	.	_	0	SENT_100	[p5l7t472r109b524],

1	Statistical	JJ	O	statistical	amod	2	SENT_101	[p5l133t469r423b524],
2	analyses	NNS	O	analysis	_	0	SENT_101	[p5l446t469r695b538],

1	Statistical	JJ	O	statistical	amod	2	SENT_102	[p5l113t647r400b702],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_102	[p5l430t647r681b716],
3	were	VBD	O	be	auxpass	4	SENT_102	[p5l710t663r861b702],
4	performed	VBN	O	perform	_	0	SENT_102	[p5l891t647r1208b716],
5	using	VBG	O	use	xcomp	4	SENT_102	[p5l1239t648r1401b716],
6	SPSS	NNP	ORGANIZATION	SPSS	dobj	5	SENT_102	[p5l1428t650r1565b702],
7	17.0	CD	NUMBER	17.0	dep	13	SENT_102	[p5l1598t650r1720b703],
8	for	IN	O	for	_	0	SENT_102	[p5l1751t647r1835b702],
9	Windows	NNP	MISC	Windows	prep_for	7	SENT_102	[p5l1859t647r2150b702],
10	software	NN	O	software	dep	13	SENT_102	[p5l12t736r271b791],
11	(	CD	NUMBER	(	num	10	SENT_102	[p5l294t737r457b805],
12	SPSS	NNP	ORGANIZATION	SPSS	nn	13	SENT_102	[p5l294t737r457b805],
13	Inc.	NNP	ORGANIZATION	Inc.	dep	5	SENT_102	[p5l477t740r592b800],
14	,	,	O	,	_	0	SENT_102	[p5l477t740r592b800],
15	Chicago	NNP	LOCATION	Chicago	dep	5	SENT_102	[p5l613t736r860b805],
16	,	,	O	,	_	0	SENT_102	[p5l613t736r860b805],
17	IL	NN	LOCATION	il	dep	5	SENT_102	[p5l880t740r942b800],
18	,	,	O	,	_	0	SENT_102	[p5l880t740r942b800],
19	USA	NNP	LOCATION	USA	dep	5	SENT_102	[p5l961t737r1110b805],
20	)	CD	NUMBER	)	num	19	SENT_102	[p5l961t737r1110b805],
21	and	CC	O	and	_	0	SENT_102	[p5l1132t736r1241b791],
22	web	NN	O	web	nn	23	SENT_102	[p5l1260t736r1589b791],
23	—	NN	O	—	dep	5	SENT_102	[p5l1260t736r1589b791],
24	based	VBN	O	base	prep	4	SENT_102	[p5l1260t736r1589b791],
25	software	NN	O	software	nn	26	SENT_102	[p5l1610t736r1869b791],
26	SNPStats	NNS	O	snpstat	nsubj	27	SENT_102	[p5l1888t739r2150b791],
27	(	VBP	O	(	pcomp	24	SENT_102	[p5l15t826r1858b894],
28	http://bioinfo.iconcologia.net/index.php?module=Snpstats	NNS	O	http://bioinfo.iconcologia.net/index.php?module=snpstats	dobj	27	SENT_102	[p5l15t826r1858b894],
29	)	CD	NUMBER	)	number	30	SENT_102	[p5l15t826r1858b894],
30	[	CD	NUMBER	[	num	32	SENT_102	[p5l2034t826r2148b894],
31	20	CD	NUMBER	20	num	32	SENT_102	[p5l2034t826r2148b894],
32	]	NN	O	]	nsubj	43	SENT_102	[p5l2034t826r2148b894],
33	which	WDT	O	which	nsubjpass	36	SENT_102	[p5l9t914r196b970],
34	was	VBD	O	be	auxpass	36	SENT_102	[p5l233t930r351b970],
35	speciﬁcally	RB	O	speciﬁcally	advmod	36	SENT_102	[p5l391t914r723b983],
36	designed	VBN	O	design	rcmod	32	SENT_102	[p5l759t915r1028b983],
37	for	IN	O	for	_	0	SENT_102	[p5l1068t914r1152b970],
38	evaluation	NN	O	evaluation	prep_for	36	SENT_102	[p5l1189t915r1503b970],
39	of	IN	O	of	_	0	SENT_102	[p5l1543t914r1606b970],
40	different	JJ	O	different	amod	42	SENT_102	[p5l1637t914r1898b970],
41	genetic	JJ	O	genetic	amod	42	SENT_102	[p5l1933t915r2151b983],
42	models	NNS	O	model	prep_of	38	SENT_102	[p5l11t1003r227b1058],
43	[	VBP	O	[	rcmod	28	SENT_102	[p5l262t1003r392b1072],
44	21	CD	NUMBER	21	num	45	SENT_102	[p5l262t1003r392b1072],
45	]	CD	NUMBER	]	dobj	43	SENT_102	[p5l262t1003r392b1072],
46	.	.	O	.	_	0	SENT_102	[p5l262t1003r392b1072],

1	Continuous	JJ	O	continuous	amod	2	SENT_103	[p5l424t1004r766b1058],
2	variables	NNS	O	variable	nsubjpass	4	SENT_103	[p5l796t1003r1063b1058],
3	are	VBP	O	be	auxpass	4	SENT_103	[p5l1095t1019r1187b1058],
4	presented	VBN	O	present	_	0	SENT_103	[p5l1218t1003r1517b1072],
5	as	IN	O	as	_	0	SENT_103	[p5l1548t1019r1607b1058],
6	meanistandard	NN	O	meanistandard	nn	7	SENT_103	[p5l1639t1003r2150b1061],
7	error	NN	O	error	prep_as	4	SENT_103	[p5l11t1108r162b1147],
8	of	IN	O	of	_	0	SENT_103	[p5l201t1092r263b1147],
9	mean	NN	O	mean	nn	12	SENT_103	[p5l297t1108r464b1147],
10	(	CD	NUMBER	(	num	12	SENT_103	[p5l508t1092r708b1160],
11	SEM	NN	O	sem	nn	12	SENT_103	[p5l508t1092r708b1160],
12	)	NN	O	)	prep_of	7	SENT_103	[p5l508t1092r708b1160],
13	.	.	O	.	_	0	SENT_103	[p5l508t1092r708b1160],

1	For	IN	O	for	_	0	SENT_104	[p5l749t1095r845b1147],
2	the	DT	O	the	det	3	SENT_104	[p5l883t1092r979b1147],
3	comparison	NN	O	comparison	prep_for	21	SENT_104	[p5l1020t1093r1373b1161],
4	of	IN	O	of	_	0	SENT_104	[p5l1413t1092r1476b1147],
5	continuous	JJ	O	continuous	amod	6	SENT_104	[p5l1509t1093r1843b1147],
6	variables	NNS	O	variable	prep_of	3	SENT_104	[p5l1882t1092r2149b1147],
7	unpaired	JJ	O	unpaired	amod	10	SENT_104	[p5l11t1181r280b1250],
8	and	CC	O	and	_	0	SENT_104	[p5l317t1181r426b1236],
9	paired	JJ	O	paired	amod	10	SENT_104	[p5l463t1181r652b1250],
10	t	NN	O	t	dep	3	SENT_104	[p5l691t1189r849b1236],
11	—	CD	NUMBER	—	num	12	SENT_104	[p5l691t1189r849b1236],
12	test	NN	O	test	dep	10	SENT_104	[p5l691t1189r849b1236],
13	and	CC	O	and	_	0	SENT_104	[p5l883t1181r993b1236],
14	analysis	NN	O	analysis	conj_and	3	SENT_104	[p5l1029t1181r1265b1250],
15	of	IN	O	of	_	0	SENT_104	[p5l1302t1181r1366b1236],
16	variance	NN	O	variance	prep_of	14	SENT_104	[p5l1392t1182r1646b1236],
17	(	CD	NUMBER	(	num	16	SENT_104	[p5l1686t1181r1960b1250],
18	ANOVA	NNP	O	ANOVA	nsubjpass	21	SENT_104	[p5l1686t1181r1960b1250],
19	)	CD	NUMBER	)	num	18	SENT_104	[p5l1686t1181r1960b1250],
20	were	VBD	O	be	auxpass	21	SENT_104	[p5l1999t1197r2150b1236],
21	used	VBN	O	use	_	0	SENT_104	[p5l11t1270r150b1324],
22	where	WRB	O	where	advmod	23	SENT_104	[p5l184t1269r376b1324],
23	appropriate	JJ	O	appropriate	advcl	21	SENT_104	[p5l412t1270r777b1338],
24	.	.	O	.	_	0	SENT_104	[p5l412t1270r777b1338],

1	;	:	O	;	_	0	SENT_105	[p5l814t1259r1031b1338],
2	(	NN	O	(	nsubjpass	7	SENT_105	[p5l814t1259r1031b1338],
3	2	CD	NUMBER	2	num	2	SENT_105	[p5l814t1259r1031b1338],
4	—	CD	NUMBER	—	num	5	SENT_105	[p5l814t1259r1031b1338],
5	test	NN	O	test	dep	2	SENT_105	[p5l814t1259r1031b1338],
6	was	VBD	O	be	auxpass	7	SENT_105	[p5l1063t1286r1181b1324],
7	used	VBN	O	use	_	0	SENT_105	[p5l1217t1270r1356b1324],
8	to	TO	O	to	aux	9	SENT_105	[p5l1392t1278r1451b1324],
9	test	VB	O	test	xcomp	7	SENT_105	[p5l1486t1278r1597b1324],
10	Hardy	NNP	PERSON	Hardy	dobj	9	SENT_105	[p5l1631t1269r2151b1338],
11	.	.	O	.	_	0	SENT_105	[p5l1631t1269r2151b1338],

1	—	NN	O	—	_	0	SENT_106	[p5l1631t1269r2151b1338],
2	.	.	O	.	_	0	SENT_106	[p5l1631t1269r2151b1338],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_107	[p5l1631t1269r2151b1338],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_107	[p5l11t1359r364b1427],
3	and	CC	O	and	_	0	SENT_107	[p5l384t1359r494b1414],
4	for	IN	O	for	_	0	SENT_107	[p5l518t1359r601b1414],
5	comparison	NN	O	comparison	prep_for	6	SENT_107	[p5l622t1360r974b1427],
6	of	IN	O	of	dep	1	SENT_107	[p5l996t1359r1059b1414],
7	gender	NN	O	gender	nn	8	SENT_107	[p5l1072t1359r1283b1427],
8	representation	NN	O	representation	pobj	6	SENT_107	[p5l1304t1360r1759b1427],
9	.	.	O	.	_	0	SENT_107	[p5l1304t1360r1759b1427],

1	Multivariate	JJ	O	multivariate	amod	4	SENT_108	[p5l1782t1359r2150b1414],
2	general	JJ	O	general	amod	4	SENT_108	[p5l10t1448r232b1516],
3	linear	JJ	O	linear	amod	4	SENT_108	[p5l259t1448r431b1503],
4	models	NNS	O	model	nsubjpass	6	SENT_108	[p5l455t1448r671b1503],
5	were	VBD	O	be	auxpass	6	SENT_108	[p5l696t1464r847b1503],
6	used	VBN	O	use	_	0	SENT_108	[p5l874t1448r1012b1503],
7	for	IN	O	for	_	0	SENT_108	[p5l1040t1448r1122b1503],
8	testing	NN	O	testing	prep_for	6	SENT_108	[p5l1146t1449r1352b1516],
9	of	IN	O	of	_	0	SENT_108	[p5l1376t1448r1439b1503],
10	the	DT	O	the	det	11	SENT_108	[p5l1457t1448r1553b1503],
11	response	NN	O	response	prep_of	8	SENT_108	[p5l1579t1464r1847b1516],
12	of	IN	O	of	_	0	SENT_108	[p5l1873t1448r1935b1503],
13	HbA1c	NN	O	hba1c	prep_of	11	SENT_108	[p5l1954t1448r2152b1503],
14	to	TO	O	to	_	0	SENT_108	[p5l10t1544r68b1591],
15	sulfonylurea	NN	O	sulfonylurea	prep_to	13	SENT_108	[p5l98t1536r471b1605],
16	according	VBG	O	accord	_	0	SENT_108	[p5l497t1536r791b1605],
17	to	TO	O	to	prepc_according_to	6	SENT_108	[p5l817t1544r874b1591],
18	genotypes	NNS	O	genotype	pobj	6	SENT_108	[p5l903t1544r1225b1605],
19	.	.	O	.	_	0	SENT_108	[p5l903t1544r1225b1605],

1	All	DT	O	all	det	2	SENT_109	[p5l1251t1536r1332b1591],
2	models	NNS	O	model	nsubjpass	4	SENT_109	[p5l1361t1536r1577b1591],
3	were	VBD	O	be	auxpass	4	SENT_109	[p5l1605t1552r1756b1591],
4	adjusted	VBN	O	adjust	_	0	SENT_109	[p5l1784t1536r2039b1605],
5	for	IN	O	for	_	0	SENT_109	[p5l2069t1536r2152b1591],
6	the	DT	O	the	det	7	SENT_109	[p5l10t1625r106b1680],
7	age	NN	O	age	prep_for	4	SENT_109	[p5l137t1641r238b1694],
8	at	IN	O	at	_	0	SENT_109	[p5l269t1633r326b1680],
9	the	DT	O	the	det	10	SENT_109	[p5l354t1625r450b1680],
10	beginning	NN	O	beginning	prep_at	7	SENT_109	[p5l480t1625r783b1694],
11	of	IN	O	of	_	0	SENT_109	[p5l812t1625r874b1680],
12	sulfonylurea	NN	O	sulfonylurea	nn	13	SENT_109	[p5l899t1625r1272b1694],
13	treatment	NN	O	treatment	prep_of	10	SENT_109	[p5l1301t1633r1615b1688],
14	,	,	O	,	_	0	SENT_109	[p5l1301t1633r1615b1688],
15	gender	NN	O	gender	prep_of	10	SENT_109	[p5l1646t1625r1869b1694],
16	,	,	O	,	_	0	SENT_109	[p5l1646t1625r1869b1694],
17	diabetes	NN	O	diabetes	nn	18	SENT_109	[p5l1902t1625r2150b1680],
18	duration	NN	O	duration	conj_and	13	SENT_109	[p5l11t1714r282b1778],
19	,	,	O	,	_	0	SENT_109	[p5l11t1714r282b1778],
20	baseline	NN	O	baseline	nn	21	SENT_109	[p5l299t1714r545b1769],
21	BMI	NNP	O	BMI	conj_and	13	SENT_109	[p5l563t1718r694b1778],
22	,	,	O	,	_	0	SENT_109	[p5l563t1718r694b1778],
23	baseline	NN	O	baseline	nn	25	SENT_109	[p5l712t1714r957b1769],
24	HbA1	NN	O	hba1	nn	25	SENT_109	[p5l976t1714r1134b1769],
25	c	NN	O	c	conj_and	13	SENT_109	[p5l1145t1730r1187b1778],
26	,	,	O	,	_	0	SENT_109	[p5l1145t1730r1187b1778],
27	sulfonylurea	NN	O	sulfonylurea	nn	28	SENT_109	[p5l1206t1714r1578b1783],
28	type	NN	O	type	conj_and	13	SENT_109	[p5l1594t1722r1739b1783],
29	,	,	O	,	_	0	SENT_109	[p5l1594t1722r1739b1783],
30	and	CC	O	and	_	0	SENT_109	[p5l1758t1714r1867b1769],
31	sulfonylurea	NN	O	sulfonylurea	nn	32	SENT_109	[p5l1887t1714r2150b1783, p5l11t1819r142b1858],
32	dose	NN	O	dose	conj_and	13	SENT_109	[p5l164t1803r315b1858],
33	.	.	O	.	_	0	SENT_109	[p5l164t1803r315b1858],

1	3	LS	NUMBER	3	_	0	SENT_110	[p5l9t1985r63b2037],
2	.	.	O	.	_	0	SENT_110	[p5l9t1985r63b2037],

1	Results	NNS	O	result	_	0	SENT_111	[p5l86t1982r317b2036],

1	In	IN	O	in	_	0	SENT_112	[p5l113t2164r170b2215],
2	the	DT	O	the	det	4	SENT_112	[p5l192t2161r289b2216],
3	entire	JJ	O	entire	amod	4	SENT_112	[p5l311t2161r491b2216],
4	cohort	NN	O	cohort	prep_in	15	SENT_112	[p5l513t2161r712b2216],
5	of	IN	O	of	_	0	SENT_112	[p5l733t2160r797b2216],
6	patients	NNS	O	patient	prep_of	4	SENT_112	[p5l811t2161r1057b2229],
7	with	IN	O	with	_	0	SENT_112	[p5l1078t2161r1219b2216],
8	type	NN	O	type	nn	10	SENT_112	[p5l1241t2169r1374b2229],
9	2	CD	NUMBER	2	num	10	SENT_112	[p5l1396t2163r1429b2215],
10	diabetes	NN	O	diabetes	prep_with	6	SENT_112	[p5l1453t2161r1723b2224],
11	,	,	O	,	_	0	SENT_112	[p5l1453t2161r1723b2224],
12	6-month	JJ	DURATION	6-month	amod	14	SENT_112	[p5l1746t2161r2016b2216],
13	sulfonylurea	NN	O	sulfonylurea	nn	14	SENT_112	[p5l2038t2161r2150b2216, p5l11t2249r303b2318],
14	treatment	NN	O	treatment	nsubj	15	SENT_112	[p5l330t2257r639b2304],
15	resulted	VBD	O	result	_	0	SENT_112	[p5l665t2249r913b2304],
16	in	IN	O	in	_	0	SENT_112	[p5l942t2250r998b2304],
17	highly	RB	O	highly	advmod	18	SENT_112	[p5l1027t2249r1220b2318],
18	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_112	[p5l1246t2249r1564b2318],
19	average	JJ	O	average	amod	20	SENT_112	[p5l1590t2265r1827b2318],
20	reduction	NN	O	reduction	prep_in	15	SENT_112	[p5l1856t2249r2151b2304],
21	in	IN	O	in	_	0	SENT_112	[p5l11t2340r68b2393],
22	HbA1	NN	O	hba1	nn	23	SENT_112	[p5l88t2339r248b2394],
23	c	NN	O	c	prep_in	20	SENT_112	[p5l261t2355r289b2394],
24	and	CC	O	and	_	0	SENT_112	[p5l308t2339r420b2394],
25	fasting	NN	O	fasting	nn	26	SENT_112	[p5l441t2339r647b2407],
26	glycemia	NN	O	glycemia	conj_and	23	SENT_112	[p5l664t2339r939b2407],
27	by	IN	O	by	_	0	SENT_112	[p5l958t2339r1032b2407],
28	1.05	CD	PERCENT	1.05	num	29	SENT_112	[p5l1054t2342r1221b2394],
29	%	NN	PERCENT	%	prep_by	15	SENT_112	[p5l1054t2342r1221b2394],
30	and	CC	O	and	_	0	SENT_112	[p5l1241t2339r1352b2394],
31	1.45	CD	NUMBER	1.45	num	32	SENT_112	[p5l1376t2342r1499b2394],
32	mmol/l	NN	O	mmol/l	prep_by	15	SENT_112	[p5l1523t2339r1760b2403],
33	,	,	O	,	_	0	SENT_112	[p5l1523t2339r1760b2403],
34	respectively	RB	O	respectively	advmod	29	SENT_112	[p5l1782t2339r2152b2407],
35	(	CD	NUMBER	(	num	36	SENT_112	[p5l15t2428r203b2496],
36	Table	NNP	O	Table	dep	29	SENT_112	[p5l15t2428r203b2496],
37	1	CD	NUMBER	1	number	38	SENT_112	[p5l229t2428r304b2496],
38	)	CD	NUMBER	)	dep	36	SENT_112	[p5l229t2428r304b2496],
39	.	.	O	.	_	0	SENT_112	[p5l229t2428r304b2496],

1	Small	JJ	O	small	nsubjpass	13	SENT_113	[p5l328t2428r495b2483],
2	and	CC	O	and	_	0	SENT_113	[p5l517t2428r629b2483],
3	non	JJ	O	non	amod	6	SENT_113	[p5l652t2428r1118b2496],
4	—	NN	O	—	nn	6	SENT_113	[p5l652t2428r1118b2496],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_113	[p5l652t2428r1118b2496],
6	increase	NN	O	increase	nsubjpass	13	SENT_113	[p5l1139t2429r1390b2483],
7	of	IN	O	of	_	0	SENT_113	[p5l1413t2428r1476b2483],
8	body	NN	O	body	nn	9	SENT_113	[p5l1490t2428r1643b2496],
9	weight	NN	O	weight	prep_of	6	SENT_113	[p5l1661t2428r1876b2496],
10	and	CC	O	and	_	0	SENT_113	[p5l1897t2428r2008b2483],
11	BMI	NN	O	bmus	conj_and	9	SENT_113	[p5l2031t2431r2150b2482],
12	was	VBD	O	be	auxpass	13	SENT_113	[p5l9t2532r128b2571],
13	observed	VBN	O	observe	_	0	SENT_113	[p5l154t2516r447b2572],
14	.	.	O	.	_	0	SENT_113	[p5l154t2516r447b2572],

1	After	IN	O	after	_	0	SENT_114	[p5l470t2516r625b2571],
2	6-month	JJ	DURATION	6-month	amod	4	SENT_114	[p5l649t2516r918b2571],
3	treatment	NN	O	treatment	nn	4	SENT_114	[p5l943t2524r1252b2571],
4	period	NN	O	period	prep_after	25	SENT_114	[p5l1275t2516r1487b2585],
5	,	,	O	,	_	0	SENT_114	[p5l1275t2516r1487b2585],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_114	[p5l1514t2516r1832b2585],
7	reduction	NN	O	reduction	nsubjpass	25	SENT_114	[p5l1856t2516r2151b2571],
8	in	IN	O	in	_	0	SENT_114	[p5l11t2606r68b2660],
9	LDL	NN	O	ldl	nn	10	SENT_114	[p5l94t2609r207b2660],
10	cholesterol	NN	O	cholesterol	prep_in	7	SENT_114	[p5l231t2605r567b2660],
11	and	CC	O	and	_	0	SENT_114	[p5l594t2605r705b2660],
12	triglyceride	NN	O	triglyceride	nn	13	SENT_114	[p5l732t2605r1083b2674],
13	levels	NNS	O	level	conj_and	10	SENT_114	[p5l1111t2605r1297b2669],
14	,	,	O	,	_	0	SENT_114	[p5l1111t2605r1297b2669],
15	in	IN	O	in	_	0	SENT_114	[p5l1325t2606r1382b2660],
16	association	NN	O	association	prep_in	7	SENT_114	[p5l1408t2606r1747b2660],
17	with	IN	O	with	_	0	SENT_114	[p5l1771t2605r1912b2660],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_114	[p5l1939t2605r2150b2674, p5l11t2703r141b2750],
19	increases	NNS	O	increase	prep_with	16	SENT_114	[p5l164t2695r444b2750],
20	in	IN	O	in	_	0	SENT_114	[p5l469t2695r526b2749],
21	HDL	NN	O	hdl	nn	23	SENT_114	[p5l550t2698r680b2749],
22	cholesterol	NN	O	cholesterol	nn	23	SENT_114	[p5l702t2695r1039b2750],
23	level	NN	O	level	prep_in	19	SENT_114	[p5l1064t2695r1206b2750],
24	were	VBD	O	be	auxpass	25	SENT_114	[p5l1230t2710r1383b2750],
25	observed	VBN	O	observe	_	0	SENT_114	[p5l1408t2695r1685b2750],
26	(	RB	O	(	advmod	25	SENT_114	[p5l1714t2695r1902b2763],
27	Table	NNP	O	Table	prep	25	SENT_114	[p5l1714t2695r1902b2763],
28	1	CD	NUMBER	1	num	29	SENT_114	[p5l1931t2695r2007b2763],
29	)	CD	NUMBER	)	dep	27	SENT_114	[p5l1931t2695r2007b2763],
30	.	.	O	.	_	0	SENT_114	[p5l1931t2695r2007b2763],

1	Anthropometric	NN	O	anthropometric	nn	4	SENT_115	[p5l110t2783r607b2852],
2	and	CC	O	and	_	0	SENT_115	[p5l631t2783r742b2838],
3	biochemical	JJ	O	biochemical	conj_and	1	SENT_115	[p5l768t2783r1137b2838],
4	characteristics	NNS	O	characteristic	nsubjpass	15	SENT_115	[p5l1163t2783r1603b2838],
5	of	IN	O	of	_	0	SENT_115	[p5l1629t2783r1693b2838],
6	study	NN	O	study	nn	7	SENT_115	[p5l1712t2783r1880b2852],
7	subjects	NNS	O	subject	prep_of	4	SENT_115	[p5l1905t2783r2149b2852],
8	according	VBG	O	accord	_	0	SENT_115	[p5l11t2873r309b2941],
9	to	TO	O	to	prepc_according_to	15	SENT_115	[p5l340t2881r399b2928],
10	KCN	NNP	O	KCN	nn	13	SENT_115	[p5l430t2876r644b2941],
11	]	CD	NUMBER	]	num	13	SENT_115	[p5l430t2876r644b2941],
12	11	CD	NUMBER	11	num	13	SENT_115	[p5l430t2876r644b2941],
13	genotypes	NNS	O	genotype	pobj	15	SENT_115	[p5l683t2881r997b2941],
14	are	VBP	O	be	auxpass	15	SENT_115	[p5l1031t2889r1124b2928],
15	shown	VBN	O	show	_	0	SENT_115	[p5l1158t2873r1361b2928],
16	in	IN	O	in	_	0	SENT_115	[p5l1394t2874r1450b2927],
17	Table	NNP	O	Table	prep_in	15	SENT_115	[p5l1480t2873r1645b2928],
18	2	CD	NUMBER	2	num	17	SENT_115	[p5l1677t2876r1727b2928],
19	.	.	O	.	_	0	SENT_115	[p5l1677t2876r1727b2928],

1	Thirty	CD	NUMBER	thirty	num	3	SENT_116	[p5l1758t2873r1946b2941],
2	seven	CD	NUMBER	seven	num	3	SENT_116	[p5l1978t2889r2151b2928],
3	patients	NNS	O	patient	nsubj	5	SENT_116	[p5l11t2963r256b3030],
4	were	VBD	O	be	cop	5	SENT_116	[p5l289t2978r443b3017],
5	homozygous	JJ	O	homozygous	_	0	SENT_116	[p5l477t2962r866b3030],
6	for	IN	O	for	_	0	SENT_116	[p5l901t2962r986b3017],
7	the	DT	O	the	det	11	SENT_116	[p5l1018t2962r1115b3017],
8	wild	JJ	O	wild	amod	11	SENT_116	[p5l1147t2962r1282b3017],
9	E	NN	O	e	nn	11	SENT_116	[p5l1317t2962r1543b3017],
10	—	CD	NUMBER	—	num	11	SENT_116	[p5l1317t2962r1543b3017],
11	allele	NN	O	allele	prep_for	5	SENT_116	[p5l1317t2962r1543b3017],
12	(	CD	NUMBER	(	num	15	SENT_116	[p5l1581t2962r1680b3030],
13	EE	NN	O	ee	nn	15	SENT_116	[p5l1581t2962r1680b3030],
14	genotype	NN	O	genotype	nn	15	SENT_116	[p5l1712t2962r2042b3030],
15	)	NN	O	)	tmod	5	SENT_116	[p5l1712t2962r2042b3030],
16	,	,	O	,	_	0	SENT_116	[p5l1712t2962r2042b3030],
17	47	CD	NUMBER	47	num	18	SENT_116	[p5l2075t2965r2149b3016],
18	patients	NNS	O	patient	appos	15	SENT_116	[p5l11t3051r256b3119],
19	were	VBD	O	be	cop	24	SENT_116	[p5l294t3066r447b3105],
20	heterozygous	JJ	O	heterozygous	amod	24	SENT_116	[p5l486t3050r898b3119],
21	(	NN	O	(	nn	24	SENT_116	[p5l941t3050r1047b3119],
22	EK	NN	O	ek	nn	24	SENT_116	[p5l941t3050r1047b3119],
23	genotype	NN	O	genotype	nn	24	SENT_116	[p5l1083t3050r1412b3119],
24	)	NN	O	)	rcmod	18	SENT_116	[p5l1083t3050r1412b3119],
25	,	,	O	,	_	0	SENT_116	[p5l1083t3050r1412b3119],
26	and	CC	O	and	_	0	SENT_116	[p5l1452t3050r1563b3105],
27	17	CD	NUMBER	17	num	28	SENT_116	[p5l1605t3053r1674b3105],
28	patients	NNS	O	patient	nsubj	37	SENT_116	[p5l1714t3051r1960b3119],
29	were	VBD	O	be	cop	37	SENT_116	[p5l1997t3066r2150b3105],
30	homozygous	JJ	O	homozygous	amod	37	SENT_116	[p5l11t3139r400b3208],
31	for	IN	O	for	_	0	SENT_116	[p5l433t3139r518b3194],
32	type	NN	O	type	nn	34	SENT_116	[p5l547t3147r680b3208],
33	2	CD	NUMBER	2	num	34	SENT_116	[p5l713t3142r745b3193],
34	diabetes	NN	O	diabetes	prep_for	30	SENT_116	[p5l779t3139r1033b3194],
35	associated	VBN	O	associate	partmod	34	SENT_116	[p5l1065t3139r1380b3194],
36	l	NN	O	l	tmod	35	SENT_116	[p5l1412t3139r1643b3194],
37	(	NN	O	(	conj_and	5	SENT_116	[p5l1412t3139r1643b3194],
38	.	.	O	.	_	0	SENT_116	[p5l1412t3139r1643b3194],

1	—	NN	O	—	_	0	SENT_117	[p5l1412t3139r1643b3194],
2	.	.	O	.	_	0	SENT_117	[p5l1412t3139r1643b3194],

1	allele	NN	O	allele	_	0	SENT_118	[p5l1412t3139r1643b3194],
2	(	CD	NUMBER	(	num	5	SENT_118	[p5l1679t3139r1791b3207],
3	KK	NNP	O	KK	nn	5	SENT_118	[p5l1679t3139r1791b3207],
4	genotype	NN	O	genotype	nn	5	SENT_118	[p5l1820t3139r2149b3208],
5	)	NN	O	)	dep	1	SENT_118	[p5l1820t3139r2149b3208],
6	.	.	O	.	_	0	SENT_118	[p5l1820t3139r2149b3208],

1	Minor	JJ	O	minor	amod	3	SENT_119	[p5l11t3229r199b3283],
2	allele	NN	O	allele	nn	3	SENT_119	[p5l223t3228r383b3283],
3	frequency	NN	O	frequency	nsubj	6	SENT_119	[p5l412t3228r718b3297],
4	was	VBD	O	be	cop	6	SENT_119	[p5l743t3244r862b3283],
5	40	CD	PERCENT	40	num	6	SENT_119	[p5l888t3231r1020b3284],
6	%	NN	PERCENT	%	_	0	SENT_119	[p5l888t3231r1020b3284],
7	.	.	O	.	_	0	SENT_119	[p5l888t3231r1020b3284],

1	Genotype	NN	O	genotype	nn	2	SENT_120	[p5l1048t3231r1343b3297],
2	distribution	NN	O	distribution	nsubj	3	SENT_120	[p5l1371t3228r1732b3283],
3	followed	VBD	O	follow	_	0	SENT_120	[p5l1759t3228r2025b3283],
4	the	DT	O	the	det	5	SENT_120	[p5l2053t3228r2150b3283],
5	Hardy	NNP	PERSON	Hardy	dobj	3	SENT_120	[p5l11t3317r541b3386],
6	.	.	O	.	_	0	SENT_120	[p5l11t3317r541b3386],

1	—	NN	O	—	_	0	SENT_121	[p5l11t3317r541b3386],
2	.	.	O	.	_	0	SENT_121	[p5l11t3317r541b3386],

1	Weinberg	NNP	PERSON	Weinberg	nn	4	SENT_122	[p5l11t3317r541b3386],
2	equilibrium	NN	O	equilibrium	nn	4	SENT_122	[p5l565t3317r925b3386],
3	(	NN	O	(	nn	4	SENT_122	[p5l953t3317r1015b3386],
4	p	NN	O	p	nsubj	5	SENT_122	[p5l953t3317r1015b3386],
5	=	JJ	O	=	_	0	SENT_122	[p5l1032t3340r1086b3361],
6	0.84	CD	NUMBER	0.84	num	7	SENT_122	[p5l1103t3317r1276b3386],
7	)	NN	O	)	dobj	5	SENT_122	[p5l1103t3317r1276b3386],
8	.	.	O	.	_	0	SENT_122	[p5l1103t3317r1276b3386],

1	The	DT	O	the	det	4	SENT_123	[p5l110t3407r222b3462],
2	three	CD	NUMBER	three	num	4	SENT_123	[p5l250t3407r410b3462],
3	genotype	NN	O	genotype	nn	4	SENT_123	[p5l437t3415r722b3475],
4	groups	NNS	O	group	nsubj	5	SENT_123	[p5l750t3423r959b3475],
5	differed	VBD	O	differ	_	0	SENT_123	[p5l988t3407r1226b3462],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_123	[p5l1255t3407r1630b3475],
7	only	RB	O	only	advmod	5	SENT_123	[p5l1656t3407r1789b3475],
8	in	IN	O	in	_	0	SENT_123	[p5l1816t3408r1872b3461],
9	baseline	NN	O	baseline	prep_in	5	SENT_123	[p5l1899t3407r2150b3462],

1	BMI	NN	O	bmus	nn	2	SENT_124	[p6l11t20r130b71],
2	values	NNS	O	value	nsubj	3	SENT_124	[p6l151t17r345b72],
3	(	VBP	O	(	_	0	SENT_124	[p6l373t17r435b85],
4	p	NN	O	p	dobj	3	SENT_124	[p6l373t17r435b85],
5	=	JJ	O	=	advmod	3	SENT_124	[p6l452t40r506b61],
6	0.026	CD	NUMBER	0.026	num	7	SENT_124	[p6l523t17r716b85],
7	)	NN	O	)	dep	5	SENT_124	[p6l523t17r716b85],
8	with	IN	O	with	_	0	SENT_124	[p6l742t17r883b72],
9	the	DT	O	the	det	12	SENT_124	[p6l906t17r1002b72],
10	highest	JJS	O	highest	amod	12	SENT_124	[p6l1026t17r1252b85],
11	mean	NN	O	mean	nn	12	SENT_124	[p6l1274t33r1442b72],
12	values	NNS	O	value	prep_with	3	SENT_124	[p6l1463t17r1657b72],
13	in	IN	O	in	_	0	SENT_124	[p6l1681t18r1737b71],
14	the	DT	O	the	det	17	SENT_124	[p6l1760t17r1857b72],
15	EE	NN	O	ee	nn	17	SENT_124	[p6l1881t20r1953b71],
16	genotype	NN	O	genotype	nn	17	SENT_124	[p6l1975t33r2150b85, p6l10t113r144b174],
17	group	NN	O	group	prep_in	12	SENT_124	[p6l174t121r369b174],
18	.	.	O	.	_	0	SENT_124	[p6l174t121r369b174],

1	There	EX	O	there	expl	2	SENT_125	[p6l399t105r574b160],
2	were	VBD	O	be	_	0	SENT_125	[p6l605t121r758b160],
3	no	DT	O	no	det	5	SENT_125	[p6l790t121r864b160],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_125	[p6l898t105r1216b174],
5	differences	NNS	O	difference	conj_or	5	SENT_125	[p6l1246t105r1581b160],
6	among	IN	O	among	_	0	SENT_125	[p6l1613t121r1823b174],
7	groups	NNS	O	group	prep_among	5	SENT_125	[p6l1853t121r2062b174],
8	in	IN	O	in	_	0	SENT_125	[p6l2094t106r2150b160],
9	other	JJ	O	other	amod	10	SENT_125	[p6l11t194r176b249],
10	anthropometric	NN	O	anthropometric	prep_in	7	SENT_125	[p6l224t194r708b263],
11	and	CC	O	and	_	0	SENT_125	[p6l758t194r869b249],
12	biochemical	JJ	O	biochemical	amod	13	SENT_125	[p6l921t194r1290b249],
13	characteristics	NNS	O	characteristic	conj_and	10	SENT_125	[p6l1342t194r1781b249],
14	or	CC	O	or	_	0	SENT_125	[p6l1833t210r1897b249],
15	in	IN	O	in	_	0	SENT_125	[p6l1946t195r2003b248],
16	the	DT	O	the	det	17	SENT_125	[p6l2053t194r2150b249],
17	metformin	NN	O	metformin	prep_in	5	SENT_125	[p6l11t283r340b338],
18	dose	NN	O	dose	nn	20	SENT_125	[p6l364t283r503b338],
19	(	CD	NUMBER	(	num	20	SENT_125	[p6l532t283r720b352],
20	Table	NNP	O	Table	dep	5	SENT_125	[p6l532t283r720b352],
21	2	CD	NUMBER	2	number	22	SENT_125	[p6l745t284r824b352],
22	)	CD	NUMBER	)	num	20	SENT_125	[p6l745t284r824b352],
23	.	.	O	.	_	0	SENT_125	[p6l745t284r824b352],

1	M.	NNP	O	M.	nn	2	SENT_126	[p6l312t429r339b449],
2	javorsky	NNP	O	javorsky	_	0	SENT_126	[p6l345t427r447b454],
3	et	FW	O	et	nn	4	SENT_126	[p6l456t430r478b449],
4	al.	FW	O	al.	dep	2	SENT_126	[p6l486t427r510b449],
5	/	:	O	/	punct	2	SENT_126	[p6l520t428r646b454],
6	European	JJ	MISC	european	amod	7	SENT_126	[p6l520t428r646b454],
7	journal	NN	O	journal	dep	2	SENT_126	[p6l652t427r739b454],
8	of	IN	O	of	_	0	SENT_126	[p6l749t427r774b454],
9	Internal	JJ	ORGANIZATION	internal	amod	10	SENT_126	[p6l778t427r869b449],
10	Medicine	NN	ORGANIZATION	medicine	prep_of	7	SENT_126	[p6l878t427r983b449],
11	23	CD	NUMBER	23	number	12	SENT_126	[p6l991t428r1020b449],
12	(	CD	NUMBER	(	num	13	SENT_126	[p6l1030t427r1109b454],
13	2012	CD	DATE	2012	dep	10	SENT_126	[p6l1030t427r1109b454],
14	)	CD	NUMBER	)	num	15	SENT_126	[p6l1030t427r1109b454],
15	245-249	CD	NUMBER	245-249	dep	13	SENT_126	[p6l1118t428r1222b449],

1	Table	NNP	O	Table	_	0	SENT_127	[p6l7t569r146b612],
2	2	CD	NUMBER	2	num	1	SENT_127	[p6l164t571r193b612],
3	Clinical	JJ	O	clinical	amod	6	SENT_127	[p6l9t640r187b684],
4	and	CC	O	and	_	0	SENT_127	[p6l205t640r295b684],
5	biochemical	JJ	O	biochemical	amod	6	SENT_127	[p6l312t640r607b684],
6	characteristics	NNS	O	characteristic	npadvmod	1	SENT_127	[p6l626t640r978b684],
7	of	IN	O	of	_	0	SENT_127	[p6l997t640r1048b684],
8	the	DT	O	the	det	9	SENT_127	[p6l1059t640r1136b684],
9	subjects	NNS	O	subject	prep_of	1	SENT_127	[p6l1155t640r1351b695],
10	according	VBG	O	accord	_	0	SENT_127	[p6l1369t640r1609b695],
11	to	TO	O	to	prepc_according_to	9	SENT_127	[p6l1625t647r1672b684],
12	KCN	NNP	O	KCN	nn	15	SENT_127	[p6l1688t642r1859b695],
13	]	CD	NUMBER	]	num	15	SENT_127	[p6l1688t642r1859b695],
14	11	CD	NUMBER	11	num	15	SENT_127	[p6l1688t642r1859b695],
15	genotypes	NNS	O	genotype	pobj	9	SENT_127	[p6l1882t647r2146b695],
16	.	.	O	.	_	0	SENT_127	[p6l1882t647r2146b695],

1	EE	NN	O	ee	dep	9	SENT_128	[p6l865t785r923b826],
2	(	CD	NUMBER	(	num	3	SENT_128	[p6l945t783r1146b837],
3	n	NN	O	n	dep	1	SENT_128	[p6l945t783r1146b837],
4	=	JJ	O	=	amod	3	SENT_128	[p6l945t783r1146b837],
5	37	CD	NUMBER	37	tmod	4	SENT_128	[p6l945t783r1146b837],
6	)	CD	NUMBER	)	num	7	SENT_128	[p6l945t783r1146b837],
7	EK	NN	O	ek	dep	9	SENT_128	[p6l1221t785r1284b826],
8	(	NN	O	(	nn	9	SENT_128	[p6l1306t783r1506b837],
9	n	NN	O	n	dep	19	SENT_128	[p6l1306t783r1506b837],
10	=	JJ	O	=	quantmod	12	SENT_128	[p6l1306t783r1506b837],
11	47	CD	NUMBER	47	number	12	SENT_128	[p6l1306t783r1506b837],
12	)	CD	NUMBER	)	num	15	SENT_128	[p6l1306t783r1506b837],
13	KK	NNP	ORGANIZATION	KK	nn	15	SENT_128	[p6l1576t785r1644b826],
14	(	CD	NUMBER	(	num	15	SENT_128	[p6l1666t783r1866b837],
15	n	NN	O	n	dep	9	SENT_128	[p6l1666t783r1866b837],
16	=	JJ	O	=	amod	15	SENT_128	[p6l1666t783r1866b837],
17	17	CD	NUMBER	17	tmod	16	SENT_128	[p6l1666t783r1866b837],
18	)	NN	O	)	nn	19	SENT_128	[p6l1666t783r1866b837],
19	p	NN	O	p	_	0	SENT_128	[p6l1935t795r1963b837],

1	Gender	NN	O	gender	nn	2	SENT_129	[p6l60t893r240b937],
2	(	NN	O	(	nsubj	3	SENT_129	[p6l262t893r657b947],
3	males/females	VBZ	O	males/females	_	0	SENT_129	[p6l262t893r657b947],
4	)	CD	NUMBER	)	num	10	SENT_129	[p6l262t893r657b947],
5	20/17	CD	NUMBER	20/17	num	10	SENT_129	[p6l940t895r1080b944],
6	23/24	CD	NUMBER	23/24	num	10	SENT_129	[p6l1295t895r1437b944],
7	7/10	CD	NUMBER	7/10	num	10	SENT_129	[p6l1669t895r1777b944],
8	0676	CD	DATE	0676	num	10	SENT_129	[p6l1935t877r2095b937],
9	*	NNP	O	*	nn	10	SENT_129	[p6l1935t877r2095b937],
10	Age	NNP	O	Age	nsubj	13	SENT_129	[p6l58t968r150b1020],
11	(	CD	NUMBER	(	num	12	SENT_129	[p6l174t966r343b1020],
12	years	NNS	NUMBER	year	tmod	10	SENT_129	[p6l174t966r343b1020],
13	)	VBP	O	)	ccomp	3	SENT_129	[p6l174t966r343b1020],
14	60.5	CD	NUMBER	60.5	number	15	SENT_129	[p6l884t968r984b1010],
15	:1	CD	NUMBER	:1	dobj	13	SENT_129	[p6l999t972r1039b1012],
16	:	:	O	:	_	0	SENT_129	[p6l999t972r1039b1012],
17	1.5	CD	NUMBER	1.5	number	18	SENT_129	[p6l1056t968r1123b1010],
18	63.4	CD	NUMBER	63.4	dep	15	SENT_129	[p6l1240t968r1342b1010],
19	:1	CD	NUMBER	:1	dep	18	SENT_129	[p6l1354t972r1395b1012],
20	:	:	O	:	_	0	SENT_129	[p6l1354t972r1395b1012],
21	1.7	CD	NUMBER	1.7	number	22	SENT_129	[p6l1411t968r1479b1010],
22	60.8	CD	NUMBER	60.8	dep	18	SENT_129	[p6l1595t968r1696b1010],
23	:1	CD	NUMBER	:1	dep	22	SENT_129	[p6l1710t972r1750b1012],
24	:	:	O	:	_	0	SENT_129	[p6l1710t972r1750b1012],
25	1.8	CD	NUMBER	1.8	num	30	SENT_129	[p6l1766t968r1834b1010],
26	0.367	CD	NUMBER	0.367	num	30	SENT_129	[p6l1935t968r2067b1010],
27	Diabetes	NNP	O	Diabetes	nn	30	SENT_129	[p6l60t1037r270b1081],
28	duration	NN	O	duration	nn	30	SENT_129	[p6l290t1037r500b1081],
29	(	CD	NUMBER	(	num	30	SENT_129	[p6l524t1037r693b1091],
30	years	NNS	NUMBER	year	dep	18	SENT_129	[p6l524t1037r693b1091],
31	)	CD	NUMBER	)	number	32	SENT_129	[p6l524t1037r693b1091],
32	2.6	CD	NUMBER	2.6	num	33	SENT_129	[p6l915t1039r986b1081],
33	d	NN	O	d	dep	30	SENT_129	[p6l999t1043r1039b1083],
34	:	:	O	:	_	0	SENT_129	[p6l999t1043r1039b1083],
35	0.6	CD	NUMBER	0.6	dep	18	SENT_129	[p6l1053t1039r1124b1081],
36	2.3	CD	NUMBER	2.3	number	37	SENT_129	[p6l1270t1039r1339b1081],
37	3	CD	NUMBER	3	dep	35	SENT_129	[p6l1354t1043r1395b1083],
38	:	:	O	:	_	0	SENT_129	[p6l1354t1043r1395b1083],
39	0.3	CD	NUMBER	0.3	num	40	SENT_129	[p6l1409t1039r1477b1081],
40	1.9	CD	NUMBER	1.9	dep	37	SENT_129	[p6l1628t1039r1696b1081],
41	:	:	O	:	_	0	SENT_129	[p6l1710t1043r1750b1083],
42	t	NN	O	t	dep	50	SENT_129	[p6l1710t1043r1750b1083],
43	0.4	CD	NUMBER	0.4	num	42	SENT_129	[p6l1764t1039r1836b1081],
44	0.546	CD	NUMBER	0.546	num	47	SENT_129	[p6l1935t1039r2068b1081],
45	Metformin	NNP	O	Metformin	nn	47	SENT_129	[p6l60t1108r324b1152],
46	dose	NN	O	dose	nn	47	SENT_129	[p6l344t1108r455b1152],
47	(	NN	O	(	dep	42	SENT_129	[p6l479t1108r596b1163],
48	mg	NN	O	mg	dep	50	SENT_129	[p6l479t1108r596b1163],
49	)	CD	NUMBER	)	num	48	SENT_129	[p6l479t1108r596b1163],
50	1975	CD	DATE	1975	dep	52	SENT_129	[p6l868t1110r984b1152],
51	i	FW	O	i	dep	50	SENT_129	[p6l999t1114r1039b1154],
52	63	CD	NUMBER	63	dep	54	SENT_129	[p6l1054t1110r1109b1152],
53	1872	CD	DATE	1872	num	54	SENT_129	[p6l1223t1110r1340b1152],
54	j	NN	O	j	dep	57	SENT_129	[p6l1354t1114r1395b1154],
55	:	:	O	:	_	0	SENT_129	[p6l1354t1114r1395b1154],
56	64	CD	NUMBER	64	num	57	SENT_129	[p6l1409t1110r1468b1152],
57	1975	CD	DATE	1975	dep	40	SENT_129	[p6l1579t1110r1695b1152],
58	:	:	O	:	_	0	SENT_129	[p6l1710t1114r1750b1154],
59	t	NN	O	t	dep	63	SENT_129	[p6l1710t1114r1750b1154],
60	93	CD	NUMBER	93	num	61	SENT_129	[p6l1764t1110r1820b1152],
61	0.473	CD	NUMBER	0.473	dep	59	SENT_129	[p6l1935t1110r2065b1152],
62	Sulfonylurea	NNP	O	Sulfonylurea	dep	63	SENT_129	[p6l60t1180r371b1234],
63	dose	NN	O	dose	dep	66	SENT_129	[p6l390t1180r501b1223],
64	(	CD	PERCENT	(	num	65	SENT_129	[p6l525t1180r576b1234],
65	%	NN	PERCENT	%	dep	63	SENT_129	[p6l525t1180r576b1234],
66	max	NN	O	max	dep	57	SENT_129	[p6l595t1180r732b1234],
67	.	.	O	.	_	0	SENT_129	[p6l595t1180r732b1234],
68	)	SYM	O	)	dep	15	SENT_129	[p6l595t1180r732b1234],

1	46.2	CD	NUMBER	46.2	dep	195	SENT_130	[p6l883t1182r985b1224],
2	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l999t1186r1039b1226],
3	:	:	O	:	_	0	SENT_130	[p6l999t1186r1039b1226],
4	3.3	CD	NUMBER	3.3	dep	195	SENT_130	[p6l1052t1182r1122b1224],
5	48.4	CD	NUMBER	48.4	dep	195	SENT_130	[p6l1238t1182r1342b1224],
6	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l1354t1186r1395b1226],
7	:	:	O	:	_	0	SENT_130	[p6l1354t1186r1395b1226],
8	2.6	CD	NUMBER	2.6	dep	195	SENT_130	[p6l1409t1182r1480b1224],
9	44.6	CD	NUMBER	44.6	dep	195	SENT_130	[p6l1593t1182r1697b1224],
10	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l1710t1186r1750b1226],
11	:	:	O	:	_	0	SENT_130	[p6l1710t1186r1750b1226],
12	4.7	CD	NUMBER	4.7	dep	195	SENT_130	[p6l1762t1182r1834b1224],
13	0.740	CD	NUMBER	0.740	dep	195	SENT_130	[p6l1935t1182r2068b1224],
14	BMI	NN	O	bmus	dep	195	SENT_130	[p6l60t1254r155b1294],
15	(	CD	NUMBER	(	dep	195	SENT_130	[p6l179t1243r370b1305],
16	kg/m2	NN	O	kg/m2	dep	195	SENT_130	[p6l179t1243r370b1305],
17	)	CD	NUMBER	)	dep	195	SENT_130	[p6l179t1243r370b1305],
18	—	CD	NUMBER	—	dep	195	SENT_130	[p6l395t1277r433b1282],
19	baseline	NN	O	baseline	dep	195	SENT_130	[p6l453t1251r654b1295],
20	32.0	CD	NUMBER	32.0	dep	195	SENT_130	[p6l883t1253r986b1295],
21	:	:	O	:	_	0	SENT_130	[p6l999t1257r1039b1297],
22	t	NN	O	t	dep	195	SENT_130	[p6l999t1257r1039b1297],
23	0.9	CD	NUMBER	0.9	dep	195	SENT_130	[p6l1053t1253r1124b1295],
24	29.7	CD	NUMBER	29.7	dep	195	SENT_130	[p6l1239t1253r1340b1295],
25	3	CD	NUMBER	3	dep	195	SENT_130	[p6l1354t1257r1395b1297],
26	:	:	O	:	_	0	SENT_130	[p6l1354t1257r1395b1297],
27	0.4	CD	NUMBER	0.4	dep	195	SENT_130	[p6l1408t1253r1480b1295],
28	30.1	CD	NUMBER	30.1	dep	195	SENT_130	[p6l1594t1253r1691b1295],
29	:	:	O	:	_	0	SENT_130	[p6l1710t1257r1750b1297],
30	t	NN	O	t	dep	195	SENT_130	[p6l1710t1257r1750b1297],
31	0.7	CD	NUMBER	0.7	dep	195	SENT_130	[p6l1764t1253r1834b1295],
32	0.026	CD	NUMBER	0.026	dep	195	SENT_130	[p6l1935t1253r2068b1295],
33	BMI	NN	O	bmus	dep	195	SENT_130	[p6l60t1326r155b1366],
34	(	CD	NUMBER	(	dep	195	SENT_130	[p6l179t1315r370b1377],
35	kg/m2	NN	O	kg/m2	dep	195	SENT_130	[p6l179t1315r370b1377],
36	)	CD	NUMBER	)	dep	195	SENT_130	[p6l179t1315r370b1377],
37	—	NN	O	—	dep	195	SENT_130	[p6l395t1349r433b1353],
38	after	IN	O	after	dep	195	SENT_130	[p6l454t1323r568b1366],
39	therapy	NN	O	therapy	dep	195	SENT_130	[p6l585t1323r777b1377],
40	31.8	CD	NUMBER	31.8	dep	195	SENT_130	[p6l883t1325r985b1367],
41	:	:	O	:	_	0	SENT_130	[p6l999t1329r1039b1369],
42	t	NN	O	t	dep	195	SENT_130	[p6l999t1329r1039b1369],
43	0.9	CD	NUMBER	0.9	dep	195	SENT_130	[p6l1053t1325r1124b1367],
44	29.4	CD	NUMBER	29.4	dep	195	SENT_130	[p6l1239t1325r1342b1367],
45	i	FW	O	i	dep	195	SENT_130	[p6l1354t1329r1395b1369],
46	0.5	CD	NUMBER	0.5	dep	195	SENT_130	[p6l1408t1325r1478b1367],
47	29.8	CD	NUMBER	29.8	dep	195	SENT_130	[p6l1594t1325r1696b1367],
48	:	:	O	:	_	0	SENT_130	[p6l1710t1329r1750b1369],
49	t	NN	O	t	dep	195	SENT_130	[p6l1710t1329r1750b1369],
50	0.6	CD	NUMBER	0.6	dep	195	SENT_130	[p6l1764t1325r1835b1367],
51	0.024	CD	NUMBER	0.024	dep	195	SENT_130	[p6l1935t1325r2068b1367],
52	FPG	NNP	O	FPG	dep	195	SENT_130	[p6l60t1396r152b1438],
53	(	CD	NUMBER	(	dep	195	SENT_130	[p6l176t1394r395b1448],
54	mmol/1	NN	O	mmol/1	dep	195	SENT_130	[p6l176t1394r395b1448],
55	)	CD	NUMBER	)	dep	195	SENT_130	[p6l176t1394r395b1448],
56	—	CD	NUMBER	—	dep	195	SENT_130	[p6l420t1420r459b1425],
57	baseline	NN	O	baseline	dep	195	SENT_130	[p6l479t1394r679b1438],
58	8.59	CD	NUMBER	8.59	dep	195	SENT_130	[p6l884t1396r986b1438],
59	i	FW	O	i	dep	195	SENT_130	[p6l999t1400r1039b1440],
60	0.29	CD	NUMBER	0.29	dep	195	SENT_130	[p6l1053t1396r1155b1438],
61	8.63	CD	NUMBER	8.63	dep	195	SENT_130	[p6l1240t1396r1339b1438],
62	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l1354t1400r1395b1440],
63	:	:	O	:	_	0	SENT_130	[p6l1354t1400r1395b1440],
64	0.14	CD	NUMBER	0.14	dep	195	SENT_130	[p6l1408t1396r1511b1438],
65	8.69	CD	NUMBER	8.69	dep	195	SENT_130	[p6l1595t1396r1697b1438],
66	:	:	O	:	_	0	SENT_130	[p6l1710t1400r1750b1440],
67	t	NN	O	t	dep	195	SENT_130	[p6l1710t1400r1750b1440],
68	0.39	CD	NUMBER	0.39	dep	195	SENT_130	[p6l1764t1396r1866b1438],
69	0.970	CD	NUMBER	0.970	dep	195	SENT_130	[p6l1935t1396r2068b1438],
70	FPG	NNP	O	FPG	dep	195	SENT_130	[p6l60t1468r152b1509],
71	(	CD	NUMBER	(	dep	195	SENT_130	[p6l175t1465r395b1520],
72	mmol/1	NN	O	mmol/1	dep	195	SENT_130	[p6l175t1465r395b1520],
73	)	CD	NUMBER	)	dep	195	SENT_130	[p6l175t1465r395b1520],
74	—	NN	O	—	dep	195	SENT_130	[p6l420t1491r459b1496],
75	after	IN	O	after	dep	195	SENT_130	[p6l479t1465r593b1509],
76	therapy	NN	O	therapy	dep	195	SENT_130	[p6l611t1466r801b1520],
77	7.28	CD	NUMBER	7.28	dep	195	SENT_130	[p6l885t1468r985b1509],
78	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l999t1472r1039b1512],
79	:	:	O	:	_	0	SENT_130	[p6l999t1472r1039b1512],
80	0.21	CD	NUMBER	0.21	dep	195	SENT_130	[p6l1053t1468r1149b1509],
81	7.13	CD	NUMBER	7.13	dep	195	SENT_130	[p6l1240t1468r1339b1509],
82	i	FW	O	i	dep	195	SENT_130	[p6l1354t1472r1395b1512],
83	0.14	CD	NUMBER	0.14	dep	195	SENT_130	[p6l1408t1468r1511b1509],
84	7.10	CD	NUMBER	7.10	dep	195	SENT_130	[p6l1595t1468r1697b1509],
85	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l1710t1472r1750b1512],
86	:	:	O	:	_	0	SENT_130	[p6l1710t1472r1750b1512],
87	0.33	CD	PERCENT	0.33	dep	195	SENT_130	[p6l1764t1468r1864b1509],
88	0.805	CD	PERCENT	0.805	dep	195	SENT_130	[p6l1935t1468r2066b1509],
89	HbA1c	NN	PERCENT	hba1c	dep	195	SENT_130	[p6l60t1537r221b1580],
90	(	CD	PERCENT	(	dep	195	SENT_130	[p6l243t1537r315b1591],
91	%	NN	PERCENT	%	dep	195	SENT_130	[p6l243t1537r315b1591],
92	)	CD	NUMBER	)	dep	195	SENT_130	[p6l243t1537r315b1591],
93	—	CD	NUMBER	—	dep	195	SENT_130	[p6l339t1563r378b1567],
94	baseline	NN	O	baseline	dep	195	SENT_130	[p6l398t1537r599b1580],
95	8.21	CD	NUMBER	8.21	dep	195	SENT_130	[p6l884t1539r980b1581],
96	:	:	O	:	_	0	SENT_130	[p6l999t1543r1039b1583],
97	t	NN	O	t	dep	195	SENT_130	[p6l999t1543r1039b1583],
98	0.20	CD	NUMBER	0.20	dep	195	SENT_130	[p6l1053t1539r1155b1581],
99	7.88	CD	NUMBER	7.88	dep	195	SENT_130	[p6l1240t1539r1340b1581],
100	:	:	O	:	_	0	SENT_130	[p6l1354t1543r1395b1583],
101	t	NN	O	t	dep	195	SENT_130	[p6l1354t1543r1395b1583],
102	0.10	CD	NUMBER	0.10	dep	195	SENT_130	[p6l1408t1539r1511b1581],
103	8.12	CD	NUMBER	8.12	dep	195	SENT_130	[p6l1595t1539r1696b1581],
104	:	:	O	:	_	0	SENT_130	[p6l1710t1543r1750b1583],
105	t	NN	O	t	dep	195	SENT_130	[p6l1710t1543r1750b1583],
106	0.18	CD	PERCENT	0.18	dep	195	SENT_130	[p6l1764t1539r1865b1581],
107	0.239	CD	PERCENT	0.239	dep	195	SENT_130	[p6l1935t1539r2067b1581],
108	HbA1c	NN	PERCENT	hba1c	dep	195	SENT_130	[p6l60t1608r221b1652],
109	(	CD	PERCENT	(	dep	195	SENT_130	[p6l243t1608r315b1662],
110	%	NN	PERCENT	%	dep	195	SENT_130	[p6l243t1608r315b1662],
111	)	CD	NUMBER	)	dep	195	SENT_130	[p6l243t1608r315b1662],
112	—	NN	O	—	dep	195	SENT_130	[p6l339t1634r378b1639],
113	after	IN	O	after	dep	195	SENT_130	[p6l399t1608r513b1652],
114	therapy	NN	O	therapy	dep	195	SENT_130	[p6l530t1608r721b1663],
115	7.16	CD	NUMBER	7.16	dep	195	SENT_130	[p6l885t1610r986b1652],
116	i	FW	O	i	dep	195	SENT_130	[p6l999t1614r1039b1654],
117	0.14	CD	NUMBER	0.14	dep	195	SENT_130	[p6l1053t1610r1156b1652],
118	6.91	CD	NUMBER	6.91	dep	195	SENT_130	[p6l1240t1610r1335b1652],
119	d	NN	O	d	dep	195	SENT_130	[p6l1354t1614r1395b1654],
120	:	:	O	:	_	0	SENT_130	[p6l1354t1614r1395b1654],
121	0.07	CD	NUMBER	0.07	dep	195	SENT_130	[p6l1408t1610r1509b1652],
122	6.86	CD	NUMBER	6.86	dep	195	SENT_130	[p6l1595t1610r1697b1652],
123	:	:	O	:	_	0	SENT_130	[p6l1710t1614r1750b1654],
124	t	NN	O	t	dep	195	SENT_130	[p6l1710t1614r1750b1654],
125	0.16	CD	NUMBER	0.16	dep	195	SENT_130	[p6l1764t1610r1866b1652],
126	0.145	CD	NUMBER	0.145	dep	195	SENT_130	[p6l1935t1610r2066b1652],
127	Total	JJ	O	total	dep	195	SENT_130	[p6l58t1679r180b1723],
128	cholesterol	NN	O	cholesterol	dep	195	SENT_130	[p6l201t1679r470b1723],
129	(	NN	O	(	dep	195	SENT_130	[p6l494t1679r713b1734],
130	mmol/1	NN	O	mmol/1	dep	195	SENT_130	[p6l494t1679r713b1734],
131	)	CD	NUMBER	)	dep	195	SENT_130	[p6l494t1679r713b1734],
132	5.08	CD	NUMBER	5.08	dep	195	SENT_130	[p6l885t1682r985b1723],
133	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l999t1686r1039b1726],
134	:	:	O	:	_	0	SENT_130	[p6l999t1686r1039b1726],
135	0.14	CD	NUMBER	0.14	dep	195	SENT_130	[p6l1053t1682r1156b1723],
136	5.22	CD	NUMBER	5.22	dep	195	SENT_130	[p6l1240t1682r1340b1723],
137	i	FW	O	i	dep	195	SENT_130	[p6l1354t1686r1395b1726],
138	0.12	CD	NUMBER	0.12	dep	195	SENT_130	[p6l1409t1682r1509b1723],
139	5.07	CD	NUMBER	5.07	dep	195	SENT_130	[p6l1595t1682r1696b1723],
140	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l1710t1686r1750b1726],
141	:	:	O	:	_	0	SENT_130	[p6l1710t1686r1750b1726],
142	0.31	CD	NUMBER	0.31	dep	195	SENT_130	[p6l1764t1682r1860b1723],
143	0.759	CD	NUMBER	0.759	dep	195	SENT_130	[p6l1935t1682r2067b1723],
144	LDL	NN	O	ldl	dep	195	SENT_130	[p6l60t1754r151b1794],
145	cholesterol	NN	O	cholesterol	dep	195	SENT_130	[p6l168t1751r438b1794],
146	(	CD	NUMBER	(	dep	195	SENT_130	[p6l462t1751r681b1805],
147	mmol/1	NN	O	mmol/1	dep	195	SENT_130	[p6l462t1751r681b1805],
148	)	CD	NUMBER	)	dep	195	SENT_130	[p6l462t1751r681b1805],
149	2.83	CD	NUMBER	2.83	dep	195	SENT_130	[p6l884t1753r984b1795],
150	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l999t1757r1039b1797],
151	:	:	O	:	_	0	SENT_130	[p6l999t1757r1039b1797],
152	0.08	CD	NUMBER	0.08	dep	195	SENT_130	[p6l1053t1753r1154b1795],
153	2.75	CD	NUMBER	2.75	dep	195	SENT_130	[p6l1239t1753r1340b1795],
154	:	:	O	:	_	0	SENT_130	[p6l1354t1757r1395b1797],
155	t	NN	O	t	dep	195	SENT_130	[p6l1354t1757r1395b1797],
156	0.10	CD	NUMBER	0.10	dep	195	SENT_130	[p6l1409t1753r1511b1795],
157	2.85	CD	NUMBER	2.85	dep	195	SENT_130	[p6l1594t1753r1695b1795],
158	:	:	O	:	_	0	SENT_130	[p6l1710t1757r1750b1797],
159	t	NN	O	t	dep	195	SENT_130	[p6l1710t1757r1750b1797],
160	0.27	CD	NUMBER	0.27	dep	195	SENT_130	[p6l1764t1753r1865b1795],
161	0.808	CD	NUMBER	0.808	dep	195	SENT_130	[p6l1935t1753r2066b1795],
162	HDL	NN	O	hdl	dep	195	SENT_130	[p6l60t1825r165b1865],
163	cholesterol	NN	O	cholesterol	dep	195	SENT_130	[p6l182t1822r451b1866],
164	(	CD	NUMBER	(	dep	195	SENT_130	[p6l475t1822r695b1876],
165	mmol/1	NN	O	mmol/1	dep	195	SENT_130	[p6l475t1822r695b1876],
166	)	CD	NUMBER	)	dep	195	SENT_130	[p6l475t1822r695b1876],
167	1.14	CD	NUMBER	1.14	dep	195	SENT_130	[p6l886t1824r987b1866],
168	i	FW	O	i	dep	195	SENT_130	[p6l999t1828r1039b1868],
169	0.06	CD	NUMBER	0.06	dep	195	SENT_130	[p6l1053t1824r1155b1866],
170	1.10	CD	NUMBER	1.10	dep	195	SENT_130	[p6l1242t1824r1341b1866],
171	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l1354t1828r1395b1868],
172	:	:	O	:	_	0	SENT_130	[p6l1354t1828r1395b1868],
173	0.03	CD	NUMBER	0.03	dep	195	SENT_130	[p6l1408t1824r1508b1866],
174	1.12	CD	NUMBER	1.12	dep	195	SENT_130	[p6l1597t1824r1696b1866],
175	:	:	O	:	_	0	SENT_130	[p6l1710t1828r1750b1868],
176	t	NN	O	t	dep	195	SENT_130	[p6l1710t1828r1750b1868],
177	0.03	CD	NUMBER	0.03	dep	195	SENT_130	[p6l1764t1824r1864b1866],
178	0.737	CD	NUMBER	0.737	dep	195	SENT_130	[p6l1935t1824r2067b1866],
179	Triglycerides	NNS	MISC	triglyceride	dep	195	SENT_130	[p6l58t1894r375b1948],
180	(	VBP	O	(	dep	195	SENT_130	[p6l399t1894r618b1948],
181	mmol/1	NN	O	mmol/1	dep	195	SENT_130	[p6l399t1894r618b1948],
182	)	CD	NUMBER	)	dep	195	SENT_130	[p6l399t1894r618b1948],
183	2.20	CD	NUMBER	2.20	dep	195	SENT_130	[p6l884t1896r986b1938],
184	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l999t1900r1039b1940],
185	:	:	O	:	_	0	SENT_130	[p6l999t1900r1039b1940],
186	0.14	CD	NUMBER	0.14	dep	195	SENT_130	[p6l1053t1896r1156b1938],
187	1.96	CD	NUMBER	1.96	dep	195	SENT_130	[p6l1242t1896r1342b1938],
188	:1	CD	NUMBER	:1	dep	195	SENT_130	[p6l1354t1900r1395b1940],
189	:	:	O	:	_	0	SENT_130	[p6l1354t1900r1395b1940],
190	0.08	CD	NUMBER	0.08	dep	195	SENT_130	[p6l1408t1896r1509b1938],
191	1.88	CD	NUMBER	1.88	dep	195	SENT_130	[p6l1597t1896r1696b1938],
192	:	:	O	:	_	0	SENT_130	[p6l1710t1900r1750b1940],
193	t	NN	O	t	dep	195	SENT_130	[p6l1710t1900r1750b1940],
194	0.18	CD	NUMBER	0.18	dep	195	SENT_130	[p6l1764t1896r1865b1938],
195	0.164	CD	NUMBER	0.164	_	0	SENT_130	[p6l1935t1896r2068b1938],

1	Data	NNS	O	datum	nsubjpass	3	SENT_131	[p6l10t2007r120b2048],
2	are	VBP	O	be	auxpass	3	SENT_131	[p6l141t2017r215b2048],
3	expressed	VBN	O	express	_	0	SENT_131	[p6l236t2004r482b2059],
4	as	IN	O	as	_	0	SENT_131	[p6l504t2017r551b2048],
5	mean	NN	O	mean	nn	7	SENT_131	[p6l574t2017r708b2048],
6	1	CD	NUMBER	1	num	7	SENT_131	[p6l721t2011r762b2051],
7	SEM	NN	O	sem	prep_as	3	SENT_131	[p6l776t2007r893b2049],
8	.	.	O	.	_	0	SENT_131	[p6l776t2007r893b2049],

1	p-values	NNS	O	p-value	nsubj	2	SENT_132	[p6l915t2005r1122b2059],
2	refer	VBP	O	refer	_	0	SENT_132	[p6l1145t2004r1261b2048],
3	to	TO	O	to	_	0	SENT_132	[p6l1280t2011r1327b2048],
4	ANOVA	NNP	ORGANIZATION	ANOVA	prep_to	2	SENT_132	[p6l1347t2006r1533b2048],
5	and	CC	O	and	_	0	SENT_132	[p6l1551t2004r1640b2048],
6	*	CD	NUMBER	*	dep	7	SENT_132	[p6l1663t1988r1686b2014],
7	12-test	JJ	O	12-test	conj_and	2	SENT_132	[p6l1690t1996r1875b2059],
8	.	.	O	.	_	0	SENT_132	[p6l1690t1996r1875b2059],

1	BMI	NNP	O	BMI	_	0	SENT_133	[p6l1898t2007r2005b2055],
2	,	,	O	,	_	0	SENT_133	[p6l1898t2007r2005b2055],
3	body	NN	O	body	nn	5	SENT_133	[p6l2026t2004r2148b2059],
4	mass	NN	O	mass	nn	5	SENT_133	[p6l10t2090r130b2121],
5	index	NN	O	index	appos	1	SENT_133	[p6l160t2077r310b2127],
6	;	:	O	;	_	0	SENT_133	[p6l160t2077r310b2127],
7	FPG	NNP	ORGANIZATION	FPG	dep	1	SENT_133	[p6l343t2079r447b2127],
8	,	,	O	,	_	0	SENT_133	[p6l343t2079r447b2127],
9	fasting	VBG	O	fast	amod	11	SENT_133	[p6l477t2077r641b2131],
10	plasma	NN	O	plasma	nn	11	SENT_133	[p6l669t2077r843b2131],
11	glucose	NN	O	glucose	appos	7	SENT_133	[p6l870t2077r1068b2131],
12	;	:	O	;	_	0	SENT_133	[p6l870t2077r1068b2131],
13	LDL	NN	O	ldl	dep	7	SENT_133	[p6l1101t2080r1201b2127],
14	,	,	O	,	_	0	SENT_133	[p6l1101t2080r1201b2127],
15	low-density	JJ	O	low-density	amod	16	SENT_133	[p6l1231t2077r1526b2131],
16	lipoprotein	NN	O	lipoprotein	appos	13	SENT_133	[p6l1554t2077r1841b2131],
17	;	:	O	;	_	0	SENT_133	[p6l1554t2077r1841b2131],
18	HDL	NNP	O	HDL	dep	7	SENT_133	[p6l1874t2080r1987b2127],
19	,	,	O	,	_	0	SENT_133	[p6l1874t2080r1987b2127],
20	highdensity	JJ	O	highdensity	amod	21	SENT_133	[p6l2017t2077r2146b2131, p6l9t2148r189b2203],
21	lipoprotein	NN	O	lipoprotein	appos	18	SENT_133	[p6l208t2148r492b2203],
22	.	.	O	.	_	0	SENT_133	[p6l208t2148r492b2203],

1	We	PRP	O	we	nsubj	2	SENT_134	[p6l109t2343r213b2394],
2	examined	VBD	O	examine	dep	19	SENT_134	[p6l237t2339r537b2394],
3	the	DT	O	the	det	4	SENT_134	[p6l560t2339r657b2394],
4	effect	NN	O	effect	dobj	2	SENT_134	[p6l681t2339r849b2394],
5	of	IN	O	of	_	0	SENT_134	[p6l871t2339r934b2394],
6	sulfonylurea	NN	O	sulfonylurea	nn	7	SENT_134	[p6l950t2339r1330b2408],
7	treatment	NN	O	treatment	prep_of	4	SENT_134	[p6l1353t2347r1661b2394],
8	with	IN	O	with	_	0	SENT_134	[p6l1680t2339r1822b2394],
9	respect	NN	O	respect	_	0	SENT_134	[p6l1845t2347r2067b2408],
10	to	TO	O	to	_	0	SENT_134	[p6l2087t2348r2146b2394],
11	KCN	NNP	O	KCN	prep_with_respect_to	7	SENT_134	[p6l8t2432r221b2497],
12	]	CD	NUMBER	]	num	11	SENT_134	[p6l8t2432r221b2497],
13	11	CD	NUMBER	11	num	14	SENT_134	[p6l8t2432r221b2497],
14	genotype	NN	O	genotype	tmod	2	SENT_134	[p6l267t2437r552b2497],
15	in	IN	O	in	_	0	SENT_134	[p6l592t2430r649b2483],
16	different	JJ	O	different	amod	18	SENT_134	[p6l688t2429r953b2484],
17	genetic	JJ	O	genetic	amod	18	SENT_134	[p6l990t2430r1214b2497],
18	models	NNS	O	model	prep_in	14	SENT_134	[p6l1252t2429r1472b2484],
19	(	VBP	O	(	_	0	SENT_134	[p6l1517t2429r1705b2497],
20	Table	NNP	O	Table	dobj	19	SENT_134	[p6l1517t2429r1705b2497],
21	3	CD	NUMBER	3	num	22	SENT_134	[p6l1744t2429r1824b2497],
22	)	NN	O	)	nsubj	19	SENT_134	[p6l1744t2429r1824b2497],
23	.	.	O	.	_	0	SENT_134	[p6l1744t2429r1824b2497],

1	Although	IN	O	although	mark	3	SENT_135	[p6l1862t2429r2147b2497],
2	there	EX	O	there	expl	3	SENT_135	[p6l9t2518r169b2573],
3	was	VBD	O	be	advcl	29	SENT_135	[p6l188t2533r307b2573],
4	not	RB	O	not	neg	3	SENT_135	[p6l328t2526r429b2573],
5	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_135	[p6l448t2517r766b2586],
6	overall	JJ	O	overall	amod	7	SENT_135	[p6l784t2518r991b2573],
7	difference	NN	O	difference	nn	21	SENT_135	[p6l1012t2517r1317b2573],
8	among	IN	O	among	_	0	SENT_135	[p6l1337t2533r1547b2586],
9	the	DT	O	the	det	12	SENT_135	[p6l1565t2518r1662b2573],
10	three	CD	NUMBER	three	num	12	SENT_135	[p6l1683t2518r1842b2573],
11	genotype	NN	O	genotype	nn	12	SENT_135	[p6l1861t2526r2146b2586],
12	groups	NNS	O	group	prep_among	7	SENT_135	[p6l9t2622r218b2675],
13	in	IN	O	in	_	0	SENT_135	[p6l239t2607r296b2660],
14	the	DT	O	the	det	18	SENT_135	[p6l315t2606r412b2661],
15	codominant	NN	O	codominant	nn	18	SENT_135	[p6l433t2606r802b2661],
16	model	NN	O	model	nn	18	SENT_135	[p6l822t2606r1012b2661],
17	(	CD	NUMBER	(	num	18	SENT_135	[p6l1037t2606r1099b2675],
18	p	NN	O	p	prep_in	12	SENT_135	[p6l1037t2606r1099b2675],
19	=	JJ	O	=	amod	21	SENT_135	[p6l1116t2629r1170b2650],
20	0.097	CD	NUMBER	0.097	tmod	19	SENT_135	[p6l1188t2606r1398b2674],
21	)	NN	O	)	nsubj	3	SENT_135	[p6l1188t2606r1398b2674],
22	,	,	O	,	_	0	SENT_135	[p6l1188t2606r1398b2674],
23	increasing	VBG	O	increase	amod	24	SENT_135	[p6l1420t2607r1734b2675],
24	means	NNS	O	means	nsubj	29	SENT_135	[p6l1754t2622r1952b2661],
25	in	IN	O	in	_	0	SENT_135	[p6l1973t2607r2029b2660],
26	the	DT	O	the	det	28	SENT_135	[p6l2049t2606r2146b2661],
27	genotype	NN	O	genotype	nn	28	SENT_135	[p6l9t2703r294b2764],
28	groups	NNS	O	group	prep_in	24	SENT_135	[p6l318t2711r527b2764],
29	implicated	VBD	O	implicate	_	0	SENT_135	[p6l553t2695r876b2764],
30	an	DT	O	a	det	34	SENT_135	[p6l902t2711r974b2750],
31	allele	NN	O	allele	nn	34	SENT_135	[p6l999t2695r1342b2750],
32	—	CD	NUMBER	—	num	34	SENT_135	[p6l999t2695r1342b2750],
33	dose	NN	O	dose	nn	34	SENT_135	[p6l999t2695r1342b2750],
34	effect	NN	O	effect	dobj	29	SENT_135	[p6l1367t2695r1549b2751],
35	.	.	O	.	_	0	SENT_135	[p6l1367t2695r1549b2751],

1	Indeed	RB	O	indeed	advmod	30	SENT_136	[p6l1575t2695r1798b2758],
2	,	,	O	,	_	0	SENT_136	[p6l1575t2695r1798b2758],
3	in	IN	O	in	_	0	SENT_136	[p6l1825t2696r1881b2749],
4	the	DT	O	the	det	6	SENT_136	[p6l1905t2695r2003b2750],
5	logadditive	JJ	O	logadditive	amod	6	SENT_136	[p6l2029t2695r2146b2764, p6l10t2784r257b2839],
6	model	NN	O	model	prep_in	30	SENT_136	[p6l297t2784r487b2839],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_136	[p6l528t2784r902b2853],
8	greater	JJR	O	greater	amod	9	SENT_136	[p6l938t2793r1159b2853],
9	reduction	NN	O	reduction	dep	20	SENT_136	[p6l1197t2784r1492b2839],
10	in	IN	O	in	_	0	SENT_136	[p6l1531t2785r1587b2839],
11	HbA1c	NN	O	hba1c	prep_in	9	SENT_136	[p6l1627t2784r1828b2839],
12	by	IN	O	by	_	0	SENT_136	[p6l1865t2784r1939b2853],
13	0.16	CD	PERCENT	0.16	num	14	SENT_136	[p6l1977t2787r2147b2840],
14	%	NN	PERCENT	%	prep_by	11	SENT_136	[p6l1977t2787r2147b2840],
15	(	CD	PERCENT	(	number	16	SENT_136	[p6l14t2874r156b2942],
16	95	CD	PERCENT	95	dep	17	SENT_136	[p6l14t2874r156b2942],
17	%	NN	PERCENT	%	dep	14	SENT_136	[p6l14t2874r156b2942],
18	CI	NN	O	ci	dep	20	SENT_136	[p6l183t2876r239b2928],
19	0.01-0	CD	NUMBER	0.01-0	num	18	SENT_136	[p6l267t2876r580b2937],
20	.32	CD	NUMBER	.32	dep	6	SENT_136	[p6l267t2876r580b2937],
21	,	,	O	,	_	0	SENT_136	[p6l267t2876r580b2937],
22	p	NN	O	p	appos	20	SENT_136	[p6l609t2889r644b2942],
23	=	JJ	O	=	amod	22	SENT_136	[p6l662t2896r715b2917],
24	0.038	CD	NUMBER	0.038	number	25	SENT_136	[p6l733t2874r925b2942],
25	)	CD	NUMBER	)	dep	23	SENT_136	[p6l733t2874r925b2942],
26	per	IN	O	per	_	0	SENT_136	[p6l957t2889r1058b2942],
27	each	DT	O	each	det	28	SENT_136	[p6l1084t2873r1222b2928],
28	additional	JJ	O	additional	prep_per	20	SENT_136	[p6l1249t2873r1558b2928],
29	I	PRP	O	I	nsubj	30	SENT_136	[p6l1586t2873r1817b2928],
30	(	VBP	O	(	_	0	SENT_136	[p6l1586t2873r1817b2928],
31	.	.	O	.	_	0	SENT_136	[p6l1586t2873r1817b2928],

1	—	NN	O	—	_	0	SENT_137	[p6l1586t2873r1817b2928],
2	.	.	O	.	_	0	SENT_137	[p6l1586t2873r1817b2928],

1	allele	NN	O	allele	nsubjpass	7	SENT_138	[p6l1586t2873r1817b2928],
2	of	IN	O	of	_	0	SENT_138	[p6l1845t2873r1909b2928],
3	KCN	NNP	O	KCN	prep_of	1	SENT_138	[p6l1926t2876r2140b2942],
4	]	CD	NUMBER	]	number	5	SENT_138	[p6l1926t2876r2140b2942],
5	11	CD	NUMBER	11	num	3	SENT_138	[p6l1926t2876r2140b2942],
6	was	VBD	O	be	auxpass	7	SENT_138	[p6l8t2979r127b3018],
7	observed	VBN	O	observe	_	0	SENT_138	[p6l162t2963r453b3018],
8	.	.	O	.	_	0	SENT_138	[p6l162t2963r453b3018],

1	In	IN	O	in	_	0	SENT_139	[p6l489t2966r546b3017],
2	the	DT	O	the	det	4	SENT_139	[p6l579t2963r676b3018],
3	dominant	JJ	O	dominant	amod	4	SENT_139	[p6l710t2963r1009b3018],
4	model	NN	O	model	prep_in	33	SENT_139	[p6l1042t2963r1247b3026],
5	,	,	O	,	_	0	SENT_139	[p6l1042t2963r1247b3026],
6	in	IN	O	in	_	0	SENT_139	[p6l1282t2964r1338b3017],
7	which	WDT	O	which	rel	11	SENT_139	[p6l1371t2963r1560b3018],
8	risk	NN	O	risk	nn	9	SENT_139	[p6l1594t2963r1705b3018],
9	homozygotes	NNS	O	homozygote	nsubjpass	20	SENT_139	[p6l1737t2963r2146b3031],
10	were	VBD	O	be	auxpass	11	SENT_139	[p6l8t3067r162b3107],
11	pooled	VBN	O	pool	rcmod	4	SENT_139	[p6l187t3052r394b3120],
12	with	IN	O	with	_	0	SENT_139	[p6l418t3051r559b3107],
13	heterozygotes	NNS	O	heterozygote	prep_with	11	SENT_139	[p6l584t3052r1014b3120],
14	(	CD	NUMBER	(	num	15	SENT_139	[p6l1044t3052r1150b3120],
15	EK	NN	O	ek	dep	13	SENT_139	[p6l1044t3052r1150b3120],
16	+	CC	O	+	_	0	SENT_139	[p6l1166t3059r1216b3110],
17	KK	NNP	O	KK	nn	18	SENT_139	[p6l1234t3052r1343b3120],
18	)	NNP	O	)	conj_+	15	SENT_139	[p6l1234t3052r1343b3120],
19	and	CC	O	and	_	0	SENT_139	[p6l1371t3052r1483b3107],
20	compared	VBN	O	compare	rcmod	4	SENT_139	[p6l1508t3052r1813b3120],
21	with	IN	O	with	_	0	SENT_139	[p6l1837t3052r1978b3107],
22	nonrisk	JJ	O	nonrisk	amod	23	SENT_139	[p6l2003t3067r2146b3107, p6l10t3140r122b3195],
23	homozygotes	NNS	O	homozygote	prep_with	20	SENT_139	[p6l149t3140r558b3209],
24	(	VBP	O	(	dep	23	SENT_139	[p6l591t3140r734b3208],
25	EE	NN	O	ee	nn	26	SENT_139	[p6l591t3140r734b3208],
26	)	NN	O	)	dobj	24	SENT_139	[p6l591t3140r734b3208],
27	,	,	O	,	_	0	SENT_139	[p6l591t3140r734b3208],
28	reduction	NN	O	reduction	nsubj	33	SENT_139	[p6l764t3140r1058b3195],
29	in	IN	O	in	_	0	SENT_139	[p6l1088t3141r1144b3194],
30	HbA1c	NN	O	hba1c	prep_in	28	SENT_139	[p6l1172t3140r1373b3195],
31	was	VBD	O	be	cop	33	SENT_139	[p6l1400t3156r1519b3195],
32	signiﬁcantly	RB	O	signiﬁcantly	advmod	33	SENT_139	[p6l1549t3140r1923b3209],
33	higher	JJR	O	higher	_	0	SENT_139	[p6l1950t3140r2149b3209],
34	in	IN	O	in	_	0	SENT_139	[p6l10t3230r66b3283],
35	the	DT	O	the	det	39	SENT_139	[p6l90t3229r187b3284],
36	EK	NN	ORGANIZATION	ek	nn	39	SENT_139	[p6l212t3232r291b3283],
37	+	CC	ORGANIZATION	+	_	0	SENT_139	[p6l307t3237r357b3287],
38	KK	NNP	ORGANIZATION	KK	nn	39	SENT_139	[p6l375t3232r459b3283],
39	group	NN	O	group	prep_in	33	SENT_139	[p6l481t3245r660b3298],
40	in	IN	O	in	_	0	SENT_139	[p6l685t3230r741b3283],
41	comparison	NN	O	comparison	prep_in	39	SENT_139	[p6l765t3230r1125b3298],
42	with	IN	O	with	_	0	SENT_139	[p6l1146t3229r1287b3284],
43	the	DT	O	the	det	45	SENT_139	[p6l1310t3229r1407b3284],
44	EE	NN	O	ee	nn	45	SENT_139	[p6l1432t3232r1504b3283],
45	group	NN	O	group	prep_with	33	SENT_139	[p6l1527t3245r1706b3298],
46	with	IN	O	with	_	0	SENT_139	[p6l1729t3229r1870b3284],
47	an	DT	O	a	det	49	SENT_139	[p6l1893t3245r1965b3284],
48	average	JJ	O	average	amod	49	SENT_139	[p6l1989t3245r2146b3284, p6l10t3334r112b3387],
49	difference	NN	O	difference	prep_with	33	SENT_139	[p6l140t3318r445b3373],
50	of	IN	O	of	_	0	SENT_139	[p6l473t3318r537b3373],
51	0.25	CD	PERCENT	0.25	number	52	SENT_139	[p6l556t3321r726b3374],
52	%	NN	PERCENT	%	amod	54	SENT_139	[p6l556t3321r726b3374],
53	(	CD	NUMBER	(	num	54	SENT_139	[p6l757t3319r819b3387],
54	p	NN	O	p	prep_of	49	SENT_139	[p6l757t3319r819b3387],
55	=	JJ	O	=	amod	57	SENT_139	[p6l836t3341r890b3362],
56	0.036	CD	NUMBER	0.036	tmod	55	SENT_139	[p6l908t3319r1119b3387],
57	)	NN	O	)	dep	54	SENT_139	[p6l908t3319r1119b3387],
58	.	.	O	.	_	0	SENT_139	[p6l908t3319r1119b3387],

1	In	IN	O	in	_	0	SENT_140	[p6l1147t3322r1204b3373],
2	this	DT	O	this	det	3	SENT_140	[p6l1231t3318r1342b3373],
3	model	NN	O	model	prep_in	14	SENT_140	[p6l1370t3318r1561b3373],
4	further	RB	O	further	advmod	6	SENT_140	[p6l1589t3318r1805b3373],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_140	[p6l1831t3318r2148b3387],
6	predictors	NNS	O	predictor	nsubj	14	SENT_140	[p6l10t3407r320b3476],
7	of	IN	O	of	_	0	SENT_140	[p6l348t3407r411b3462],
8	AHbA1c	NN	O	ahba1c	prep_of	6	SENT_140	[p6l429t3407r680b3462],
9	were	VBD	O	be	cop	14	SENT_140	[p6l704t3423r857b3462],
10	baseline	JJ	O	baseline	amod	13	SENT_140	[p6l884t3407r1134b3462],
11	HbA1c	NN	O	hba1c	nn	13	SENT_140	[p6l1162t3407r1363b3462],
12	(	NN	O	(	nn	13	SENT_140	[p6l1393t3408r1706b3476],
13	p	NN	O	p	dep	14	SENT_140	[p6l1393t3408r1706b3476],
14	<	JJR	O	<	_	0	SENT_140	[p6l1393t3408r1706b3476],
15	0.001	CD	NUMBER	0.001	num	16	SENT_140	[p6l1393t3408r1706b3476],
16	)	NN	O	)	dep	14	SENT_140	[p6l1393t3408r1706b3476],
17	and	CC	O	and	_	0	SENT_140	[p6l1737t3407r1848b3462],
18	sulfonylurea	NN	O	sulfonylurea	nn	21	SENT_140	[p6l1877t3407r2146b3476, p6l10t3513r144b3552],
19	dose	NN	O	dose	nn	21	SENT_140	[p6l174t3497r313b3552],
20	(	NN	O	(	nn	21	SENT_140	[p6l349t3497r710b3565],
21	p	NN	O	p	conj_and	14	SENT_140	[p6l349t3497r710b3565],
22	=	JJ	O	=	amod	24	SENT_140	[p6l349t3497r710b3565],
23	0.024	CD	NUMBER	0.024	tmod	22	SENT_140	[p6l349t3497r710b3565],
24	)	NN	O	)	dep	21	SENT_140	[p6l349t3497r710b3565],
25	.	.	O	.	_	0	SENT_140	[p6l349t3497r710b3565],

1	These	DT	O	these	det	3	SENT_141	[p6l739t3497r916b3552],
2	three	CD	NUMBER	three	num	3	SENT_141	[p6l946t3497r1106b3552],
3	variables	NNS	O	variable	nsubj	4	SENT_141	[p6l1136t3497r1410b3552],
4	explained	VBD	O	explain	_	0	SENT_141	[p6l1441t3497r1740b3565],
5	56	CD	PERCENT	56	num	6	SENT_141	[p6l1772t3500r1887b3552],
6	%	NN	PERCENT	%	dobj	4	SENT_141	[p6l1772t3500r1887b3552],
7	of	IN	O	of	_	0	SENT_141	[p6l1918t3497r1981b3552],
8	variance	NN	O	variance	prep_of	6	SENT_141	[p6l2003t3498r2146b3552, p6l10t3601r148b3640],
9	of	IN	O	of	_	0	SENT_141	[p6l173t3585r236b3640],
10	AHbA1c	NN	O	ahba1c	nn	11	SENT_141	[p6l251t3586r503b3640],
11	values	NNS	O	value	prep_of	8	SENT_141	[p6l524t3586r733b3640],
12	.	.	O	.	_	0	SENT_141	[p6l524t3586r733b3640],

1	We	PRP	O	we	nsubj	3	SENT_142	[p7l109t26r213b78],
2	further	RB	O	further	advmod	3	SENT_142	[p7l251t23r467b78],
3	examined	VBD	O	examine	_	0	SENT_142	[p7l502t23r803b78],
4	the	DT	O	the	det	5	SENT_142	[p7l840t23r937b78],
5	effect	NN	O	effect	dobj	3	SENT_142	[p7l975t23r1144b78],
6	of	IN	O	of	prep	5	SENT_142	[p7l1179t23r1243b78],
7	different	JJ	O	different	amod	9	SENT_142	[p7l1273t23r1538b78],
8	sulfonylurea	NN	O	sulfonylurea	nn	9	SENT_142	[p7l1574t23r1954b92],
9	compounds	NNS	O	compound	dep	18	SENT_142	[p7l1991t39r2146b78, p7l10t112r234b181],
10	in	IN	O	in	_	0	SENT_142	[p7l267t113r323b167],
11	relation	NN	O	relation	prep_in	9	SENT_142	[p7l355t112r591b167],
12	to	TO	O	to	_	0	SENT_142	[p7l621t120r680b167],
13	I	PRP	O	I	prep_to	11	SENT_142	[p7l710t115r923b181],
14	<	JJR	O	<	amod	15	SENT_142	[p7l710t115r923b181],
15	CN	NN	O	cn	dep	18	SENT_142	[p7l710t115r923b181],
16	]	CD	NUMBER	]	number	17	SENT_142	[p7l710t115r923b181],
17	11	CD	NUMBER	11	num	18	SENT_142	[p7l710t115r923b181],
18	genotypes	NNS	O	genotype	dep	6	SENT_142	[p7l961t120r1274b181],
19	in	IN	O	in	_	0	SENT_142	[p7l1307t113r1363b166],
20	the	DT	O	the	det	22	SENT_142	[p7l1394t112r1491b167],
21	dominant	JJ	O	dominant	amod	22	SENT_142	[p7l1522t112r1822b167],
22	model	NN	O	model	prep_in	18	SENT_142	[p7l1851t112r2057b168],
23	.	.	O	.	_	0	SENT_142	[p7l1851t112r2057b168],

1	In	IN	O	in	_	0	SENT_143	[p7l2089t115r2147b166],
2	the	DT	O	the	det	4	SENT_143	[p7l9t201r106b256],
3	largest	JJS	O	largest	amod	4	SENT_143	[p7l133t201r338b270],
4	subgroup	NN	O	subgroup	prep_in	20	SENT_143	[p7l363t201r650b270],
5	of	IN	O	of	_	0	SENT_143	[p7l676t201r739b256],
6	patients	NNS	O	patient	prep_of	4	SENT_143	[p7l757t202r1002b270],
7	treated	VBN	O	treat	partmod	6	SENT_143	[p7l1028t201r1246b256],
8	with	IN	O	with	_	0	SENT_143	[p7l1271t201r1412b256],
9	gliclazide	NN	O	gliclazide	nn	11	SENT_143	[p7l1436t201r1723b270],
10	(	NN	O	(	nn	11	SENT_143	[p7l1754t201r1817b270],
11	n	NN	O	n	prep_with	7	SENT_143	[p7l1754t201r1817b270],
12	=	JJ	O	=	amod	11	SENT_143	[p7l1834t224r1887b245],
13	55	CD	NUMBER	55	num	14	SENT_143	[p7l1906t201r2023b270],
14	)	NN	O	)	dep	12	SENT_143	[p7l1906t201r2023b270],
15	,	,	O	,	_	0	SENT_143	[p7l1906t201r2023b270],
16	the	DT	O	the	det	18	SENT_143	[p7l2049t201r2146b256],
17	observed	VBN	O	observe	amod	18	SENT_143	[p7l10t290r281b345],
18	effect	NN	O	effect	nsubj	20	SENT_143	[p7l303t290r467b345],
19	was	VBD	O	be	cop	20	SENT_143	[p7l485t306r602b345],
20	similar	JJ	O	similar	_	0	SENT_143	[p7l624t290r830b345],
21	to	TO	O	to	_	0	SENT_143	[p7l848t298r906b345],
22	that	DT	O	that	prep_to	20	SENT_143	[p7l926t290r1048b345],
23	in	IN	O	in	_	0	SENT_143	[p7l1066t291r1121b345],
24	the	DT	O	the	det	27	SENT_143	[p7l1142t290r1237b345],
25	entire	JJ	O	entire	amod	27	SENT_143	[p7l1258t291r1434b345],
26	study	NN	O	study	nn	27	SENT_143	[p7l1455t290r1620b359],
27	group	NN	O	group	prep_in	22	SENT_143	[p7l1638t306r1815b359],
28	of	IN	O	of	_	0	SENT_143	[p7l1836t290r1898b345],
29	diabetic	JJ	O	diabetic	amod	30	SENT_143	[p7l1911t290r2147b345],
30	patients	NNS	O	patient	prep_of	27	SENT_143	[p7l10t381r264b448],
31	.	.	O	.	_	0	SENT_143	[p7l10t381r264b448],

1	Reduction	NN	O	reduction	_	0	SENT_144	[p7l296t380r598b435],
2	in	IN	O	in	_	0	SENT_144	[p7l629t381r684b434],
3	HbA1c	NN	O	hba1c	prep_in	1	SENT_144	[p7l715t380r913b435],
4	in	IN	O	in	_	0	SENT_144	[p7l943t381r998b434],
5	the	DT	O	the	det	6	SENT_144	[p7l1028t380r1123b435],
6	EK	NNP	O	EK	prep_in	1	SENT_144	[p7l1155t383r1298b438],
7	.	.	O	.	_	0	SENT_144	[p7l1155t383r1298b438],

1	—	NN	O	—	_	0	SENT_145	[p7l1155t383r1298b438],
2	.	.	O	.	_	0	SENT_145	[p7l1155t383r1298b438],

1	I	PRP	O	I	nsubj	5	SENT_146	[p7l1155t383r1298b438],
2	KK	NNP	O	KK	nn	4	SENT_146	[p7l1316t383r1400b434],
3	genotype	NN	O	genotype	nn	4	SENT_146	[p7l1427t388r1707b448],
4	group	NN	O	group	nsubj	5	SENT_146	[p7l1736t396r1913b448],
5	was	VBD	O	be	_	0	SENT_146	[p7l1942t396r2060b435],
6	in	IN	O	in	_	0	SENT_146	[p7l2091t381r2146b434],
7	average	NN	O	average	amod	21	SENT_146	[p7l10t484r241b537],
8	higher	JJR	O	higher	dep	7	SENT_146	[p7l265t468r460b537],
9	by	IN	O	by	prep	7	SENT_146	[p7l479t468r553b537],
10	0.35	CD	PERCENT	0.35	num	11	SENT_146	[p7l573t471r740b524],
11	%	NN	PERCENT	%	npadvmod	12	SENT_146	[p7l573t471r740b524],
12	than	IN	O	than	advmod	13	SENT_146	[p7l762t468r897b523],
13	in	IN	O	in	pcomp	9	SENT_146	[p7l920t469r975b523],
14	EE	NNP	O	EE	nn	16	SENT_146	[p7l997t472r1069b523],
15	genotype	NN	O	genotype	nn	16	SENT_146	[p7l1090t476r1370b537],
16	group	NN	O	group	pobj	13	SENT_146	[p7l1391t484r1568b537],
17	(	CD	NUMBER	(	num	18	SENT_146	[p7l1594t468r1656b537],
18	p	NN	O	p	dep	16	SENT_146	[p7l1594t468r1656b537],
19	=	JJ	O	=	amod	21	SENT_146	[p7l1672t491r1725b512],
20	0.036	CD	NUMBER	0.036	tmod	19	SENT_146	[p7l1742t468r1949b536],
21	)	NN	O	)	prep_in	5	SENT_146	[p7l1742t468r1949b536],
22	.	.	O	.	_	0	SENT_146	[p7l1742t468r1949b536],

1	In	IN	O	in	_	0	SENT_147	[p7l1973t472r2029b523],
2	the	DT	O	the	det	3	SENT_147	[p7l2050t468r2146b523],
3	subgroups	NNS	O	subgroup	prep_in	37	SENT_147	[p7l11t557r320b626],
4	of	IN	O	of	_	0	SENT_147	[p7l351t557r414b612],
5	patients	NNS	O	patient	prep_of	3	SENT_147	[p7l437t558r676b626],
6	treated	VBN	O	treat	partmod	5	SENT_147	[p7l706t557r921b612],
7	by	IN	O	by	_	0	SENT_147	[p7l950t557r1024b626],
8	glimepiride	NN	O	glimepiride	nn	10	SENT_147	[p7l1051t557r1396b626],
9	(	NN	O	(	nn	10	SENT_147	[p7l1431t557r1677b625],
10	n	NN	O	n	agent	6	SENT_147	[p7l1431t557r1677b625],
11	=	JJ	O	=	amod	10	SENT_147	[p7l1431t557r1677b625],
12	28	CD	NUMBER	28	tmod	11	SENT_147	[p7l1431t557r1677b625],
13	)	NN	O	)	nn	22	SENT_147	[p7l1431t557r1677b625],
14	and	CC	O	and	_	0	SENT_147	[p7l1712t557r1821b612],
15	glibencla	NN	O	glibenclum	nn	22	SENT_147	[p7l1851t557r2146b626],
16	—	CD	NUMBER	—	num	22	SENT_147	[p7l1851t557r2146b626],
17	mide	NN	O	mide	nn	22	SENT_147	[p7l10t646r161b701],
18	(	CD	NUMBER	(	num	22	SENT_147	[p7l188t647r252b715],
19	n	NN	O	n	nn	22	SENT_147	[p7l188t647r252b715],
20	=	JJ	O	=	amod	22	SENT_147	[p7l267t669r320b690],
21	14	CD	NUMBER	14	num	22	SENT_147	[p7l341t647r453b715],
22	)	NN	O	)	dobj	6	SENT_147	[p7l341t647r453b715],
23	,	,	O	,	_	0	SENT_147	[p7l341t647r453b715],
24	similar	JJ	O	similar	amod	25	SENT_147	[p7l479t646r685b701],
25	trend	NN	O	trend	nsubjpass	37	SENT_147	[p7l706t646r867b701],
26	toward	IN	O	toward	_	0	SENT_147	[p7l891t646r1105b701],
27	higher	JJR	O	higher	amod	28	SENT_147	[p7l1130t646r1325b715],
28	reduction	NN	O	reduction	prep_toward	25	SENT_147	[p7l1347t646r1635b701],
29	in	IN	O	in	_	0	SENT_147	[p7l1659t647r1714b701],
30	HbA1c	NN	O	hba1c	prep_in	28	SENT_147	[p7l1739t646r1936b701],
31	in	IN	O	in	_	0	SENT_147	[p7l1959t647r2015b701],
32	risk	NN	O	risk	nn	35	SENT_147	[p7l2039t646r2149b701],
33	K	NN	O	k	nn	35	SENT_147	[p7l10t739r51b790],
34	allele	NN	O	allele	nn	35	SENT_147	[p7l76t735r232b790],
35	carriers	NNS	O	carrier	prep_in	30	SENT_147	[p7l259t736r482b790],
36	was	VBD	O	be	auxpass	37	SENT_147	[p7l508t751r626b790],
37	observed	VBN	O	observe	_	0	SENT_147	[p7l653t735r939b799],
38	,	,	O	,	_	0	SENT_147	[p7l653t735r939b799],
39	but	CC	O	but	_	0	SENT_147	[p7l965t735r1066b790],
40	the	DT	O	the	det	41	SENT_147	[p7l1090t735r1186b790],
41	differences	NNS	O	difference	nsubj	48	SENT_147	[p7l1213t735r1539b790],
42	between	IN	O	between	_	0	SENT_147	[p7l1566t735r1827b790],
43	the	DT	O	the	det	45	SENT_147	[p7l1853t735r1949b790],
44	genotype	NN	O	genotype	nn	45	SENT_147	[p7l1974t751r2146b804, p7l9t833r141b893],
45	groups	NNS	O	group	prep_between	41	SENT_147	[p7l161t841r365b893],
46	were	VBD	O	be	cop	48	SENT_147	[p7l387t841r538b880],
47	not	RB	O	not	neg	48	SENT_147	[p7l560t833r659b880],
48	signiﬁcant	JJ	O	signiﬁcant	conj_but	37	SENT_147	[p7l680t825r992b893],
49	(	NN	O	(	nn	50	SENT_147	[p7l1015t825r1198b893],
50	Table	NNP	O	Table	dep	48	SENT_147	[p7l1015t825r1198b893],
51	4	CD	NUMBER	4	number	52	SENT_147	[p7l1219t825r1299b893],
52	)	CD	NUMBER	)	num	50	SENT_147	[p7l1219t825r1299b893],
53	.	.	O	.	_	0	SENT_147	[p7l1219t825r1299b893],

1	4	LS	NUMBER	4	_	0	SENT_148	[p7l7t1008r61b1060],
2	.	.	O	.	_	0	SENT_148	[p7l7t1008r61b1060],

1	Discussion	NN	O	discussion	_	0	SENT_149	[p7l85t1005r428b1059],

1	In	IN	O	in	_	0	SENT_150	[p7l112t1186r169b1237],
2	the	DT	O	the	det	5	SENT_150	[p7l187t1182r283b1237],
3	present	JJ	DATE	present	amod	5	SENT_150	[p7l303t1191r530b1251],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_150	[p7l547t1182r1068b1251],
5	study	NN	O	study	prep_in	7	SENT_150	[p7l1087t1182r1253b1251],
6	we	PRP	O	we	nsubj	7	SENT_150	[p7l1269t1198r1358b1237],
7	observed	VBD	O	observe	_	0	SENT_150	[p7l1378t1182r1650b1237],
8	that	IN	O	that	complm	23	SENT_150	[p7l1669t1182r1790b1237],
9	the	DT	O	the	det	10	SENT_150	[p7l1807t1182r1902b1237],
10	carriers	NNS	O	carrier	nsubj	23	SENT_150	[p7l1923t1183r2146b1237],
11	of	IN	O	of	_	0	SENT_150	[p7l10t1271r73b1326],
12	the	DT	O	the	det	15	SENT_150	[p7l104t1271r200b1326],
13	K	NNP	O	K	nn	15	SENT_150	[p7l241t1275r282b1326],
14	(	CD	NUMBER	(	num	15	SENT_150	[p7l325t1271r549b1340],
15	lysine	NN	O	lysine	prep_of	10	SENT_150	[p7l325t1271r549b1340],
16	)	CD	NUMBER	)	num	17	SENT_150	[p7l325t1271r549b1340],
17	allele	NN	O	allele	dep	15	SENT_150	[p7l594t1271r750b1326],
18	of	IN	O	of	_	0	SENT_150	[p7l791t1271r854b1326],
19	KCNj11	NN	O	kcnj11	nn	20	SENT_150	[p7l884t1274r1093b1340],
20	E23I	NN	O	e23us	prep_of	17	SENT_150	[p7l1142t1274r1296b1326],
21	(	CD	NUMBER	(	num	22	SENT_150	[p7l1142t1274r1296b1326],
22	polymorphism	NN	O	polymorphism	dep	17	SENT_150	[p7l1335t1271r1779b1340],
23	had	VBD	O	have	ccomp	7	SENT_150	[p7l1818t1271r1927b1326],
24	better	JJR	O	better	dobj	23	SENT_150	[p7l1968t1271r2148b1326],

1	Table	NNP	O	Table	_	0	SENT_151	[p7l7t1483r146b1526],
2	3	CD	NUMBER	3	num	5	SENT_151	[p7l163t1485r192b1526],
3	Different	JJ	O	different	amod	5	SENT_151	[p7l10t1554r228b1598],
4	genetic	JJ	O	genetic	amod	5	SENT_151	[p7l244t1555r423b1608],
5	models	NNS	O	model	npadvmod	1	SENT_151	[p7l441t1554r617b1598],
6	with	IN	O	with	_	0	SENT_151	[p7l635t1554r748b1598],
7	respect	NN	O	respect	prep_with_respect_to	1	SENT_151	[p7l767t1560r944b1608],
8	to	TO	O	to	_	0	SENT_151	[p7l961t1560r1008b1598],
9	response	NN	O	response	pobj	1	SENT_151	[p7l1027t1567r1245b1608],
10	to	TO	O	to	_	0	SENT_151	[p7l1264t1560r1311b1598],
11	sulfonylurea	NN	O	sulfonylurea	prep_to	1	SENT_151	[p7l1330t1554r1635b1608],
12	according	VBG	O	accord	_	0	SENT_151	[p7l1653t1554r1893b1608],
13	to	TO	O	to	prepc_according_to	11	SENT_151	[p7l1910t1560r1957b1598],
14	KCN	NNP	O	KCN	nn	17	SENT_151	[p7l1974t1556r2145b1608],
15	]	CD	NUMBER	]	num	17	SENT_151	[p7l1974t1556r2145b1608],
16	11	CD	NUMBER	11	num	17	SENT_151	[p7l1974t1556r2145b1608],
17	genotypes	NNS	O	genotype	pobj	11	SENT_151	[p7l8t1617r272b1665],
18	.	.	O	.	_	0	SENT_151	[p7l8t1617r272b1665],

1	Genetic	JJ	O	genetic	amod	3	SENT_152	[p7l60t1733r246b1776],
2	KCN	NN	O	kcn	nn	3	SENT_152	[p7l425t1735r597b1787],
3	]	NN	O	]	_	0	SENT_152	[p7l425t1735r597b1787],
4	11	CD	NUMBER	11	num	5	SENT_152	[p7l425t1735r597b1787],
5	Number	NN	O	number	dep	3	SENT_152	[p7l715t1732r917b1776],
6	of	IN	O	of	_	0	SENT_152	[p7l935t1732r986b1776],
7	AHbA1ca	NN	O	ahba1ca	nn	8	SENT_152	[p7l1038t1732r1260b1776],
8	Difference	NN	O	difference	prep_of	5	SENT_152	[p7l1371t1732r1622b1776],
9	in	IN	O	in	_	0	SENT_152	[p7l1643t1733r1688b1776],
10	AHbA1c	NN	O	ahba1c	nn	14	SENT_152	[p7l1707t1732r1907b1776],
11	p	NN	O	p	nn	14	SENT_152	[p7l1967t1745r1995b1787],
12	model	NN	O	model	nn	14	SENT_152	[p7l60t1804r213b1848],
13	genotype	NN	O	genotype	nn	14	SENT_152	[p7l426t1811r655b1859],
14	patients	NNS	O	patient	prep_in	8	SENT_152	[p7l715t1805r912b1859],
15	(	CD	PERCENT	(	num	16	SENT_152	[p7l1042t1804r1114b1858],
16	%	NN	PERCENT	%	dep	5	SENT_152	[p7l1042t1804r1114b1858],
17	)	CD	PERCENT	)	number	18	SENT_152	[p7l1042t1804r1114b1858],
18	(	CD	PERCENT	(	num	16	SENT_152	[p7l1374t1804r1488b1858],
19	95	CD	PERCENT	95	number	20	SENT_152	[p7l1374t1804r1488b1858],
20	%	NN	PERCENT	%	amod	16	SENT_152	[p7l1374t1804r1488b1858],
21	CI	NN	O	ci	nn	22	SENT_152	[p7l1508t1804r1573b1858],
22	)	NN	O	)	dep	3	SENT_152	[p7l1508t1804r1573b1858],

1	Codominant	JJ	O	codominant	amod	2	SENT_153	[p7l60t1942r363b1985],
2	EE	NN	O	ee	_	0	SENT_153	[p7l427t1945r485b1985],
3	37	CD	NUMBER	37	number	4	SENT_153	[p7l714t1944r772b1985],
4	0.79	CD	NUMBER	0.79	dep	2	SENT_153	[p7l1039t1944r1136b1986],
5	:1	CD	NUMBER	:1	num	7	SENT_153	[p7l1148t1948r1188b1988],
6	:	:	O	:	_	0	SENT_153	[p7l1148t1948r1188b1988],
7	0.12	CD	NUMBER	0.12	dep	4	SENT_153	[p7l1200t1944r1297b1986],
8	Reference	NNP	O	Reference	dep	2	SENT_153	[p7l1372t1942r1612b1985],

1	EK	NNP	O	EK	_	0	SENT_154	[p7l428t2016r491b2056],
2	47	CD	NUMBER	47	number	3	SENT_154	[p7l713t2015r772b2056],
3	1.02	CD	NUMBER	1.02	dep	1	SENT_154	[p7l1042t2015r1136b2057],
4	:1	CD	NUMBER	:1	dep	3	SENT_154	[p7l1150t2019r1190b2059],
5	:	:	O	:	_	0	SENT_154	[p7l1150t2019r1190b2059],
6	0.11	CD	NUMBER	0.11	num	7	SENT_154	[p7l1202t2015r1295b2057],
7	0.22	CD	NUMBER	0.22	dep	3	SENT_154	[p7l1371t2015r1472b2057],
8	(	NN	O	(	dep	7	SENT_154	[p7l1497t2013r1562b2067],
9	0.02	CD	NUMBER	0.02	num	8	SENT_154	[p7l1575t2015r1693b2063],
10	;	:	O	;	_	0	SENT_154	[p7l1575t2015r1693b2063],
11	0.47	CD	NUMBER	0.47	num	12	SENT_154	[p7l1716t2013r1839b2067],
12	)	CD	NUMBER	)	dep	3	SENT_154	[p7l1716t2013r1839b2067],
13	KK	NNP	ORGANIZATION	KK	prep	12	SENT_154	[p7l428t2086r495b2127],
14	17	CD	NUMBER	17	num	15	SENT_154	[p7l717t2086r772b2127],
15	1.11	CD	NUMBER	1.11	dep	13	SENT_154	[p7l1042t2086r1132b2127],
16	:	:	O	:	_	0	SENT_154	[p7l1150t2090r1190b2130],
17	l	NN	O	l	dep	3	SENT_154	[p7l1150t2090r1190b2130],
18	:	:	O	:	_	0	SENT_154	[p7l1150t2090r1190b2130],
19	0.16	CD	NUMBER	0.16	num	20	SENT_154	[p7l1202t2086r1301b2127],
20	0.32	CD	NUMBER	0.32	dep	17	SENT_154	[p7l1371t2086r1472b2127],
21	(	NN	O	(	dep	20	SENT_154	[p7l1497t2084r1562b2137],
22	0.01	CD	NUMBER	0.01	num	21	SENT_154	[p7l1575t2086r1693b2134],
23	;	:	O	;	_	0	SENT_154	[p7l1575t2086r1693b2134],
24	0.62	CD	NUMBER	0.62	number	25	SENT_154	[p7l1716t2084r1839b2137],
25	)	CD	NUMBER	)	dep	3	SENT_154	[p7l1716t2084r1839b2137],
26	0.097	CD	NUMBER	0.097	dep	25	SENT_154	[p7l1966t2086r2099b2127],

1	Dominant	JJ	O	dominant	amod	2	SENT_155	[p7l60t2157r306b2199],
2	EE	NN	O	ee	_	0	SENT_155	[p7l428t2159r485b2199],
3	37	CD	NUMBER	37	num	4	SENT_155	[p7l714t2158r772b2199],
4	0.79	CD	NUMBER	0.79	dep	2	SENT_155	[p7l1039t2158r1137b2200],
5	:	:	O	:	_	0	SENT_155	[p7l1150t2162r1190b2202],
6	I	PRP	O	I	dep	2	SENT_155	[p7l1150t2162r1190b2202],
7	:	:	O	:	_	0	SENT_155	[p7l1150t2162r1190b2202],
8	0.12	CD	NUMBER	0.12	num	9	SENT_155	[p7l1202t2158r1300b2200],
9	Reference	NNP	O	Reference	dep	6	SENT_155	[p7l1372t2156r1612b2199],

1	EK	NN	ORGANIZATION	ek	_	0	SENT_156	[p7l428t2230r491b2270],
2	+	CC	ORGANIZATION	+	_	0	SENT_156	[p7l504t2233r544b2273],
3	KK	NNP	ORGANIZATION	KK	conj_+	1	SENT_156	[p7l558t2230r626b2270],
4	64	CD	NUMBER	64	number	5	SENT_156	[p7l715t2229r774b2271],
5	1.04	CD	NUMBER	1.04	dep	3	SENT_156	[p7l1042t2229r1138b2271],
6	:	:	O	:	_	0	SENT_156	[p7l1150t2233r1190b2273],
7	t	NN	O	t	dep	3	SENT_156	[p7l1150t2233r1190b2273],
8	0.10	CD	NUMBER	0.10	num	7	SENT_156	[p7l1202t2229r1301b2271],
9	0.25	CD	NUMBER	0.25	num	10	SENT_156	[p7l1371t2229r1472b2271],
10	(	NN	O	(	dep	7	SENT_156	[p7l1497t2227r1635b2281],
11	0.02	CD	NUMBER	0.02	num	13	SENT_156	[p7l1497t2227r1635b2281],
12	;	:	O	;	_	0	SENT_156	[p7l1497t2227r1635b2281],
13	0.48	CD	NUMBER	0.48	dep	1	SENT_156	[p7l1659t2227r1782b2281],
14	)	CD	NUMBER	)	number	15	SENT_156	[p7l1659t2227r1782b2281],
15	0.036	CD	NUMBER	0.036	dep	13	SENT_156	[p7l1966t2229r2100b2271],

1	Recessive	JJ	O	recessive	amod	2	SENT_157	[p7l60t2299r293b2342],
2	EE	NN	O	ee	_	0	SENT_157	[p7l428t2301r485b2342],
3	+	CC	O	+	_	0	SENT_157	[p7l499t2305r539b2345],
4	EI	NN	O	eus	conj_+	2	SENT_157	[p7l554t2301r617b2342],
5	(	CD	NUMBER	(	num	4	SENT_157	[p7l554t2301r617b2342],
6	84	CD	NUMBER	84	number	7	SENT_157	[p7l715t2301r774b2342],
7	0.93	CD	NUMBER	0.93	dep	2	SENT_157	[p7l1039t2301r1136b2342],
8	:	:	O	:	_	0	SENT_157	[p7l1150t2305r1190b2345],
9	I	PRP	O	I	dep	7	SENT_157	[p7l1150t2305r1190b2345],
10	:	:	O	:	_	0	SENT_157	[p7l1150t2305r1190b2345],
11	0.10	CD	NUMBER	0.10	num	12	SENT_157	[p7l1202t2301r1301b2342],
12	Reference	NNP	O	Reference	dep	9	SENT_157	[p7l1372t2298r1612b2342],

1	KK	NNP	ORGANIZATION	KK	_	0	SENT_158	[p7l428t2373r496b2413],
2	17	CD	NUMBER	17	num	1	SENT_158	[p7l717t2373r772b2413],
3	1.11	CD	NUMBER	1.11	num	5	SENT_158	[p7l1042t2372r1311b2416],
4	;	:	O	;	_	0	SENT_158	[p7l1042t2372r1311b2416],
5	|	CD	NUMBER	|	dep	1	SENT_158	[p7l1042t2372r1311b2416],
6	;	:	O	;	_	0	SENT_158	[p7l1042t2372r1311b2416],
7	0.16	CD	NUMBER	0.16	num	8	SENT_158	[p7l1042t2372r1311b2416],
8	0.18	CD	NUMBER	0.18	dep	1	SENT_158	[p7l1371t2372r1472b2414],
9	(	NN	O	(	dep	8	SENT_158	[p7l1497t2370r1693b2424],
10	-0.10	CD	NUMBER	-0.10	num	9	SENT_158	[p7l1497t2370r1693b2424],
11	;	:	O	;	_	0	SENT_158	[p7l1497t2370r1693b2424],
12	0.34	CD	NUMBER	0.34	number	13	SENT_158	[p7l1716t2370r1839b2424],
13	)	CD	NUMBER	)	dep	1	SENT_158	[p7l1716t2370r1839b2424],
14	0.224	CD	NUMBER	0.224	npadvmod	15	SENT_158	[p7l1966t2372r2100b2414],
15	Log-additive	JJ	O	log-additive	amod	13	SENT_158	[p7l60t2441r367b2495],
16	per	IN	O	per	_	0	SENT_158	[p7l424t2453r505b2495],
17	l	NN	O	l	prep_per	13	SENT_158	[p7l522t2443r574b2484],
18	(	SYM	O	(	dep	17	SENT_158	[p7l522t2443r574b2484],
19	-	:	O	-	_	0	SENT_158	[p7l522t2443r574b2484],
20	—	NN	O	—	dep	1	SENT_158	[p7l715t2467r741b2471],
21	—	CD	NUMBER	—	num	20	SENT_158	[p7l1040t2466r1066b2471],
22	0.16	CD	NUMBER	0.16	num	23	SENT_158	[p7l1371t2443r1474b2485],
23	(	NN	O	(	dep	20	SENT_158	[p7l1497t2441r1614b2495],
24	0.01	CD	NUMBER	0.01	num	26	SENT_158	[p7l1497t2441r1614b2495],
25	;	:	O	;	_	0	SENT_158	[p7l1627t2453r1635b2491],
26	0.32	CD	NUMBER	0.32	dep	1	SENT_158	[p7l1659t2441r1782b2495],
27	)	CD	NUMBER	)	number	28	SENT_158	[p7l1659t2441r1782b2495],
28	0.038	CD	NUMBER	0.038	dep	26	SENT_158	[p7l1966t2443r2098b2485],

1	allele	NN	O	allele	_	0	SENT_159	[p7l427t2513r556b2557],

1	3	CD	NUMBER	3	num	3	SENT_160	[p7l55t2648r73b2669],
2	AHbA1c	NN	O	ahba1c	nn	3	SENT_160	[p7l109t2650r306b2693],
3	means	NNS	O	means	nsubjpass	5	SENT_160	[p7l322t2662r477b2693],
4	were	VBD	O	be	auxpass	5	SENT_160	[p7l492t2662r614b2693],
5	adjusted	VBN	O	adjust	_	0	SENT_160	[p7l629t2650r833b2704],
6	in	IN	O	in	_	0	SENT_160	[p7l850t2650r895b2693],
7	general	JJ	O	general	amod	9	SENT_160	[p7l910t2650r1088b2704],
8	linear	JJ	O	linear	amod	9	SENT_160	[p7l1104t2650r1242b2693],
9	models	NNS	O	model	prep_in	5	SENT_160	[p7l1256t2650r1430b2693],
10	for	IN	O	for	_	0	SENT_160	[p7l1446t2649r1513b2693],
11	age	NN	O	age	prep_for	9	SENT_160	[p7l1527t2662r1619b2704],
12	,	,	O	,	_	0	SENT_160	[p7l1527t2662r1619b2704],
13	gender	NN	O	gender	dep	32	SENT_160	[p7l1635t2650r1813b2704],
14	,	,	O	,	_	0	SENT_160	[p7l1635t2650r1813b2704],
15	BMI	NN	O	bmus	conj_and	13	SENT_160	[p7l1830t2652r1936b2700],
16	,	,	O	,	_	0	SENT_160	[p7l1830t2652r1936b2700],
17	diabetes	NN	O	diabetes	nn	18	SENT_160	[p7l1952t2650r2151b2693],
18	duration	NN	O	duration	conj_and	13	SENT_160	[p7l9t2721r225b2771],
19	,	,	O	,	_	0	SENT_160	[p7l9t2721r225b2771],
20	sulfonylurea	NN	O	sulfonylurea	nn	21	SENT_160	[p7l244t2721r541b2775],
21	type	NN	O	type	conj_and	13	SENT_160	[p7l557t2727r672b2775],
22	,	,	O	,	_	0	SENT_160	[p7l557t2727r672b2775],
23	sulfonylurea	NN	O	sulfonylurea	nn	24	SENT_160	[p7l692t2721r988b2775],
24	dose	NN	O	dose	conj_and	13	SENT_160	[p7l1005t2721r1126b2771],
25	,	,	O	,	_	0	SENT_160	[p7l1005t2721r1126b2771],
26	and	CC	O	and	_	0	SENT_160	[p7l1143t2721r1231b2765],
27	baseline	NN	O	baseline	nn	29	SENT_160	[p7l1248t2721r1444b2765],
28	HbA1	NN	O	hba1	nn	29	SENT_160	[p7l1462t2721r1588b2765],
29	c.	NN	O	c.	dep	32	SENT_160	[p7l1596t2734r1630b2765],
30	Table	NNP	O	Table	dep	32	SENT_160	[p7l9t2793r148b2836],
31	4	CD	NUMBER	4	num	32	SENT_160	[p7l165t2796r196b2836],
32	Effect	NN	O	effect	dep	9	SENT_160	[p7l12t2864r142b2908],
33	of	IN	O	of	_	0	SENT_160	[p7l156t2864r205b2908],
34	different	JJ	O	different	amod	36	SENT_160	[p7l214t2864r416b2908],
35	sulfonylurea	NN	O	sulfonylurea	nn	36	SENT_160	[p7l430t2864r721b2919],
36	drugs	NNS	O	drug	prep_of	32	SENT_160	[p7l736t2864r866b2919],
37	on	IN	O	on	_	0	SENT_160	[p7l882t2877r941b2908],
38	AHbA1C	NN	O	ahba1c	prep_on	5	SENT_160	[p7l955t2864r1135b2917],
39	with	IN	O	with	_	0	SENT_160	[p7l1148t2864r1257b2908],
40	respect	NN	O	respect	prep_with	38	SENT_160	[p7l1272t2871r1442b2919],
41	to	TO	O	to	_	0	SENT_160	[p7l1455t2871r1501b2908],
42	genotypes	NNS	O	genotype	prep_to	5	SENT_160	[p7l1515t2871r1756b2919],
43	in	IN	O	in	_	0	SENT_160	[p7l1772t2865r1817b2907],
44	the	DT	O	the	det	46	SENT_160	[p7l1830t2864r1905b2908],
45	dominant	JJ	O	dominant	amod	46	SENT_160	[p7l1921t2864r2152b2908],
46	model	NN	O	model	prep_in	42	SENT_160	[p7l12t2937r170b2981],
47	.	.	O	.	_	0	SENT_160	[p7l12t2937r170b2981],

1	Drug	NNP	O	Drug	nn	3	SENT_161	[p7l62t3064r182b3115],
2	EE	NNP	O	EE	nn	3	SENT_161	[p7l1070t3064r1128b3104],
3	EK	NNP	O	EK	_	0	SENT_161	[p7l1518t3064r1582b3104],
4	+	CC	O	+	_	0	SENT_161	[p7l1594t3067r1634b3107],
5	KK	NNP	O	KK	conj_+	3	SENT_161	[p7l1649t3064r1717b3104],
6	p	NN	O	p	dep	3	SENT_161	[p7l1966t3074r1994b3115],

1	Gliclazide	FW	O	gliclazide	nn	3	SENT_162	[p7l63t3171r288b3214],
2	(	FW	O	(	nn	3	SENT_162	[p7l310t3171r359b3225],
3	n	NN	O	n	_	0	SENT_162	[p7l310t3171r359b3225],
4	=	JJ	O	=	amod	5	SENT_162	[p7l375t3189r421b3206],
5	55	CD	NUMBER	55	dep	3	SENT_162	[p7l430t3171r508b3225],
6	)	CD	NUMBER	)	num	7	SENT_162	[p7l430t3171r508b3225],
7	Number	NN	O	number	dep	5	SENT_162	[p7l62t3242r263b3286],
8	of	IN	O	of	_	0	SENT_162	[p7l282t3242r333b3286],
9	patients	NNS	O	patient	prep_of	7	SENT_162	[p7l346t3243r542b3296],
10	19	CD	NUMBER	19	number	11	SENT_162	[p7l1072t3244r1128b3286],
11	36	CD	NUMBER	36	num	12	SENT_162	[p7l1517t3244r1576b3286],
12	Final	JJ	O	final	dep	18	SENT_162	[p7l62t3313r178b3357],
13	on	IN	O	on	_	0	SENT_162	[p7l198t3320r529b3357],
14	—	NN	O	—	nn	16	SENT_162	[p7l198t3320r529b3357],
15	treatment	NN	O	treatment	nn	16	SENT_162	[p7l198t3320r529b3357],
16	dose	NN	O	dose	prep_on	12	SENT_162	[p7l548t3313r659b3357],
17	(	CD	PERCENT	(	num	18	SENT_162	[p7l682t3313r734b3367],
18	%	NN	PERCENT	%	dep	7	SENT_162	[p7l682t3313r734b3367],
19	max	NN	O	max	dep	18	SENT_162	[p7l754t3313r890b3367],
20	.	.	O	.	_	0	SENT_162	[p7l754t3313r890b3367],
21	)	SYM	O	)	dep	7	SENT_162	[p7l754t3313r890b3367],

1	40.8	CD	NUMBER	40.8	_	0	SENT_163	[p7l1068t3315r1171b3357],
2	:	:	O	:	_	0	SENT_163	[p7l1185t3319r1225b3359],
3	I	CD	NUMBER	i	dep	1	SENT_163	[p7l1185t3319r1225b3359],
4	:	:	O	:	_	0	SENT_163	[p7l1185t3319r1225b3359],
5	4.4	CD	NUMBER	4.4	number	6	SENT_163	[p7l1238t3315r1311b3357],
6	46.5	CD	NUMBER	46.5	dep	3	SENT_163	[p7l1516t3315r1618b3357],
7	:	:	O	:	_	0	SENT_163	[p7l1633t3319r1673b3359],
8	I	CD	NUMBER	i	dep	3	SENT_163	[p7l1633t3319r1673b3359],
9	:	:	O	:	_	0	SENT_163	[p7l1633t3319r1673b3359],
10	2.8	CD	NUMBER	2.8	number	11	SENT_163	[p7l1687t3315r1757b3357],
11	0.259	CD	NUMBER	0.259	num	12	SENT_163	[p7l1966t3315r2098b3357],
12	AHbA1c	NN	O	ahba1c	dep	8	SENT_163	[p7l61t3383r283b3428],
13	“‘	CD	PERCENT	“‘	number	14	SENT_163	[p7l61t3383r283b3428],
14	(	CD	PERCENT	(	dep	15	SENT_163	[p7l305t3385r377b3439],
15	%	NN	PERCENT	%	dep	12	SENT_163	[p7l305t3385r377b3439],
16	)	CD	NUMBER	)	number	17	SENT_163	[p7l305t3385r377b3439],
17	0.80	CD	NUMBER	0.80	dep	12	SENT_163	[p7l1070t3387r1172b3429],
18	:1	CD	NUMBER	:1	dep	17	SENT_163	[p7l1185t3391r1225b3431],
19	:	:	O	:	_	0	SENT_163	[p7l1185t3391r1225b3431],
20	0.13	CD	NUMBER	0.13	dep	3	SENT_163	[p7l1239t3387r1339b3429],
21	1.15	CD	NUMBER	1.15	dep	20	SENT_163	[p7l1520t3387r1618b3429],
22	:	:	O	:	_	0	SENT_163	[p7l1633t3391r1673b3431],
23	I	PRP	O	I	dep	3	SENT_163	[p7l1633t3391r1673b3431],
24	:	:	O	:	_	0	SENT_163	[p7l1633t3391r1673b3431],
25	0.09	CD	NUMBER	0.09	number	26	SENT_163	[p7l1687t3387r1789b3429],
26	0.036	CD	NUMBER	0.036	dep	23	SENT_163	[p7l1966t3387r2099b3429],

1	Glimepiride	NN	O	glimepiride	nn	3	SENT_164	[p7l63t3530r335b3584],
2	(	NN	O	(	nn	3	SENT_164	[p7l357t3530r406b3584],
3	n	NN	O	n	_	0	SENT_164	[p7l357t3530r406b3584],
4	:28	CD	NUMBER	:28	dep	3	SENT_164	[p7l422t3530r555b3584],
5	)	CD	NUMBER	)	num	6	SENT_164	[p7l422t3530r555b3584],
6	Number	NN	O	number	dep	4	SENT_164	[p7l62t3601r263b3645],
7	of	IN	O	of	_	0	SENT_164	[p7l282t3601r333b3645],
8	patients	NNS	O	patient	prep_of	6	SENT_164	[p7l346t3602r542b3656],
9	8	CD	NUMBER	8	number	10	SENT_164	[p7l1070t3603r1096b3645],
10	20	CD	NUMBER	20	num	11	SENT_164	[p7l1517t3603r1576b3645],
11	Final	JJ	O	final	dep	17	SENT_164	[p7l63t3673r178b3716],
12	on	IN	O	on	_	0	SENT_164	[p7l198t3679r529b3716],
13	—	NN	O	—	nn	15	SENT_164	[p7l198t3679r529b3716],
14	treatment	NN	O	treatment	nn	15	SENT_164	[p7l198t3679r529b3716],
15	dose	NN	O	dose	prep_on	11	SENT_164	[p7l548t3672r659b3716],
16	(	CD	PERCENT	(	num	17	SENT_164	[p7l682t3673r734b3726],
17	%	NN	PERCENT	%	dep	6	SENT_164	[p7l682t3673r734b3726],
18	max	NN	O	max	dep	17	SENT_164	[p7l754t3673r890b3726],
19	.	.	O	.	_	0	SENT_164	[p7l754t3673r890b3726],
20	)	SYM	O	)	dep	6	SENT_164	[p7l754t3673r890b3726],

1	50.0	CD	NUMBER	50.0	_	0	SENT_165	[p7l1071t3675r1172b3716],
2	:	:	O	:	_	0	SENT_165	[p7l1185t3679r1225b3719],
3	I	CD	NUMBER	i	dep	1	SENT_165	[p7l1185t3679r1225b3719],
4	:	:	O	:	_	0	SENT_165	[p7l1185t3679r1225b3719],
5	8.3	CD	NUMBER	8.3	number	6	SENT_165	[p7l1240t3675r1308b3716],
6	42.9	CD	NUMBER	42.9	dep	3	SENT_165	[p7l1516t3675r1620b3716],
7	:	:	O	:	_	0	SENT_165	[p7l1633t3679r1673b3719],
8	I	CD	NUMBER	i	dep	1	SENT_165	[p7l1633t3679r1673b3719],
9	:	:	O	:	_	0	SENT_165	[p7l1633t3679r1673b3719],
10	4.4	CD	NUMBER	4.4	number	11	SENT_165	[p7l1686t3675r1759b3716],
11	0.424	CD	NUMBER	0.424	num	12	SENT_165	[p7l1966t3675r2100b3716],
12	AHbA1ca	NN	O	ahba1ca	dep	8	SENT_165	[p7l61t3743r283b3787],
13	(	CD	PERCENT	(	num	14	SENT_165	[p7l305t3744r377b3798],
14	%	NN	PERCENT	%	dep	12	SENT_165	[p7l305t3744r377b3798],
15	)	CD	NUMBER	)	num	16	SENT_165	[p7l305t3744r377b3798],
16	l.	NN	O	l.	dep	12	SENT_165	[p7l1072t3746r1341b3790],
17	00	CD	NUMBER	00	dep	16	SENT_165	[p7l1072t3746r1341b3790],
18	:	:	O	:	_	0	SENT_165	[p7l1072t3746r1341b3790],
19	l	NN	O	l	dep	1	SENT_165	[p7l1072t3746r1341b3790],
20	:0.19	CD	NUMBER	:0.19	number	21	SENT_165	[p7l1072t3746r1341b3790],
21	1	CD	NUMBER	1	dep	19	SENT_165	[p7l1520t3746r1788b3790],
22	.	.	O	.	_	0	SENT_165	[p7l1520t3746r1788b3790],

1	l0	NN	O	l0	_	0	SENT_166	[p7l1520t3746r1788b3790],
2	:	:	O	:	_	0	SENT_166	[p7l1520t3746r1788b3790],
3	l	NN	O	l	dep	1	SENT_166	[p7l1520t3746r1788b3790],
4	:0	CD	NUMBER	:0	num	3	SENT_166	[p7l1520t3746r1788b3790],
5	.	.	O	.	_	0	SENT_166	[p7l1520t3746r1788b3790],

1	l2	NN	O	l2	_	0	SENT_167	[p7l1520t3746r1788b3790],
2	0.676	CD	NUMBER	0.676	num	1	SENT_167	[p7l1966t3746r2099b3788],

1	Glibenclamide	NN	O	glibenclamide	nn	3	SENT_168	[p8l63t79r397b123],
2	(	NN	O	(	nn	3	SENT_168	[p8l419t80r468b134],
3	n	NN	O	n	_	0	SENT_168	[p8l419t80r468b134],
4	=	JJ	O	=	amod	5	SENT_168	[p8l484t97r530b114],
5	14	CD	NUMBER	14	dep	3	SENT_168	[p8l544t79r617b133],
6	)	CD	NUMBER	)	num	7	SENT_168	[p8l544t79r617b133],
7	Number	NN	O	number	dep	5	SENT_168	[p8l62t151r263b194],
8	of	IN	O	of	_	0	SENT_168	[p8l282t151r333b194],
9	patients	NNS	O	patient	prep_of	7	SENT_168	[p8l346t152r542b205],
10	8	CD	NUMBER	8	number	11	SENT_168	[p8l1070t153r1096b194],
11	6	CD	NUMBER	6	num	12	SENT_168	[p8l1518t153r1545b194],
12	Final	JJ	O	final	dep	18	SENT_168	[p8l62t222r178b266],
13	on	IN	O	on	_	0	SENT_168	[p8l198t229r529b266],
14	—	NN	O	—	nn	16	SENT_168	[p8l198t229r529b266],
15	treatment	NN	O	treatment	nn	16	SENT_168	[p8l198t229r529b266],
16	dose	NN	O	dose	prep_on	12	SENT_168	[p8l548t222r659b266],
17	(	CD	PERCENT	(	num	18	SENT_168	[p8l682t222r734b276],
18	%	NN	PERCENT	%	dep	7	SENT_168	[p8l682t222r734b276],
19	max	NN	O	max	dep	18	SENT_168	[p8l754t222r890b276],
20	.	.	O	.	_	0	SENT_168	[p8l754t222r890b276],
21	)	SYM	O	)	dep	7	SENT_168	[p8l754t222r890b276],

1	58.3	CD	NUMBER	58.3	num	3	SENT_169	[p8l1071t224r1170b266],
2	:	:	O	:	_	0	SENT_169	[p8l1185t228r1225b268],
3	I	CD	NUMBER	i	_	0	SENT_169	[p8l1185t228r1225b268],
4	:	:	O	:	_	0	SENT_169	[p8l1185t228r1225b268],
5	5.5	CD	NUMBER	5.5	number	6	SENT_169	[p8l1240t225r1309b266],
6	66.7	CD	NUMBER	66.7	amod	7	SENT_169	[p8l1518t224r1619b266],
7	d	NN	O	d	dep	3	SENT_169	[p8l1633t228r1673b268],
8	:	:	O	:	_	0	SENT_169	[p8l1633t228r1673b268],
9	o.o	NN	O	o.o	nn	11	SENT_169	[p8l1687t224r1758b266],
10	0.215	CD	NUMBER	0.215	num	11	SENT_169	[p8l1966t224r2097b266],
11	AHbA1c	NN	O	ahba1c	dep	7	SENT_169	[p8l61t293r283b338],
12	“	CD	PERCENT	“	number	13	SENT_169	[p8l61t293r283b338],
13	(	CD	PERCENT	(	num	14	SENT_169	[p8l305t294r377b348],
14	%	NN	PERCENT	%	dep	11	SENT_169	[p8l305t294r377b348],
15	)	CD	NUMBER	)	number	16	SENT_169	[p8l305t294r377b348],
16	0.98	CD	NUMBER	0.98	num	14	SENT_169	[p8l1070t296r1171b338],
17	i	FW	O	i	dep	11	SENT_169	[p8l1185t300r1225b340],
18	0.09	CD	NUMBER	0.09	number	19	SENT_169	[p8l1239t296r1341b338],
19	1.05	CD	NUMBER	1.05	dep	17	SENT_169	[p8l1520t296r1618b338],
20	:	:	O	:	_	0	SENT_169	[p8l1633t300r1673b340],
21	l	NN	O	l	dep	7	SENT_169	[p8l1633t300r1673b340],
22	:	:	O	:	_	0	SENT_169	[p8l1633t300r1673b340],
23	0.11	CD	NUMBER	0.11	num	24	SENT_169	[p8l1687t296r1783b338],
24	0.633	CD	NUMBER	0.633	dep	21	SENT_169	[p8l1966t296r2097b338],

1	3	CD	NUMBER	3	num	3	SENT_170	[p8l57t402r75b423],
2	AHbA1c	NN	O	ahba1c	nn	3	SENT_170	[p8l111t404r308b447],
3	means	NNS	O	means	nsubjpass	5	SENT_170	[p8l323t416r478b447],
4	were	VBD	O	be	auxpass	5	SENT_170	[p8l494t416r615b447],
5	adjusted	VBN	O	adjust	_	0	SENT_170	[p8l631t404r835b458],
6	in	IN	O	in	_	0	SENT_170	[p8l852t404r896b447],
7	general	JJ	O	general	amod	9	SENT_170	[p8l911t404r1088b458],
8	linear	JJ	O	linear	amod	9	SENT_170	[p8l1105t404r1242b447],
9	models	NNS	O	model	prep_in	5	SENT_170	[p8l1257t404r1430b447],
10	for	IN	O	for	_	0	SENT_170	[p8l1446t403r1513b447],
11	age	NN	O	age	prep_for	9	SENT_170	[p8l1527t416r1620b458],
12	,	,	O	,	_	0	SENT_170	[p8l1527t416r1620b458],
13	gender	NN	O	gender	prep_for	9	SENT_170	[p8l1635t404r1813b458],
14	,	,	O	,	_	0	SENT_170	[p8l1635t404r1813b458],
15	BMI	NN	O	bmus	prep_for	9	SENT_170	[p8l1830t406r1936b454],
16	,	,	O	,	_	0	SENT_170	[p8l1830t406r1936b454],
17	diabetes	NN	O	diabetes	nn	18	SENT_170	[p8l1952t404r2150b447],
18	duration	NN	O	duration	prep_for	9	SENT_170	[p8l12t475r227b525],
19	,	,	O	,	_	0	SENT_170	[p8l12t475r227b525],
20	sulfonylurea	NN	O	sulfonylurea	nn	21	SENT_170	[p8l246t475r542b529],
21	dose	NN	O	dose	conj_and	11	SENT_170	[p8l559t475r679b525],
22	,	,	O	,	_	0	SENT_170	[p8l559t475r679b525],
23	and	CC	O	and	_	0	SENT_170	[p8l697t475r784b519],
24	baseline	NN	O	baseline	nn	25	SENT_170	[p8l802t475r997b519],
25	HbA1c	NN	O	hba1c	conj_and	11	SENT_170	[p8l1015t475r1183b519],
26	.	.	O	.	_	0	SENT_170	[p8l1015t475r1183b519],

1	therapeutic	JJ	O	therapeutic	amod	2	SENT_171	[p8l11t682r356b750],
2	response	NN	O	response	_	0	SENT_171	[p8l381t698r647b750],
3	to	TO	O	to	_	0	SENT_171	[p8l672t690r731b737],
4	sulfonylurea	NN	O	sulfonylurea	prep_to	2	SENT_171	[p8l757t682r1128b750],
5	in	IN	O	in	_	0	SENT_171	[p8l1153t683r1208b736],
6	comparison	NN	O	comparison	prep_in	2	SENT_171	[p8l1234t683r1586b750],
7	with	IN	O	with	_	0	SENT_171	[p8l1609t682r1748b737],
8	the	DT	O	the	det	10	SENT_171	[p8l1773t682r1868b737],
9	non-risk	JJ	O	non-risk	amod	10	SENT_171	[p8l1894t682r2148b737],
10	homozygotes	NNS	O	homozygote	prep_with	2	SENT_171	[p8l12t770r427b837],
11	.	.	O	.	_	0	SENT_171	[p8l12t770r427b837],

1	Previous	JJ	O	previous	amod	2	SENT_172	[p8l114t857r374b911],
2	studies	NNS	O	study	nsubj	11	SENT_172	[p8l396t857r609b911],
3	on	IN	O	on	_	0	SENT_172	[p8l630t872r705b911],
4	the	DT	O	the	det	5	SENT_172	[p8l724t857r822b911],
5	role	NN	O	role	prep_on	2	SENT_172	[p8l843t857r958b911],
6	of	IN	O	of	_	0	SENT_172	[p8l979t856r1042b911],
7	the	DT	O	the	det	10	SENT_172	[p8l1054t857r1151b911],
8	mentioned	VBN	O	mention	amod	10	SENT_172	[p8l1172t856r1504b911],
9	gene	NN	O	gene	nn	10	SENT_172	[p8l1523t872r1668b924],
10	variant	NN	O	variant	prep_of	5	SENT_172	[p8l1687t857r1905b911],
11	yielded	VBD	O	yield	_	0	SENT_172	[p8l1921t857r2145b924],
12	controversial	JJ	O	controversial	amod	13	SENT_172	[p8l12t943r411b997],
13	results	NNS	O	result	dobj	11	SENT_172	[p8l434t943r651b1005],
14	,	,	O	,	_	0	SENT_172	[p8l434t943r651b1005],
15	which	WDT	O	which	nsubjpass	18	SENT_172	[p8l671t943r860b997],
16	could	MD	O	could	aux	18	SENT_172	[p8l882t943r1047b997],
17	be	VB	O	be	auxpass	18	SENT_172	[p8l1068t943r1138b997],
18	explained	VBN	O	explain	rcmod	13	SENT_172	[p8l1160t943r1458b1011],
19	by	IN	O	by	_	0	SENT_172	[p8l1480t943r1554b1011],
20	different	JJ	O	different	amod	22	SENT_172	[p8l1573t943r1838b997],
21	study	NN	O	study	nn	22	SENT_172	[p8l1859t943r2027b1011],
22	designs	NNS	O	design	agent	18	SENT_172	[p8l2047t943r2145b997, p8l13t1031r164b1098],
23	and	CC	O	and	_	0	SENT_172	[p8l185t1030r296b1084],
24	outcome	NN	O	outcome	nn	25	SENT_172	[p8l318t1038r584b1084],
25	deﬁnitions	NNS	O	deﬁnitions	agent	18	SENT_172	[p8l605t1030r946b1092],
26	,	,	O	,	_	0	SENT_172	[p8l605t1030r946b1092],
27	as	RB	O	as	_	0	SENT_172	[p8l968t1046r1027b1084],
28	well	RB	O	well	_	0	SENT_172	[p8l1047t1030r1177b1084],
29	as	IN	O	as	_	0	SENT_172	[p8l1198t1046r1257b1084],
30	by	IN	O	by	_	0	SENT_172	[p8l1279t1030r1352b1098],
31	ethnic	JJ	O	ethnic	amod	32	SENT_172	[p8l1372t1030r1562b1084],
32	differences	NNS	O	difference	conj_and	22	SENT_172	[p8l1582t1030r1916b1084],
33	among	IN	O	among	_	0	SENT_172	[p8l1938t1046r2147b1098],
34	the	DT	O	the	det	36	SENT_172	[p8l11t1117r108b1172],
35	studied	VBN	O	study	amod	36	SENT_172	[p8l133t1117r357b1172],
36	populations	NNS	O	population	prep_among	32	SENT_172	[p8l381t1117r756b1185],
37	.	.	O	.	_	0	SENT_172	[p8l381t1117r756b1185],

1	In	IN	O	in	_	0	SENT_173	[p8l781t1121r838b1171],
2	the	DT	O	the	det	4	SENT_173	[p8l860t1117r957b1172],
3	United	NNP	LOCATION	United	nn	4	SENT_173	[p8l980t1117r1184b1172],
4	Kingdom	NNP	LOCATION	Kingdom	prep_in	20	SENT_173	[p8l1209t1117r1487b1185],
5	Prospective	JJ	O	prospective	amod	8	SENT_173	[p8l1508t1118r1861b1185],
6	Diabetes	NNP	O	Diabetes	nn	8	SENT_173	[p8l1885t1117r2145b1172],
7	Study	NNP	O	Study	nn	8	SENT_173	[p8l12t1204r187b1272],
8	population	NN	O	population	dep	4	SENT_173	[p8l206t1204r553b1272],
9	,	,	O	,	_	0	SENT_173	[p8l206t1204r553b1272],
10	a	DT	O	a	det	11	SENT_173	[p8l575t1220r606b1258],
11	group	NN	O	group	nsubjpass	20	SENT_173	[p8l626t1220r805b1272],
12	of	IN	O	of	_	0	SENT_173	[p8l827t1204r890b1259],
13	363	CD	NUMBER	363	num	14	SENT_173	[p8l902t1207r1013b1259],
14	patients	NNS	O	patient	prep_of	11	SENT_173	[p8l1038t1205r1282b1272],
15	primarily	RB	O	primarily	advmod	16	SENT_173	[p8l1305t1204r1590b1272],
16	assigned	VBN	O	assign	partmod	14	SENT_173	[p8l1609t1204r1871b1272],
17	to	TO	O	to	_	0	SENT_173	[p8l1892t1212r1951b1259],
18	sulfonylurea	NN	O	sulfonylurea	prep_to	16	SENT_173	[p8l1974t1204r2145b1259, p8l12t1292r243b1359],
19	was	VBD	O	be	auxpass	20	SENT_173	[p8l263t1307r382b1346],
20	analyzed	VBN	O	analyze	_	0	SENT_173	[p8l404t1292r689b1359],
21	.	.	O	.	_	0	SENT_173	[p8l404t1292r689b1359],

1	No	DT	O	no	det	3	SENT_174	[p8l712t1295r795b1346],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_174	[p8l818t1292r1135b1359],
3	relationship	NN	O	relationship	nsubjpass	5	SENT_174	[p8l1155t1292r1522b1359],
4	was	VBD	O	be	auxpass	5	SENT_174	[p8l1542t1307r1661b1346],
5	found	VBN	O	find	_	0	SENT_174	[p8l1684t1292r1860b1346],
6	between	IN	O	between	_	0	SENT_174	[p8l1881t1292r2146b1346],
7	two	CD	NUMBER	two	num	10	SENT_174	[p8l11t1387r128b1433],
8	I	PRP	O	I	npadvmod	9	SENT_174	[p8l156t1381r369b1446],
9	<	JJR	O	<	amod	10	SENT_174	[p8l156t1381r369b1446],
10	CN	NN	O	cn	prep_between	5	SENT_174	[p8l156t1381r369b1446],
11	]	CD	NUMBER	]	number	12	SENT_174	[p8l156t1381r369b1446],
12	11	CD	NUMBER	11	num	13	SENT_174	[p8l156t1381r369b1446],
13	polymorphisms	NNS	O	polymorphism	nsubj	14	SENT_174	[p8l405t1379r884b1446],
14	(	VBP	O	(	rcmod	10	SENT_174	[p8l918t1379r1102b1446],
15	E23I	NN	O	e23us	nn	16	SENT_174	[p8l918t1379r1102b1446],
16	(	NN	O	(	dobj	14	SENT_174	[p8l918t1379r1102b1446],
17	and	CC	O	and	_	0	SENT_174	[p8l1129t1379r1240b1433],
18	L270V	NN	O	l270v	nn	19	SENT_174	[p8l1271t1379r1485b1446],
19	)	NN	O	)	conj_and	16	SENT_174	[p8l1271t1379r1485b1446],
20	and	CC	O	and	_	0	SENT_174	[p8l1518t1379r1630b1433],
21	the	DT	O	the	det	22	SENT_174	[p8l1659t1379r1756b1433],
22	response	NN	O	response	dobj	14	SENT_174	[p8l1786t1394r2057b1446],
23	to	TO	O	to	_	0	SENT_174	[p8l2086t1387r2145b1433],
24	sulfonylurea	NN	O	sulfonylurea	prep_to	14	SENT_174	[p8l13t1465r407b1533],
25	.	.	O	.	_	0	SENT_174	[p8l13t1465r407b1533],

1	However	RB	O	however	advmod	7	SENT_175	[p8l446t1468r737b1527],
2	,	,	O	,	_	0	SENT_175	[p8l446t1468r737b1527],
3	the	DT	O	the	det	5	SENT_175	[p8l775t1465r872b1519],
4	evaluated	VBN	O	evaluate	amod	5	SENT_175	[p8l910t1465r1206b1519],
5	outcome	NN	O	outcome	nsubj	25	SENT_175	[p8l1245t1473r1510b1519],
6	was	VBD	O	be	auxpass	7	SENT_175	[p8l1547t1481r1666b1519],
7	based	VBN	O	base	_	0	SENT_175	[p8l1703t1465r1878b1519],
8	on	IN	O	on	_	0	SENT_175	[p8l1917t1481r1992b1519],
9	two	CD	NUMBER	two	num	10	SENT_175	[p8l2028t1473r2145b1519],
10	measurements	NNS	O	measurement	prep_on	7	SENT_175	[p8l12t1560r464b1606],
11	of	IN	O	of	_	0	SENT_175	[p8l493t1552r557b1606],
12	FPG	NNP	ORGANIZATION	FPG	prep_of	10	SENT_175	[p8l578t1555r693b1606],
13	within	IN	O	within	_	0	SENT_175	[p8l719t1552r922b1606],
14	the	DT	O	the	det	16	SENT_175	[p8l949t1552r1046b1606],
15	ﬁrst	NN	O	ﬁrst	nn	16	SENT_175	[p8l1075t1552r1196b1606],
16	year	NN	DURATION	year	prep_within	7	SENT_175	[p8l1221t1568r1354b1620],
17	of	IN	O	of	_	0	SENT_175	[p8l1381t1552r1444b1606],
18	treatment	NN	O	treatment	prep_of	16	SENT_175	[p8l1464t1560r1785b1615],
19	,	,	O	,	_	0	SENT_175	[p8l1464t1560r1785b1615],
20	but	CC	O	but	_	0	SENT_175	[p8l1814t1552r1916b1606],
21	not	RB	O	not	neg	25	SENT_175	[p8l1943t1560r2044b1606],
22	on	IN	O	on	_	0	SENT_175	[p8l2071t1568r2146b1606],
23	HbA1c	NN	O	hba1c	nn	24	SENT_175	[p8l12t1639r213b1693],
24	measurements	NNS	O	measurement	prep_on	21	SENT_175	[p8l244t1647r695b1694],
25	[	VBP	O	[	conj_but	7	SENT_175	[p8l731t1639r863b1707],
26	14	CD	NUMBER	14	number	27	SENT_175	[p8l731t1639r863b1707],
27	]	CD	NUMBER	]	dobj	25	SENT_175	[p8l731t1639r863b1707],
28	.	.	O	.	_	0	SENT_175	[p8l731t1639r863b1707],

1	Another	DT	O	another	det	2	SENT_176	[p8l893t1639r1146b1694],
2	study	NN	O	study	nsubj	11	SENT_176	[p8l1176t1639r1344b1707],
3	performed	VBN	O	perform	partmod	2	SENT_176	[p8l1374t1639r1697b1707],
4	in	IN	O	in	_	0	SENT_176	[p8l1730t1640r1786b1693],
5	a	DT	O	a	det	6	SENT_176	[p8l1818t1655r1849b1694],
6	group	NN	O	group	prep_in	3	SENT_176	[p8l1878t1655r2057b1707],
7	of	IN	O	of	_	0	SENT_176	[p8l2090t1639r2153b1694],
8	525	CD	NUMBER	525	num	10	SENT_176	[p8l13t1729r122b1780],
9	Italian	JJ	MISC	italian	amod	10	SENT_176	[p8l154t1726r344b1780],
10	patients	NNS	O	patient	prep_of	6	SENT_176	[p8l373t1727r617b1794],
11	showed	VBD	O	show	_	0	SENT_176	[p8l648t1726r885b1780],
12	that	IN	O	that	complm	17	SENT_176	[p8l914t1726r1037b1780],
13	the	DT	O	the	det	14	SENT_176	[p8l1063t1726r1160b1780],
14	carriers	NNS	O	carrier	nsubj	17	SENT_176	[p8l1189t1727r1418b1780],
15	of	IN	O	of	_	0	SENT_176	[p8l1448t1726r1511b1780],
16	K-allele	NN	O	k-allele	prep_of	14	SENT_176	[p8l1533t1726r1764b1780],
17	had	VBD	O	have	ccomp	11	SENT_176	[p8l1794t1726r1904b1780],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_176	[p8l1935t1726r2145b1794, p8l12t1814r198b1881],
19	higher	JJR	O	higher	amod	20	SENT_176	[p8l232t1814r431b1881],
20	probability	NN	O	probability	dobj	17	SENT_176	[p8l464t1814r800b1881],
21	of	IN	O	of	_	0	SENT_176	[p8l834t1813r897b1868],
22	secondary	JJ	O	secondary	amod	24	SENT_176	[p8l926t1813r1238b1881],
23	sulfonylurea	NN	O	sulfonylurea	nn	24	SENT_176	[p8l1272t1813r1651b1881],
24	failure	NN	O	failure	prep_of	20	SENT_176	[p8l1687t1813r1896b1868],
25	.	.	O	.	_	0	SENT_176	[p8l1687t1813r1896b1868],

1	In	IN	O	in	_	0	SENT_177	[p8l1932t1817r1990b1867],
2	that	DT	O	that	det	3	SENT_177	[p8l2025t1813r2148b1868],
3	study	NN	O	study	prep_in	8	SENT_177	[p8l13t1900r181b1968],
4	secondary	JJ	O	secondary	amod	6	SENT_177	[p8l215t1901r527b1968],
5	sulfonylurea	NN	O	sulfonylurea	nn	6	SENT_177	[p8l561t1900r941b1968],
6	failure	NN	O	failure	nsubjpass	8	SENT_177	[p8l976t1900r1170b1955],
7	was	VBD	O	be	auxpass	8	SENT_177	[p8l1204t1916r1322b1955],
8	deﬁned	VBN	O	deﬁned	_	0	SENT_177	[p8l1359t1900r1587b1955],
9	as	IN	O	as	_	0	SENT_177	[p8l1623t1916r1683b1955],
10	not	RB	O	not	neg	11	SENT_177	[p8l1719t1909r1820b1955],
11	achieving	VBG	O	achieve	prepc_as	8	SENT_177	[p8l1854t1901r2147b1968],
12	FPG	NNP	ORGANIZATION	FPG	dep	19	SENT_177	[p8l12t1990r297b2041],
13	<	JJR	O	<	dep	12	SENT_177	[p8l12t1990r297b2041],
14	300	CD	NUMBER	300	num	15	SENT_177	[p8l12t1990r297b2041],
15	mg/dl	NN	O	mg/dl	dep	19	SENT_177	[p8l319t1987r498b2055],
16	(	CD	NUMBER	(	number	17	SENT_177	[p8l523t1987r675b2054],
17	16.7	CD	NUMBER	16.7	num	19	SENT_177	[p8l523t1987r675b2054],
18	mmol/1	NN	O	mmol/1	nn	19	SENT_177	[p8l698t1987r945b2054],
19	)	NN	O	)	dep	11	SENT_177	[p8l698t1987r945b2054],
20	on	IN	O	on	_	0	SENT_177	[p8l970t2003r1045b2041],
21	treatment	NN	O	treatment	prep_on	19	SENT_177	[p8l1065t1995r1373b2041],
22	with	IN	O	with	_	0	SENT_177	[p8l1390t1987r1531b2041],
23	combination	NN	O	combination	prep_with	11	SENT_177	[p8l1551t1987r1936b2041],
24	of	IN	O	of	_	0	SENT_177	[p8l1956t1987r2020b2041],
25	sulfonylurea	NN	O	sulfonylurea	prep_of	23	SENT_177	[p8l2034t1987r2145b2041, p8l12t2074r304b2142],
26	as	IN	O	as	_	0	SENT_177	[p8l330t2090r389b2128],
27	the	DT	O	the	det	29	SENT_177	[p8l417t2074r514b2128],
28	ﬁrst-choice	JJ	O	ﬁrst-choice	amod	29	SENT_177	[p8l541t2074r885b2128],
29	drug	NN	O	drug	prep_as	11	SENT_177	[p8l913t2074r1055b2142],
30	and	CC	O	and	_	0	SENT_177	[p8l1080t2074r1191b2128],
31	metformin	NN	O	metformin	prep_as	11	SENT_177	[p8l1220t2074r1548b2128],
32	as	IN	O	as	_	0	SENT_177	[p8l1574t2090r1634b2128],
33	an	DT	O	a	det	38	SENT_177	[p8l1661t2090r1733b2128],
34	add-on	JJ	O	add-on	amod	38	SENT_177	[p8l1760t2074r1978b2128],
35	drug	NN	O	drug	nn	38	SENT_177	[p8l2005t2074r2147b2142],
36	[	NN	O	[	nn	38	SENT_177	[p8l15t2161r148b2229],
37	12	CD	NUMBER	12	num	38	SENT_177	[p8l15t2161r148b2229],
38	]	NN	O	]	prep_as	29	SENT_177	[p8l15t2161r148b2229],
39	.	.	O	.	_	0	SENT_177	[p8l15t2161r148b2229],

1	Thus	RB	O	thus	advmod	9	SENT_178	[p8l172t2161r334b2224],
2	,	,	O	,	_	0	SENT_178	[p8l172t2161r334b2224],
3	the	DT	O	the	det	4	SENT_178	[p8l360t2161r458b2216],
4	study	NN	O	study	nsubj	9	SENT_178	[p8l485t2161r653b2229],
5	of	IN	O	of	_	0	SENT_178	[p8l677t2161r741b2215],
6	Sesti	NNP	O	Sesti	prep_of	4	SENT_178	[p8l760t2162r899b2216],
7	et	FW	O	et	nn	8	SENT_178	[p8l927t2169r984b2216],
8	al.	FW	O	al.	dep	6	SENT_178	[p8l1008t2161r1073b2216],
9	describes	VBZ	O	describe	_	0	SENT_178	[p8l1100t2161r1383b2216],
10	rather	RB	O	rather	advmod	12	SENT_178	[p8l1411t2161r1598b2216],
11	the	DT	O	the	det	12	SENT_178	[p8l1622t2161r1719b2216],
12	failure	NN	O	failure	dep	9	SENT_178	[p8l1746t2161r1940b2216],
13	of	IN	O	of	_	0	SENT_178	[p8l1967t2161r2030b2215],
14	the	DT	O	the	det	15	SENT_178	[p8l2048t2161r2145b2216],
15	combination	NN	O	combination	prep_of	12	SENT_178	[p8l12t2248r397b2302],
16	of	IN	O	of	_	0	SENT_178	[p8l419t2248r482b2302],
17	sulfonylurea	NN	O	sulfonylurea	prep_of	15	SENT_178	[p8l497t2248r877b2316],
18	plus	CC	O	plus	prep	17	SENT_178	[p8l898t2248r1023b2316],
19	metformin	NN	O	metformin	nn	20	SENT_178	[p8l1045t2248r1373b2302],
20	treatment	NN	O	treatment	dep	18	SENT_178	[p8l1394t2256r1715b2311],
21	,	,	O	,	_	0	SENT_178	[p8l1394t2256r1715b2311],
22	than	IN	O	than	advmod	26	SENT_178	[p8l1736t2248r1874b2302],
23	of	IN	O	of	_	0	SENT_178	[p8l1895t2248r1959b2302],
24	sulfonylurea	NN	O	sulfonylurea	nn	25	SENT_178	[p8l1974t2248r2145b2302, p8l12t2335r243b2403],
25	treatment	NN	O	treatment	prep_of	22	SENT_178	[p8l266t2344r574b2390],
26	itself	PRP	O	itself	dep	12	SENT_178	[p8l597t2335r758b2390],
27	.	.	O	.	_	0	SENT_178	[p8l597t2335r758b2390],

1	Feng	NNP	O	Feng	nsubj	4	SENT_179	[p8l114t2425r258b2490],
2	et	FW	O	et	nn	3	SENT_179	[p8l277t2430r334b2476],
3	al.	FW	O	al.	dep	1	SENT_179	[p8l353t2422r418b2477],
4	evaluated	VBN	O	evaluate	_	0	SENT_179	[p8l440t2422r736b2476],
5	glycemic	JJ	O	glycemic	amod	6	SENT_179	[p8l756t2422r1028b2490],
6	response	NN	O	response	dobj	4	SENT_179	[p8l1048t2438r1320b2490],
7	to	TO	O	to	_	0	SENT_179	[p8l1340t2430r1399b2476],
8	8-week	JJ	DURATION	8-week	amod	10	SENT_179	[p8l1420t2422r1650b2476],
9	gliclazide	NN	O	gliclazide	nn	10	SENT_179	[p8l1667t2422r1955b2490],
10	treatment	NN	O	treatment	prep_to	4	SENT_179	[p8l1975t2430r2145b2476, p8l12t2517r173b2563],
11	in	IN	O	in	_	0	SENT_179	[p8l195t2510r251b2563],
12	661	CD	NUMBER	661	num	14	SENT_179	[p8l275t2512r379b2563],
13	Chinese	JJ	MISC	chinese	amod	14	SENT_179	[p8l411t2509r648b2563],
14	patients	NNS	O	patient	prep_in	4	SENT_179	[p8l672t2510r917b2577],
15	according	VBG	O	accord	_	0	SENT_179	[p8l941t2509r1239b2577],
16	to	TO	O	to	prepc_according_to	4	SENT_179	[p8l1261t2517r1319b2563],
17	25	CD	NUMBER	25	num	20	SENT_179	[p8l1344t2512r1415b2563],
18	single	JJ	O	single	amod	20	SENT_179	[p8l1442t2509r1619b2577],
19	nucleotide	NN	O	nucleotide	nn	20	SENT_179	[p8l1643t2509r1964b2563],
20	polymorphisms	NNS	O	polymorphism	pobj	4	SENT_179	[p8l1988t2509r2145b2577, p8l13t2596r372b2664],
21	.	.	O	.	_	0	SENT_179	[p8l1988t2509r2145b2577, p8l13t2596r372b2664],

1	KCN	NN	O	kcn	nsubjpass	17	SENT_180	[p8l395t2599r608b2664],
2	]	CD	NUMBER	]	dep	1	SENT_180	[p8l395t2599r608b2664],
3	11	CD	NUMBER	11	num	4	SENT_180	[p8l395t2599r608b2664],
4	rs5210	NN	O	rs5210	dep	1	SENT_180	[p8l639t2599r846b2650],
5	(	CD	NUMBER	(	num	14	SENT_180	[p8l874t2596r1166b2664],
6	different	JJ	O	different	amod	14	SENT_180	[p8l874t2596r1166b2664],
7	from	IN	O	from	_	0	SENT_180	[p8l1188t2596r1334b2651],
8	E23I	NN	O	e23us	nn	10	SENT_180	[p8l1358t2597r1538b2664],
9	(	CD	NUMBER	(	num	10	SENT_180	[p8l1358t2597r1538b2664],
10	)	NN	O	)	prep_from	6	SENT_180	[p8l1358t2597r1538b2664],
11	and	CC	O	and	_	0	SENT_180	[p8l1565t2596r1677b2651],
12	ABCC8	NN	O	abcc8	nn	13	SENT_180	[p8l1695t2599r1892b2651],
13	S1369A	NN	O	s1369a	prep_from	6	SENT_180	[p8l1916t2599r2148b2651],
14	polymorphisms	NNS	O	polymorphism	dep	4	SENT_180	[p8l12t2683r491b2751],
15	were	VBD	O	be	auxpass	17	SENT_180	[p8l523t2699r676b2738],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_180	[p8l709t2683r1082b2751],
17	associated	VBN	O	associate	_	0	SENT_180	[p8l1112t2683r1426b2738],
18	with	IN	O	with	_	0	SENT_180	[p8l1457t2683r1597b2738],
19	decrease	NN	O	decrease	prep_with	17	SENT_180	[p8l1630t2683r1895b2738],
20	in	IN	O	in	_	0	SENT_180	[p8l1927t2684r1983b2737],
21	FPG	NNP	ORGANIZATION	FPG	prep_in	19	SENT_180	[p8l2016t2686r2145b2738],
22	.	.	O	.	_	0	SENT_180	[p8l2016t2686r2145b2738],

1	Association	NN	O	association	nn	2	SENT_181	[p8l9t2772r359b2825],
2	analysis	NN	O	analysis	nsubjpass	10	SENT_181	[p8l398t2771r639b2838],
3	of	IN	O	of	_	0	SENT_181	[p8l679t2771r743b2825],
4	ABCC8	NN	O	abcc8	nn	5	SENT_181	[p8l769t2773r966b2825],
5	S1369A	NN	O	s1369a	prep_of	2	SENT_181	[p8l1005t2773r1238b2825],
6	with	IN	O	with	_	0	SENT_181	[p8l1273t2771r1414b2825],
7	sulfonylurea	NN	O	sulfonylurea	nn	8	SENT_181	[p8l1455t2771r1834b2838],
8	response	NN	O	response	prep_with	5	SENT_181	[p8l1874t2786r2145b2838],
9	was	VBD	O	be	auxpass	10	SENT_181	[p8l10t2873r129b2912],
10	replicated	VBN	O	replicate	_	0	SENT_181	[p8l159t2858r463b2925],
11	in	IN	O	in	_	0	SENT_181	[p8l493t2859r549b2911],
12	a	DT	O	a	det	13	SENT_181	[p8l578t2874r609b2912],
13	cohort	NN	O	cohort	prep_in	10	SENT_181	[p8l637t2858r836b2912],
14	of	IN	O	of	_	0	SENT_181	[p8l863t2858r927b2912],
15	607	CD	NUMBER	607	num	16	SENT_181	[p8l949t2861r1059b2912],
16	patients	NNS	O	patient	prep_of	13	SENT_181	[p8l1089t2859r1334b2925],
17	[	CD	NUMBER	[	number	18	SENT_181	[p8l1367t2858r1499b2925],
18	15	CD	NUMBER	15	num	19	SENT_181	[p8l1367t2858r1499b2925],
19	]	NN	O	]	dep	16	SENT_181	[p8l1367t2858r1499b2925],
20	.	.	O	.	_	0	SENT_181	[p8l1367t2858r1499b2925],

1	Since	IN	O	since	mark	4	SENT_182	[p8l1530t2859r1688b2912],
2	this	DT	O	this	det	3	SENT_182	[p8l1717t2858r1827b2912],
3	variant	NN	O	variant	nsubj	4	SENT_182	[p8l1855t2859r2073b2912],
4	is	VBZ	O	be	advcl	19	SENT_182	[p8l2101t2859r2144b2912],
5	in	IN	O	in	_	0	SENT_182	[p8l12t2945r69b2998],
6	strong	JJ	O	strong	amod	8	SENT_182	[p8l98t2952r291b3012],
7	linkage	NN	O	linkage	nn	8	SENT_182	[p8l318t2944r538b3012],
8	disequilibrium	NN	O	disequilibrium	prep_in	4	SENT_182	[p8l565t2944r1014b3012],
9	with	IN	O	with	_	0	SENT_182	[p8l1039t2944r1180b2998],
10	KCN	NN	O	kcn	prep_with	8	SENT_182	[p8l1206t2947r1419b3012],
11	]	CD	NUMBER	]	num	10	SENT_182	[p8l1206t2947r1419b3012],
12	11	CD	NUMBER	11	num	14	SENT_182	[p8l1206t2947r1419b3012],
13	E23I	NN	O	e23us	nn	14	SENT_182	[p8l1454t2947r1624b3007],
14	(	NN	O	(	dep	10	SENT_182	[p8l1454t2947r1624b3007],
15	,	,	O	,	_	0	SENT_182	[p8l1454t2947r1624b3007],
16	it	PRP	O	it	nsubjpass	19	SENT_182	[p8l1653t2945r1694b2998],
17	could	MD	O	could	aux	19	SENT_182	[p8l1720t2944r1885b2998],
18	be	VB	O	be	auxpass	19	SENT_182	[p8l1913t2944r1983b2998],
19	considered	VBN	O	consider	_	0	SENT_182	[p8l2012t2960r2145b2998, p8l13t3031r235b3085],
20	a	DT	O	a	det	21	SENT_182	[p8l264t3047r295b3085],
21	proxy	NN	O	proxy	dobj	19	SENT_182	[p8l324t3047r501b3099],
22	for	IN	O	for	_	0	SENT_182	[p8l528t3031r613b3085],
23	the	DT	O	the	det	27	SENT_182	[p8l639t3031r736b3085],
24	KCN	NNP	O	KCN	nn	27	SENT_182	[p8l763t3034r976b3099],
25	]	CD	NUMBER	]	num	27	SENT_182	[p8l763t3034r976b3099],
26	11	CD	NUMBER	11	amod	27	SENT_182	[p8l763t3034r976b3099],
27	variant	NN	O	variant	prep_for	19	SENT_182	[p8l1010t3032r1241b3093],
28	,	,	O	,	_	0	SENT_182	[p8l1010t3032r1241b3093],
29	because	IN	O	because	mark	33	SENT_182	[p8l1270t3031r1512b3085],
30	it	PRP	O	it	nsubj	33	SENT_182	[p8l1541t3032r1583b3085],
31	is	VBZ	O	be	cop	33	SENT_182	[p8l1610t3032r1654b3085],
32	not	RB	O	not	neg	33	SENT_182	[p8l1684t3039r1784b3085],
33	possible	JJ	O	possible	dep	27	SENT_182	[p8l1812t3031r2058b3099],
34	to	TO	O	to	aux	35	SENT_182	[p8l2086t3039r2145b3085],
35	distinguish	VB	O	distinguish	xcomp	33	SENT_182	[p8l12t3118r350b3186],
36	on	IN	O	on	_	0	SENT_182	[p8l394t3134r469b3172],
37	statistical	JJ	O	statistical	amod	38	SENT_182	[p8l515t3118r802b3173],
38	grounds	NNS	O	grounds	prep_on	35	SENT_182	[p8l846t3118r1096b3186],
39	alone	RB	O	alone	advmod	35	SENT_182	[p8l1140t3118r1319b3181],
40	,	,	O	,	_	0	SENT_182	[p8l1140t3118r1319b3181],
41	whether	IN	O	whether	complm	45	SENT_182	[p8l1363t3118r1625b3173],
42	the	DT	O	the	det	44	SENT_182	[p8l1667t3118r1764b3173],
43	association	NN	O	association	nn	44	SENT_182	[p8l1808t3119r2146b3173],
44	signal	NN	O	signal	nsubj	45	SENT_182	[p8l13t3205r189b3273],
45	arises	VBZ	O	arise	ccomp	33	SENT_182	[p8l214t3206r386b3260],
46	from	IN	O	from	_	0	SENT_182	[p8l412t3205r558b3260],
47	the	DT	O	the	det	49	SENT_182	[p8l582t3205r679b3260],
48	one	CD	NUMBER	one	num	49	SENT_182	[p8l705t3221r815b3260],
49	variant	NN	O	variant	prep_from	45	SENT_182	[p8l838t3206r1057b3260],
50	or	CC	O	or	_	0	SENT_182	[p8l1080t3221r1143b3259],
51	the	DT	O	the	det	53	SENT_182	[p8l1166t3205r1263b3260],
52	other	JJ	O	other	amod	53	SENT_182	[p8l1289t3205r1453b3260],
53	[	NN	O	[	conj_or	49	SENT_182	[p8l1479t3205r1612b3273],
54	10	CD	NUMBER	10	num	55	SENT_182	[p8l1479t3205r1612b3273],
55	]	NN	O	]	dep	53	SENT_182	[p8l1479t3205r1612b3273],
56	.	.	O	.	_	0	SENT_182	[p8l1479t3205r1612b3273],

1	In	IN	O	in	_	0	SENT_183	[p8l1639t3209r1696b3259],
2	the	DT	O	the	det	4	SENT_183	[p8l1721t3205r1817b3260],
3	combined	JJ	O	combined	amod	4	SENT_183	[p8l1843t3205r2145b3260],
4	analysis	NN	O	analysis	prep_in	14	SENT_183	[p8l12t3293r253b3360],
5	of	IN	O	of	prep	14	SENT_183	[p8l274t3293r338b3347],
6	both	CC	O	both	dep	5	SENT_183	[p8l350t3293r490b3347],
7	cohorts	NNS	O	cohort	conj	5	SENT_183	[p8l511t3293r751b3355],
8	,	,	O	,	_	0	SENT_183	[p8l511t3293r751b3355],
9	subjects	NNS	O	subject	nsubj	14	SENT_183	[p8l774t3293r1018b3360],
10	with	IN	O	with	_	0	SENT_183	[p8l1038t3293r1179b3347],
11	ABCC8	NN	O	abcc8	nn	13	SENT_183	[p8l1194t3295r1391b3347],
12	AA	NN	O	aa	nn	13	SENT_183	[p8l1409t3295r1498b3346],
13	genotype	NN	O	genotype	prep_with	9	SENT_183	[p8l1516t3301r1800b3360],
14	had	VBD	O	have	_	0	SENT_183	[p8l1822t3293r1932b3347],
15	significantly	RB	O	significantly	advmod	16	SENT_183	[p8l1955t3293r2145b3360, p8l12t3380r218b3447],
16	greater	JJR	O	greater	amod	17	SENT_183	[p8l236t3388r457b3447],
17	decrease	NN	O	decrease	dobj	14	SENT_183	[p8l476t3380r741b3434],
18	in	IN	O	in	prep	14	SENT_183	[p8l763t3381r820b3433],
19	FPG	NNP	ORGANIZATION	FPG	pobj	18	SENT_183	[p8l841t3383r970b3442],
20	,	,	O	,	_	0	SENT_183	[p8l841t3383r970b3442],
21	but	CC	O	but	_	0	SENT_183	[p8l992t3380r1094b3434],
22	not	RB	O	not	prep	14	SENT_183	[p8l1114t3388r1215b3434],
23	in	IN	O	in	dep	18	SENT_183	[p8l1235t3381r1291b3433],
24	HbA1	NN	O	hba1	nn	25	SENT_183	[p8l1313t3380r1473b3434],
25	c	NN	O	c	pobj	23	SENT_183	[p8l1485t3395r1527b3442],
26	,	,	O	,	_	0	SENT_183	[p8l1485t3395r1527b3442],
27	in	IN	O	in	_	0	SENT_183	[p8l1550t3381r1606b3433],
28	comparison	NN	O	comparison	prep_in	14	SENT_183	[p8l1627t3381r1986b3447],
29	with	IN	O	with	_	0	SENT_183	[p8l2005t3380r2146b3434],
30	patients	NNS	O	patient	prep_with	28	SENT_183	[p8l12t3467r257b3534],
31	with	IN	O	with	_	0	SENT_183	[p8l276t3466r416b3520],
32	SS	NN	O	ss	nn	33	SENT_183	[p8l436t3469r502b3520],
33	genotype	NN	O	genotype	prep_with	14	SENT_183	[p8l521t3474r805b3534],
34	[	CD	NUMBER	[	number	35	SENT_183	[p8l829t3466r962b3534],
35	15	CD	NUMBER	15	num	36	SENT_183	[p8l829t3466r962b3534],
36	]	NN	O	]	dep	14	SENT_183	[p8l829t3466r962b3534],
37	.	.	O	.	_	0	SENT_183	[p8l829t3466r962b3534],

1	In	IN	O	in	_	0	SENT_184	[p8l983t3470r1039b3520],
2	a	DT	O	a	det	5	SENT_184	[p8l1059t3482r1090b3520],
3	similarly	RB	O	similarly	advmod	4	SENT_184	[p8l1110t3466r1377b3534],
4	designed	VBN	O	design	amod	5	SENT_184	[p8l1394t3466r1668b3534],
5	study	NN	O	study	prep_in	45	SENT_184	[p8l1689t3466r1857b3534],
6	with	IN	O	with	_	0	SENT_184	[p8l1873t3466r2014b3520],
7	115	CD	NUMBER	115	num	9	SENT_184	[p8l2037t3469r2143b3520],
8	Chinese	JJ	MISC	chinese	amod	9	SENT_184	[p8l12t3553r250b3607],
9	patients	NNS	O	patient	prep_with	5	SENT_184	[p8l301t3554r561b3621],
10	,	,	O	,	_	0	SENT_184	[p8l301t3554r561b3621],
11	a	DT	O	a	det	14	SENT_184	[p8l613t3569r644b3607],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_184	[p8l695t3553r1069b3621],
13	greater	JJR	O	greater	amod	14	SENT_184	[p8l1117t3561r1337b3621],
14	reduction	NN	O	reduction	nsubjpass	45	SENT_184	[p8l1386t3553r1680b3607],
15	in	IN	O	in	_	0	SENT_184	[p8l1731t3554r1787b3607],
16	HbA1c	NN	O	hba1c	prep_in	14	SENT_184	[p8l1839t3553r2039b3607],
17	in	IN	O	in	_	0	SENT_184	[p8l2089t3554r2146b3607],
18	response	NN	O	response	prep_in	16	SENT_184	[p8l13t3656r284b3708],
19	to	TO	O	to	_	0	SENT_184	[p8l319t3648r377b3695],
20	8-week	JJ	DURATION	8-week	amod	22	SENT_184	[p8l413t3640r642b3695],
21	gliclazide	NN	O	gliclazide	nn	22	SENT_184	[p8l674t3640r961b3708],
22	treatment	NN	O	treatment	prep_to	18	SENT_184	[p8l995t3648r1303b3695],
23	in	IN	O	in	_	0	SENT_184	[p8l1337t3641r1393b3694],
24	the	DT	O	the	det	25	SENT_184	[p8l1427t3640r1524b3695],
25	carriers	NNS	O	carrier	prep_in	22	SENT_184	[p8l1559t3641r1787b3695],
26	of	IN	O	of	_	0	SENT_184	[p8l1823t3640r1886b3695],
27	A-allele	JJ	O	a-allele	amod	29	SENT_184	[p8l1911t3640r2145b3695],
28	(	NN	O	(	nn	29	SENT_184	[p8l16t3728r120b3795],
29	SA	NNP	O	SA	prep_of	25	SENT_184	[p8l16t3728r120b3795],
30	and	CC	O	and	_	0	SENT_184	[p8l153t3727r264b3782],
31	AA	NNP	O	AA	nn	32	SENT_184	[p8l298t3728r411b3795],
32	)	NN	O	)	conj_and	25	SENT_184	[p8l298t3728r411b3795],
33	of	IN	O	of	_	0	SENT_184	[p8l450t3727r514b3782],
34	ABCC8	NN	O	abcc8	nn	36	SENT_184	[p8l536t3730r733b3782],
35	S1369A	NN	O	s1369a	nn	36	SENT_184	[p8l768t3730r1001b3782],
36	polymorphism	NN	O	polymorphism	prep_of	32	SENT_184	[p8l1035t3727r1486b3795],
37	in	IN	O	in	_	0	SENT_184	[p8l1521t3728r1577b3781],
38	comparison	NN	O	comparison	prep_in	36	SENT_184	[p8l1613t3728r1971b3795],
39	with	IN	O	with	_	0	SENT_184	[p8l2005t3727r2146b3781],
40	homozygous	JJ	O	homozygous	amod	41	SENT_184	[p9l12t17r400b84],
41	carriers	NNS	O	carrier	prep_with	38	SENT_184	[p9l426t18r654b71],
42	of	IN	O	of	_	0	SENT_184	[p9l679t17r743b71],
43	S-allele	NN	MISC	s-allele	prep_of	41	SENT_184	[p9l760t17r982b71],
44	was	VBD	O	be	auxpass	45	SENT_184	[p9l1005t32r1124b71],
45	reported	VBN	O	report	_	0	SENT_184	[p9l1150t17r1413b84],
46	[	RB	O	[	advmod	45	SENT_184	[p9l1441t17r1574b84],
47	16	CD	NUMBER	16	num	48	SENT_184	[p9l1441t17r1574b84],
48	]	NN	O	]	dobj	45	SENT_184	[p9l1441t17r1574b84],
49	.	.	O	.	_	0	SENT_184	[p9l1441t17r1574b84],

1	To	TO	O	to	_	0	SENT_185	[p9l111t107r185b158],
2	the	DT	O	the	det	3	SENT_185	[p9l207t104r303b158],
3	best	JJS	O	best	prep_to	13	SENT_185	[p9l325t103r452b158],
4	of	IN	O	of	_	0	SENT_185	[p9l472t103r536b158],
5	our	PRP$	O	we	poss	6	SENT_185	[p9l550t119r653b158],
6	knowledge	NN	O	knowledge	prep_of	3	SENT_185	[p9l674t104r1025b171],
7	,	,	O	,	_	0	SENT_185	[p9l674t104r1025b171],
8	the	DT	O	the	det	10	SENT_185	[p9l1048t104r1145b158],
9	present	JJ	DATE	present	amod	10	SENT_185	[p9l1168t112r1399b171],
10	study	NN	O	study	nsubj	13	SENT_185	[p9l1419t104r1587b171],
11	is	VBZ	O	be	cop	13	SENT_185	[p9l1608t104r1652b158],
12	the	DT	O	the	det	13	SENT_185	[p9l1675t104r1771b158],
13	ﬁrst	NN	O	ﬁrst	_	0	SENT_185	[p9l1794t103r1915b158],
14	to	TO	O	to	aux	15	SENT_185	[p9l1934t112r1993b158],
15	suggest	VB	O	suggest	infmod	13	SENT_185	[p9l2017t119r2145b171, p9l11t198r136b258],
16	that	IN	O	that	complm	21	SENT_185	[p9l159t190r282b244],
17	sulfonylurea	NN	O	sulfonylurea	nn	18	SENT_185	[p9l305t190r686b258],
18	drugs	NNS	O	drug	nsubj	21	SENT_185	[p9l710t190r879b258],
19	are	VBP	O	be	cop	21	SENT_185	[p9l905t206r997b244],
20	more	RBR	O	more	advmod	21	SENT_185	[p9l1023t206r1181b244],
21	effective	JJ	O	effective	ccomp	15	SENT_185	[p9l1207t190r1465b244],
22	in	IN	O	in	_	0	SENT_185	[p9l1490t191r1546b244],
23	reducing	VBG	O	reduce	prepc_in	21	SENT_185	[p9l1572t190r1841b258],
24	HbA1c	NN	O	hba1c	dobj	23	SENT_185	[p9l1865t190r2065b244],
25	in	IN	O	in	_	0	SENT_185	[p9l2089t191r2146b244],
26	carriers	NNS	O	carrier	prep_in	23	SENT_185	[p9l12t278r241b331],
27	of	IN	O	of	_	0	SENT_185	[p9l273t277r336b331],
28	the	DT	O	the	det	29	SENT_185	[p9l359t277r456b331],
29	K-allele	NN	O	k-allele	prep_of	26	SENT_185	[p9l488t277r719b331],
30	of	IN	O	of	_	0	SENT_185	[p9l751t277r814b331],
31	KCN	NNP	O	KCN	prep_of	29	SENT_185	[p9l836t280r1049b345],
32	]	CD	NUMBER	]	num	31	SENT_185	[p9l836t280r1049b345],
33	11	CD	NUMBER	11	num	35	SENT_185	[p9l836t280r1049b345],
34	E23K	NN	O	e23k	nn	35	SENT_185	[p9l1088t280r1244b331],
35	polymorphism	NN	O	polymorphism	tmod	23	SENT_185	[p9l1274t277r1725b345],
36	in	IN	O	in	_	0	SENT_185	[p9l1756t278r1813b331],
37	Caucasian	JJ	LOCATION	caucasian	amod	38	SENT_185	[p9l1844t278r2146b331],
38	population	NN	O	population	prep_in	35	SENT_185	[p9l12t364r358b432],
39	.	.	O	.	_	0	SENT_185	[p9l12t364r358b432],

1	When	WRB	O	when	advmod	5	SENT_186	[p9l411t364r598b419],
2	taking	VBG	O	take	csubj	5	SENT_186	[p9l651t364r842b432],
3	into	IN	O	into	_	0	SENT_186	[p9l896t365r1014b418],
4	account	NN	O	account	prep_into	2	SENT_186	[p9l1068t372r1308b419],
5	reported	VBD	O	report	advcl	24	SENT_186	[p9l1360t364r1624b432],
6	strong	JJ	O	strong	amod	8	SENT_186	[p9l1679t372r1873b432],
7	linkage	NN	O	linkage	nn	8	SENT_186	[p9l1926t364r2146b432],
8	disequilibrium	NN	O	disequilibrium	dobj	5	SENT_186	[p9l12t451r460b519],
9	between	IN	O	between	_	0	SENT_186	[p9l502t451r767b506],
10	examined	VBN	O	examine	amod	11	SENT_186	[p9l809t451r1110b506],
11	polymorphisms	NNS	O	polymorphism	prep_between	8	SENT_186	[p9l1153t451r1632b519],
12	of	IN	O	of	_	0	SENT_186	[p9l1675t451r1739b506],
13	KCN	NNP	O	KCN	prep_of	11	SENT_186	[p9l1772t454r1985b519],
14	]	CD	NUMBER	]	number	19	SENT_186	[p9l1772t454r1985b519],
15	11	CD	NUMBER	11	number	19	SENT_186	[p9l1772t454r1985b519],
16	and	CC	O	and	_	0	SENT_186	[p9l2034t451r2145b505],
17	ABCC8	CD	NUMBER	abcc8	conj_and	19	SENT_186	[p9l6t541r203b593],
18	[	CD	NUMBER	[	number	19	SENT_186	[p9l231t539r363b606],
19	10	CD	NUMBER	10	num	20	SENT_186	[p9l231t539r363b606],
20	]	NN	O	]	dep	13	SENT_186	[p9l231t539r363b606],
21	,	,	O	,	_	0	SENT_186	[p9l231t539r363b606],
22	our	PRP$	O	we	poss	23	SENT_186	[p9l389t555r493b593],
23	observation	NN	O	observation	nsubj	26	SENT_186	[p9l516t539r876b593],
24	replicates	VBZ	O	replicate	dep	33	SENT_186	[p9l900t539r1193b606],
25	and	CC	O	and	_	0	SENT_186	[p9l1219t539r1330b593],
26	extends	VBZ	O	extend	dep	33	SENT_186	[p9l1355t539r1594b593],
27	the	DT	O	the	det	28	SENT_186	[p9l1619t539r1716b593],
28	results	NNS	O	result	dobj	24	SENT_186	[p9l1741t539r1943b593],
29	of	IN	O	of	_	0	SENT_186	[p9l1968t539r2032b593],
30	the	DT	O	the	det	32	SENT_186	[p9l2048t539r2145b593],
31	above	JJ	O	above	amod	32	SENT_186	[p9l12t626r555b680],
32	—	NN	O	—	prep_of	28	SENT_186	[p9l12t626r555b680],
33	mentioned	VBD	O	mention	_	0	SENT_186	[p9l12t626r555b680],
34	studies	NNS	O	study	dobj	33	SENT_186	[p9l602t626r815b680],
35	in	IN	O	in	_	0	SENT_186	[p9l862t626r918b679],
36	Asian	JJ	LOCATION	asian	amod	37	SENT_186	[p9l961t626r1129b680],
37	population	NN	O	population	prep_in	33	SENT_186	[p9l1174t626r1507b693],
38	with	IN	O	with	_	0	SENT_186	[p9l1550t626r1691b680],
39	sulfonylureas	NN	O	sulfonylurea	prep_with	33	SENT_186	[p9l1737t625r2145b693],
40	[	CD	NUMBER	[	num	39	SENT_186	[p9l15t712r223b780],
41	15,16	CD	NUMBER	15,16	num	42	SENT_186	[p9l15t712r223b780],
42	]	NN	O	]	nsubj	33	SENT_186	[p9l15t712r223b780],
43	to	TO	O	to	_	0	SENT_186	[p9l251t720r310b766],
44	a	DT	O	a	det	46	SENT_186	[p9l335t728r366b766],
45	longer	JJR	O	longer	amod	46	SENT_186	[p9l392t712r588b780],
46	period	NN	O	period	prep_to	42	SENT_186	[p9l611t712r807b780],
47	of	IN	O	of	_	0	SENT_186	[p9l833t712r896b766],
48	six	CD	DURATION	six	num	49	SENT_186	[p9l915t713r998b766],
49	months	NNS	NUMBER	month	prep_of	46	SENT_186	[p9l1022t712r1268b767],
50	.	.	O	.	_	0	SENT_186	[p9l1022t712r1268b767],

1	6-month	JJ	DURATION	6-month	amod	2	SENT_187	[p9l1295t712r1564b766],
2	duration	NN	O	duration	nsubj	5	SENT_187	[p9l1589t712r1851b766],
3	probably	RB	O	probably	advmod	4	SENT_187	[p9l1876t712r2148b780],
4	best	RB	O	best	advmod	5	SENT_187	[p9l11t799r138b853],
5	reﬂects	VBZ	O	reﬂects	_	0	SENT_187	[p9l184t799r405b853],
6	the	DT	O	the	det	8	SENT_187	[p9l452t799r549b853],
7	maximal	JJ	O	maximal	amod	8	SENT_187	[p9l598t799r863b853],
8	effect	NN	O	effect	dobj	5	SENT_187	[p9l911t799r1079b853],
9	of	IN	O	of	_	0	SENT_187	[p9l1125t799r1189b853],
10	sulfonylurea	NN	O	sulfonylurea	prep_of	8	SENT_187	[p9l1229t799r1609b867],
11	as	IN	O	as	_	0	SENT_187	[p9l1656t815r1716b853],
12	observed	VBN	O	observe	prepc_as	5	SENT_187	[p9l1764t799r2041b853],
13	in	IN	O	in	prep	12	SENT_187	[p9l2089t800r2146b853],

1	248	CD	NUMBER	248	num	3	SENT_188	[p9l312t943r355b964],
2	M.	NNP	NUMBER	M.	nn	3	SENT_188	[p9l937t943r965b964],
3	javorsky	NNP	O	javorsky	_	0	SENT_188	[p9l970t942r1072b969],
4	et	FW	O	et	nn	5	SENT_188	[p9l1081t945r1104b964],
5	al.	FW	O	al.	dep	3	SENT_188	[p9l1111t942r1136b964],
6	/	:	O	/	punct	3	SENT_188	[p9l1145t943r1155b967],
7	European	JJ	MISC	european	amod	8	SENT_188	[p9l1162t944r1272b969],
8	journal	NN	O	journal	dep	3	SENT_188	[p9l1277t942r1365b969],
9	of	IN	O	of	_	0	SENT_188	[p9l1374t942r1399b969],
10	Internal	JJ	ORGANIZATION	internal	amod	11	SENT_188	[p9l1403t942r1494b964],
11	Medicine	NN	ORGANIZATION	medicine	prep_of	8	SENT_188	[p9l1503t942r1608b964],
12	23	CD	NUMBER	23	number	13	SENT_188	[p9l1616t943r1645b964],
13	(	CD	NUMBER	(	num	14	SENT_188	[p9l1656t942r1734b969],
14	2012	CD	DATE	2012	dep	11	SENT_188	[p9l1656t942r1734b969],
15	)	CD	NUMBER	)	num	16	SENT_188	[p9l1656t942r1734b969],
16	245-249	CD	NUMBER	245-249	dep	14	SENT_188	[p9l1744t943r1847b964],

1	ADOPT	VB	O	adopt	_	0	SENT_189	[p9l6t1083r223b1136],
2	—	CD	NUMBER	—	nsubj	7	SENT_189	[p9l250t1114r298b1119],
3	a	DT	O	a	det	6	SENT_189	[p9l327t1097r358b1136],
4	large	JJ	O	large	amod	6	SENT_189	[p9l385t1081r535b1150],
5	interventional	JJ	O	interventional	amod	6	SENT_189	[p9l563t1081r997b1136],
6	study	NN	O	study	dep	2	SENT_189	[p9l1026t1081r1194b1150],
7	comparing	VBG	O	compare	dep	1	SENT_189	[p9l1221t1082r1549b1150],
8	three	CD	NUMBER	three	num	13	SENT_189	[p9l1575t1081r1736b1136],
9	oral	JJ	O	oral	amod	13	SENT_189	[p9l1764t1081r1879b1136],
10	antidia	JJ	O	antidia	amod	13	SENT_189	[p9l1907t1081r2145b1136],
11	—	NN	O	—	nn	13	SENT_189	[p9l1907t1081r2145b1136],
12	betic	JJ	O	betic	amod	13	SENT_189	[p9l8t1170r156b1225],
13	drugs	NNS	O	drug	dobj	7	SENT_189	[p9l185t1170r355b1239],
14	including	VBG	O	include	_	0	SENT_189	[p9l386t1170r672b1239],
15	glibenclamide	NN	O	glibenclamide	prep_including	13	SENT_189	[p9l700t1170r1132b1239],
16	[	CD	NUMBER	[	num	15	SENT_189	[p9l1165t1170r1298b1239],
17	19	CD	NUMBER	19	num	18	SENT_189	[p9l1165t1170r1298b1239],
18	]	NN	O	]	dep	15	SENT_189	[p9l1165t1170r1298b1239],
19	.	.	O	.	_	0	SENT_189	[p9l1165t1170r1298b1239],

1	In	IN	O	in	_	0	SENT_190	[p9l1330t1173r1387b1224],
2	the	DT	O	the	det	5	SENT_190	[p9l1416t1170r1514b1225],
3	entire	JJ	O	entire	amod	5	SENT_190	[p9l1544t1171r1723b1225],
4	study	NN	O	study	nn	5	SENT_190	[p9l1754t1170r1923b1239],
5	group	NN	O	group	prep_in	27	SENT_190	[p9l1950t1186r2144b1239],
6	,	,	O	,	_	0	SENT_190	[p9l1950t1186r2144b1239],
7	the	DT	O	the	det	9	SENT_190	[p9l8t1259r105b1314],
8	mean	JJ	O	mean	amod	9	SENT_190	[p9l137t1275r306b1314],
9	effect	NN	O	effect	nsubj	27	SENT_190	[p9l337t1259r506b1314],
10	of	IN	O	of	_	0	SENT_190	[p9l535t1259r599b1314],
11	sulfonylurea	NN	O	sulfonylurea	prep_of	9	SENT_190	[p9l623t1259r1003b1328],
12	in	IN	O	in	_	0	SENT_190	[p9l1035t1260r1091b1314],
13	combination	NN	O	combination	prep_in	11	SENT_190	[p9l1123t1259r1508b1314],
14	with	IN	O	with	_	0	SENT_190	[p9l1538t1259r1679b1314],
15	metformin	NN	O	metformin	prep_with	13	SENT_190	[p9l1711t1259r2039b1314],
16	on	IN	O	on	_	0	SENT_190	[p9l2070t1275r2145b1314],
17	HbA1c	NN	O	hba1c	nn	19	SENT_190	[p9l9t1348r210b1403],
18	reduction	NN	O	reduction	nn	19	SENT_190	[p9l236t1348r531b1403],
19	(	NN	O	(	prep_on	15	SENT_190	[p9l562t1348r663b1417],
20	on	IN	O	on	_	0	SENT_190	[p9l562t1348r663b1417],
21	average	NN	O	average	prep_on	19	SENT_190	[p9l690t1364r927b1417],
22	by	IN	O	by	_	0	SENT_190	[p9l954t1348r1028b1417],
23	1.05	CD	PERCENT	1.05	num	24	SENT_190	[p9l1057t1348r1248b1417],
24	%	NN	PERCENT	%	prep_by	21	SENT_190	[p9l1057t1348r1248b1417],
25	)	CD	NUMBER	)	dep	24	SENT_190	[p9l1057t1348r1248b1417],
26	was	VBD	O	be	cop	27	SENT_190	[p9l1278t1364r1397b1403],
27	typical	JJ	O	typical	_	0	SENT_190	[p9l1424t1348r1628b1417],
28	for	IN	O	for	_	0	SENT_190	[p9l1657t1348r1742b1403],
29	studies	NNS	O	study	prep_for	27	SENT_190	[p9l1768t1348r1981b1403],
30	with	IN	O	with	_	0	SENT_190	[p9l2008t1348r2145b1403],
31	similar	JJ	O	similar	amod	32	SENT_190	[p9l9t1438r212b1493],
32	design	NN	O	design	prep_with	27	SENT_190	[p9l248t1438r440b1506],
33	[	CD	NUMBER	[	number	34	SENT_190	[p9l482t1438r722b1506],
34	22	CD	NUMBER	22	num	35	SENT_190	[p9l482t1438r722b1506],
35	—	NN	O	—	dep	32	SENT_190	[p9l482t1438r722b1506],
36	24	CD	NUMBER	24	num	37	SENT_190	[p9l482t1438r722b1506],
37	]	NN	O	]	dep	35	SENT_190	[p9l482t1438r722b1506],
38	.	.	O	.	_	0	SENT_190	[p9l482t1438r722b1506],

1	Thus	RB	O	thus	advmod	10	SENT_191	[p9l758t1438r914b1501],
2	,	,	O	,	_	0	SENT_191	[p9l758t1438r914b1501],
3	the	DT	O	the	det	4	SENT_191	[p9l953t1438r1047b1493],
4	difference	NN	O	difference	nsubj	10	SENT_191	[p9l1086t1438r1380b1493],
5	among	IN	O	among	_	0	SENT_191	[p9l1418t1454r1622b1506],
6	KCN	NNP	O	KCN	nn	9	SENT_191	[p9l1658t1441r1865b1506],
7	]	CD	NUMBER	]	num	9	SENT_191	[p9l1658t1441r1865b1506],
8	11	CD	NUMBER	11	num	9	SENT_191	[p9l1658t1441r1865b1506],
9	variants	NNS	O	variant	prep_among	4	SENT_191	[p9l1908t1439r2145b1493],
10	reﬂects	VBZ	O	reﬂects	_	0	SENT_191	[p9l9t1526r222b1582],
11	the	DT	O	the	det	12	SENT_191	[p9l242t1527r337b1582],
12	effect	NN	O	effect	dobj	10	SENT_191	[p9l357t1526r519b1582],
13	of	IN	O	of	_	0	SENT_191	[p9l538t1526r600b1582],
14	genotype	NN	O	genotype	prep_of	12	SENT_191	[p9l611t1535r886b1595],
15	on	IN	O	on	_	0	SENT_191	[p9l907t1542r981b1582],
16	sulfonylurea	NN	O	sulfonylurea	nn	17	SENT_191	[p9l1002t1526r1367b1595],
17	response	NN	O	response	prep_on	10	SENT_191	[p9l1388t1542r1651b1595],
18	in	IN	O	in	_	0	SENT_191	[p9l1672t1527r1726b1581],
19	a	DT	O	a	det	21	SENT_191	[p9l1746t1542r1777b1582],
20	typical	JJ	O	typical	amod	21	SENT_191	[p9l1797t1527r1992b1595],
21	situation	NN	O	situation	prep_in	17	SENT_191	[p9l2014t1527r2145b1582, p9l8t1616r158b1670],
22	in	IN	O	in	_	0	SENT_191	[p9l179t1616r234b1669],
23	clinical	JJ	O	clinical	amod	24	SENT_191	[p9l255t1615r460b1670],
24	practice	NN	O	practice	prep_in	21	SENT_191	[p9l482t1616r727b1684],
25	.	.	O	.	_	0	SENT_191	[p9l482t1616r727b1684],

1	Better	RBR	O	better	amod	3	SENT_192	[p9l111t1708r297b1759],
2	sulfonylurea	JJ	O	sulfonylurea	amod	3	SENT_192	[p9l316t1704r696b1773],
3	response	NN	O	response	nsubjpass	9	SENT_192	[p9l717t1720r989b1773],
4	in	IN	O	in	_	0	SENT_192	[p9l1011t1705r1067b1759],
5	risk	NN	O	risk	nn	7	SENT_192	[p9l1089t1704r1200b1759],
6	allele	NN	O	allele	nn	7	SENT_192	[p9l1219t1704r1379b1759],
7	carriers	NNS	O	carrier	prep_in	3	SENT_192	[p9l1401t1705r1629b1759],
8	was	VBD	O	be	auxpass	9	SENT_192	[p9l1650t1720r1769b1759],
9	observed	VBN	O	observe	_	0	SENT_192	[p9l1790t1704r2067b1759],
10	in	IN	O	in	_	0	SENT_192	[p9l2089t1705r2146b1759],
11	an	DT	O	a	det	13	SENT_192	[p9l8t1809r80b1848],
12	experimental	JJ	O	experimental	amod	13	SENT_192	[p9l107t1793r516b1862],
13	study	NN	O	study	prep_in	9	SENT_192	[p9l543t1793r712b1862],
14	on	IN	O	on	_	0	SENT_192	[p9l737t1809r812b1848],
15	cell	NN	O	cell	nn	16	SENT_192	[p9l839t1793r940b1848],
16	cultures	NNS	O	culture	prep_on	13	SENT_192	[p9l968t1793r1212b1848],
17	using	VBG	O	use	xcomp	9	SENT_192	[p9l1240t1794r1404b1862],
18	patch	NN	O	patch	nn	20	SENT_192	[p9l1430t1793r1813b1862],
19	—	JJ	O	—	amod	20	SENT_192	[p9l1430t1793r1813b1862],
20	clamp	NN	O	clamp	nn	21	SENT_192	[p9l1430t1793r1813b1862],
21	technique	NN	O	technique	dobj	17	SENT_192	[p9l1840t1793r2145b1862],
22	in	IN	O	in	_	0	SENT_192	[p9l9t1884r65b1937],
23	accordance	NN	O	accordance	prep_in	21	SENT_192	[p9l98t1883r441b1938],
24	with	IN	O	with	_	0	SENT_192	[p9l473t1883r614b1938],
25	our	PRP$	O	we	poss	26	SENT_192	[p9l648t1899r751b1938],
26	results	NNS	O	result	prep_with	21	SENT_192	[p9l784t1883r1000b1938],
27	.	.	O	.	_	0	SENT_192	[p9l784t1883r1000b1938],

1	When	WRB	O	when	advmod	2	SENT_193	[p9l1031t1883r1218b1938],
2	compared	VBN	O	compare	advcl	18	SENT_193	[p9l1252t1883r1557b1951],
3	with	IN	O	with	_	0	SENT_193	[p9l1590t1883r1731b1938],
4	cell	NN	O	cell	nn	5	SENT_193	[p9l1764t1883r1866b1938],
5	cultures	NNS	O	culture	prep_with	2	SENT_193	[p9l1900t1883r2144b1938],
6	transfected	VBN	O	transfect	partmod	5	SENT_193	[p9l8t1970r351b2025],
7	with	IN	O	with	_	0	SENT_193	[p9l376t1971r517b2025],
8	wild	JJ	O	wild	amod	10	SENT_193	[p9l541t1971r676b2025],
9	E23/S1369	NN	O	e23/s1369	nn	10	SENT_193	[p9l703t1973r1029b2034],
10	variants	NNS	O	variant	prep_with	6	SENT_193	[p9l1055t1971r1315b2033],
11	,	,	O	,	_	0	SENT_193	[p9l1055t1971r1315b2033],
12	cells	NNS	O	cell	nsubj	18	SENT_193	[p9l1342t1971r1474b2025],
13	transfected	VBN	O	transfect	partmod	12	SENT_193	[p9l1500t1970r1843b2025],
14	with	IN	O	with	_	0	SENT_193	[p9l1868t1971r2009b2025],
15	risk	NN	O	risk	nn	17	SENT_193	[p9l2036t1971r2147b2025],
16	K23/A1369	NN	O	k23/a1369	nn	17	SENT_193	[p9l9t2060r349b2122],
17	variants	NNS	O	variant	prep_with	13	SENT_193	[p9l375t2059r620b2113],
18	showed	VBD	O	show	_	0	SENT_193	[p9l648t2058r885b2113],
19	decreased	VBN	O	decrease	amod	20	SENT_193	[p9l912t2058r1216b2113],
20	inhibition	NN	O	inhibition	dobj	18	SENT_193	[p9l1244t2058r1543b2113],
21	of	IN	O	of	_	0	SENT_193	[p9l1569t2058r1633b2113],
22	KATP	NN	O	katp	nn	23	SENT_193	[p9l1652t2061r1783b2124],
23	channel	NN	O	channel	prep_of	20	SENT_193	[p9l1808t2058r2048b2113],
24	by	IN	O	by	_	0	SENT_193	[p9l2073t2058r2147b2127],
25	ATP	NN	ORGANIZATION	atp	prep_by	18	SENT_193	[p9l6t2149r126b2201],
26	and	CC	O	and	_	0	SENT_193	[p9l154t2147r265b2202],
27	increased	VBD	O	increase	conj_and	18	SENT_193	[p9l297t2147r587b2202],
28	inhibition	NN	O	inhibition	iobj	27	SENT_193	[p9l619t2147r918b2202],
29	of	IN	O	of	_	0	SENT_193	[p9l948t2147r1011b2202],
30	the	DT	O	the	det	31	SENT_193	[p9l1033t2147r1131b2202],
31	channel	NN	O	channel	prep_of	28	SENT_193	[p9l1161t2147r1401b2202],
32	by	IN	O	by	prep	31	SENT_193	[p9l1431t2147r1505b2216],
33	A	DT	O	a	det	39	SENT_193	[p9l1531t2148r1710b2202],
34	—	NN	O	—	nn	39	SENT_193	[p9l1531t2148r1710b2202],
35	site	NN	O	site	nn	39	SENT_193	[p9l1531t2148r1710b2202],
36	ligand	NN	O	ligand	nn	39	SENT_193	[p9l1742t2147r1929b2216],
37	glicla	NN	O	gliclum	nn	39	SENT_193	[p9l1958t2147r2144b2216],
38	—	CD	NUMBER	—	num	39	SENT_193	[p9l1958t2147r2144b2216],
39	zide	NN	O	zide	pobj	32	SENT_193	[p9l9t2236r147b2300],
40	,	,	O	,	_	0	SENT_193	[p9l9t2236r147b2300],
41	but	CC	O	but	_	0	SENT_193	[p9l184t2236r286b2291],
42	not	RB	O	not	conj_but	32	SENT_193	[p9l321t2244r422b2291],
43	by	IN	O	by	dep	32	SENT_193	[p9l456t2236r530b2305],
44	AB	NNP	O	AB	nn	46	SENT_193	[p9l562t2237r782b2291],
45	—	NN	O	—	nn	46	SENT_193	[p9l562t2237r782b2291],
46	site	NN	O	site	pobj	43	SENT_193	[p9l562t2237r782b2291],
47	ligand	NN	O	ligand	nn	48	SENT_193	[p9l819t2236r1006b2305],
48	glibenclamide	NN	O	glibenclamide	dobj	27	SENT_193	[p9l1041t2236r1473b2305],
49	[	CD	NUMBER	[	number	50	SENT_193	[p9l1513t2236r1646b2305],
50	13	CD	NUMBER	13	num	51	SENT_193	[p9l1513t2236r1646b2305],
51	]	NN	O	]	dobj	18	SENT_193	[p9l1513t2236r1646b2305],
52	.	.	O	.	_	0	SENT_193	[p9l1513t2236r1646b2305],

1	Observation	NN	O	observation	nsubj	11	SENT_194	[p9l1683t2236r2053b2291],
2	of	IN	O	of	_	0	SENT_194	[p9l2089t2236r2153b2291],
3	higher	JJR	O	higher	amod	4	SENT_194	[p9l9t2325r208b2394],
4	effect	NN	O	effect	prep_of	1	SENT_194	[p9l230t2325r399b2380],
5	of	IN	O	of	_	0	SENT_194	[p9l422t2325r486b2380],
6	sulfonylureas	NNS	O	sulfonylurea	prep_of	4	SENT_194	[p9l504t2325r913b2394],
7	in	IN	O	in	_	0	SENT_194	[p9l939t2326r995b2380],
8	risk	NN	O	risk	nn	10	SENT_194	[p9l1021t2325r1133b2380],
9	allele	NN	O	allele	nn	10	SENT_194	[p9l1155t2325r1315b2380],
10	carriers	NNS	O	carrier	prep_in	6	SENT_194	[p9l1341t2326r1570b2380],
11	is	VBZ	O	be	dep	36	SENT_194	[p9l1596t2326r1639b2380],
12	in	IN	O	in	_	0	SENT_194	[p9l1666t2326r1722b2380],
13	line	NN	O	line	prep_in	11	SENT_194	[p9l1748t2325r1859b2380],
14	with	IN	O	with	_	0	SENT_194	[p9l1882t2325r2023b2380],
15	the	DT	O	the	det	16	SENT_194	[p9l2048t2325r2145b2380],
16	ﬁndings	NNS	O	ﬁndings	prep_with	11	SENT_194	[p9l9t2415r254b2483],
17	in	IN	O	in	_	0	SENT_194	[p9l291t2416r348b2469],
18	neonatal	JJ	O	neonatal	amod	19	SENT_194	[p9l385t2415r649b2470],
19	diabetes	NN	O	diabetes	prep_in	16	SENT_194	[p9l686t2415r939b2470],
20	in	IN	O	in	_	0	SENT_194	[p9l977t2416r1034b2469],
21	which	WDT	O	which	rel	28	SENT_194	[p9l1068t2415r1258b2470],
22	functional	JJ	O	functional	amod	23	SENT_194	[p9l1294t2415r1603b2470],
23	changes	NNS	O	change	nsubj	28	SENT_194	[p9l1640t2415r1885b2483],
24	in	IN	O	in	_	0	SENT_194	[p9l1923t2416r1979b2469],
25	KATP	NN	O	katp	nn	27	SENT_194	[p9l2016t2418r2147b2480],
26	channel	NN	O	channel	nn	27	SENT_194	[p9l9t2504r249b2559],
27	proteins	NNS	O	protein	prep_in	23	SENT_194	[p9l277t2504r528b2572],
28	encoded	VBN	O	encode	rcmod	16	SENT_194	[p9l557t2504r815b2559],
29	by	IN	O	by	_	0	SENT_194	[p9l843t2504r917b2572],
30	KCNj11	NN	O	kcnj11	nn	34	SENT_194	[p9l941t2506r1154b2572],
31	and	CC	O	and	_	0	SENT_194	[p9l1190t2504r1301b2559],
32	ABCC8	NN	O	abcc8	conj_and	30	SENT_194	[p9l1323t2506r1521b2559],
33	gene	NN	O	gene	nn	34	SENT_194	[p9l1547t2519r1692b2572],
34	variants	NNS	O	variant	prep_by	28	SENT_194	[p9l1719t2504r1964b2559],
35	were	VBD	O	be	auxpass	36	SENT_194	[p9l1991t2519r2145b2559],
36	corrected	VBN	O	correct	_	0	SENT_194	[p9l9t2592r296b2647],
37	by	IN	O	by	_	0	SENT_194	[p9l321t2592r394b2661],
38	sulfonylurea	NN	O	sulfonylurea	nn	39	SENT_194	[p9l418t2592r798b2661],
39	treatment	NN	O	treatment	agent	36	SENT_194	[p9l822t2600r1130b2647],
40	[	CD	NUMBER	[	num	39	SENT_194	[p9l1156t2592r1405b2661],
41	25	CD	NUMBER	25	num	44	SENT_194	[p9l1156t2592r1405b2661],
42	—	NN	O	—	nn	44	SENT_194	[p9l1156t2592r1405b2661],
43	27	CD	NUMBER	27	num	44	SENT_194	[p9l1156t2592r1405b2661],
44	]	NN	O	]	nsubjpass	36	SENT_194	[p9l1156t2592r1405b2661],
45	.	.	O	.	_	0	SENT_194	[p9l1156t2592r1405b2661],

1	There	EX	O	there	expl	2	SENT_195	[p9l108t2681r283b2736],
2	are	VBP	O	be	_	0	SENT_195	[p9l320t2697r413b2736],
3	several	JJ	O	several	amod	4	SENT_195	[p9l452t2681r666b2736],
4	limitations	NNS	O	limitation	nsubj	2	SENT_195	[p9l704t2681r1033b2736],
5	to	TO	O	to	_	0	SENT_195	[p9l1071t2689r1129b2736],
6	the	DT	O	the	det	8	SENT_195	[p9l1167t2681r1264b2736],
7	present	JJ	DATE	present	amod	8	SENT_195	[p9l1302t2689r1534b2750],
8	study	NN	O	study	prep_to	4	SENT_195	[p9l1570t2681r1739b2750],
9	such	JJ	O	such	_	0	SENT_195	[p9l1775t2681r1913b2736],
10	as	IN	O	as	_	0	SENT_195	[p9l1950t2697r2010b2736],
11	the	DT	O	the	det	15	SENT_195	[p9l2048t2681r2145b2736],
12	relatively	RB	O	relatively	advmod	13	SENT_195	[p9l9t2770r297b2839],
13	small	JJ	O	small	amod	15	SENT_195	[p9l324t2770r484b2825],
14	sample	NN	O	sample	nn	15	SENT_195	[p9l514t2770r731b2839],
15	size	NN	O	size	prep_such_as	8	SENT_195	[p9l760t2771r887b2826],
16	.	.	O	.	_	0	SENT_195	[p9l760t2771r887b2826],

1	However	RB	O	however	advmod	18	SENT_196	[p9l917t2774r1209b2834],
2	,	,	O	,	_	0	SENT_196	[p9l917t2774r1209b2834],
3	more	JJR	O	more	mwe	4	SENT_196	[p9l1238t2786r1396b2825],
4	than	IN	O	than	quantmod	5	SENT_196	[p9l1424t2770r1563b2825],
5	30	CD	PERCENT	30	num	6	SENT_196	[p9l1589t2773r1706b2825],
6	%	NN	PERCENT	%	nsubj	18	SENT_196	[p9l1589t2773r1706b2825],
7	observed	VBN	O	observe	partmod	6	SENT_196	[p9l1734t2770r2011b2825],
8	difference	NN	O	difference	dobj	7	SENT_196	[p9l2040t2770r2145b2825, p9l9t2859r232b2914],
9	in	IN	O	in	_	0	SENT_196	[p9l257t2860r313b2914],
10	reduction	NN	O	reduction	prep_in	7	SENT_196	[p9l336t2859r631b2914],
11	of	IN	O	of	_	0	SENT_196	[p9l654t2859r717b2914],
12	HbA1c	NN	O	hba1c	prep_of	10	SENT_196	[p9l734t2859r934b2914],
13	between	IN	O	between	_	0	SENT_196	[p9l956t2859r1221b2914],
14	EE	NN	O	ee	prep_between	12	SENT_196	[p9l1245t2863r1317b2914],
15	and	CC	O	and	_	0	SENT_196	[p9l1340t2859r1451b2914],
16	KK	NNP	ORGANIZATION	KK	nn	17	SENT_196	[p9l1476t2863r1561b2914],
17	homozygotes	NNS	O	homozygote	prep_between	12	SENT_196	[p9l1583t2859r1991b2928],
18	suggests	VBZ	O	suggest	_	0	SENT_196	[p9l2016t2875r2145b2928, p9l7t2957r160b3017],
19	that	IN	O	that	complm	31	SENT_196	[p9l181t2949r304b3004],
20	the	DT	O	the	det	22	SENT_196	[p9l322t2949r419b3004],
21	sample	NN	O	sample	nn	22	SENT_196	[p9l441t2949r658b3017],
22	size	NN	O	size	nsubj	31	SENT_196	[p9l679t2950r792b3004],
23	of	IN	O	of	_	0	SENT_196	[p9l813t2949r877b3004],
24	this	DT	O	this	det	25	SENT_196	[p9l889t2949r1000b3004],
25	study	NN	O	study	prep_of	22	SENT_196	[p9l1022t2949r1203b3017],
26	,	,	O	,	_	0	SENT_196	[p9l1022t2949r1203b3017],
27	although	IN	O	although	mark	28	SENT_196	[p9l1225t2949r1497b3017],
28	limited	JJ	O	limited	parataxis	31	SENT_196	[p9l1518t2949r1750b3012],
29	,	,	O	,	_	0	SENT_196	[p9l1518t2949r1750b3012],
30	is	VBZ	O	be	cop	31	SENT_196	[p9l1772t2950r1816b3004],
31	enough	JJ	O	enough	ccomp	18	SENT_196	[p9l1838t2949r2066b3017],
32	to	TO	O	to	aux	33	SENT_196	[p9l2086t2957r2145b3004],
33	gain	VB	O	gain	xcomp	31	SENT_196	[p9l7t3038r134b3106],
34	understanding	NN	O	understanding	dobj	33	SENT_196	[p9l170t3038r610b3106],
35	on	IN	O	on	_	0	SENT_196	[p9l646t3053r720b3093],
36	the	DT	O	the	det	37	SENT_196	[p9l756t3038r852b3093],
37	role	NN	O	role	prep_on	33	SENT_196	[p9l889t3038r1002b3093],
38	of	IN	O	of	_	0	SENT_196	[p9l1039t3037r1101b3093],
39	KCNJ11	NN	O	kcnj11	nn	40	SENT_196	[p9l1128t3040r1338b3106],
40	variants	NNS	O	variant	prep_of	37	SENT_196	[p9l1379t3038r1620b3093],
41	in	IN	O	in	_	0	SENT_196	[p9l1657t3038r1712b3092],
42	the	DT	O	the	det	44	SENT_196	[p9l1749t3038r1844b3093],
43	glycemic	JJ	O	glycemic	amod	44	SENT_196	[p9l1880t3038r2146b3106],
44	response	NN	O	response	prep_in	40	SENT_196	[p9l9t3142r275b3195],
45	to	TO	O	to	_	0	SENT_196	[p9l295t3134r352b3181],
46	sulfonylurea	NN	O	sulfonylurea	nn	47	SENT_196	[p9l373t3126r746b3195],
47	treatment	NN	O	treatment	prep_to	33	SENT_196	[p9l764t3134r1078b3182],
48	.	.	O	.	_	0	SENT_196	[p9l764t3134r1078b3182],

1	Further	JJ	O	further	amod	2	SENT_197	[p9l1098t3126r1321b3181],
2	limitation	NN	O	limitation	nsubjpass	5	SENT_197	[p9l1339t3126r1632b3181],
3	might	MD	O	might	aux	5	SENT_197	[p9l1652t3126r1830b3195],
4	be	VB	O	be	auxpass	5	SENT_197	[p9l1848t3126r1917b3181],
5	related	VBN	O	relate	_	0	SENT_197	[p9l1937t3126r2145b3181],
6	to	TO	O	to	_	0	SENT_197	[p9l8t3223r67b3270],
7	the	DT	O	the	det	8	SENT_197	[p9l91t3215r186b3270],
8	use	NN	O	use	prep_to	5	SENT_197	[p9l211t3231r310b3270],
9	of	IN	O	of	_	0	SENT_197	[p9l335t3215r399b3270],
10	four	CD	NUMBER	four	num	13	SENT_197	[p9l416t3215r538b3270],
11	different	JJ	O	different	amod	13	SENT_197	[p9l562t3215r821b3270],
12	sulfonylurea	NN	O	sulfonylurea	nn	13	SENT_197	[p9l844t3215r1216b3284],
13	drugs	NNS	O	drug	prep_of	8	SENT_197	[p9l1241t3215r1422b3284],
14	.	.	O	.	_	0	SENT_197	[p9l1241t3215r1422b3284],

1	Although	IN	O	although	mark	3	SENT_198	[p9l1445t3215r1723b3284],
2	there	EX	O	there	expl	3	SENT_198	[p9l1748t3215r1904b3270],
3	was	VBD	O	be	advcl	23	SENT_198	[p9l1928t3231r2046b3270],
4	no	DT	O	no	det	6	SENT_198	[p9l2071t3231r2146b3270],
5	signiﬁcant	NN	O	signiﬁcant	nn	6	SENT_198	[p9l9t3304r320b3373],
6	difference	NN	O	difference	nsubj	3	SENT_198	[p9l340t3304r640b3359],
7	among	IN	O	among	_	0	SENT_198	[p9l662t3320r869b3373],
8	the	DT	O	the	det	10	SENT_198	[p9l889t3304r984b3359],
9	used	VBN	O	use	amod	10	SENT_198	[p9l1007t3304r1145b3359],
10	drugs	NNS	O	drug	prep_among	6	SENT_198	[p9l1168t3304r1334b3373],
11	in	IN	O	in	_	0	SENT_198	[p9l1358t3305r1414b3359],
12	their	PRP$	O	they	poss	13	SENT_198	[p9l1435t3304r1578b3359],
13	effect	NN	O	effect	prep_in	10	SENT_198	[p9l1599t3304r1764b3359],
14	on	IN	O	on	_	0	SENT_198	[p9l1784t3320r1858b3359],
15	glycemic	JJ	O	glycemic	amod	16	SENT_198	[p9l1879t3304r2146b3373],
16	control	NN	O	control	prep_on	13	SENT_198	[p9l9t3393r221b3448],
17	in	IN	O	in	_	0	SENT_198	[p9l259t3394r314b3448],
18	the	DT	O	the	det	20	SENT_198	[p9l350t3393r446b3448],
19	present	JJ	DATE	present	amod	20	SENT_198	[p9l483t3402r710b3462],
20	study	NN	O	study	prep_in	16	SENT_198	[p9l746t3393r923b3462],
21	,	,	O	,	_	0	SENT_198	[p9l746t3393r923b3462],
22	we	PRP	O	we	nsubj	23	SENT_198	[p9l959t3409r1050b3448],
23	controlled	VBD	O	control	_	0	SENT_198	[p9l1087t3393r1391b3448],
24	for	IN	O	for	_	0	SENT_198	[p9l1429t3393r1513b3448],
25	this	DT	O	this	det	26	SENT_198	[p9l1547t3393r1656b3448],
26	confounder	NN	O	confounder	prep_for	23	SENT_198	[p9l1693t3393r2039b3448],
27	by	IN	O	by	_	0	SENT_198	[p9l2074t3393r2147b3462],
28	adjusting	VBG	O	adjust	prepc_by	23	SENT_198	[p10l8t17r287b85],
29	for	IN	O	for	_	0	SENT_198	[p10l312t17r395b72],
30	the	DT	O	the	det	31	SENT_198	[p10l419t17r515b72],
31	type	NN	O	type	prep_for	28	SENT_198	[p10l540t25r670b85],
32	of	IN	O	of	_	0	SENT_198	[p10l698t17r760b72],
33	sulfonylurea	NN	O	sulfonylurea	nn	34	SENT_198	[p10l779t17r1151b85],
34	medication	NN	O	medication	prep_of	31	SENT_198	[p10l1177t17r1513b72],
35	in	IN	O	in	_	0	SENT_198	[p10l1539t18r1595b71],
36	multivariate	JJ	O	multivariate	amod	37	SENT_198	[p10l1621t17r1988b72],
37	analyses	NNS	O	analysis	prep_in	34	SENT_198	[p10l2014t33r2145b72, p10l9t106r166b174],
38	,	,	O	,	_	0	SENT_198	[p10l2014t33r2145b72, p10l9t106r166b174],
39	in	IN	O	in	_	0	SENT_198	[p10l187t106r242b160],
40	addition	NN	O	addition	_	0	SENT_198	[p10l260t106r509b161],
41	to	TO	O	to	_	0	SENT_198	[p10l527t114r586b161],
42	the	DT	O	the	det	43	SENT_198	[p10l604t106r699b161],
43	adjustment	NN	O	adjustment	prep_of	31	SENT_198	[p10l718t106r1063b174],
44	for	IN	O	for	_	0	SENT_198	[p10l1079t105r1163b161],
45	the	DT	O	the	det	47	SENT_198	[p10l1179t106r1275b161],
46	drug	NN	O	drug	nn	47	SENT_198	[p10l1294t106r1433b174],
47	dose	NN	O	dose	prep_for	43	SENT_198	[p10l1450t106r1601b161],
48	.	.	O	.	_	0	SENT_198	[p10l1450t106r1601b161],

1	A	DT	O	a	det	3	SENT_199	[p10l1618t108r1663b160],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_199	[p10l1680t105r1992b174],
3	relationship	NN	O	relationship	nsubjpass	10	SENT_199	[p10l2008t106r2145b161, p10l8t194r252b263],
4	between	IN	O	between	_	0	SENT_199	[p10l272t194r533b249],
5	genotype	NN	O	genotype	nn	8	SENT_199	[p10l552t202r831b263],
6	and	CC	O	and	_	0	SENT_199	[p10l851t194r961b249],
7	sulfonylurea	NN	O	sulfonylurea	nn	8	SENT_199	[p10l982t194r1354b263],
8	response	NN	O	response	prep_between	3	SENT_199	[p10l1374t210r1640b263],
9	was	VBD	O	be	auxpass	10	SENT_199	[p10l1660t210r1777b249],
10	observed	VBN	O	observe	_	0	SENT_199	[p10l1798t194r2068b249],
11	in	IN	O	in	_	0	SENT_199	[p10l2090t195r2145b248],
12	the	DT	O	the	det	14	SENT_199	[p10l8t283r103b338],
13	biggest	JJS	O	biggest	amod	14	SENT_199	[p10l119t283r335b352],
14	subgroup	NN	O	subgroup	prep_in	10	SENT_199	[p10l351t283r632b352],
15	of	IN	O	of	_	0	SENT_199	[p10l649t283r711b338],
16	patients	NNS	O	patient	prep_of	14	SENT_199	[p10l720t284r960b352],
17	treated	VBN	O	treat	partmod	16	SENT_199	[p10l977t283r1190b338],
18	with	IN	O	with	_	0	SENT_199	[p10l1206t283r1345b338],
19	gliclazide	NN	O	gliclazide	prep_with	17	SENT_199	[p10l1360t283r1655b352],
20	.	.	O	.	_	0	SENT_199	[p10l1360t283r1655b352],

1	Association	NNP	O	Association	nsubj	10	SENT_200	[p10l1670t284r2012b338],
2	was	VBD	O	be	cop	10	SENT_200	[p10l2027t299r2145b338],
3	not	RB	O	not	neg	10	SENT_200	[p10l9t380r108b427],
4	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_200	[p10l125t372r435b441],
5	in	IN	O	in	_	0	SENT_200	[p10l451t373r506b427],
6	glimepiride	NN	O	glimepiride	prep_in	4	SENT_200	[p10l521t372r868b441],
7	and	CC	O	and	_	0	SENT_200	[p10l884t372r993b427],
8	glibenclamide	NN	O	glibenclamide	prep_in	4	SENT_200	[p10l1010t372r1432b441],
9	treated	JJ	O	treated	amod	10	SENT_200	[p10l1449t372r1663b427],
10	patients	NNS	O	patient	_	0	SENT_200	[p10l1680t373r1935b441],
11	.	.	O	.	_	0	SENT_200	[p10l1680t373r1935b441],

1	Differences	NNS	O	difference	nsubj	17	SENT_201	[p10l1952t372r2144b427, p10l9t477r173b516],
2	in	IN	O	in	_	0	SENT_201	[p10l197t462r253b516],
3	genotype	NN	O	genotype	nn	4	SENT_201	[p10l274t461r909b530],
4	—	NN	O	—	prep_in	1	SENT_201	[p10l274t461r909b530],
5	dependent	JJ	O	dependent	amod	6	SENT_201	[p10l274t461r909b530],
6	effects	NNS	O	effect	nsubjpass	12	SENT_201	[p10l929t461r1120b516],
7	of	IN	O	of	_	0	SENT_201	[p10l1143t461r1207b516],
8	individual	JJ	O	individual	amod	9	SENT_201	[p10l1222t461r1522b516],
9	sulfonylureas	NNS	O	sulfonylurea	prep_of	6	SENT_201	[p10l1545t461r1945b530],
10	might	MD	O	might	aux	12	SENT_201	[p10l1969t461r2147b530],
11	be	VB	O	be	auxpass	12	SENT_201	[p10l8t551r78b606],
12	related	VBN	O	relate	rcmod	4	SENT_201	[p10l110t551r318b606],
13	to	TO	O	to	_	0	SENT_201	[p10l351t559r408b606],
14	the	DT	O	the	det	16	SENT_201	[p10l441t551r536b606],
15	above	JJ	O	above	amod	16	SENT_201	[p10l569t551r1101b606],
16	—	NN	O	—	prep_to	12	SENT_201	[p10l569t551r1101b606],
17	mentioned	VBD	O	mention	_	0	SENT_201	[p10l569t551r1101b606],
18	speciﬁc	NN	O	speciﬁc	nn	19	SENT_201	[p10l1136t551r1357b619],
19	binding	NN	O	binding	dobj	17	SENT_201	[p10l1388t551r1618b619],
20	to	TO	O	to	_	0	SENT_201	[p10l1649t559r1708b606],
21	A	DT	O	a	det	23	SENT_201	[p10l1737t552r1913b606],
22	—	NN	O	—	nn	23	SENT_201	[p10l1737t552r1913b606],
23	site	NN	O	site	prep_to	17	SENT_201	[p10l1737t552r1913b606],
24	or	CC	O	or	_	0	SENT_201	[p10l1945t567r2009b606],
25	ABsite	NN	O	absite	conj_or	23	SENT_201	[p10l2036t553r2145b605, p10l9t640r112b695],
26	of	IN	O	of	_	0	SENT_201	[p10l133t639r196b695],
27	the	DT	O	the	det	29	SENT_201	[p10l208t640r303b695],
28	KATP	NN	O	katp	nn	29	SENT_201	[p10l325t643r454b706],
29	channel	NN	O	channel	prep_of	23	SENT_201	[p10l473t640r708b695],
30	[	CD	NUMBER	[	number	31	SENT_201	[p10l732t639r863b708],
31	13	CD	NUMBER	13	num	32	SENT_201	[p10l732t639r863b708],
32	]	NN	O	]	dep	29	SENT_201	[p10l732t639r863b708],
33	,	,	O	,	_	0	SENT_201	[p10l732t639r863b708],
34	or	CC	O	or	_	0	SENT_201	[p10l885t655r947b695],
35	could	MD	O	could	aux	38	SENT_201	[p10l966t640r1129b695],
36	be	VB	O	be	cop	38	SENT_201	[p10l1149t640r1218b695],
37	simply	RB	O	simply	advmod	38	SENT_201	[p10l1241t640r1442b708],
38	due	JJ	O	due	conj_or	17	SENT_201	[p10l1461t640r1572b695],
39	to	TO	O	to	_	0	SENT_201	[p10l1592t648r1650b695],
40	lower	JJR	O	lower	amod	42	SENT_201	[p10l1672t640r1845b695],
41	statistical	JJ	O	statistical	amod	42	SENT_201	[p10l1864t640r2145b695],
42	power	NN	O	power	prep_to	38	SENT_201	[p10l9t744r203b797],
43	with	IN	O	with	_	0	SENT_201	[p10l221t728r360b783],
44	smaller	JJR	O	smaller	amod	46	SENT_201	[p10l382t728r604b783],
45	sample	NN	O	sample	nn	46	SENT_201	[p10l623t728r835b797],
46	sizes	NNS	O	size	prep_with	42	SENT_201	[p10l859t729r997b783],
47	in	IN	O	in	_	0	SENT_201	[p10l1021t729r1076b782],
48	subgroups	NNS	O	subgroup	prep_in	46	SENT_201	[p10l1098t728r1422b797],
49	.	.	O	.	_	0	SENT_201	[p10l1098t728r1422b797],

1	In	IN	O	in	_	0	SENT_202	[p10l111t820r168b871],
2	conclusion	NN	O	conclusion	prep_in	5	SENT_202	[p10l206t817r548b881],
3	,	,	O	,	_	0	SENT_202	[p10l206t817r548b881],
4	we	PRP	O	we	nsubj	5	SENT_202	[p10l584t833r674b872],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_202	[p10l713t817r1141b872],
6	for	IN	O	for	_	0	SENT_202	[p10l1180t817r1265b872],
7	the	DT	O	the	det	9	SENT_202	[p10l1301t817r1398b872],
8	ﬁrst	JJ	O	ﬁrst	amod	9	SENT_202	[p10l1437t817r1557b872],
9	time	NN	O	time	prep_for	5	SENT_202	[p10l1593t818r1731b872],
10	that	WDT	O	that	dobj	17	SENT_202	[p10l1768t817r1891b872],
11	greater	JJR	O	greater	amod	12	SENT_202	[p10l1927t825r2148b886],
12	effect	NN	O	effect	nsubjpass	17	SENT_202	[p10l9t906r177b961],
13	of	IN	O	of	_	0	SENT_202	[p10l221t906r285b961],
14	sulfonylurea	NN	O	sulfonylurea	nn	15	SENT_202	[p10l324t906r704b975],
15	treatment	NN	O	treatment	prep_of	12	SENT_202	[p10l749t914r1057b961],
16	was	VBD	O	be	auxpass	17	SENT_202	[p10l1100t922r1218b961],
17	related	VBN	O	relate	ccomp	5	SENT_202	[p10l1266t906r1478b961],
18	to	TO	O	to	_	0	SENT_202	[p10l1524t914r1582b961],
19	the	DT	O	the	det	20	SENT_202	[p10l1628t906r1725b961],
20	presence	NN	O	presence	prep_to	17	SENT_202	[p10l1772t922r2044b975],
21	of	IN	O	of	_	0	SENT_202	[p10l2089t906r2153b961],
22	KCN	NNP	O	KCN	prep_of	20	SENT_202	[p10l7t998r156b1064],
23	]	CD	NUMBER	]	num	22	SENT_202	[p10l7t998r156b1064],
24	11	CD	NUMBER	11	num	26	SENT_202	[p10l163t998r220b1050],
25	23K	NN	O	23k	nn	26	SENT_202	[p10l257t998r376b1050],
26	variant	NN	O	variant	dobj	17	SENT_202	[p10l402t996r621b1050],
27	in	IN	O	in	_	0	SENT_202	[p10l649t996r705b1050],
28	a	DT	O	a	det	30	SENT_202	[p10l735t1011r766b1050],
29	Caucasian	JJ	LOCATION	caucasian	amod	30	SENT_202	[p10l796t996r1098b1050],
30	population	NN	O	population	prep_in	26	SENT_202	[p10l1128t995r1475b1064],
31	.	.	O	.	_	0	SENT_202	[p10l1128t995r1475b1064],

1	This	DT	O	this	det	2	SENT_203	[p10l1503t995r1629b1050],
2	association	NN	O	association	nsubj	4	SENT_203	[p10l1660t996r1998b1050],
3	was	VBD	O	be	cop	4	SENT_203	[p10l2025t1011r2144b1050],
4	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_203	[p10l9t1085r327b1153],
5	also	RB	O	also	advmod	4	SENT_203	[p10l348t1085r466b1140],
6	in	IN	O	in	_	0	SENT_203	[p10l491t1086r547b1139],
7	subgroup	NN	O	subgroup	prep_in	4	SENT_203	[p10l571t1085r858b1153],
8	of	IN	O	of	_	0	SENT_203	[p10l881t1085r945b1140],
9	patients	NNS	O	patient	prep_of	7	SENT_203	[p10l961t1086r1206b1153],
10	treated	VBN	O	treat	partmod	9	SENT_203	[p10l1230t1085r1448b1140],
11	with	IN	O	with	_	0	SENT_203	[p10l1470t1085r1611b1140],
12	gliclazide	NN	O	gliclazide	prep_with	10	SENT_203	[p10l1633t1085r1936b1153],
13	.	.	O	.	_	0	SENT_203	[p10l1633t1085r1936b1153],

1	If	IN	O	if	mark	2	SENT_204	[p10l1961t1085r2006b1139],
2	veriﬁed	VBN	O	veriﬁed	advcl	11	SENT_204	[p10l2020t1101r2144b1140, p10l9t1173r140b1228],
3	in	IN	O	in	_	0	SENT_204	[p10l175t1174r231b1228],
4	larger	JJR	O	larger	amod	6	SENT_204	[p10l265t1173r444b1242],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_204	[p10l475t1173r1006b1242],
6	studies	NNS	O	study	prep_in	2	SENT_204	[p10l1039t1173r1268b1237],
7	,	,	O	,	_	0	SENT_204	[p10l1039t1173r1268b1237],
8	this	DT	O	this	det	9	SENT_204	[p10l1301t1173r1412b1228],
9	observation	NN	O	observation	nsubj	11	SENT_204	[p10l1446t1173r1806b1228],
10	may	MD	O	may	aux	11	SENT_204	[p10l1840t1189r1971b1242],
11	have	VB	O	have	_	0	SENT_204	[p10l2002t1173r2145b1228],
12	several	JJ	O	several	amod	14	SENT_204	[p10l9t1262r223b1317],
13	clinical	JJ	O	clinical	amod	14	SENT_204	[p10l268t1262r482b1317],
14	implications	NNS	O	implication	dobj	11	SENT_204	[p10l527t1262r918b1331],
15	.	.	O	.	_	0	SENT_204	[p10l527t1262r918b1331],

1	Combining	VBG	O	combine	_	0	SENT_205	[p10l964t1262r1299b1331],
2	the	DT	O	the	det	6	SENT_205	[p10l1341t1262r1438b1317],
3	KCN	NN	O	kcn	nn	6	SENT_205	[p10l1482t1265r1631b1331],
4	]	NN	O	]	nn	6	SENT_205	[p10l1482t1265r1631b1331],
5	11	CD	NUMBER	11	num	6	SENT_205	[p10l1638t1265r1695b1316],
6	variant	NN	O	variant	dobj	1	SENT_205	[p10l1745t1263r1963b1317],
7	with	IN	O	with	_	0	SENT_205	[p10l2004t1262r2145b1317],
8	variants	NNS	O	variant	prep_with	1	SENT_205	[p10l7t1352r252b1406],
9	of	IN	O	of	_	0	SENT_205	[p10l281t1351r344b1406],
10	other	JJ	O	other	amod	11	SENT_205	[p10l365t1351r529b1406],
11	genes	NNS	O	gene	prep_of	8	SENT_205	[p10l554t1367r728b1420],
12	implicated	VBN	O	implicate	partmod	11	SENT_205	[p10l758t1351r1081b1420],
13	in	IN	O	in	_	0	SENT_205	[p10l1110t1352r1166b1406],
14	sulfonylurea	NN	O	sulfonylurea	nn	15	SENT_205	[p10l1195t1351r1575b1420],
15	response	NN	O	response	prep_in	12	SENT_205	[p10l1603t1367r1889b1420],
16	,	,	O	,	_	0	SENT_205	[p10l1603t1367r1889b1420],
17	such	JJ	O	such	_	0	SENT_205	[p10l1920t1351r2057b1406],
18	as	IN	O	as	_	0	SENT_205	[p10l2085t1367r2144b1406],
19	TCF7L2	NN	O	tcf7l2	prep_such_as	1	SENT_205	[p10l9t1443r217b1495],
20	[	CD	NUMBER	[	number	21	SENT_205	[p10l248t1440r378b1509],
21	4,5	CD	NUMBER	4,5	num	22	SENT_205	[p10l248t1440r378b1509],
22	]	NN	O	]	dep	19	SENT_205	[p10l248t1440r378b1509],
23	or	CC	O	or	_	0	SENT_205	[p10l409t1456r473b1495],
24	CYP2C9	NN	O	cyp2c9	conj_or	19	SENT_205	[p10l499t1443r721b1495],
25	[	CD	NUMBER	[	number	26	SENT_205	[p10l751t1440r845b1509],
26	3	CD	NUMBER	3	num	27	SENT_205	[p10l751t1440r845b1509],
27	]	NN	O	]	dep	24	SENT_205	[p10l751t1440r845b1509],
28	,	,	O	,	_	0	SENT_205	[p10l751t1440r845b1509],
29	could	MD	O	could	aux	31	SENT_205	[p10l874t1440r1039b1495],
30	eventually	RB	O	eventually	advmod	31	SENT_205	[p10l1067t1440r1389b1509],
31	lead	VB	O	lead	dep	1	SENT_205	[p10l1415t1440r1539b1495],
32	to	TO	O	to	_	0	SENT_205	[p10l1567t1448r1626b1495],
33	identiﬁcation	NN	O	identiﬁcation	prep_to	31	SENT_205	[p10l1654t1440r2062b1495],
34	of	IN	O	of	_	0	SENT_205	[p10l2089t1440r2153b1495],
35	those	DT	O	those	prep_of	33	SENT_205	[p10l8t1530r173b1585],
36	patients	NNS	O	patient	nsubj	1	SENT_205	[p10l204t1531r449b1598],
37	who	WP	O	who	nsubj	39	SENT_205	[p10l479t1530r613b1585],
38	will	MD	O	will	aux	39	SENT_205	[p10l642t1530r757b1584],
39	have	VB	O	have	ccomp	36	SENT_205	[p10l788t1530r931b1585],
40	the	DT	O	the	det	42	SENT_205	[p10l962t1530r1059b1585],
41	highest	JJS	O	highest	amod	42	SENT_205	[p10l1091t1530r1316b1598],
42	beneﬁt	NN	O	beneﬁt	dobj	39	SENT_205	[p10l1344t1530r1559b1585],
43	from	IN	O	from	_	0	SENT_205	[p10l1588t1530r1734b1585],
44	sulfonylurea	NN	O	sulfonylurea	nn	45	SENT_205	[p10l1765t1530r2145b1598],
45	treatment	NN	O	treatment	prep_from	42	SENT_205	[p10l8t1627r329b1674],
46	.	.	O	.	_	0	SENT_205	[p10l8t1627r329b1674],

1	5	CD	NUMBER	5	_	0	SENT_206	[p10l8t1799r60b1851],
2	.	.	O	.	_	0	SENT_206	[p10l8t1799r60b1851],

1	Learning	NNP	O	Learning	nn	2	SENT_207	[p10l84t1796r370b1865],
2	points	NNS	O	point	_	0	SENT_207	[p10l391t1796r594b1865],

1	-	:	O	-	_	0	SENT_208	[p10l8t1993r27b2011],
2	KCNJII	NN	O	kcnjius	nn	3	SENT_208	[p10l63t1977r268b2043],
3	gene	NN	O	gene	nsubj	4	SENT_208	[p10l290t1990r430b2043],
4	encodes	VBZ	O	encode	_	0	SENT_208	[p10l447t1974r684b2029],
5	Kir	NNP	O	Kir	nn	7	SENT_208	[p10l701t1975r786b2029],
6	6.2	CD	NUMBER	6.2	num	7	SENT_208	[p10l801t1977r884b2030],
7	protein	NN	O	protein	dobj	4	SENT_208	[p10l903t1975r1115b2043],
8	constituting	VBG	O	constitute	partmod	7	SENT_208	[p10l1131t1975r1481b2043],
9	the	DT	O	the	det	11	SENT_208	[p10l1496t1974r1589b2029],
10	inner	JJ	O	inner	amod	11	SENT_208	[p10l1607t1975r1762b2029],
11	pore	NN	O	pore	dobj	8	SENT_208	[p10l1776t1990r1907b2043],
12	of	IN	O	of	_	0	SENT_208	[p10l1925t1974r1986b2029],
13	KA	NN	O	ka	prep_of	11	SENT_208	[p10l1995t1978r2144b2040],
14	'	''	O	'	_	0	SENT_208	[p10l1995t1978r2144b2040],
15	1	CD	NUMBER	1	dobj	8	SENT_208	[p10l1995t1978r2144b2040],
16	"	``	O	"	punct	19	SENT_208	[p10l1995t1978r2144b2040],
17	p	NN	O	p	nn	19	SENT_208	[p10l1995t1978r2144b2040],
18	'	''	O	'	_	0	SENT_208	[p10l1995t1978r2144b2040],
19	channel	NN	O	channel	npadvmod	4	SENT_208	[p10l66t2064r295b2119],
20	in	IN	O	in	_	0	SENT_208	[p10l326t2065r380b2118],
21	pancreatic	JJ	O	pancreatic	amod	24	SENT_208	[p10l409t2065r712b2132],
22	B	NN	O	b	nn	24	SENT_208	[p10l741t2064r932b2132],
23	—	NN	O	—	nn	24	SENT_208	[p10l741t2064r932b2132],
24	cells	NNS	O	cell	prep_in	4	SENT_208	[p10l741t2064r932b2132],
25	which	WDT	O	which	nsubj	26	SENT_208	[p10l961t2064r1142b2119],
26	plays	VBZ	O	play	rcmod	24	SENT_208	[p10l1172t2064r1321b2132],
27	a	DT	O	a	det	29	SENT_208	[p10l1351t2080r1382b2119],
28	critical	JJ	O	critical	amod	29	SENT_208	[p10l1411t2064r1604b2119],
29	role	NN	O	role	nsubj	34	SENT_208	[p10l1634t2064r1745b2119],
30	in	IN	O	in	_	0	SENT_208	[p10l1775t2065r1830b2118],
31	triggering	VBG	O	trigger	amod	33	SENT_208	[p10l1858t2065r2146b2132],
32	glucose	NN	O	glucose	nn	33	SENT_208	[p10l64t2153r622b2221],
33	—	NN	O	—	prep_in	29	SENT_208	[p10l64t2153r622b2221],
34	stimulated	VBD	O	stimulate	ccomp	26	SENT_208	[p10l64t2153r622b2221],
35	insulin	NN	O	insulin	nn	36	SENT_208	[p10l644t2153r840b2208],
36	secretion	NN	O	secretion	dobj	34	SENT_208	[p10l862t2154r1139b2208],
37	.	.	O	.	_	0	SENT_208	[p10l862t2154r1139b2208],

1	-	:	O	-	_	0	SENT_209	[p10l8t2260r27b2278],
2	Carriers	NNS	O	carrier	nsubj	9	SENT_209	[p10l66t2242r303b2296],
3	of	IN	O	of	_	0	SENT_209	[p10l343t2241r406b2296],
4	the	DT	O	the	det	6	SENT_209	[p10l437t2241r534b2296],
5	diabetes	NN	O	diabetes	nn	6	SENT_209	[p10l573t2241r826b2296],
6	risk	NN	O	risk	prep_of	2	SENT_209	[p10l866t2241r978b2296],
7	associated	VBN	O	associate	partmod	6	SENT_209	[p10l1015t2241r1328b2296],
8	I	PRP	O	I	dobj	7	SENT_209	[p10l1368t2241r1599b2296],
9	(	VBP	O	(	_	0	SENT_209	[p10l1368t2241r1599b2296],
10	.	.	O	.	_	0	SENT_209	[p10l1368t2241r1599b2296],

1	—	NN	O	—	_	0	SENT_210	[p10l1368t2241r1599b2296],
2	.	.	O	.	_	0	SENT_210	[p10l1368t2241r1599b2296],

1	allele	NN	O	allele	nsubj	7	SENT_211	[p10l1368t2241r1599b2296],
2	of	IN	O	of	_	0	SENT_211	[p10l1638t2241r1702b2296],
3	KCNJII	NN	O	kcnjius	nn	4	SENT_211	[p10l1731t2244r1944b2310],
4	E23I	NN	O	e23us	prep_of	1	SENT_211	[p10l1990t2244r2147b2296],
5	(	CD	NUMBER	(	num	6	SENT_211	[p10l1990t2244r2147b2296],
6	polymorphism	NN	O	polymorphism	dep	4	SENT_211	[p10l66t2330r518b2399],
7	have	VBP	O	have	_	0	SENT_211	[p10l557t2330r700b2385],
8	better	JJR	O	better	amod	10	SENT_211	[p10l740t2330r925b2385],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_211	[p10l962t2330r1315b2399],
10	response	NN	O	response	dobj	7	SENT_211	[p10l1354t2346r1626b2399],
11	to	TO	O	to	_	0	SENT_211	[p10l1665t2338r1724b2385],
12	sulfonylurea	NN	O	sulfonylurea	nn	13	SENT_211	[p10l1765t2330r2146b2399],
13	treatment	NN	O	treatment	prep_to	10	SENT_211	[p10l65t2427r387b2474],
14	.	.	O	.	_	0	SENT_211	[p10l65t2427r387b2474],

1	-	:	O	-	_	0	SENT_212	[p10l8t2526r27b2544],
2	The	DT	O	the	det	3	SENT_212	[p10l63t2508r175b2563],
3	results	NNS	O	result	nsubj	17	SENT_212	[p10l212t2508r413b2563],
4	of	IN	O	of	_	0	SENT_212	[p10l450t2508r514b2563],
5	the	DT	O	the	det	7	SENT_212	[p10l542t2508r639b2563],
6	present	JJ	DATE	present	amod	7	SENT_212	[p10l675t2516r907b2576],
7	study	NN	O	study	prep_of	3	SENT_212	[p10l941t2508r1110b2576],
8	synthesized	VBN	O	synthesize	partmod	7	SENT_212	[p10l1145t2508r1505b2576],
9	with	IN	O	with	_	0	SENT_212	[p10l1541t2508r1682b2563],
10	the	DT	O	the	det	11	SENT_212	[p10l1717t2508r1814b2563],
11	results	NNS	O	result	prep_with	8	SENT_212	[p10l1851t2508r2053b2563],
12	of	IN	O	of	_	0	SENT_212	[p10l2089t2508r2153b2563],
13	other	JJ	O	other	amod	15	SENT_212	[p10l66t2597r230b2652],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_212	[p10l256t2597r787b2665],
15	studies	NNS	O	study	prep_of	11	SENT_212	[p10l814t2597r1028b2652],
16	might	MD	O	might	aux	17	SENT_212	[p10l1057t2597r1238b2665],
17	lead	VB	O	lead	_	0	SENT_212	[p10l1265t2597r1389b2652],
18	to	TO	O	to	_	0	SENT_212	[p10l1417t2605r1476b2652],
19	development	NN	O	development	prep_to	17	SENT_212	[p10l1504t2597r1909b2665],
20	of	IN	O	of	_	0	SENT_212	[p10l1936t2597r1999b2652],
21	personalized	JJ	O	personalized	amod	23	SENT_212	[p10l2019t2613r2145b2665, p10l66t2685r353b2740],
22	treatment	NN	O	treatment	nn	23	SENT_212	[p10l377t2693r686b2740],
23	strategies	NNS	O	strategy	prep_of	19	SENT_212	[p10l709t2686r1001b2754],
24	in	IN	O	in	_	0	SENT_212	[p10l1027t2686r1083b2740],
25	patients	NNS	O	patient	prep_in	17	SENT_212	[p10l1108t2686r1353b2754],
26	with	IN	O	with	_	0	SENT_212	[p10l1376t2685r1517b2740],
27	type	NN	O	type	nn	29	SENT_212	[p10l1541t2693r1674b2754],
28	2	CD	NUMBER	2	num	29	SENT_212	[p10l1699t2688r1731b2740],
29	diabetes	NN	O	diabetes	prep_with	25	SENT_212	[p10l1758t2685r2027b2741],
30	.	.	O	.	_	0	SENT_212	[p10l1758t2685r2027b2741],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_213	[p10l8t2863r257b2918],
2	of	IN	O	of	_	0	SENT_213	[p10l279t2863r348b2918],
3	interest	NN	O	interest	prep_of	1	SENT_213	[p10l365t2864r616b2918],

1	None	NN	O	none	_	0	SENT_214	[p10l111t3044r270b3096],
2	of	IN	O	of	_	0	SENT_214	[p10l307t3041r370b3096],
3	the	DT	O	the	det	4	SENT_214	[p10l398t3041r495b3096],
4	authors	NNS	O	author	prep_of	1	SENT_214	[p10l532t3041r763b3096],
5	of	IN	O	of	_	0	SENT_214	[p10l799t3041r863b3096],
6	the	DT	O	the	det	7	SENT_214	[p10l891t3041r988b3096],
7	manuscript	NN	O	manuscript	prep_of	4	SENT_214	[p10l1025t3042r1374b3109],
8	(	CD	NUMBER	(	num	7	SENT_214	[p10l1412t3041r1645b3109],
9	Martin	NNP	PERSON	Martin	nn	10	SENT_214	[p10l1412t3041r1645b3109],
10	Javorsky	NNP	PERSON	Javorsky	dep	1	SENT_214	[p10l1673t3041r1953b3109],
11	,	,	O	,	_	0	SENT_214	[p10l1673t3041r1953b3109],
12	Lucia	NNP	PERSON	Lucia	appos	10	SENT_214	[p10l1990t3042r2146b3096],

1	Klimcakova	NNP	PERSON	Klimcakova	nsubj	80	SENT_215	[p11l9t17r377b80],
2	,	,	O	,	_	0	SENT_215	[p11l9t17r377b80],
3	Zbynek	NNP	PERSON	Zbynek	nn	4	SENT_215	[p11l421t17r647b85],
4	Schroner	NNP	PERSON	Schroner	appos	1	SENT_215	[p11l688t17r976b80],
5	,	,	O	,	_	0	SENT_215	[p11l688t17r976b80],
6	Jozef	NNP	PERSON	Jozef	nn	7	SENT_215	[p11l1013t17r1173b85],
7	Zidzik	NNP	PERSON	Zidzik	appos	1	SENT_215	[p11l1207t17r1407b80],
8	,	,	O	,	_	0	SENT_215	[p11l1207t17r1407b80],
9	Eva	NNP	PERSON	Eva	nn	10	SENT_215	[p11l1452t20r1557b72],
10	Babjakova	NNP	PERSON	Babjakova	appos	1	SENT_215	[p11l1600t17r1925b85],
11	,	,	O	,	_	0	SENT_215	[p11l1600t17r1925b85],
12	Maria	NNP	PERSON	Maria	nn	13	SENT_215	[p11l1970t18r2146b72],
13	Fabianova	NNP	PERSON	Fabianova	appos	1	SENT_215	[p11l9t105r331b169],
14	,	,	O	,	_	0	SENT_215	[p11l9t105r331b169],
15	Miriam	NNP	PERSON	Miriam	nn	16	SENT_215	[p11l374t106r597b160],
16	Kozarova	NNP	PERSON	Kozarova	appos	1	SENT_215	[p11l637t109r934b169],
17	,	,	O	,	_	0	SENT_215	[p11l637t109r934b169],
18	Ruzena	NNP	PERSON	Ruzena	nn	19	SENT_215	[p11l977t109r1199b160],
19	Tkacova	NNP	PERSON	Tkacova	appos	1	SENT_215	[p11l1237t105r1501b169],
20	,	,	O	,	_	0	SENT_215	[p11l1237t105r1501b169],
21	Jan	NNP	PERSON	Jan	nn	22	SENT_215	[p11l1535t109r1635b174],
22	Salagovic	NNP	PERSON	Salagovic	appos	1	SENT_215	[p11l1677t105r1974b174],
23	,	,	O	,	_	0	SENT_215	[p11l1677t105r1974b174],
24	Ivan	NNP	PERSON	Ivan	nn	25	SENT_215	[p11l2017t109r2145b160],
25	Tkac	NNP	PERSON	Tkac	appos	1	SENT_215	[p11l6t194r171b262],
26	)	CD	NUMBER	)	dep	25	SENT_215	[p11l6t194r171b262],
27	submitted	VBN	O	submit	partmod	1	SENT_215	[p11l196t194r506b249],
28	to	TO	O	to	_	0	SENT_215	[p11l526t202r585b249],
29	the	DT	O	the	det	31	SENT_215	[p11l605t194r702b249],
30	European	JJ	MISC	european	amod	31	SENT_215	[p11l722t197r1013b263],
31	journal	NN	O	journal	prep_to	27	SENT_215	[p11l1025t194r1251b263],
32	of	IN	O	of	_	0	SENT_215	[p11l1271t194r1335b249],
33	Internal	JJ	ORGANIZATION	internal	amod	34	SENT_215	[p11l1347t194r1587b249],
34	Medicine	NN	ORGANIZATION	medicine	prep_of	31	SENT_215	[p11l1607t194r1889b249],
35	entitled	VBN	O	entitle	partmod	34	SENT_215	[p11l1908t194r2145b249],
36	Potassium	NNP	O	Potassium	nn	38	SENT_215	[p11l7t285r307b338],
37	inward	JJ	O	inward	amod	38	SENT_215	[p11l324t283r533b338],
38	rectiﬁer	NN	O	rectiﬁer	dobj	35	SENT_215	[p11l550t283r779b352],
39	6.2	CD	NUMBER	6.2	num	41	SENT_215	[p11l793t286r877b339],
40	channel	NN	O	channel	nn	41	SENT_215	[p11l895t283r1125b338],
41	gene	NN	O	gene	nsubj	75	SENT_215	[p11l1135t299r1275b352],
42	E23K	NN	O	e23k	nn	43	SENT_215	[p11l1290t286r1448b338],
43	variant	NN	O	variant	nsubj	49	SENT_215	[p11l1457t285r1673b338],
44	and	CC	O	and	_	0	SENT_215	[p11l1685t283r1795b338],
45	therapeutic	JJ	O	therapeutic	amod	46	SENT_215	[p11l1813t283r2148b352],
46	response	NN	O	response	conj_and	43	SENT_215	[p11l10t388r265b441],
47	to	TO	O	to	_	0	SENT_215	[p11l284t380r337b427],
48	sulfonylureas	NN	O	sulfonylurea	prep_to	43	SENT_215	[p11l353t372r746b441],
49	has	VBZ	O	have	rcmod	41	SENT_215	[p11l767t372r867b427],
50	any	DT	O	any	det	54	SENT_215	[p11l887t388r997b441],
51	actual	JJ	O	actual	amod	54	SENT_215	[p11l1015t372r1196b427],
52	or	CC	O	or	_	0	SENT_215	[p11l1217t388r1280b427],
53	potential	JJ	O	potential	amod	54	SENT_215	[p11l1298t372r1572b441],
54	conﬂict	NN	O	conﬂict	dobj	49	SENT_215	[p11l1592t372r1819b427],
55	of	IN	O	of	_	0	SENT_215	[p11l1837t372r1900b427],
56	interest	NN	O	interest	prep_of	54	SENT_215	[p11l1913t373r2148b427],
57	including	VBG	O	include	_	0	SENT_215	[p11l10t461r297b530],
58	any	DT	O	any	det	64	SENT_215	[p11l331t477r441b530],
59	ﬁnancial	JJ	O	ﬁnancial	amod	64	SENT_215	[p11l475t461r749b524],
60	,	,	O	,	_	0	SENT_215	[p11l475t461r749b524],
61	personal	JJ	O	personal	conj_or	59	SENT_215	[p11l786t461r1047b530],
62	or	CC	O	or	_	0	SENT_215	[p11l1083t477r1146b516],
63	other	JJ	O	other	amod	64	SENT_215	[p11l1179t461r1344b516],
64	relationships	NNS	O	relationship	prep_including	56	SENT_215	[p11l1377t461r1773b530],
65	with	IN	O	with	_	0	SENT_215	[p11l1808t461r1948b516],
66	other	JJ	O	other	amod	67	SENT_215	[p11l1984t461r2148b516],
67	people	NNS	O	people	prep_with	64	SENT_215	[p11l10t550r214b619],
68	or	CC	O	or	_	0	SENT_215	[p11l258t566r321b605],
69	organizations	NNS	O	organization	prep_with	64	SENT_215	[p11l361t551r776b619],
70	within	IN	O	within	_	0	SENT_215	[p11l817t550r1019b605],
71	three	CD	NUMBER	three	num	72	SENT_215	[p11l1060t550r1220b605],
72	(	CD	NUMBER	(	prep_within	67	SENT_215	[p11l1267t550r1353b619],
73	3	CD	NUMBER	3	number	74	SENT_215	[p11l1267t550r1353b619],
74	)	CD	NUMBER	)	num	75	SENT_215	[p11l1267t550r1353b619],
75	years	NNS	NUMBER	year	xcomp	35	SENT_215	[p11l1399t566r1559b619],
76	of	IN	O	of	_	0	SENT_215	[p11l1603t550r1666b605],
77	beginning	VBG	O	begin	prepc_of	75	SENT_215	[p11l1700t550r2008b619],
78	the	DT	O	the	det	79	SENT_215	[p11l2049t550r2146b605],
79	work	NN	O	work	dobj	77	SENT_215	[p11l8t639r169b694],
80	submitted	VBD	O	submit	_	0	SENT_215	[p11l210t639r520b694],
81	that	DT	O	that	nsubj	84	SENT_215	[p11l563t639r687b694],
82	could	MD	O	could	aux	84	SENT_215	[p11l728t639r893b694],
83	inappropriately	RB	O	inappropriately	advmod	84	SENT_215	[p11l937t639r1414b708],
84	inﬂuence	VB	O	inﬂuence	ccomp	80	SENT_215	[p11l1456t639r1737b694],
85	(	NN	O	(	nn	86	SENT_215	[p11l1785t639r1955b708],
86	bias	NN	O	bias	dobj	84	SENT_215	[p11l1785t639r1955b708],
87	)	CD	NUMBER	)	num	86	SENT_215	[p11l1785t639r1955b708],
88	their	PRP$	O	they	poss	89	SENT_215	[p11l2002t639r2148b694],
89	work	NN	O	work	xcomp	84	SENT_215	[p11l8t729r181b783],
90	.	.	O	.	_	0	SENT_215	[p11l8t729r181b783],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_216	[p11l6t928r646b996],

1	The	DT	O	the	det	2	SENT_217	[p11l109t1106r221b1161],
2	study	NN	O	study	nsubjpass	4	SENT_217	[p11l247t1106r415b1175],
3	was	VBD	O	be	auxpass	4	SENT_217	[p11l438t1122r557b1161],
4	supported	VBN	O	support	_	0	SENT_217	[p11l583t1106r894b1175],
5	by	IN	O	by	_	0	SENT_217	[p11l919t1106r992b1175],
6	research	NN	O	research	nn	7	SENT_217	[p11l1016t1106r1275b1161],
7	grants	NNS	O	grant	agent	4	SENT_217	[p11l1298t1114r1489b1175],
8	from	IN	O	from	_	0	SENT_217	[p11l1515t1106r1661b1161],
9	the	DT	O	the	det	10	SENT_217	[p11l1685t1106r1782b1161],
10	Ministry	NNP	ORGANIZATION	Ministry	prep_from	4	SENT_217	[p11l1808t1107r2067b1175],
11	of	IN	ORGANIZATION	of	_	0	SENT_217	[p11l2091t1106r2154b1161],
12	Education	NNP	ORGANIZATION	Education	prep_of	10	SENT_217	[p11l10t1196r328b1259],
13	,	,	O	,	_	0	SENT_217	[p11l10t1196r328b1259],
14	Science	NNP	O	Science	prep_of	10	SENT_217	[p11l382t1196r622b1259],
15	,	,	O	,	_	0	SENT_217	[p11l382t1196r622b1259],
16	Research	NNP	O	Research	prep_of	10	SENT_217	[p11l675t1196r948b1251],
17	and	CC	O	and	_	0	SENT_217	[p11l999t1196r1110b1251],
18	Sport	NNP	O	Sport	conj_and	12	SENT_217	[p11l1163t1198r1326b1264],
19	of	IN	O	of	_	0	SENT_217	[p11l1377t1195r1440b1251],
20	the	DT	O	the	det	22	SENT_217	[p11l1484t1196r1581b1251],
21	Slovak	NNP	MISC	Slovak	nn	22	SENT_217	[p11l1634t1196r1833b1251],
22	Republic	NNP	MISC	Republic	prep_of	10	SENT_217	[p11l1883t1196r2148b1264],
23	(	CD	NUMBER	(	num	24	SENT_217	[p11l14t1285r213b1353],
24	VEGA	NNP	O	VEGA	dep	22	SENT_217	[p11l14t1285r213b1353],
25	1/0380/10	CD	NUMBER	1/0380/10	num	24	SENT_217	[p11l240t1287r554b1349],
26	and	CC	O	and	_	0	SENT_217	[p11l580t1284r691b1339],
27	VEGA	NNP	O	VEGA	conj_and	22	SENT_217	[p11l716t1287r891b1339],
28	1/0112/11	CD	NUMBER	1/0112/11	number	29	SENT_217	[p11l918t1285r1276b1353],
29	)	CD	NUMBER	)	dep	27	SENT_217	[p11l918t1285r1276b1353],
30	.	.	O	.	_	0	SENT_217	[p11l918t1285r1276b1353],

1	Authors	NNS	O	author	nsubj	3	SENT_218	[p11l1301t1284r1544b1339],
2	also	RB	O	also	advmod	3	SENT_218	[p11l1572t1284r1689b1339],
3	wish	VBP	O	wish	_	0	SENT_218	[p11l1714t1284r1860b1339],
4	to	TO	O	to	aux	5	SENT_218	[p11l1886t1292r1945b1339],
5	thank	VB	O	thank	xcomp	3	SENT_218	[p11l1971t1284r2148b1339],
6	Dr.	NNP	O	Dr.	nn	8	SENT_218	[p11l10t1377r96b1429],
7	Monika	NNP	PERSON	Monika	nn	8	SENT_218	[p11l129t1374r359b1429],
8	Rudikova	NNP	PERSON	Rudikova	dobj	5	SENT_218	[p11l391t1374r690b1437],
9	,	,	O	,	_	0	SENT_218	[p11l391t1374r690b1437],
10	Dr.	NNP	O	Dr.	nn	12	SENT_218	[p11l723t1377r809b1429],
11	Dana	NNP	PERSON	Dana	nn	12	SENT_218	[p11l843t1377r997b1429],
12	Krajnakova	NNP	PERSON	Krajnakova	dobj	5	SENT_218	[p11l1029t1374r1388b1442],
13	,	,	O	,	_	0	SENT_218	[p11l1029t1374r1388b1442],
14	Dr.	NNP	O	Dr.	nn	16	SENT_218	[p11l1421t1377r1507b1429],
15	Lucia	NNP	PERSON	Lucia	nn	16	SENT_218	[p11l1540t1375r1696b1429],
16	Kizekova	NNP	PERSON	Kizekova	dobj	5	SENT_218	[p11l1728t1374r2004b1429],
17	and	CC	O	and	_	0	SENT_218	[p11l2035t1374r2146b1429],
18	Dr.	NNP	O	Dr.	nn	20	SENT_218	[p11l10t1466r96b1518],
19	Dana	NNP	PERSON	Dana	nn	20	SENT_218	[p11l130t1466r284b1518],
20	Solcova	NNP	PERSON	Solcova	dobj	5	SENT_218	[p11l316t1463r546b1518],
21	who	WP	O	who	nsubj	22	SENT_218	[p11l576t1463r710b1518],
22	participated	VBD	O	participate	rcmod	20	SENT_218	[p11l743t1463r1111b1531],
23	in	IN	O	in	_	0	SENT_218	[p11l1145t1464r1201b1517],
24	the	DT	O	the	det	25	SENT_218	[p11l1233t1463r1330b1518],
25	recruitment	NN	O	recruitment	prep_in	22	SENT_218	[p11l1364t1464r1730b1518],
26	of	IN	O	of	_	0	SENT_218	[p11l1761t1463r1825b1518],
27	the	DT	O	the	det	29	SENT_218	[p11l1849t1463r1946b1518],
28	study	NN	O	study	nn	29	SENT_218	[p11l1980t1463r2148b1531],
29	subjects	NNS	O	subject	prep_of	25	SENT_218	[p11l11t1551r256b1620],
30	and	CC	O	and	_	0	SENT_218	[p11l280t1551r392b1606],
31	to	TO	O	to	_	0	SENT_218	[p11l416t1559r475b1606],
32	all	DT	O	all	det	33	SENT_218	[p11l500t1551r569b1606],
33	patients	NNS	O	patient	prep_to	22	SENT_218	[p11l595t1552r840b1620],
34	who	WP	O	who	nsubj	35	SENT_218	[p11l863t1551r998b1606],
35	participated	VBD	O	participate	rcmod	33	SENT_218	[p11l1022t1551r1391b1620],
36	in	IN	O	in	_	0	SENT_218	[p11l1417t1552r1473b1606],
37	the	DT	O	the	det	38	SENT_218	[p11l1497t1551r1594b1606],
38	study	NN	O	study	prep_in	35	SENT_218	[p11l1620t1551r1801b1620],
39	.	.	O	.	_	0	SENT_218	[p11l1620t1551r1801b1620],

1	References	NNS	O	reference	_	0	SENT_219	[p11l9t1750r357b1804],

1	[	NN	O	[	nn	5	SENT_220	[p11l39t1896r100b1951],
2	1	CD	NUMBER	1	num	5	SENT_220	[p11l39t1896r100b1951],
3	]	CD	NUMBER	]	num	5	SENT_220	[p11l39t1896r100b1951],
4	Tabak	NNP	ORGANIZATION	Tabak	nn	5	SENT_220	[p11l131t1895r279b1940],
5	AG	NNP	ORGANIZATION	AG	_	0	SENT_220	[p11l291t1899r375b1947],
6	,	,	O	,	_	0	SENT_220	[p11l291t1899r375b1947],
7	jokela	NN	O	jokelum	nn	8	SENT_220	[p11l385t1897r537b1951],
8	M	NN	O	m	conj_and	5	SENT_220	[p11l553t1899r611b1947],
9	,	,	O	,	_	0	SENT_220	[p11l553t1899r611b1947],
10	Akbaraly	NNP	O	Akbaraly	nn	11	SENT_220	[p11l626t1897r846b1951],
11	TN	NN	O	tn	conj_and	5	SENT_220	[p11l858t1899r938b1947],
12	,	,	O	,	_	0	SENT_220	[p11l858t1899r938b1947],
13	Brunner	NNP	PERSON	Brunner	nn	15	SENT_220	[p11l955t1899r1155b1940],
14	E	NNP	O	E	nn	15	SENT_220	[p11l1170t1899r1225b1951],
15	]	NN	O	]	conj_and	5	SENT_220	[p11l1170t1899r1225b1951],
16	,	,	O	,	_	0	SENT_220	[p11l1170t1899r1225b1951],
17	Kivimaki	NNP	PERSON	Kivimaki	nn	18	SENT_220	[p11l1242t1897r1458b1940],
18	M	NNP	PERSON	M	conj_and	5	SENT_220	[p11l1474t1899r1533b1947],
19	,	,	O	,	_	0	SENT_220	[p11l1474t1899r1533b1947],
20	Witte	NNP	PERSON	Witte	nn	22	SENT_220	[p11l1547t1897r1686b1940],
21	DR.	NNP	O	DR.	nn	22	SENT_220	[p11l1703t1899r1783b1941],
22	Trajectories	NNPS	O	Trajectories	conj_and	5	SENT_220	[p11l1797t1897r2085b1951],
23	of	IN	O	of	_	0	SENT_220	[p11l2102t1896r2153b1940],
24	glycaemia	NN	O	glycaemia	prep_of	22	SENT_220	[p11l133t1963r391b2018],
25	,	,	O	,	_	0	SENT_220	[p11l133t1963r391b2018],
26	insulin	NN	O	insulin	nn	27	SENT_220	[p11l421t1963r586b2007],
27	sensitivity	NN	O	sensitivity	appos	24	SENT_220	[p11l615t1964r877b2018],
28	,	,	O	,	_	0	SENT_220	[p11l615t1964r877b2018],
29	and	CC	O	and	_	0	SENT_220	[p11l907t1963r996b2007],
30	insulin	NN	O	insulin	nn	31	SENT_220	[p11l1025t1963r1190b2007],
31	secretion	NN	O	secretion	conj_and	5	SENT_220	[p11l1220t1964r1443b2007],
32	before	IN	O	before	_	0	SENT_220	[p11l1470t1963r1625b2007],
33	diagnosis	NN	O	diagnosis	prep_before	31	SENT_220	[p11l1654t1963r1882b2018],
34	of	IN	O	of	_	0	SENT_220	[p11l1911t1963r1963b2007],
35	type	NN	O	type	nn	37	SENT_220	[p11l1984t1970r2090b2018],
36	2	CD	NUMBER	2	num	37	SENT_220	[p11l2119t1965r2145b2006],
37	diabetes	NN	O	diabetes	prep_of	33	SENT_220	[p11l134t2029r352b2073],
38	:	:	O	:	_	0	SENT_220	[p11l134t2029r352b2073],
39	an	DT	O	a	det	40	SENT_220	[p11l375t2042r433b2073],
40	analysis	NN	O	analysis	dep	5	SENT_220	[p11l452t2029r646b2084],
41	from	IN	O	from	_	0	SENT_220	[p11l667t2029r784b2073],
42	the	DT	O	the	det	45	SENT_220	[p11l802t2029r880b2073],
43	Whitehall	NNP	O	Whitehall	nn	45	SENT_220	[p11l897t2029r1142b2073],
44	II	NNP	O	II	nn	45	SENT_220	[p11l1163t2032r1191b2072],
45	study	NN	O	study	prep_from	40	SENT_220	[p11l1212t2029r1357b2084],
46	.	.	O	.	_	0	SENT_220	[p11l1212t2029r1357b2084],

1	Lancet	NNP	O	Lancet	_	0	SENT_221	[p11l1378t2032r1537b2073],
2	2009	CD	DATE	2009	num	1	SENT_221	[p11l1555t2031r2037b2079],
3	;	:	O	;	_	0	SENT_221	[p11l1555t2031r2037b2079],
4	373:2215	CD	NUMBER	373:2215	number	5	SENT_221	[p11l1555t2031r2037b2079],
5	—	CD	NUMBER	—	dep	1	SENT_221	[p11l1555t2031r2037b2079],
6	21	CD	NUMBER	21	dep	5	SENT_221	[p11l1555t2031r2037b2079],
7	.	.	O	.	_	0	SENT_221	[p11l1555t2031r2037b2079],

1	[	NN	O	[	_	0	SENT_222	[p11l39t2095r100b2149],
2	2	CD	NUMBER	2	num	1	SENT_222	[p11l39t2095r100b2149],
3	]	CD	NUMBER	]	num	5	SENT_222	[p11l39t2095r100b2149],
4	Nathan	NNP	PERSON	Nathan	nn	5	SENT_222	[p11l134t2095r302b2138],
5	DM	NN	PERSON	dm	dep	1	SENT_222	[p11l320t2097r413b2145],
6	,	,	O	,	_	0	SENT_222	[p11l320t2097r413b2145],
7	Buse	NNP	PERSON	Buse	nn	9	SENT_222	[p11l431t2098r538b2138],
8	]	NN	O	]	nn	9	SENT_222	[p11l550t2098r610b2149],
9	B	NN	O	b	appos	5	SENT_222	[p11l550t2098r610b2149],
10	,	,	O	,	_	0	SENT_222	[p11l550t2098r610b2149],
11	Davidson	NNP	PERSON	Davidson	nn	12	SENT_222	[p11l628t2095r843b2138],
12	MB	NNP	O	MB	appos	5	SENT_222	[p11l861t2098r948b2145],
13	,	,	O	,	_	0	SENT_222	[p11l861t2098r948b2145],
14	Slama	NNP	PERSON	Slama	nn	15	SENT_222	[p11l966t2095r1106b2138],
15	G	NNP	PERSON	G	appos	5	SENT_222	[p11l1122t2097r1167b2145],
16	,	,	O	,	_	0	SENT_222	[p11l1122t2097r1167b2145],
17	Balkau	NNP	PERSON	Balkau	nn	18	SENT_222	[p11l1185t2095r1339b2138],
18	B	NNP	PERSON	B	appos	5	SENT_222	[p11l1356t2098r1395b2145],
19	,	,	O	,	_	0	SENT_222	[p11l1356t2098r1395b2145],
20	Valensi	NNP	PERSON	Valensi	nn	21	SENT_222	[p11l1410t2095r1579b2138],
21	P	NN	O	p	appos	5	SENT_222	[p11l1596t2098r1633b2145],
22	,	,	O	,	_	0	SENT_222	[p11l1596t2098r1633b2145],
23	et	FW	O	et	nn	24	SENT_222	[p11l1651t2101r1696b2138],
24	al.	FW	O	al.	appos	5	SENT_222	[p11l1711t2095r1760b2139],
25	.	.	O	.	_	0	SENT_222	[p11l1711t2095r1760b2139],

1	Management	NN	O	management	_	0	SENT_223	[p11l1778t2098r2088b2149],
2	of	IN	O	of	_	0	SENT_223	[p11l2104t2095r2153b2138],
3	hyperglycaemia	NN	O	hyperglycaemia	prep_of	1	SENT_223	[p11l134t2161r503b2215],
4	in	IN	O	in	_	0	SENT_223	[p11l517t2162r561b2204],
5	type	NN	O	type	nn	7	SENT_223	[p11l574t2167r676b2215],
6	2	CD	NUMBER	2	num	7	SENT_223	[p11l689t2163r716b2204],
7	diabetes	NN	O	diabetes	prep_in	3	SENT_223	[p11l731t2161r936b2205],
8	:	:	O	:	_	0	SENT_223	[p11l731t2161r936b2205],
9	a	DT	O	a	det	11	SENT_223	[p11l953t2174r978b2205],
10	consensus	NN	O	consensus	nn	11	SENT_223	[p11l991t2174r1228b2205],
11	algorithm	NN	O	algorithm	dep	1	SENT_223	[p11l1242t2161r1470b2215],
12	for	IN	O	for	_	0	SENT_223	[p11l1483t2161r1548b2205],
13	initiation	NN	O	initiation	prep_for	11	SENT_223	[p11l1560t2162r1769b2205],
14	and	CC	O	and	_	0	SENT_223	[p11l1782t2161r1868b2205],
15	adjustment	NN	O	adjustment	conj_and	13	SENT_223	[p11l1882t2161r2148b2215],
16	of	IN	O	of	_	0	SENT_223	[p11l134t2226r182b2270],
17	therapy	NN	O	therapy	prep_of	11	SENT_223	[p11l198t2227r388b2281],
18	.	.	O	.	_	0	SENT_223	[p11l198t2227r388b2281],

1	A	DT	O	a	det	3	SENT_224	[p11l409t2229r446b2270],
2	consensus	NN	O	consensus	nn	3	SENT_224	[p11l466t2239r703b2270],
3	statement	NN	O	statement	_	0	SENT_224	[p11l726t2233r960b2270],
4	from	IN	O	from	_	0	SENT_224	[p11l982t2227r1094b2270],
5	the	DT	O	the	det	8	SENT_224	[p11l1115t2227r1190b2270],
6	American	JJ	ORGANIZATION	american	amod	8	SENT_224	[p11l1211t2227r1436b2270],
7	Diabetes	NNP	ORGANIZATION	Diabetes	nn	8	SENT_224	[p11l1459t2227r1656b2270],
8	Association	NNP	ORGANIZATION	Association	prep_from	3	SENT_224	[p11l1678t2227r1941b2270],
9	and	CC	O	and	_	0	SENT_224	[p11l1963t2227r2049b2270],
10	the	DT	O	the	det	12	SENT_224	[p11l2072t2227r2146b2270],
11	European	NNP	ORGANIZATION	European	nn	12	SENT_224	[p11l134t2296r355b2348],
12	Association	NNP	ORGANIZATION	Association	prep_from	3	SENT_224	[p11l369t2294r633b2337],
13	for	IN	O	for	_	0	SENT_224	[p11l650t2293r715b2337],
14	the	DT	O	the	det	15	SENT_224	[p11l729t2293r803b2337],
15	Study	NN	O	study	prep_for	3	SENT_224	[p11l820t2293r954b2348],
16	of	IN	O	of	_	0	SENT_224	[p11l969t2293r1018b2337],
17	Diabetes	NNP	O	Diabetes	prep_of	15	SENT_224	[p11l1028t2293r1236b2337],
18	.	.	O	.	_	0	SENT_224	[p11l1028t2293r1236b2337],

1	Diabetes	NNP	O	Diabetes	nn	2	SENT_225	[p11l1254t2293r1451b2337],
2	Care	NNP	O	Care	_	0	SENT_225	[p11l1468t2295r1570b2337],
3	2009	CD	DATE	2009	num	2	SENT_225	[p11l1587t2295r2012b2344],
4	;	:	O	;	_	0	SENT_225	[p11l1587t2295r2012b2344],
5	32:193	CD	NUMBER	32:193	number	6	SENT_225	[p11l1587t2295r2012b2344],
6	-203	CD	NUMBER	-203	dep	2	SENT_225	[p11l1587t2295r2012b2344],
7	.	.	O	.	_	0	SENT_225	[p11l1587t2295r2012b2344],

1	[	NN	O	[	nn	3	SENT_226	[p11l39t2358r100b2413],
2	3	CD	NUMBER	3	num	3	SENT_226	[p11l39t2358r100b2413],
3	]	NN	O	]	_	0	SENT_226	[p11l39t2358r100b2413],
4	Zhou	NNP	PERSON	Zhou	nn	5	SENT_226	[p11l133t2358r254b2402],
5	K	NNP	PERSON	K	dep	3	SENT_226	[p11l271t2361r314b2409],
6	,	,	O	,	_	0	SENT_226	[p11l271t2361r314b2409],
7	Donnelly	NNP	PERSON	Donnelly	nn	8	SENT_226	[p11l331t2359r549b2413],
8	L	NNP	PERSON	L	appos	5	SENT_226	[p11l563t2361r597b2409],
9	,	,	O	,	_	0	SENT_226	[p11l563t2361r597b2409],
10	Burch	NNP	ORGANIZATION	Burch	nn	11	SENT_226	[p11l615t2359r753b2402],
11	L	NNP	ORGANIZATION	L	appos	5	SENT_226	[p11l770t2361r804b2409],
12	,	,	O	,	_	0	SENT_226	[p11l770t2361r804b2409],
13	Tavensdale	NNP	ORGANIZATION	Tavensdale	nn	14	SENT_226	[p11l819t2358r1088b2402],
14	R	NNP	ORGANIZATION	R	appos	5	SENT_226	[p11l1104t2361r1145b2409],
15	,	,	O	,	_	0	SENT_226	[p11l1104t2361r1145b2409],
16	Doney	NNP	PERSON	Doney	nn	17	SENT_226	[p11l1163t2361r1317b2413],
17	AS	NNP	O	AS	appos	5	SENT_226	[p11l1330t2360r1403b2409],
18	,	,	O	,	_	0	SENT_226	[p11l1330t2360r1403b2409],
19	Leese	NNP	PERSON	Leese	nn	20	SENT_226	[p11l1420t2361r1549b2402],
20	G	NNP	PERSON	G	appos	5	SENT_226	[p11l1566t2361r1612b2409],
21	,	,	O	,	_	0	SENT_226	[p11l1566t2361r1612b2409],
22	et	FW	O	et	nn	23	SENT_226	[p11l1628t2365r1674b2402],
23	al.	FW	O	al.	appos	5	SENT_226	[p11l1689t2358r1740b2402],
24	.	.	O	.	_	0	SENT_226	[p11l1689t2358r1740b2402],

1	Loss-of-function	JJ	O	loss-of-function	amod	3	SENT_227	[p11l1758t2358r2147b2402],
2	CYP2C9	NN	O	cyp2c9	nn	3	SENT_227	[p11l134t2427r317b2469],
3	variants	NNS	O	variant	nsubj	4	SENT_227	[p11l331t2426r522b2469],
4	improve	VBP	O	improve	_	0	SENT_227	[p11l538t2426r738b2479],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_227	[p11l753t2425r1030b2479],
6	response	NN	O	response	dobj	4	SENT_227	[p11l1043t2438r1256b2479],
7	to	TO	O	to	_	0	SENT_227	[p11l1271t2431r1318b2469],
8	sulfonylureas	NNS	O	sulfonylurea	prep_to	4	SENT_227	[p11l1334t2425r1653b2479],
9	in	IN	O	in	_	0	SENT_227	[p11l1669t2426r1714b2468],
10	type	NN	O	type	nn	12	SENT_227	[p11l1727t2431r1833b2479],
11	2	CD	NUMBER	2	num	12	SENT_227	[p11l1848t2427r1874b2468],
12	diabetes	NN	O	diabetes	prep_in	8	SENT_227	[p11l1891t2425r2104b2469],
13	:	:	O	:	_	0	SENT_227	[p11l1891t2425r2104b2469],
14	a	DT	O	a	det	15	SENT_227	[p11l2122t2438r2147b2469],
15	Go	NNP	O	Go	dobj	4	SENT_227	[p11l134t2493r381b2535],
16	.	.	O	.	_	0	SENT_227	[p11l134t2493r381b2535],

1	—	NN	O	—	_	0	SENT_228	[p11l134t2493r381b2535],
2	.	.	O	.	_	0	SENT_228	[p11l134t2493r381b2535],

1	DARTS	NN	O	dart	_	0	SENT_229	[p11l134t2493r381b2535],
2	study	NN	O	study	dep	1	SENT_229	[p11l399t2491r541b2546],
3	.	.	O	.	_	0	SENT_229	[p11l399t2491r541b2546],

1	Clin	NNP	O	Clin	nn	3	SENT_230	[p11l559t2491r651b2535],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_230	[p11l668t2491r921b2535],
3	Ther	NNP	O	Ther	_	0	SENT_230	[p11l936t2491r1048b2535],
4	2010	CD	DATE	2010	num	3	SENT_230	[p11l1063t2493r1412b2542],
5	;	:	O	;	_	0	SENT_230	[p11l1063t2493r1412b2542],
6	87:52	CD	NUMBER	87:52	number	7	SENT_230	[p11l1063t2493r1412b2542],
7	—	CD	NUMBER	—	dep	3	SENT_230	[p11l1063t2493r1412b2542],
8	6	CD	NUMBER	6	dep	7	SENT_230	[p11l1063t2493r1412b2542],
9	.	.	O	.	_	0	SENT_230	[p11l1063t2493r1412b2542],

1	[	NN	O	[	_	0	SENT_231	[p11l39t2557r100b2611],
2	4	CD	NUMBER	4	num	1	SENT_231	[p11l39t2557r100b2611],
3	]	CD	NUMBER	]	num	5	SENT_231	[p11l39t2557r100b2611],
4	Pearson	NNP	ORGANIZATION	Pearson	nn	5	SENT_231	[p11l134t2560r326b2600],
5	ER	NN	ORGANIZATION	er	dep	1	SENT_231	[p11l354t2560r426b2607],
6	,	,	O	,	_	0	SENT_231	[p11l354t2560r426b2607],
7	Donnelly	NNP	ORGANIZATION	Donnelly	nn	8	SENT_231	[p11l454t2557r676b2611],
8	LA	NNP	ORGANIZATION	LA	appos	5	SENT_231	[p11l702t2559r773b2607],
9	,	,	O	,	_	0	SENT_231	[p11l702t2559r773b2607],
10	Kimber	NNP	PERSON	Kimber	nn	11	SENT_231	[p11l801t2557r981b2600],
11	C	NNP	O	C	appos	5	SENT_231	[p11l1007t2559r1048b2607],
12	,	,	O	,	_	0	SENT_231	[p11l1007t2559r1048b2607],
13	Whitley	NNP	PERSON	Whitley	nn	14	SENT_231	[p11l1073t2557r1273b2611],
14	A	NNP	O	A	appos	5	SENT_231	[p11l1296t2559r1342b2607],
15	,	,	O	,	_	0	SENT_231	[p11l1296t2559r1342b2607],
16	Doney	NNP	PERSON	Doney	nn	17	SENT_231	[p11l1371t2560r1528b2611],
17	AS	NNP	O	AS	appos	5	SENT_231	[p11l1552t2559r1626b2607],
18	,	,	O	,	_	0	SENT_231	[p11l1552t2559r1626b2607],
19	McCarthy	NNP	PERSON	McCarthy	nn	20	SENT_231	[p11l1655t2557r1893b2611],
20	MI	NNP	O	MI	appos	5	SENT_231	[p11l1919t2559r1994b2607],
21	,	,	O	,	_	0	SENT_231	[p11l1919t2559r1994b2607],
22	et	FW	O	et	nn	23	SENT_231	[p11l2022t2563r2068b2600],
23	al.	FW	O	al.	appos	5	SENT_231	[p11l2094t2557r2146b2601],
24	.	.	O	.	_	0	SENT_231	[p11l2094t2557r2146b2601],

1	Variation	NN	O	variation	_	0	SENT_232	[p11l132t2623r358b2666],
2	in	IN	O	in	_	0	SENT_232	[p11l377t2623r423b2666],
3	TCF7L2	NN	O	tcf7l2	nn	4	SENT_232	[p11l439t2625r615b2666],
4	inﬂuences	NNS	O	inﬂuences	prep_in	1	SENT_232	[p11l636t2622r884b2666],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_232	[p11l904t2622r1186b2677],
6	response	NN	O	response	dep	1	SENT_232	[p11l1205t2635r1423b2677],
7	to	TO	O	to	_	0	SENT_232	[p11l1442t2629r1489b2666],
8	sulfonylureas	NNS	O	sulfonylurea	prep_to	6	SENT_232	[p11l1509t2622r1848b2677],
9	.	.	O	.	_	0	SENT_232	[p11l1509t2622r1848b2677],

1	A	DT	O	a	det	3	SENT_233	[p11l1866t2624r1903b2666],
2	GoDARTs	JJ	O	godarts	amod	3	SENT_233	[p11l1920t2624r2146b2666],
3	study	NN	O	study	_	0	SENT_233	[p11l134t2688r279b2743],
4	.	.	O	.	_	0	SENT_233	[p11l134t2688r279b2743],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_234	[p11l300t2688r509b2732],
2	2007	CD	DATE	2007	num	1	SENT_234	[p11l530t2691r980b2739],
3	;	:	O	;	_	0	SENT_234	[p11l530t2691r980b2739],
4	56:2178	CD	NUMBER	56:2178	number	5	SENT_234	[p11l530t2691r980b2739],
5	—	CD	NUMBER	—	dep	1	SENT_234	[p11l530t2691r980b2739],
6	82	CD	NUMBER	82	dep	5	SENT_234	[p11l530t2691r980b2739],
7	.	.	O	.	_	0	SENT_234	[p11l530t2691r980b2739],

1	[	NN	O	[	_	0	SENT_235	[p11l39t2755r100b2810],
2	5	CD	NUMBER	5	num	1	SENT_235	[p11l39t2755r100b2810],
3	]	CD	NUMBER	]	num	5	SENT_235	[p11l39t2755r100b2810],
4	Schroner	NNP	O	Schroner	nn	5	SENT_235	[p11l134t2755r354b2799],
5	Z	NN	O	z	dep	1	SENT_235	[p11l370t2758r410b2806],
6	,	,	O	,	_	0	SENT_235	[p11l370t2758r410b2806],
7	Javorsky	NNP	PERSON	Javorsky	nn	8	SENT_235	[p11l424t2755r638b2810],
8	M	NNP	O	M	appos	5	SENT_235	[p11l656t2758r714b2806],
9	,	,	O	,	_	0	SENT_235	[p11l656t2758r714b2806],
10	Tkacova	NNP	PERSON	Tkacova	nn	11	SENT_235	[p11l732t2755r932b2799],
11	R	NNP	PERSON	R	appos	5	SENT_235	[p11l951t2758r992b2805],
12	,	,	O	,	_	0	SENT_235	[p11l951t2758r992b2805],
13	Klimcakova	NNP	ORGANIZATION	Klimcakova	nn	14	SENT_235	[p11l1013t2755r1296b2799],
14	L	NNP	ORGANIZATION	L	appos	5	SENT_235	[p11l1316t2758r1351b2805],
15	,	,	O	,	_	0	SENT_235	[p11l1316t2758r1351b2805],
16	Dobrikova	NNP	O	Dobrikova	nn	17	SENT_235	[p11l1371t2755r1623b2799],
17	M	NNP	O	M	appos	5	SENT_235	[p11l1642t2758r1701b2805],
18	,	,	O	,	_	0	SENT_235	[p11l1642t2758r1701b2805],
19	Habalova	NNP	O	Habalova	nn	20	SENT_235	[p11l1721t2755r1948b2799],
20	V	NNP	O	V	appos	5	SENT_235	[p11l1964t2758r2010b2805],
21	,	,	O	,	_	0	SENT_235	[p11l1964t2758r2010b2805],
22	et	FW	O	et	nn	23	SENT_235	[p11l2030t2762r2076b2799],
23	al.	FW	O	al.	appos	5	SENT_235	[p11l2094t2755r2146b2799],
24	.	.	O	.	_	0	SENT_235	[p11l2094t2755r2146b2799],

1	Effect	NN	O	effect	nsubj	9	SENT_236	[p11l134t2821r270b2865],
2	of	IN	O	of	_	0	SENT_236	[p11l286t2821r338b2865],
3	sulphonylurea	NN	O	sulphonylurea	nn	4	SENT_236	[p11l349t2821r701b2876],
4	treatment	NN	O	treatment	prep_of	1	SENT_236	[p11l717t2828r964b2865],
5	on	IN	O	on	_	0	SENT_236	[p11l980t2834r1040b2865],
6	glycaemic	JJ	O	glycaemic	amod	7	SENT_236	[p11l1057t2821r1302b2876],
7	control	NN	O	control	prep_on	4	SENT_236	[p11l1319t2821r1492b2865],
8	is	VBZ	O	be	cop	9	SENT_236	[p11l1510t2822r1545b2865],
9	related	JJ	O	related	_	0	SENT_236	[p11l1563t2821r1733b2865],
10	to	TO	O	to	_	0	SENT_236	[p11l1750t2828r1797b2865],
11	TCF7L2	NN	O	tcf7l2	nn	12	SENT_236	[p11l1812t2823r1988b2865],
12	genotype	NN	O	genotype	prep_to	9	SENT_236	[p11l2006t2834r2146b2876, p11l133t2893r240b2941],
13	in	IN	O	in	_	0	SENT_236	[p11l260t2888r305b2930],
14	patients	NNS	O	patient	prep_in	12	SENT_236	[p11l324t2888r521b2941],
15	with	IN	O	with	_	0	SENT_236	[p11l540t2887r653b2930],
16	type	NN	O	type	nn	18	SENT_236	[p11l673t2893r779b2941],
17	2	CD	NUMBER	2	num	18	SENT_236	[p11l799t2889r826b2930],
18	diabetes	NN	O	diabetes	prep_with	14	SENT_236	[p11l847t2887r1062b2931],
19	.	.	O	.	_	0	SENT_236	[p11l847t2887r1062b2931],

1	Diabetes	NNP	O	Diabetes	nn	3	SENT_237	[p11l1083t2887r1292b2930],
2	Obes	NNP	O	Obes	nn	3	SENT_237	[p11l1313t2887r1430b2930],
3	Metab	NNP	O	Metab	_	0	SENT_237	[p11l1451t2887r1605b2930],
4	2011	CD	DATE	2011	num	3	SENT_237	[p11l1625t2889r2013b2937],
5	;	:	O	;	_	0	SENT_237	[p11l1625t2889r2013b2937],
6	13:89	CD	NUMBER	13:89	number	7	SENT_237	[p11l1625t2889r2013b2937],
7	—	CD	NUMBER	—	dep	3	SENT_237	[p11l1625t2889r2013b2937],
8	91	CD	NUMBER	91	dep	7	SENT_237	[p11l1625t2889r2013b2937],
9	.	.	O	.	_	0	SENT_237	[p11l1625t2889r2013b2937],

1	[	NN	O	[	nn	5	SENT_238	[p11l39t2953r100b3007],
2	6	CD	NUMBER	6	num	5	SENT_238	[p11l39t2953r100b3007],
3	]	CD	NUMBER	]	num	5	SENT_238	[p11l39t2953r100b3007],
4	Gribble	NNP	O	Gribble	nn	5	SENT_238	[p11l134t2953r312b2997],
5	FM	NNP	O	FM	_	0	SENT_238	[p11l343t2956r429b3003],
6	,	,	O	,	_	0	SENT_238	[p11l343t2956r429b3003],
7	Reimann	NNP	PERSON	Reimann	nn	9	SENT_238	[p11l461t2954r678b2997],
8	F.	NNP	PERSON	F.	nn	9	SENT_238	[p11l710t2956r745b2997],
9	Sulphonylurea	NNP	PERSON	Sulphonylurea	appos	5	SENT_238	[p11l776t2953r1134b3007],
10	action	NN	O	action	nsubj	11	SENT_238	[p11l1165t2954r1314b2997],
11	revisited	VBD	O	revisit	rcmod	9	SENT_238	[p11l1345t2953r1572b2997],
12	:	:	O	:	_	0	SENT_238	[p11l1345t2953r1572b2997],
13	the	DT	O	the	det	14	SENT_238	[p11l1606t2953r1684b2997],
14	post	NN	O	post	dep	5	SENT_238	[p11l1715t2959r1819b3007],
15	cloning	NN	O	cloning	nn	16	SENT_238	[p11l1849t2953r2029b3007],
16	era	NN	O	era	dep	14	SENT_238	[p11l2059t2966r2146b2997],
17	.	.	O	.	_	0	SENT_238	[p11l2059t2966r2146b2997],

1	Diabetologia	NNP	O	Diabetologia	_	0	SENT_239	[p11l134t3019r442b3073],
2	2003	CD	DATE	2003	num	1	SENT_239	[p11l461t3021r881b3069],
3	;	:	O	;	_	0	SENT_239	[p11l461t3021r881b3069],
4	46:875	CD	NUMBER	46:875	number	5	SENT_239	[p11l461t3021r881b3069],
5	—	CD	NUMBER	—	dep	1	SENT_239	[p11l461t3021r881b3069],
6	91	CD	NUMBER	91	dep	5	SENT_239	[p11l461t3021r881b3069],
7	.	.	O	.	_	0	SENT_239	[p11l461t3021r881b3069],

1	[	NN	O	[	nn	4	SENT_240	[p11l39t3085r100b3140],
2	7	CD	NUMBER	7	num	4	SENT_240	[p11l39t3085r100b3140],
3	]	NN	O	]	nn	4	SENT_240	[p11l39t3085r100b3140],
4	Shyng	NN	O	shyng	_	0	SENT_240	[p11l134t3085r284b3140],
5	S	NN	O	s	dep	4	SENT_240	[p11l310t3087r347b3135],
6	,	,	O	,	_	0	SENT_240	[p11l310t3087r347b3135],
7	Nichols	NNP	PERSON	Nichols	nn	8	SENT_240	[p11l375t3085r554b3129],
8	CG	NNP	O	CG	appos	5	SENT_240	[p11l582t3087r661b3129],
9	.	.	O	.	_	0	SENT_240	[p11l582t3087r661b3129],

1	Octameric	JJ	O	octameric	_	0	SENT_241	[p11l689t3086r939b3129],
2	stoichiometry	NN	O	stoichiometry	dep	1	SENT_241	[p11l966t3085r1308b3140],
3	of	IN	O	of	prep	2	SENT_241	[p11l1333t3085r1385b3129],
4	the	DT	O	the	det	6	SENT_241	[p11l1405t3085r1483b3129],
5	KATP	NN	O	katp	nn	6	SENT_241	[p11l1510t3087r1639b3128],
6	channel	NN	O	channel	dep	3	SENT_241	[p11l1665t3085r1857b3129],
7	complex	NN	O	complex	dep	6	SENT_241	[p11l1885t3085r2147b3140],
8	.	.	O	.	_	0	SENT_241	[p11l1885t3085r2147b3140],
9	]	SYM	O	]	dep	2	SENT_241	[p11l1885t3085r2147b3140],

1	Genet	NNP	O	Genet	nn	2	SENT_242	[p11l134t3153r278b3194],
2	Physiol	NNP	O	Physiol	_	0	SENT_242	[p11l297t3151r472b3205],
3	1997	CD	DATE	1997	num	2	SENT_242	[p11l495t3153r943b3201],
4	;	:	O	;	_	0	SENT_242	[p11l495t3153r943b3201],
5	110:655	CD	NUMBER	110:655	number	6	SENT_242	[p11l495t3153r943b3201],
6	—	CD	NUMBER	—	dep	2	SENT_242	[p11l495t3153r943b3201],
7	64	CD	NUMBER	64	dep	6	SENT_242	[p11l495t3153r943b3201],
8	.	.	O	.	_	0	SENT_242	[p11l495t3153r943b3201],

1	[	NN	O	[	nn	5	SENT_243	[p11l39t3217r100b3271],
2	8	CD	NUMBER	8	num	5	SENT_243	[p11l39t3217r100b3271],
3	]	CD	NUMBER	]	num	5	SENT_243	[p11l39t3217r100b3271],
4	Ashcroft	NNP	O	Ashcroft	nn	5	SENT_243	[p11l131t3217r335b3261],
5	FM	NNP	O	FM	_	0	SENT_243	[p11l348t3220r432b3267],
6	,	,	O	,	_	0	SENT_243	[p11l348t3220r432b3267],
7	Proks	NNP	ORGANIZATION	Proks	nn	8	SENT_243	[p11l449t3217r578b3261],
8	P	NN	ORGANIZATION	p	appos	5	SENT_243	[p11l594t3220r633b3267],
9	,	,	O	,	_	0	SENT_243	[p11l594t3220r633b3267],
10	Smith	NNP	ORGANIZATION	Smith	nn	11	SENT_243	[p11l649t3217r789b3261],
11	PA	NN	ORGANIZATION	pa	appos	5	SENT_243	[p11l804t3219r877b3267],
12	,	,	O	,	_	0	SENT_243	[p11l804t3219r877b3267],
13	Amméila	NNP	ORGANIZATION	Amméila	nn	14	SENT_243	[p11l891t3217r1094b3261],
14	C	NNP	ORGANIZATION	C	appos	5	SENT_243	[p11l1110t3219r1150b3267],
15	,	,	O	,	_	0	SENT_243	[p11l1110t3219r1150b3267],
16	Bokvist	NNP	O	Bokvist	nn	17	SENT_243	[p11l1165t3217r1341b3261],
17	K	NNP	O	K	appos	5	SENT_243	[p11l1355t3220r1398b3267],
18	,	,	O	,	_	0	SENT_243	[p11l1355t3220r1398b3267],
19	Rorsman	NNP	O	Rorsman	nn	21	SENT_243	[p11l1414t3220r1627b3261],
20	P.	NNP	O	P.	nn	21	SENT_243	[p11l1642t3220r1679b3261],
21	Stimulus	NNP	O	Stimulus	appos	5	SENT_243	[p11l1696t3217r2147b3261],
22	—	NN	O	—	nn	24	SENT_243	[p11l1696t3217r2147b3261],
23	secretion	NN	O	secretion	nn	24	SENT_243	[p11l1696t3217r2147b3261],
24	coupling	NN	O	coupling	dep	21	SENT_243	[p11l134t3283r341b3338],
25	in	IN	O	in	prep	24	SENT_243	[p11l357t3284r402b3326],
26	pancreatic	JJ	O	pancreatic	amod	27	SENT_243	[p11l419t3284r668b3338],
27	[	NN	O	[	dep	25	SENT_243	[p11l683t3283r883b3338],
28	3-cells	NNS	O	3-cell	dep	27	SENT_243	[p11l683t3283r883b3338],
29	.	.	O	.	_	0	SENT_243	[p11l683t3283r883b3338],
30	]	SYM	O	]	dep	24	SENT_243	[p11l683t3283r883b3338],

1	Cell	NN	O	cell	_	0	SENT_244	[p11l901t3283r988b3327],
2	Biochem	NNP	O	Biochem	dep	1	SENT_244	[p11l1005t3283r1213b3327],
3	1994	CD	DATE	1994	num	2	SENT_244	[p11l1232t3285r1596b3334],
4	;	:	O	;	_	0	SENT_244	[p11l1232t3285r1596b3334],
5	55:54	CD	NUMBER	55:54	number	6	SENT_244	[p11l1232t3285r1596b3334],
6	—	CD	NUMBER	—	dep	1	SENT_244	[p11l1232t3285r1596b3334],
7	65	CD	NUMBER	65	num	10	SENT_244	[p11l1232t3285r1596b3334],
8	(	NN	O	(	nn	10	SENT_244	[p11l1618t3283r1807b3338],
9	Suppl	NN	O	suppl	nn	10	SENT_244	[p11l1618t3283r1807b3338],
10	)	NN	O	)	dep	6	SENT_244	[p11l1618t3283r1807b3338],
11	.	.	O	.	_	0	SENT_244	[p11l1618t3283r1807b3338],

1	[	NN	O	[	nn	3	SENT_245	[p11l39t3349r100b3403],
2	9	CD	NUMBER	9	num	3	SENT_245	[p11l39t3349r100b3403],
3	]	NN	O	]	_	0	SENT_245	[p11l39t3349r100b3403],
4	Gloyn	NNP	O	Gloyn	nn	5	SENT_245	[p11l134t3349r277b3403],
5	AL	NNP	O	AL	dep	3	SENT_245	[p11l297t3351r369b3399],
6	,	,	O	,	_	0	SENT_245	[p11l297t3351r369b3399],
7	Weedon	NNP	PERSON	Weedon	nn	8	SENT_245	[p11l390t3349r598b3392],
8	MN	NN	O	mn	appos	5	SENT_245	[p11l621t3352r719b3399],
9	,	,	O	,	_	0	SENT_245	[p11l621t3352r719b3399],
10	Owen	NNP	PERSON	Owen	nn	11	SENT_245	[p11l742t3351r885b3392],
11	KR	NNP	PERSON	KR	appos	5	SENT_245	[p11l908t3352r984b3399],
12	,	,	O	,	_	0	SENT_245	[p11l908t3352r984b3399],
13	Turner	NNP	O	Turner	nn	15	SENT_245	[p11l1005t3352r1173b3392],
14	M	NNP	O	M	nn	15	SENT_245	[p11l1194t3352r1269b3403],
15	]	NN	O	]	appos	5	SENT_245	[p11l1194t3352r1269b3403],
16	,	,	O	,	_	0	SENT_245	[p11l1194t3352r1269b3403],
17	Knight	NNP	O	Knight	nn	18	SENT_245	[p11l1293t3349r1456b3403],
18	BA	NN	O	ba	appos	5	SENT_245	[p11l1477t3351r1553b3399],
19	,	,	O	,	_	0	SENT_245	[p11l1477t3351r1553b3399],
20	Hitman	NN	O	hitman	nn	21	SENT_245	[p11l1577t3350r1760b3392],
21	G	NN	O	g	appos	5	SENT_245	[p11l1782t3351r1829b3399],
22	,	,	O	,	_	0	SENT_245	[p11l1782t3351r1829b3399],
23	et	FW	O	et	nn	24	SENT_245	[p11l1851t3355r1897b3392],
24	al.	FW	O	al.	appos	5	SENT_245	[p11l1918t3349r1970b3393],
25	.	.	O	.	_	0	SENT_245	[p11l1918t3349r1970b3393],

1	Largescale	JJ	MISC	largescale	amod	3	SENT_246	[p11l1994t3352r2146b3403, p11l134t3415r251b3458],
2	association	NN	O	association	nn	3	SENT_246	[p11l277t3415r548b3458],
3	studies	NNS	O	study	_	0	SENT_246	[p11l575t3414r746b3458],
4	of	IN	O	of	_	0	SENT_246	[p11l772t3414r823b3458],
5	variants	NNS	O	variant	nsubj	8	SENT_246	[p11l841t3415r1038b3458],
6	in	IN	O	in	_	0	SENT_246	[p11l1065t3415r1110b3458],
7	genes	NNS	O	gene	prep_in	5	SENT_246	[p11l1135t3427r1275b3469],
8	encoding	VBG	O	encode	prepc_of	3	SENT_246	[p11l1301t3414r1526b3469],
9	the	DT	O	the	det	12	SENT_246	[p11l1551t3414r1629b3458],
10	pancreatic	JJ	O	pancreatic	amod	12	SENT_246	[p11l1655t3415r1910b3469],
11	beta	NN	O	beta	nn	12	SENT_246	[p11l1935t3414r2146b3458],
12	—	NN	O	—	dobj	8	SENT_246	[p11l1935t3414r2146b3458],
13	cell	NN	O	cell	nn	16	SENT_246	[p11l1935t3414r2146b3458],
14	KATP	NN	O	katp	nn	16	SENT_246	[p11l134t3482r262b3524],
15	channel	NN	O	channel	nn	16	SENT_246	[p11l282t3480r475b3524],
16	subunits	NNS	O	subunit	dep	25	SENT_246	[p11l497t3480r704b3524],
17	Kir6	JJ	O	kir6	amod	19	SENT_246	[p11l726t3481r869b3524],
18	.2	NN	NUMBER	.2	nn	19	SENT_246	[p11l726t3481r869b3524],
19	(	NN	O	(	dep	16	SENT_246	[p11l895t3480r1119b3535],
20	l	NN	O	l	dep	25	SENT_246	[p11l895t3480r1119b3535],
21	(	CD	NUMBER	(	num	20	SENT_246	[p11l895t3480r1119b3535],
22	CN	NN	MISC	cn	nn	25	SENT_246	[p11l895t3480r1119b3535],
23	]	CD	NUMBER	]	num	25	SENT_246	[p11l895t3480r1119b3535],
24	l1	NN	O	l1	nn	25	SENT_246	[p11l895t3480r1119b3535],
25	)	NN	O	)	dep	8	SENT_246	[p11l895t3480r1119b3535],
26	and	CC	O	and	_	0	SENT_246	[p11l1144t3480r1233b3524],
27	SURI	NN	PERSON	surus	nn	30	SENT_246	[p11l1255t3483r1376b3524],
28	(	CD	NUMBER	(	num	30	SENT_246	[p11l1407t3481r1609b3535],
29	ABCC8	NN	O	abcc8	nn	30	SENT_246	[p11l1407t3481r1609b3535],
30	)	NN	O	)	conj_and	25	SENT_246	[p11l1407t3481r1609b3535],
31	conﬁrm	NN	O	conﬁrm	dep	3	SENT_246	[p11l1634t3480r1825b3524],
32	that	WDT	O	that	dobj	42	SENT_246	[p11l1846t3480r1944b3524],
33	l	NN	O	l	nsubjpass	42	SENT_246	[p11l1964t3483r2140b3535],
34	(	CD	NUMBER	(	num	35	SENT_246	[p11l1964t3483r2140b3535],
35	CN	NN	O	cn	dep	33	SENT_246	[p11l1964t3483r2140b3535],
36	]	CD	NUMBER	]	number	37	SENT_246	[p11l1964t3483r2140b3535],
37	11	CD	NUMBER	11	dep	33	SENT_246	[p11l1964t3483r2140b3535],
38	E23I	NN	O	e23us	nn	40	SENT_246	[p11l134t3549r259b3591],
39	(	NN	O	(	nn	40	SENT_246	[p11l134t3549r259b3591],
40	variant	NN	O	variant	dep	37	SENT_246	[p11l276t3548r451b3591],
41	is	VBZ	O	be	auxpass	42	SENT_246	[p11l470t3548r505b3591],
42	associated	VBN	O	associate	rcmod	31	SENT_246	[p11l526t3547r777b3591],
43	with	IN	O	with	_	0	SENT_246	[p11l797t3547r910b3591],
44	type	NN	O	type	nn	46	SENT_246	[p11l928t3554r1035b3602],
45	2	CD	NUMBER	2	num	46	SENT_246	[p11l1055t3549r1081b3590],
46	diabetes	NN	O	diabetes	prep_with	42	SENT_246	[p11l1103t3547r1318b3591],
47	.	.	O	.	_	0	SENT_246	[p11l1103t3547r1318b3591],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_247	[p11l1339t3547r1548b3591],
2	2003	CD	DATE	2003	num	1	SENT_247	[p11l1569t3549r1988b3597],
3	;	:	O	;	_	0	SENT_247	[p11l1569t3549r1988b3597],
4	52:568	CD	NUMBER	52:568	number	5	SENT_247	[p11l1569t3549r1988b3597],
5	—	CD	NUMBER	—	dep	1	SENT_247	[p11l1569t3549r1988b3597],
6	72	CD	NUMBER	72	dep	5	SENT_247	[p11l1569t3549r1988b3597],
7	.	.	O	.	_	0	SENT_247	[p11l1569t3549r1988b3597],

1	[	NN	O	[	nn	5	SENT_248	[p11l12t3613r104b3668],
2	10	CD	NUMBER	10	num	5	SENT_248	[p11l12t3613r104b3668],
3	]	CD	NUMBER	]	num	5	SENT_248	[p11l12t3613r104b3668],
4	Florez	NNP	ORGANIZATION	Florez	nn	5	SENT_248	[p11l138t3613r281b3657],
5	JC	NNP	ORGANIZATION	JC	_	0	SENT_248	[p11l292t3616r354b3668],
6	,	,	O	,	_	0	SENT_248	[p11l292t3616r354b3668],
7	Burtt	NNP	PERSON	Burtt	nn	8	SENT_248	[p11l372t3616r493b3657],
8	N	NNP	O	N	appos	5	SENT_248	[p11l509t3616r556b3663],
9	,	,	O	,	_	0	SENT_248	[p11l509t3616r556b3663],
10	de	NNP	O	de	nn	12	SENT_248	[p11l575t3613r631b3657],
11	Bakker	NNP	ORGANIZATION	Bakker	nn	12	SENT_248	[p11l649t3613r814b3657],
12	PIW	NNP	ORGANIZATION	PIW	appos	8	SENT_248	[p11l830t3616r938b3664],
13	,	,	O	,	_	0	SENT_248	[p11l830t3616r938b3664],
14	Almgren	NNP	ORGANIZATION	Almgren	nn	15	SENT_248	[p11l955t3613r1164b3668],
15	P	NN	ORGANIZATION	p	appos	8	SENT_248	[p11l1181t3616r1219b3663],
16	,	,	O	,	_	0	SENT_248	[p11l1181t3616r1219b3663],
17	Tuomi	NN	ORGANIZATION	tuomus	nn	18	SENT_248	[p11l1235t3614r1389b3657],
18	T	NN	ORGANIZATION	t	appos	8	SENT_248	[p11l1404t3616r1444b3663],
19	,	,	O	,	_	0	SENT_248	[p11l1404t3616r1444b3663],
20	Holmqvist	NNP	PERSON	Holmqvist	nn	21	SENT_248	[p11l1462t3613r1711b3668],
21	J	NNP	PERSON	J	appos	8	SENT_248	[p11l1721t3616r1752b3668],
22	,	,	O	,	_	0	SENT_248	[p11l1721t3616r1752b3668],
23	et	FW	O	et	nn	24	SENT_248	[p11l1770t3620r1816b3657],
24	al.	FW	O	al.	appos	8	SENT_248	[p11l1831t3613r1881b3657],
25	.	.	O	.	_	0	SENT_248	[p11l1831t3613r1881b3657],

1	Haplotype	NN	O	haplotype	nn	2	SENT_249	[p11l1900t3613r2147b3668],
2	structure	NN	O	structure	_	0	SENT_249	[p11l138t3685r354b3722],
3	and	CC	O	and	_	0	SENT_249	[p11l379t3679r466b3722],
4	genotype	NN	O	genotype	conj_and	2	SENT_249	[p11l492t3679r1005b3733],
5	—	CD	NUMBER	—	num	7	SENT_249	[p11l492t3679r1005b3733],
6	phenotype	NN	O	phenotype	nn	7	SENT_249	[p11l492t3679r1005b3733],
7	correlations	NNS	O	correlation	dep	2	SENT_249	[p11l1031t3679r1315b3722],
8	of	IN	O	of	_	0	SENT_249	[p11l1340t3679r1390b3722],
9	the	DT	O	the	det	11	SENT_249	[p11l1409t3679r1485b3722],
10	sulfonylurea	NN	O	sulfonylurea	nn	11	SENT_249	[p11l1511t3679r1809b3733],
11	receptor	NN	O	receptor	prep_of	7	SENT_249	[p11l1833t3685r2036b3733],
12	and	CC	O	and	_	0	SENT_249	[p11l2059t3679r2146b3722],
13	the	DT	O	the	det	16	SENT_249	[p11l137t3745r214b3789],
14	islet	NN	O	islet	nn	16	SENT_249	[p11l231t3745r329b3789],
15	ATP	NN	O	atp	nn	16	SENT_249	[p11l343t3746r669b3789],
16	—	NN	O	—	dep	2	SENT_249	[p11l343t3746r669b3789],
17	sensitive	JJ	O	sensitive	amod	21	SENT_249	[p11l343t3746r669b3789],
18	potassium	NN	O	potassium	nn	21	SENT_249	[p11l687t3746r934b3799],
19	channel	NN	O	channel	nn	21	SENT_249	[p11l950t3745r1138b3789],
20	gene	NN	O	gene	nn	21	SENT_249	[p11l1155t3758r1270b3799],
21	region	NN	O	region	dep	16	SENT_249	[p11l1287t3746r1450b3799],
22	.	.	O	.	_	0	SENT_249	[p11l1287t3746r1450b3799],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_250	[p11l1468t3745r1673b3789],
2	2004	CD	DATE	2004	num	1	SENT_250	[p11l1690t3747r2100b3795],
3	;	:	O	;	_	0	SENT_250	[p11l1690t3747r2100b3795],
4	53:1360	CD	NUMBER	53:1360	number	5	SENT_250	[p11l1690t3747r2100b3795],
5	—	CD	NUMBER	—	dep	1	SENT_250	[p11l1690t3747r2100b3795],
6	8	CD	NUMBER	8	dep	5	SENT_250	[p11l1690t3747r2100b3795],
7	.	.	O	.	_	0	SENT_250	[p11l1690t3747r2100b3795],

1	[	NN	O	[	_	0	SENT_251	[p12l12t12r104b67],
2	11	CD	NUMBER	11	num	1	SENT_251	[p12l12t12r104b67],
3	]	CD	NUMBER	]	num	5	SENT_251	[p12l12t12r104b67],
4	Inoue	NN	PERSON	inoue	nn	5	SENT_251	[p12l138t15r274b56],
5	H	NN	PERSON	h	dep	1	SENT_251	[p12l296t15r344b63],
6	,	,	O	,	_	0	SENT_251	[p12l296t15r344b63],
7	Ferrer	NNP	PERSON	Ferrer	nn	8	SENT_251	[p12l366t15r514b56],
8	J	NNP	PERSON	J	appos	5	SENT_251	[p12l528t15r559b67],
9	,	,	O	,	_	0	SENT_251	[p12l528t15r559b67],
10	Warren-Perry	NNP	O	Warren-Perry	nn	11	SENT_251	[p12l578t15r922b67],
11	M	NNP	O	M	appos	5	SENT_251	[p12l943t15r1001b63],
12	,	,	O	,	_	0	SENT_251	[p12l943t15r1001b63],
13	Zhang	NNP	PERSON	Zhang	nn	14	SENT_251	[p12l1022t13r1174b67],
14	Y	NN	PERSON	y	appos	5	SENT_251	[p12l1192t15r1236b63],
15	,	,	O	,	_	0	SENT_251	[p12l1192t15r1236b63],
16	Millns	NNP	ORGANIZATION	Millns	nn	17	SENT_251	[p12l1258t13r1408b56],
17	R	NNP	ORGANIZATION	R	appos	5	SENT_251	[p12l1430t15r1472b63],
18	,	,	O	,	_	0	SENT_251	[p12l1430t15r1472b63],
19	Turner	NNP	O	Turner	nn	20	SENT_251	[p12l1491t15r1659b56],
20	RC	NNP	O	RC	appos	5	SENT_251	[p12l1679t15r1753b63],
21	,	,	O	,	_	0	SENT_251	[p12l1679t15r1753b63],
22	et	FW	O	et	nn	23	SENT_251	[p12l1775t19r1821b56],
23	al.	FW	O	al.	appos	5	SENT_251	[p12l1841t13r1892b57],
24	.	.	O	.	_	0	SENT_251	[p12l1841t13r1892b57],

1	Sequence	NN	O	sequence	nn	2	SENT_252	[p12l1914t15r2146b67],
2	variants	NNS	O	variant	nsubj	13	SENT_252	[p12l136t80r333b123],
3	in	IN	O	in	_	0	SENT_252	[p12l358t80r403b122],
4	the	DT	O	the	det	7	SENT_252	[p12l427t79r505b123],
5	pancreatic	JJ	O	pancreatic	amod	7	SENT_252	[p12l530t80r785b134],
6	islet	NN	O	islet	nn	7	SENT_252	[p12l809t79r910b123],
7	beta-cell	NN	O	beta-cell	prep_in	2	SENT_252	[p12l933t79r1144b123],
8	inwardly	RB	O	inwardly	advmod	9	SENT_252	[p12l1170t79r1390b134],
9	rectifying	VBG	O	rectify	partmod	7	SENT_252	[p12l1414t79r1648b134],
10	I	PRP	O	I	dobj	9	SENT_252	[p12l1671t82r1756b125],
11	(	VBP	O	(	_	0	SENT_252	[p12l1671t82r1756b125],
12	+	CC	O	+	_	0	SENT_252	[p12l1671t82r1756b125],
13	channel	VBP	O	channel	conj_+	11	SENT_252	[p12l1785t79r1977b123],
14	Kir6	NN	O	kir6	nn	15	SENT_252	[p12l2002t80r2145b123],
15	.2	NN	NUMBER	.2	dobj	13	SENT_252	[p12l2002t80r2145b123],
16	(	CD	NUMBER	(	num	19	SENT_252	[p12l141t145r249b199],
17	Bit	NN	O	bit	nn	19	SENT_252	[p12l141t145r249b199],
18	)	NN	O	)	nn	19	SENT_252	[p12l141t145r249b199],
19	gene	NN	O	gene	dep	15	SENT_252	[p12l280t157r412b199],
20	:	:	O	:	_	0	SENT_252	[p12l280t157r412b199],
21	identiﬁcation	NN	O	identiﬁcation	dep	15	SENT_252	[p12l445t144r772b188],
22	and	CC	O	and	_	0	SENT_252	[p12l801t144r890b188],
23	lack	NN	O	lack	conj_and	21	SENT_252	[p12l921t144r1017b188],
24	of	IN	O	of	_	0	SENT_252	[p12l1045t144r1096b188],
25	role	NN	O	role	prep_of	21	SENT_252	[p12l1119t144r1212b188],
26	in	IN	O	in	_	0	SENT_252	[p12l1241t145r1286b188],
27	Caucasian	JJ	MISC	caucasian	amod	28	SENT_252	[p12l1316t145r1558b188],
28	patients	NNS	O	patient	prep_in	25	SENT_252	[p12l1587t145r1784b199],
29	with	IN	O	with	_	0	SENT_252	[p12l1812t144r1925b188],
30	NIDDM	NN	ORGANIZATION	niddm	prep_with	28	SENT_252	[p12l1954t147r2146b188],
31	.	.	O	.	_	0	SENT_252	[p12l1954t147r2146b188],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_253	[p12l138t211r347b255],
2	1997	CD	DATE	1997	num	1	SENT_253	[p12l369t213r755b261],
3	;	:	O	;	_	0	SENT_253	[p12l369t213r755b261],
4	46:502	CD	NUMBER	46:502	num	5	SENT_253	[p12l369t213r755b261],
5	—	NN	O	—	dep	1	SENT_253	[p12l369t213r755b261],
6	7	CD	NUMBER	7	dep	5	SENT_253	[p12l369t213r755b261],
7	.	.	O	.	_	0	SENT_253	[p12l369t213r755b261],

1	[	NN	O	[	nn	5	SENT_254	[p12l12t277r104b332],
2	12	CD	NUMBER	12	num	5	SENT_254	[p12l12t277r104b332],
3	]	CD	NUMBER	]	num	5	SENT_254	[p12l12t277r104b332],
4	Sesti	NNP	O	Sesti	nn	5	SENT_254	[p12l138t278r250b321],
5	G	NNP	O	G	_	0	SENT_254	[p12l270t279r315b327],
6	,	,	O	,	_	0	SENT_254	[p12l270t279r315b327],
7	Laratta	NNP	O	Laratta	nn	8	SENT_254	[p12l336t280r505b321],
8	E	NNP	O	E	appos	5	SENT_254	[p12l524t280r563b327],
9	,	,	O	,	_	0	SENT_254	[p12l524t280r563b327],
10	Cardellini	NNP	PERSON	Cardellini	nn	11	SENT_254	[p12l583t277r818b321],
11	M	NNP	O	M	appos	8	SENT_254	[p12l838t280r896b328],
12	,	,	O	,	_	0	SENT_254	[p12l838t280r896b328],
13	Andreozzi	NNP	PERSON	Andreozzi	nn	14	SENT_254	[p12l915t277r1164b321],
14	F	NN	PERSON	f	appos	8	SENT_254	[p12l1184t280r1219b327],
15	,	,	O	,	_	0	SENT_254	[p12l1184t280r1219b327],
16	Del	NNP	LOCATION	Del	nn	18	SENT_254	[p12l1240t277r1318b321],
17	Guerra	NNP	LOCATION	Guerra	nn	18	SENT_254	[p12l1338t279r1506b321],
18	S	NN	LOCATION	s	appos	8	SENT_254	[p12l1525t279r1562b327],
19	,	,	O	,	_	0	SENT_254	[p12l1525t279r1562b327],
20	Irace	NN	O	irace	nn	21	SENT_254	[p12l1582t280r1698b321],
21	C	NN	O	c	appos	8	SENT_254	[p12l1718t279r1758b327],
22	,	,	O	,	_	0	SENT_254	[p12l1718t279r1758b327],
23	et	FW	O	et	nn	24	SENT_254	[p12l1778t284r1825b321],
24	al.	FW	O	al.	appos	8	SENT_254	[p12l1843t277r1894b321],
25	.	.	O	.	_	0	SENT_254	[p12l1843t277r1894b321],

1	The	DT	O	the	det	3	SENT_255	[p12l1912t277r2002b321],
2	E23K	NN	O	e23k	nn	3	SENT_255	[p12l2022t279r2148b321],
3	variant	NN	O	variant	_	0	SENT_255	[p12l136t344r303b386],
4	of	IN	O	of	_	0	SENT_255	[p12l318t343r367b386],
5	KCNJ11	NN	O	kcnj11	prep_of	3	SENT_255	[p12l377t345r546b397],
6	encoding	VBG	O	encode	partmod	3	SENT_255	[p12l569t343r786b397],
7	the	DT	O	the	det	11	SENT_255	[p12l799t343r876b386],
8	pancreatic	JJ	O	pancreatic	amod	11	SENT_255	[p12l891t344r1135b397],
9	[	NN	O	[	nn	11	SENT_255	[p12l1149t343r1281b397],
10	3-cell	NN	O	3-cell	nn	11	SENT_255	[p12l1149t343r1281b397],
11	adenosine	NN	O	adenosine	dobj	6	SENT_255	[p12l1297t343r1536b386],
12	5	CD	NUMBER	5	num	13	SENT_255	[p12l1553t343r2146b397],
13	’	NN	O	’	dep	11	SENT_255	[p12l1553t343r2146b397],
14	.	.	O	.	_	0	SENT_255	[p12l1553t343r2146b397],

1	—	NN	O	—	_	0	SENT_256	[p12l1553t343r2146b397],
2	.	.	O	.	_	0	SENT_256	[p12l1553t343r2146b397],

1	triphosphate-sensitive	JJ	O	triphosphate-sensitive	amod	3	SENT_257	[p12l1553t343r2146b397],
2	potassium	NN	O	potassium	nn	3	SENT_257	[p12l138t409r380b463],
3	channel	NN	O	channel	nsubjpass	8	SENT_257	[p12l393t408r577b452],
4	subunit	NN	O	subunit	nn	6	SENT_257	[p12l591t408r771b452],
5	Kir6	NN	O	kir6	nn	6	SENT_257	[p12l782t409r918b452],
6	.2	NN	NUMBER	.2	dep	3	SENT_257	[p12l782t409r918b452],
7	is	VBZ	O	be	auxpass	8	SENT_257	[p12l933t409r968b452],
8	associated	VBN	O	associate	_	0	SENT_257	[p12l980t409r1221b452],
9	with	IN	O	with	_	0	SENT_257	[p12l1233t408r1342b452],
10	increased	VBN	O	increase	amod	11	SENT_257	[p12l1356t408r1578b452],
11	risk	NN	O	risk	prep_with	8	SENT_257	[p12l1592t409r1677b452],
12	of	IN	O	of	_	0	SENT_257	[p12l1689t408r1739b452],
13	secondary	JJ	O	secondary	amod	14	SENT_257	[p12l1747t408r1986b463],
14	failure	NN	O	failure	prep_of	11	SENT_257	[p12l1998t408r2146b452],
15	to	TO	O	to	_	0	SENT_257	[p12l137t481r182b518],
16	sulphonylurea	NN	O	sulphonylurea	prep_to	14	SENT_257	[p12l203t474r540b529],
17	in	IN	O	in	_	0	SENT_257	[p12l560t475r604b518],
18	patients	NNS	O	patient	prep_in	16	SENT_257	[p12l623t475r811b529],
19	with	IN	O	with	_	0	SENT_257	[p12l830t474r938b518],
20	type	NN	O	type	nn	22	SENT_257	[p12l957t481r1060b529],
21	2	CD	NUMBER	2	num	22	SENT_257	[p12l1080t477r1106b518],
22	diabetes	NN	O	diabetes	prep_with	18	SENT_257	[p12l1127t474r1365b529],
23	.	.	O	.	_	0	SENT_257	[p12l1127t474r1365b529],

1	_	NN	O	_	nn	5	SENT_258	[p12l1127t474r1365b529],
2	]	CD	NUMBER	]	num	5	SENT_258	[p12l1127t474r1365b529],
3	Clin	NNP	O	Clin	nn	5	SENT_258	[p12l1384t474r1476b518],
4	Endocrinol	NNP	O	Endocrinol	nn	5	SENT_258	[p12l1494t474r1748b518],
5	Metab	NNP	O	Metab	_	0	SENT_258	[p12l1767t474r1916b518],
6	2006	CD	DATE	2006	dep	5	SENT_258	[p12l1935t477r2143b525],
7	;	:	O	;	_	0	SENT_258	[p12l1935t477r2143b525],
8	91	CD	NUMBER	91	num	10	SENT_258	[p12l1935t477r2143b525],
9	:	:	O	:	_	0	SENT_258	[p12l1935t477r2143b525],
10	2334-9	CD	NUMBER	2334-9	dep	5	SENT_258	[p12l137t544r325b586],
11	.	.	O	.	_	0	SENT_258	[p12l137t544r325b586],

1	[	RB	O	[	dep	3	SENT_259	[p12l12t608r104b663],
2	13	CD	NUMBER	13	num	3	SENT_259	[p12l12t608r104b663],
3	]	CD	NUMBER	]	_	0	SENT_259	[p12l12t608r104b663],
4	Hamming	VBG	O	ham	rcmod	3	SENT_259	[p12l138t609r376b663],
5	KS	NN	O	k	dobj	4	SENT_259	[p12l391t610r461b658],
6	,	,	O	,	_	0	SENT_259	[p12l391t610r461b658],
7	Soliman	NNP	PERSON	Soliman	nn	8	SENT_259	[p12l478t608r671b652],
8	D	NNP	PERSON	D	appos	5	SENT_259	[p12l686t611r733b658],
9	,	,	O	,	_	0	SENT_259	[p12l686t611r733b658],
10	Matemisz	NNP	ORGANIZATION	Matemisz	nn	11	SENT_259	[p12l749t609r982b652],
11	LC	NNP	ORGANIZATION	LC	appos	5	SENT_259	[p12l998t610r1063b659],
12	,	,	O	,	_	0	SENT_259	[p12l998t610r1063b659],
13	Niazi	NNP	PERSON	Niazi	nn	14	SENT_259	[p12l1079t609r1199b652],
14	O	NNP	PERSON	O	appos	5	SENT_259	[p12l1214t610r1261b658],
15	,	,	O	,	_	0	SENT_259	[p12l1214t610r1261b658],
16	Lang	NNP	LOCATION	Lang	nn	17	SENT_259	[p12l1277t611r1390b663],
17	Y	NN	LOCATION	y	appos	5	SENT_259	[p12l1401t611r1444b658],
18	,	,	O	,	_	0	SENT_259	[p12l1401t611r1444b658],
19	Gloyn	NNP	ORGANIZATION	Gloyn	nn	20	SENT_259	[p12l1460t608r1601b663],
20	AL	NNP	ORGANIZATION	AL	appos	5	SENT_259	[p12l1614t610r1685b659],
21	,	,	O	,	_	0	SENT_259	[p12l1614t610r1685b659],
22	et	FW	O	et	nn	23	SENT_259	[p12l1701t615r1748b652],
23	al.	FW	O	al.	appos	5	SENT_259	[p12l1761t608r1811b652],
24	.	.	O	.	_	0	SENT_259	[p12l1761t608r1811b652],

1	Coexpression	NN	O	coexpression	nsubj	16	SENT_260	[p12l1828t609r2147b663],
2	of	IN	O	of	_	0	SENT_260	[p12l137t674r188b717],
3	the	DT	O	the	det	12	SENT_260	[p12l198t674r275b717],
4	type	NN	O	type	amod	12	SENT_260	[p12l292t680r396b728],
5	2	CD	NUMBER	2	number	4	SENT_260	[p12l414t676r441b717],
6	diabetes	NN	O	diabetes	nn	12	SENT_260	[p12l459t674r658b717],
7	susceptibility	NN	O	susceptibility	nn	12	SENT_260	[p12l676t674r994b728],
8	gene	NN	O	gene	nn	12	SENT_260	[p12l1009t686r1124b728],
9	variants	NNS	O	variant	nn	12	SENT_260	[p12l1139t675r1330b717],
10	KCNJ11	NN	O	kcnj11	nn	12	SENT_260	[p12l1349t676r1521b728],
11	E23I	NN	O	e23us	nn	12	SENT_260	[p12l1545t676r1669b717],
12	(	NN	O	(	prep_of	1	SENT_260	[p12l1545t676r1669b717],
13	and	CC	O	and	_	0	SENT_260	[p12l1685t674r1773b717],
14	ABCC8	NN	O	abcc8	nn	15	SENT_260	[p12l1788t676r1946b717],
15	S1369A	NN	O	s1369a	conj_and	12	SENT_260	[p12l1965t676r2149b717],
16	alter	VBP	O	alter	_	0	SENT_260	[p12l137t739r247b783],
17	the	DT	O	the	det	21	SENT_260	[p12l258t740r335b783],
18	ATP	NN	ORGANIZATION	atp	nn	21	SENT_260	[p12l346t741r440b783],
19	and	CC	O	and	_	0	SENT_260	[p12l453t739r541b783],
20	sulfonylurea	NN	O	sulfonylurea	conj_and	18	SENT_260	[p12l555t739r853b794],
21	sensitivities	NNS	O	sensitivity	dobj	16	SENT_260	[p12l865t740r1145b783],
22	of	IN	O	of	_	0	SENT_260	[p12l1159t739r1211b783],
23	the	DT	O	the	det	24	SENT_260	[p12l1217t740r1293b783],
24	ATP-sensitive	JJ	O	atp-sensitive	prep_of	21	SENT_260	[p12l1305t740r1630b783],
25	I	PRP	O	I	nsubj	26	SENT_260	[p12l1645t734r1712b783],
26	(	VBP	O	(	rcmod	21	SENT_260	[p12l1645t734r1712b783],
27	+	CC	O	+	cc	28	SENT_260	[p12l1645t734r1712b783],
28	channel	NN	O	channel	dobj	26	SENT_260	[p12l1728t740r1927b784],
29	.	.	O	.	_	0	SENT_260	[p12l1728t740r1927b784],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_261	[p12l1942t740r2146b783],
2	2009	CD	DATE	2009	num	1	SENT_261	[p12l137t808r577b856],
3	;	:	O	;	_	0	SENT_261	[p12l137t808r577b856],
4	58:2419	CD	NUMBER	58:2419	number	5	SENT_261	[p12l137t808r577b856],
5	—	CD	NUMBER	—	dep	1	SENT_261	[p12l137t808r577b856],
6	24	CD	NUMBER	24	dep	5	SENT_261	[p12l137t808r577b856],
7	.	.	O	.	_	0	SENT_261	[p12l137t808r577b856],

1	[	RB	O	[	dep	5	SENT_262	[p12l12t872r104b927],
2	14	CD	NUMBER	14	num	5	SENT_262	[p12l12t872r104b927],
3	]	CD	NUMBER	]	num	5	SENT_262	[p12l12t872r104b927],
4	Gloyn	NNP	O	Gloyn	nn	5	SENT_262	[p12l138t872r284b927],
5	AL	NNP	O	AL	_	0	SENT_262	[p12l302t874r375b922],
6	,	,	O	,	_	0	SENT_262	[p12l302t874r375b922],
7	Hashim	NNP	PERSON	Hashim	nn	8	SENT_262	[p12l398t872r588b916],
8	Y	NN	PERSON	y	appos	5	SENT_262	[p12l606t875r650b922],
9	,	,	O	,	_	0	SENT_262	[p12l606t875r650b922],
10	Ashcroft	NNP	PERSON	Ashcroft	nn	12	SENT_262	[p12l669t872r882b916],
11	S	NNP	O	S	nn	12	SENT_262	[p12l901t874r956b927],
12	]	NNP	O	]	appos	5	SENT_262	[p12l901t874r956b927],
13	,	,	O	,	_	0	SENT_262	[p12l901t874r956b927],
14	Ashﬁeld	NNP	ORGANIZATION	Ashﬁeld	nn	15	SENT_262	[p12l975t872r1179b916],
15	R	NNP	ORGANIZATION	R	appos	12	SENT_262	[p12l1200t875r1243b922],
16	,	,	O	,	_	0	SENT_262	[p12l1200t875r1243b922],
17	Wiltshire	NNP	LOCATION	Wiltshire	nn	18	SENT_262	[p12l1261t872r1497b916],
18	S	NNP	O	S	appos	12	SENT_262	[p12l1517t874r1555b923],
19	,	,	O	,	_	0	SENT_262	[p12l1517t874r1555b923],
20	Turner	NNP	O	Turner	nn	21	SENT_262	[p12l1574t875r1746b916],
21	RC	NNP	O	RC	appos	12	SENT_262	[p12l1764t875r1840b916],
22	.	.	O	.	_	0	SENT_262	[p12l1764t875r1840b916],

1	Association	NNP	O	Association	nn	2	SENT_263	[p12l1858t873r2147b916],
2	studies	NNS	O	study	_	0	SENT_263	[p12l138t938r314b981],
3	of	IN	O	of	_	0	SENT_263	[p12l340t937r392b981],
4	variants	NNS	O	variant	prep_of	2	SENT_263	[p12l409t938r611b981],
5	in	IN	O	in	_	0	SENT_263	[p12l638t938r684b981],
6	promoter	NN	O	promoter	prep_in	4	SENT_263	[p12l709t944r948b992],
7	and	CC	O	and	_	0	SENT_263	[p12l972t937r1062b981],
8	coding	VBG	O	code	amod	9	SENT_263	[p12l1089t937r1257b992],
9	regions	NNS	O	region	conj_and	4	SENT_263	[p12l1281t938r1464b992],
10	of	IN	O	of	_	0	SENT_263	[p12l1491t937r1543b981],
11	beta-cell	NN	O	beta-cell	nn	14	SENT_263	[p12l1561t937r1778b981],
12	ATP-sensitive	JJ	O	atp-sensitive	amod	14	SENT_263	[p12l1802t938r2146b981],
13	K-channel	NN	O	k-channel	nn	14	SENT_263	[p12l138t1004r393b1048],
14	genes	NNS	O	gene	prep_of	9	SENT_263	[p12l418t1017r561b1058],
15	SUR1	NN	O	sur1	nn	18	SENT_263	[p12l587t1006r711b1048],
16	and	CC	O	and	_	0	SENT_263	[p12l743t1004r834b1048],
17	Kir6	NN	O	kir6	nn	18	SENT_263	[p12l861t1005r1007b1048],
18	.2	NN	NUMBER	.2	dep	27	SENT_263	[p12l861t1005r1007b1048],
19	with	IN	O	with	_	0	SENT_263	[p12l1033t1004r1149b1048],
20	type	NN	O	type	nn	23	SENT_263	[p12l1174t1010r1283b1058],
21	2	CD	NUMBER	2	num	23	SENT_263	[p12l1309t1006r1335b1047],
22	diabetes	NN	O	diabetes	nn	23	SENT_263	[p12l1363t1004r1571b1048],
23	mellitus	NN	O	mellitus	prep_with	18	SENT_263	[p12l1598t1004r1801b1048],
24	(	CD	NUMBER	(	num	25	SENT_263	[p12l1831t1004r2022b1058],
25	UI	NN	O	uus	dep	27	SENT_263	[p12l1831t1004r2022b1058],
26	(	CD	NUMBER	(	num	27	SENT_263	[p12l1831t1004r2022b1058],
27	PDS	NN	O	pd	dep	9	SENT_263	[p12l1831t1004r2022b1058],
28	53	CD	NUMBER	53	num	29	SENT_263	[p12l2050t1004r2146b1058],
29	)	NN	O	)	dep	27	SENT_263	[p12l2050t1004r2146b1058],
30	.	.	O	.	_	0	SENT_263	[p12l2050t1004r2146b1058],

1	Diabet	NNP	O	Diabet	nn	2	SENT_264	[p12l138t1070r301b1114],
2	Med	NNP	O	Med	_	0	SENT_264	[p12l319t1070r427b1114],
3	2001	CD	DATE	2001	num	2	SENT_264	[p12l447t1072r564b1114],
4	;	:	O	;	_	0	SENT_264	[p12l578t1072r877b1121],
5	18:206	CD	NUMBER	18:206	number	6	SENT_264	[p12l578t1072r877b1121],
6	—	CD	NUMBER	—	dep	2	SENT_264	[p12l578t1072r877b1121],
7	12	CD	NUMBER	12	dep	6	SENT_264	[p12l578t1072r877b1121],
8	.	.	O	.	_	0	SENT_264	[p12l578t1072r877b1121],

1	[	RB	O	[	advmod	2	SENT_265	[p12l12t1136r104b1190],
2	15	CD	NUMBER	15	_	0	SENT_265	[p12l12t1136r104b1190],
3	]	CD	NUMBER	]	num	5	SENT_265	[p12l12t1136r104b1190],
4	Feng	NNP	O	Feng	nn	5	SENT_265	[p12l138t1139r251b1190],
5	Y	NN	O	y	dep	2	SENT_265	[p12l265t1138r308b1186],
6	,	,	O	,	_	0	SENT_265	[p12l265t1138r308b1186],
7	Mao	NNP	PERSON	Mao	nn	8	SENT_265	[p12l326t1139r429b1179],
8	G	NNP	PERSON	G	appos	5	SENT_265	[p12l447t1138r492b1186],
9	,	,	O	,	_	0	SENT_265	[p12l447t1138r492b1186],
10	Ren	NNP	O	Ren	nn	11	SENT_265	[p12l510t1139r600b1179],
11	X	NNP	O	X	appos	5	SENT_265	[p12l615t1139r661b1186],
12	,	,	O	,	_	0	SENT_265	[p12l615t1139r661b1186],
13	Xing	NNP	O	Xing	nn	14	SENT_265	[p12l676t1137r789b1190],
14	H	NNP	O	H	appos	5	SENT_265	[p12l804t1138r852b1186],
15	,	,	O	,	_	0	SENT_265	[p12l804t1138r852b1186],
16	Tang	NNP	PERSON	Tang	nn	17	SENT_265	[p12l868t1139r985b1190],
17	G	NNP	PERSON	G	appos	5	SENT_265	[p12l1002t1138r1048b1186],
18	,	,	O	,	_	0	SENT_265	[p12l1002t1138r1048b1186],
19	Li	NNP	O	Li	nn	20	SENT_265	[p12l1065t1137r1103b1179],
20	Q	NNP	O	Q	appos	5	SENT_265	[p12l1120t1138r1167b1188],
21	,	,	O	,	_	0	SENT_265	[p12l1120t1138r1167b1188],
22	et	FW	O	et	nn	23	SENT_265	[p12l1184t1142r1230b1179],
23	al.	FW	O	al.	appos	5	SENT_265	[p12l1245t1136r1296b1180],
24	.	.	O	.	_	0	SENT_265	[p12l1245t1136r1296b1180],

1	Ser1369Ala	NN	O	ser1369alum	nn	2	SENT_266	[p12l1314t1136r1586b1179],
2	variant	NN	O	variant	nsubjpass	9	SENT_266	[p12l1602t1137r1772b1179],
3	in	IN	O	in	_	0	SENT_266	[p12l1788t1137r1833b1179],
4	sulfonylurea	NN	O	sulfonylurea	nn	7	SENT_266	[p12l1851t1136r2148b1190],
5	receptor	NN	O	receptor	nn	7	SENT_266	[p12l138t1208r340b1256],
6	gene	NN	O	gene	nn	7	SENT_266	[p12l354t1214r469b1256],
7	ABCC8	NN	O	abcc8	prep_in	2	SENT_266	[p12l484t1203r641b1245],
8	is	VBZ	O	be	auxpass	9	SENT_266	[p12l661t1202r696b1245],
9	associated	VBN	O	associate	_	0	SENT_266	[p12l713t1201r958b1245],
10	with	IN	O	with	_	0	SENT_266	[p12l974t1201r1085b1245],
11	antidiabetic	JJ	O	antidiabetic	amod	12	SENT_266	[p12l1102t1201r1385b1245],
12	efﬁcacy	NN	O	efﬁcacy	prep_with	9	SENT_266	[p12l1400t1201r1582b1256],
13	of	IN	O	of	_	0	SENT_266	[p12l1597t1201r1648b1245],
14	gliclazide	NN	O	gliclazide	prep_of	12	SENT_266	[p12l1657t1201r1881b1256],
15	in	IN	O	in	_	0	SENT_266	[p12l1899t1202r1944b1245],
16	Chinese	JJ	MISC	chinese	amod	20	SENT_266	[p12l1960t1202r2146b1245],
17	type	NN	O	type	nn	20	SENT_266	[p12l137t1274r241b1322],
18	2	CD	NUMBER	2	num	20	SENT_266	[p12l259t1270r285b1311],
19	diabetic	JJ	O	diabetic	amod	20	SENT_266	[p12l304t1268r493b1311],
20	patients	NNS	O	patient	prep_in	9	SENT_266	[p12l509t1268r712b1322],
21	.	.	O	.	_	0	SENT_266	[p12l509t1268r712b1322],

1	Diabetes	NNP	O	Diabetes	nn	2	SENT_267	[p12l730t1268r935b1311],
2	Care	NNP	O	Care	_	0	SENT_267	[p12l952t1270r1058b1311],
3	2008	CD	DATE	2008	num	2	SENT_267	[p12l1074t1270r1514b1318],
4	;	:	O	;	_	0	SENT_267	[p12l1074t1270r1514b1318],
5	31:1939	CD	NUMBER	31:1939	number	6	SENT_267	[p12l1074t1270r1514b1318],
6	—	CD	NUMBER	—	dep	2	SENT_267	[p12l1074t1270r1514b1318],
7	44	CD	NUMBER	44	dep	6	SENT_267	[p12l1074t1270r1514b1318],
8	.	.	O	.	_	0	SENT_267	[p12l1074t1270r1514b1318],

1	[	RB	O	[	advmod	3	SENT_268	[p12l12t1334r104b1389],
2	16	CD	NUMBER	16	number	3	SENT_268	[p12l12t1334r104b1389],
3	]	CD	NUMBER	]	_	0	SENT_268	[p12l12t1334r104b1389],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_268	[p12l136t1334r289b1389],
5	H	NN	PERSON	h	dep	3	SENT_268	[p12l315t1337r363b1384],
6	,	,	O	,	_	0	SENT_268	[p12l315t1337r363b1384],
7	Liu	NNP	LOCATION	Liu	nn	8	SENT_268	[p12l391t1335r462b1378],
8	X	NNP	LOCATION	X	appos	3	SENT_268	[p12l488t1337r534b1384],
9	,	,	O	,	_	0	SENT_268	[p12l488t1337r534b1384],
10	Kuang	NNP	PERSON	Kuang	nn	11	SENT_268	[p12l562t1337r716b1389],
11	H	NNP	PERSON	H	appos	8	SENT_268	[p12l743t1337r791b1385],
12	,	,	O	,	_	0	SENT_268	[p12l743t1337r791b1385],
13	Yi	NNP	PERSON	Yi	nn	14	SENT_268	[p12l817t1335r865b1377],
14	R	NNP	PERSON	R	appos	8	SENT_268	[p12l892t1337r934b1384],
15	,	,	O	,	_	0	SENT_268	[p12l892t1337r934b1384],
16	Xing	NNP	ORGANIZATION	Xing	nn	18	SENT_268	[p12l960t1335r1074b1389],
17	H.	NNP	ORGANIZATION	H.	nn	18	SENT_268	[p12l1100t1337r1148b1378],
18	Association	NNP	ORGANIZATION	Association	appos	8	SENT_268	[p12l1174t1335r1454b1378],
19	of	IN	ORGANIZATION	of	_	0	SENT_268	[p12l1482t1334r1533b1378],
20	sulfonylurea	NN	ORGANIZATION	sulfonylurea	nn	21	SENT_268	[p12l1554t1334r1859b1389],
21	receptor	NN	O	receptor	prep_of	18	SENT_268	[p12l1887t1341r2093b1389],
22	1	CD	NUMBER	1	num	23	SENT_268	[p12l2121t1337r2140b1377],
23	genotype	NN	O	genotype	dep	3	SENT_268	[p12l137t1407r364b1455],
24	with	IN	O	with	_	0	SENT_268	[p12l392t1400r505b1444],
25	therapeutic	JJ	O	therapeutic	amod	26	SENT_268	[p12l533t1400r816b1455],
26	response	NN	O	response	prep_with	23	SENT_268	[p12l845t1413r1062b1455],
27	to	TO	O	to	_	0	SENT_268	[p12l1091t1407r1138b1444],
28	gliclazide	NN	O	gliclazide	prep_to	26	SENT_268	[p12l1166t1400r1397b1455],
29	in	IN	O	in	_	0	SENT_268	[p12l1426t1401r1472b1443],
30	type	NN	O	type	nn	32	SENT_268	[p12l1499t1407r1606b1455],
31	2	CD	NUMBER	2	num	32	SENT_268	[p12l1635t1403r1661b1443],
32	diabetes	NN	O	diabetes	prep_in	28	SENT_268	[p12l1691t1400r1907b1444],
33	.	.	O	.	_	0	SENT_268	[p12l1691t1400r1907b1444],

1	Diabetes	NNP	O	Diabetes	nn	4	SENT_269	[p12l1937t1400r2146b1444],
2	Res	NNP	O	Res	nn	4	SENT_269	[p12l138t1469r219b1509],
3	Clin	NNP	O	Clin	nn	4	SENT_269	[p12l240t1466r333b1509],
4	Pract	NNP	O	Pract	_	0	SENT_269	[p12l353t1469r476b1509],
5	2007	CD	DATE	2007	num	4	SENT_269	[p12l495t1468r883b1516],
6	;	:	O	;	_	0	SENT_269	[p12l495t1468r883b1516],
7	77:58	CD	NUMBER	77:58	number	8	SENT_269	[p12l495t1468r883b1516],
8	—	CD	NUMBER	—	dep	4	SENT_269	[p12l495t1468r883b1516],
9	61	CD	NUMBER	61	dep	8	SENT_269	[p12l495t1468r883b1516],
10	.	.	O	.	_	0	SENT_269	[p12l495t1468r883b1516],

1	[	NN	O	[	_	0	SENT_270	[p12l12t1531r104b1586],
2	17	CD	NUMBER	17	number	3	SENT_270	[p12l12t1531r104b1586],
3	]	CD	NUMBER	]	dep	1	SENT_270	[p12l12t1531r104b1586],
4	American	JJ	ORGANIZATION	american	amod	6	SENT_270	[p12l135t1532r372b1575],
5	Diabetes	NNP	ORGANIZATION	Diabetes	nn	6	SENT_270	[p12l394t1532r603b1575],
6	Association	NNP	ORGANIZATION	Association	dep	3	SENT_270	[p12l624t1532r916b1576],
7	.	.	O	.	_	0	SENT_270	[p12l624t1532r916b1576],

1	Diagnosis	NN	O	diagnosis	_	0	SENT_271	[p12l939t1532r1173b1586],
2	and	CC	O	and	_	0	SENT_271	[p12l1196t1532r1284b1575],
3	classiﬁcation	NN	O	classiﬁcation	conj_and	1	SENT_271	[p12l1307t1531r1622b1575],
4	of	IN	O	of	_	0	SENT_271	[p12l1643t1532r1695b1575],
5	diabetes	NN	O	diabetes	nn	6	SENT_271	[p12l1710t1532r1913b1575],
6	mellitus	NN	O	mellitus	prep_of	1	SENT_271	[p12l1936t1532r2146b1576],
7	.	.	O	.	_	0	SENT_271	[p12l1936t1532r2146b1576],

1	Diabetes	NNP	O	Diabetes	nn	2	SENT_272	[p12l138t1598r347b1641],
2	Care	NNP	O	Care	_	0	SENT_272	[p12l367t1600r474b1641],
3	2006	CD	DATE	2006	num	5	SENT_272	[p12l494t1600r880b1648],
4	;	:	O	;	_	0	SENT_272	[p12l494t1600r880b1648],
5	29	CD	NUMBER	29	dep	2	SENT_272	[p12l494t1600r880b1648],
6	:	:	O	:	_	0	SENT_272	[p12l494t1600r880b1648],
7	S43	CD	NUMBER	s43	number	8	SENT_272	[p12l494t1600r880b1648],
8	—	CD	NUMBER	—	dep	2	SENT_272	[p12l494t1600r880b1648],
9	8	CD	NUMBER	8	dep	8	SENT_272	[p12l494t1600r880b1648],
10	.	.	O	.	_	0	SENT_272	[p12l494t1600r880b1648],

1	[	NN	O	[	_	0	SENT_273	[p12l12t1664r104b1719],
2	18	CD	NUMBER	18	num	3	SENT_273	[p12l12t1664r104b1719],
3	]	CD	NUMBER	]	dep	1	SENT_273	[p12l12t1664r104b1719],
4	Vella	NNP	PERSON	Vella	nn	6	SENT_273	[p12l135t1664r258b1708],
5	A.	NN	PERSON	a.	nn	6	SENT_273	[p12l275t1666r321b1708],
6	Pharmacogenetics	NNP	PERSON	Pharmacogenetics	dep	3	SENT_273	[p12l343t1664r789b1719],
7	for	IN	O	for	_	0	SENT_273	[p12l811t1664r879b1708],
8	type	NN	O	type	prep_for	6	SENT_273	[p12l898t1671r1004b1719],
9	2	CD	NUMBER	2	dep	8	SENT_273	[p12l1025t1666r1051b1707],
10	diabetes	NN	O	diabetes	dep	9	SENT_273	[p12l1073t1664r1292b1708],
11	:	:	O	:	_	0	SENT_273	[p12l1073t1664r1292b1708],
12	practical	JJ	O	practical	amod	13	SENT_273	[p12l1317t1664r1525b1719],
13	considerations	NNS	O	consideration	dep	9	SENT_273	[p12l1546t1664r1904b1708],
14	for	IN	O	for	_	0	SENT_273	[p12l1926t1664r1994b1708],
15	study	NN	O	study	nn	16	SENT_273	[p12l2013t1664r2148b1719],
16	design	NN	O	design	prep_for	13	SENT_273	[p12l137t1729r342b1784],
17	.	.	O	.	_	0	SENT_273	[p12l137t1729r342b1784],
18	]	SYM	O	]	dep	6	SENT_273	[p12l137t1729r342b1784],

1	Diabetes	NNP	O	Diabetes	nn	3	SENT_274	[p12l362t1729r571b1773],
2	Sci	NNP	O	Sci	nn	3	SENT_274	[p12l591t1730r657b1773],
3	Technol	NNP	O	Technol	_	0	SENT_274	[p12l675t1730r870b1773],
4	2009	CD	DATE	2009	num	3	SENT_274	[p12l890t1732r1247b1780],
5	;	:	O	;	_	0	SENT_274	[p12l890t1732r1247b1780],
6	3:705	CD	NUMBER	3:705	number	7	SENT_274	[p12l890t1732r1247b1780],
7	—	CD	NUMBER	—	dep	3	SENT_274	[p12l890t1732r1247b1780],
8	9	CD	NUMBER	9	dep	7	SENT_274	[p12l890t1732r1247b1780],
9	.	.	O	.	_	0	SENT_274	[p12l890t1732r1247b1780],

1	[	NN	O	[	_	0	SENT_275	[p12l12t1796r104b1850],
2	19	CD	NUMBER	19	num	1	SENT_275	[p12l12t1796r104b1850],
3	]	CD	NUMBER	]	num	5	SENT_275	[p12l12t1796r104b1850],
4	Kahn	NNP	PERSON	Kahn	nn	5	SENT_275	[p12l138t1796r261b1840],
5	SE	NN	O	se	dep	1	SENT_275	[p12l278t1798r344b1846],
6	,	,	O	,	_	0	SENT_275	[p12l278t1798r344b1846],
7	Haffner	NNP	PERSON	Haffner	nn	8	SENT_275	[p12l363t1796r543b1840],
8	SM	NNP	O	SM	appos	5	SENT_275	[p12l559t1798r644b1846],
9	,	,	O	,	_	0	SENT_275	[p12l559t1798r644b1846],
10	Heise	NNP	PERSON	Heise	nn	11	SENT_275	[p12l663t1797r793b1840],
11	MA	NNP	PERSON	MA	appos	5	SENT_275	[p12l811t1798r904b1846],
12	,	,	O	,	_	0	SENT_275	[p12l811t1798r904b1846],
13	Herman	NNP	PERSON	Herman	nn	14	SENT_275	[p12l923t1799r1117b1840],
14	WH	NNP	PERSON	WH	appos	5	SENT_275	[p12l1132t1799r1238b1846],
15	,	,	O	,	_	0	SENT_275	[p12l1132t1799r1238b1846],
16	Holman	NNP	ORGANIZATION	Holman	nn	17	SENT_275	[p12l1257t1796r1447b1840],
17	RR	NNP	ORGANIZATION	RR	appos	5	SENT_275	[p12l1465t1799r1538b1846],
18	,	,	O	,	_	0	SENT_275	[p12l1465t1799r1538b1846],
19	Jones	NNP	PERSON	Jones	nn	20	SENT_275	[p12l1550t1799r1681b1850],
20	NP	NNP	O	NP	appos	5	SENT_275	[p12l1701t1799r1778b1846],
21	,	,	O	,	_	0	SENT_275	[p12l1701t1799r1778b1846],
22	et	FW	O	et	nn	23	SENT_275	[p12l1796t1802r1842b1840],
23	al.	FW	O	al.	appos	5	SENT_275	[p12l1857t1796r1909b1840],
24	.	.	O	.	_	0	SENT_275	[p12l1857t1796r1909b1840],

1	Glycemic	JJ	O	glycemic	amod	2	SENT_276	[p12l1927t1796r2148b1850],
2	durability	NN	O	durability	_	0	SENT_276	[p12l137t1862r371b1917],
3	of	IN	O	of	_	0	SENT_276	[p12l397t1862r447b1906],
4	rosiglitazone	NN	O	rosiglitazone	nn	6	SENT_276	[p12l468t1862r786b1917],
5	,	,	O	,	_	0	SENT_276	[p12l468t1862r786b1917],
6	metformin	NN	O	metformin	prep_of	2	SENT_276	[p12l814t1862r1083b1912],
7	,	,	O	,	_	0	SENT_276	[p12l814t1862r1083b1912],
8	or	CC	O	or	_	0	SENT_276	[p12l1111t1875r1162b1906],
9	glyburide	NN	O	glyburide	nn	10	SENT_276	[p12l1186t1862r1414b1917],
10	monotherapy	NN	O	monotherapy	conj_or	6	SENT_276	[p12l1442t1862r1778b1917],
11	.	.	O	.	_	0	SENT_276	[p12l1442t1862r1778b1917],

1	N	NN	O	n	nn	3	SENT_277	[p12l1806t1865r1842b1905],
2	Engl	NNP	O	Engl	nn	3	SENT_277	[p12l1870t1862r2013b1917],
3	]	NNP	O	]	nsubj	4	SENT_277	[p12l1870t1862r2013b1917],
4	Med	VBD	O	med	_	0	SENT_277	[p12l2041t1862r2146b1906],
5	2006	CD	DATE	2006	dobj	4	SENT_277	[p12l137t1930r607b1978],
6	;	:	O	;	_	0	SENT_277	[p12l137t1930r607b1978],
7	355:2427	CD	NUMBER	355:2427	number	8	SENT_277	[p12l137t1930r607b1978],
8	—	CD	NUMBER	—	dep	5	SENT_277	[p12l137t1930r607b1978],
9	43	CD	NUMBER	43	dep	8	SENT_277	[p12l137t1930r607b1978],
10	.	.	O	.	_	0	SENT_277	[p12l137t1930r607b1978],

1	[	RB	O	[	advmod	3	SENT_278	[p12l12t1993r104b2048],
2	20	CD	NUMBER	20	number	3	SENT_278	[p12l12t1993r104b2048],
3	]	CD	NUMBER	]	_	0	SENT_278	[p12l12t1993r104b2048],
4	Sole	NNP	O	Sole	nn	5	SENT_278	[p12l138t1994r237b2037],
5	X	NNP	O	X	dep	3	SENT_278	[p12l254t1996r301b2044],
6	,	,	O	,	_	0	SENT_278	[p12l254t1996r301b2044],
7	Guino	NNP	PERSON	Guino	nn	8	SENT_278	[p12l321t1994r466b2037],
8	E	NNP	O	E	appos	3	SENT_278	[p12l486t1996r524b2044],
9	,	,	O	,	_	0	SENT_278	[p12l486t1996r524b2044],
10	Valls	NNP	PERSON	Valls	nn	11	SENT_278	[p12l542t1993r659b2037],
11	J	NNP	PERSON	J	appos	8	SENT_278	[p12l672t1996r704b2048],
12	,	,	O	,	_	0	SENT_278	[p12l672t1996r704b2048],
13	lniesta	NN	O	lniesta	nn	14	SENT_278	[p12l724t1994r886b2037],
14	R	NN	O	r	appos	8	SENT_278	[p12l904t1996r946b2044],
15	,	,	O	,	_	0	SENT_278	[p12l904t1996r946b2044],
16	Moreno	NNP	PERSON	Moreno	nn	18	SENT_278	[p12l966t1996r1156b2037],
17	V.	NNP	O	V.	nn	18	SENT_278	[p12l1174t1996r1220b2037],
18	SNPStats	NNP	O	SNPStats	appos	8	SENT_278	[p12l1240t1996r1470b2037],
19	:	:	O	:	_	0	SENT_278	[p12l1240t1996r1470b2037],
20	a	DT	O	a	det	22	SENT_278	[p12l1493t2006r1518b2037],
21	web	NN	O	web	nn	22	SENT_278	[p12l1535t1993r1638b2037],
22	tool	NN	O	tool	dep	3	SENT_278	[p12l1658t1993r1751b2037],
23	for	IN	O	for	_	0	SENT_278	[p12l1770t1993r1838b2037],
24	the	DT	O	the	det	25	SENT_278	[p12l1856t1993r1933b2037],
25	analysis	NN	O	analysis	prep_for	22	SENT_278	[p12l1952t1994r2146b2048],
26	of	IN	O	of	_	0	SENT_278	[p12l137t2059r188b2103],
27	association	NN	O	association	nn	28	SENT_278	[p12l201t2060r472b2103],
28	studies	NNS	O	study	prep_of	25	SENT_278	[p12l493t2060r676b2104],
29	.	.	O	.	_	0	SENT_278	[p12l493t2060r676b2104],

1	Bioinformatics	NNS	O	bioinformatic	_	0	SENT_279	[p12l698t2059r1054b2103],
2	2006	CD	DATE	2006	num	1	SENT_279	[p12l1074t2062r1494b2110],
3	;	:	O	;	_	0	SENT_279	[p12l1074t2062r1494b2110],
4	22:1928	CD	NUMBER	22:1928	number	5	SENT_279	[p12l1074t2062r1494b2110],
5	—	CD	NUMBER	—	dep	1	SENT_279	[p12l1074t2062r1494b2110],
6	9	CD	NUMBER	9	dep	5	SENT_279	[p12l1074t2062r1494b2110],
7	.	.	O	.	_	0	SENT_279	[p12l1074t2062r1494b2110],

1	[	NN	O	[	dep	5	SENT_280	[p12l12t2126r104b2181],
2	21	CD	NUMBER	21	num	1	SENT_280	[p12l12t2126r104b2181],
3	]	CD	NUMBER	]	num	4	SENT_280	[p12l12t2126r104b2181],
4	Salanti	NNS	O	salantus	dep	1	SENT_280	[p12l138t2126r302b2170],
5	G	NN	O	g	_	0	SENT_280	[p12l318t2128r364b2177],
6	,	,	O	,	_	0	SENT_280	[p12l318t2128r364b2177],
7	Southam	NNP	ORGANIZATION	Southam	nn	8	SENT_280	[p12l382t2126r600b2170],
8	L	NNP	ORGANIZATION	L	appos	5	SENT_280	[p12l617t2129r651b2176],
9	,	,	O	,	_	0	SENT_280	[p12l617t2129r651b2176],
10	Altshuler	NNP	PERSON	Altshuler	nn	11	SENT_280	[p12l666t2126r893b2170],
11	D	NNP	O	D	appos	5	SENT_280	[p12l908t2129r954b2176],
12	,	,	O	,	_	0	SENT_280	[p12l908t2129r954b2176],
13	Ardlie	NNP	PERSON	Ardlie	nn	14	SENT_280	[p12l969t2126r1118b2170],
14	K	NNP	PERSON	K	appos	5	SENT_280	[p12l1135t2129r1178b2176],
15	,	,	O	,	_	0	SENT_280	[p12l1135t2129r1178b2176],
16	Barroso	NNP	PERSON	Barroso	nn	20	SENT_280	[p12l1195t2129r1380b2170],
17	I	PRP	O	I	dep	20	SENT_280	[p12l1397t2129r1421b2177],
18	,	,	O	,	_	0	SENT_280	[p12l1397t2129r1421b2177],
19	Boehnke	NNP	PERSON	Boehnke	dep	20	SENT_280	[p12l1439t2126r1650b2170],
20	M	NNP	O	M	appos	5	SENT_280	[p12l1667t2129r1725b2177],
21	,	,	O	,	_	0	SENT_280	[p12l1667t2129r1725b2177],
22	et	FW	O	et	nn	23	SENT_280	[p12l1743t2133r1789b2170],
23	al.	FW	O	al.	appos	5	SENT_280	[p12l1804t2126r1855b2170],
24	.	.	O	.	_	0	SENT_280	[p12l1804t2126r1855b2170],

1	Underlying	JJ	O	underlying	amod	3	SENT_281	[p12l1872t2126r2147b2181],
2	genetic	JJ	O	genetic	amod	3	SENT_281	[p12l137t2193r315b2247],
3	models	NNS	O	model	_	0	SENT_281	[p12l339t2192r515b2236],
4	of	IN	O	of	_	0	SENT_281	[p12l541t2192r592b2236],
5	inheritance	NN	O	inheritance	prep_of	3	SENT_281	[p12l610t2192r888b2236],
6	in	IN	O	in	_	0	SENT_281	[p12l913t2193r959b2235],
7	established	JJ	O	established	amod	11	SENT_281	[p12l982t2192r1258b2236],
8	type	NN	O	type	nn	11	SENT_281	[p12l1283t2199r1390b2247],
9	2	CD	NUMBER	2	num	11	SENT_281	[p12l1415t2195r1441b2235],
10	diabetes	NN	O	diabetes	nn	11	SENT_281	[p12l1467t2192r1670b2236],
11	associations	NNS	O	association	prep_in	3	SENT_281	[p12l1695t2193r2002b2236],
12	.	.	O	.	_	0	SENT_281	[p12l1695t2193r2002b2236],

1	Am	VBP	O	be	dep	3	SENT_282	[p12l2025t2194r2147b2247],
2	]	CD	NUMBER	]	num	3	SENT_282	[p12l2025t2194r2147b2247],
3	Epidemiol	NNP	O	Epidemiol	_	0	SENT_282	[p12l138t2258r385b2312],
4	2009	CD	DATE	2009	num	3	SENT_282	[p12l405t2260r856b2308],
5	;	:	O	;	_	0	SENT_282	[p12l405t2260r856b2308],
6	170:537	CD	NUMBER	170:537	dep	3	SENT_282	[p12l405t2260r856b2308],
7	—	CD	NUMBER	—	num	8	SENT_282	[p12l405t2260r856b2308],
8	45	CD	NUMBER	45	dep	6	SENT_282	[p12l405t2260r856b2308],
9	.	.	O	.	_	0	SENT_282	[p12l405t2260r856b2308],

1	M.	NNP	O	M.	nn	2	SENT_283	[p12l619t2389r646b2409],
2	javorsky	NNP	O	javorsky	_	0	SENT_283	[p12l652t2387r754b2414],
3	et	FW	O	et	nn	4	SENT_283	[p12l763t2390r785b2409],
4	al.	FW	O	al.	dep	2	SENT_283	[p12l793t2387r817b2409],
5	/	:	O	/	punct	2	SENT_283	[p12l827t2388r953b2414],
6	European	JJ	MISC	european	amod	7	SENT_283	[p12l827t2388r953b2414],
7	journal	NN	O	journal	dep	2	SENT_283	[p12l959t2387r1046b2414],
8	of	IN	O	of	_	0	SENT_283	[p12l1056t2387r1081b2414],
9	Internal	JJ	ORGANIZATION	internal	amod	10	SENT_283	[p12l1085t2387r1176b2409],
10	Medicine	NN	ORGANIZATION	medicine	prep_of	7	SENT_283	[p12l1185t2387r1290b2409],
11	23	CD	NUMBER	23	number	12	SENT_283	[p12l1298t2388r1326b2409],
12	(	CD	NUMBER	(	num	13	SENT_283	[p12l1337t2387r1416b2414],
13	2012	CD	DATE	2012	dep	10	SENT_283	[p12l1337t2387r1416b2414],
14	)	CD	NUMBER	)	num	15	SENT_283	[p12l1337t2387r1416b2414],
15	245-249 249	CD	NUMBER	245-249 249	dep	13	SENT_283	[p12l2110t2388r2154b2409],[p12l1425t2388r1529b2409],

1	[	NN	O	[	nn	4	SENT_284	[p12l6t2463r51b2490],
2	22	CD	NUMBER	22	num	4	SENT_284	[p12l6t2463r51b2490],
3	]	NN	O	]	nn	4	SENT_284	[p12l6t2463r51b2490],
4	Schernthaner	NN	O	schernthaner	_	0	SENT_284	[p12l70t2463r228b2485],
5	G	NN	O	g	dep	4	SENT_284	[p12l241t2464r264b2488],
6	,	,	O	,	_	0	SENT_284	[p12l241t2464r264b2488],
7	Grimaldi	NNP	PERSON	Grimaldi	nn	8	SENT_284	[p12l277t2463r380b2485],
8	A	NNP	O	A	appos	5	SENT_284	[p12l393t2464r416b2488],
9	,	,	O	,	_	0	SENT_284	[p12l393t2464r416b2488],
10	Di	NNP	PERSON	Di	nn	12	SENT_284	[p12l430t2464r454b2485],
11	Mario	NNP	PERSON	Mario	nn	12	SENT_284	[p12l468t2464r536b2485],
12	U	NNP	PERSON	U	appos	5	SENT_284	[p12l551t2464r574b2488],
13	,	,	O	,	_	0	SENT_284	[p12l551t2464r574b2488],
14	Drzewoski	NNP	PERSON	Drzewoski	nn	15	SENT_284	[p12l588t2463r711b2485],
15	J	NNP	PERSON	J	appos	5	SENT_284	[p12l722t2465r737b2490],
16	,	,	O	,	_	0	SENT_284	[p12l722t2465r737b2490],
17	Kempler	NNP	PERSON	Kempler	nn	18	SENT_284	[p12l752t2463r852b2490],
18	P	NN	O	p	appos	5	SENT_284	[p12l866t2465r884b2488],
19	,	,	O	,	_	0	SENT_284	[p12l866t2465r884b2488],
20	Kvapil	NNP	PERSON	Kvapil	nn	21	SENT_284	[p12l899t2463r971b2490],
21	M	NNP	O	M	appos	5	SENT_284	[p12l986t2465r1014b2488],
22	,	,	O	,	_	0	SENT_284	[p12l986t2465r1014b2488],
23	et	FW	O	et	nn	24	SENT_284	[p12l1028t2466r1051b2485],
24	al.	FW	O	al.	appos	5	SENT_284	[p12l1063t2463r1088b2485],
25	oral	JJ	O	oral	amod	26	SENT_284	[p12l1226t2463r1271b2485],
26	sulphonylureas	NNS	O	sulphonylurea	dep	4	SENT_284	[p12l1286t2463r1470b2490],
27	in	IN	O	in	_	0	SENT_284	[p12l1485t2464r1506b2485],
28	patients	NNS	O	patient	prep_in	26	SENT_284	[p12l1520t2464r1616b2490],
29	with	IN	O	with	_	0	SENT_284	[p12l1631t2463r1686b2485],
30	diabetes	NN	O	diabetes	prep_with	28	SENT_284	[p12l1700t2463r1799b2485],
31	due	JJ	O	due	_	0	SENT_284	[p12l1814t2463r1857b2485],
32	to	TO	O	to	_	0	SENT_284	[p12l1872t2466r1895b2485],
33	Kir6	JJ	O	kir6	amod	35	SENT_284	[p12l1910t2464r1979b2485],
34	.2	NN	NUMBER	.2	nn	35	SENT_284	[p12l1910t2464r1979b2485],
35	mutations	NNS	O	mutation	prep_due_to	30	SENT_284	[p12l1994t2464r2121b2485],
36	.	.	O	.	_	0	SENT_284	[p12l1994t2464r2121b2485],

1	N	NN	O	n	nn	2	SENT_285	[p12l2137t2464r2154b2485],
2	Englj	NN	O	englj	_	0	SENT_285	[p12l6t2496r75b2523],

1	GUIDE	NNP	O	GUIDE	nn	2	SENT_286	[p12l67t2530r143b2551],
2	study	NN	O	study	_	0	SENT_286	[p12l152t2529r223b2556],
3	:	:	O	:	_	0	SENT_286	[p12l152t2529r223b2556],
4	double	JJ	O	double	amod	7	SENT_286	[p12l233t2529r384b2551],
5	—	JJ	O	—	amod	7	SENT_286	[p12l233t2529r384b2551],
6	blind	JJ	O	blind	amod	7	SENT_286	[p12l233t2529r384b2551],
7	comparison	NN	O	comparison	dep	2	SENT_286	[p12l392t2529r530b2556],
8	of	IN	O	of	_	0	SENT_286	[p12l538t2529r563b2551],
9	once	RB	DATE	once	advmod	16	SENT_286	[p12l568t2529r691b2556],
10	—	CD	NUMBER	—	num	13	SENT_286	[p12l568t2529r691b2556],
11	daily	JJ	SET	daily	amod	13	SENT_286	[p12l568t2529r691b2556],
12	gliclazide	NN	O	gliclazide	nn	13	SENT_286	[p12l698t2529r808b2556],
13	MR	NN	O	mr	nsubj	16	SENT_286	[p12l816t2530r856b2550],
14	and	CC	O	and	_	0	SENT_286	[p12l863t2529r906b2551],
15	glimepiride	NN	O	glimepiride	conj_and	13	SENT_286	[p12l914t2529r1049b2556],
16	Med	VBD	O	med	prepc_of	7	SENT_286	[p12l1184t2529r1236b2551],
17	2006	CD	DATE	2006	dobj	16	SENT_286	[p12l1246t2530r1467b2554],
18	;	:	O	;	_	0	SENT_286	[p12l1246t2530r1467b2554],
19	355:467	CD	NUMBER	355:467	number	20	SENT_286	[p12l1246t2530r1467b2554],
20	—	CD	NUMBER	—	dep	2	SENT_286	[p12l1246t2530r1467b2554],
21	77	CD	NUMBER	77	dep	20	SENT_286	[p12l1246t2530r1467b2554],
22	.	.	O	.	_	0	SENT_286	[p12l1246t2530r1467b2554],

1	in	IN	O	in	_	0	SENT_287	[p12l67t2561r89b2582],
2	type	NN	O	type	amod	5	SENT_287	[p12l99t2564r150b2588],
3	2	CD	NUMBER	2	number	2	SENT_287	[p12l160t2562r173b2582],
4	diabetic	JJ	O	diabetic	amod	5	SENT_287	[p12l184t2561r277b2583],
5	patients	NNS	O	patient	pobj	1	SENT_287	[p12l287t2561r386b2588],
6	.	.	O	.	_	0	SENT_287	[p12l287t2561r386b2588],

1	Eur	NNP	O	Eur	nn	4	SENT_288	[p12l397t2562r450b2588],
2	]	CD	NUMBER	]	num	4	SENT_288	[p12l397t2562r450b2588],
3	Clin	NNP	O	Clin	nn	4	SENT_288	[p12l460t2561r505b2583],
4	Invest	NNP	O	Invest	_	0	SENT_288	[p12l516t2562r587b2583],
5	2004	CD	DATE	2004	dep	4	SENT_288	[p12l596t2562r796b2586],
6	;	:	O	;	_	0	SENT_288	[p12l596t2562r796b2586],
7	34:535	CD	NUMBER	34:535	number	8	SENT_288	[p12l596t2562r796b2586],
8	—	CD	NUMBER	—	dep	4	SENT_288	[p12l596t2562r796b2586],
9	42	CD	NUMBER	42	dep	8	SENT_288	[p12l596t2562r796b2586],
10	.	.	O	.	_	0	SENT_288	[p12l596t2562r796b2586],

1	[	NN	O	[	_	0	SENT_289	[p12l1139t2561r1184b2588],
2	26	CD	NUMBER	26	num	1	SENT_289	[p12l1139t2561r1184b2588],
3	]	CD	NUMBER	]	num	5	SENT_289	[p12l1139t2561r1184b2588],
4	Raﬁq	NN	O	raﬁq	nn	5	SENT_289	[p12l1203t2561r1263b2588],
5	M	NN	O	m	dep	1	SENT_289	[p12l1278t2562r1306b2586],
6	,	,	O	,	_	0	SENT_289	[p12l1278t2562r1306b2586],
7	Flanagan	NNP	PERSON	Flanagan	nn	8	SENT_289	[p12l1320t2561r1427b2588],
8	SE	NN	PERSON	se	appos	5	SENT_289	[p12l1441t2562r1474b2586],
9	,	,	O	,	_	0	SENT_289	[p12l1441t2562r1474b2586],
10	Patch	NNP	ORGANIZATION	Patch	nn	11	SENT_289	[p12l1489t2561r1554b2583],
11	AM	NNP	ORGANIZATION	AM	appos	5	SENT_289	[p12l1567t2562r1614b2586],
12	,	,	O	,	_	0	SENT_289	[p12l1567t2562r1614b2586],
13	Shields	NNP	O	Shields	nn	14	SENT_289	[p12l1629t2561r1714b2583],
14	BM	NN	O	bm	appos	5	SENT_289	[p12l1729t2562r1773b2586],
15	,	,	O	,	_	0	SENT_289	[p12l1729t2562r1773b2586],
16	Ellard	NNP	PERSON	Ellard	nn	17	SENT_289	[p12l1788t2561r1856b2583],
17	S	NNP	O	S	appos	5	SENT_289	[p12l1871t2562r1889b2586],
18	,	,	O	,	_	0	SENT_289	[p12l1871t2562r1889b2586],
19	Hattersley	NNP	PERSON	Hattersley	nn	20	SENT_289	[p12l1904t2561r2027b2588],
20	AT	NNP	O	AT	appos	5	SENT_289	[p12l2040t2562r2077b2586],
21	,	,	O	,	_	0	SENT_289	[p12l2040t2562r2077b2586],
22	et	FW	O	et	nn	23	SENT_289	[p12l2092t2564r2115b2583],
23	al.	FW	O	al.	appos	5	SENT_289	[p12l2128t2561r2154b2583],
24	.	.	O	.	_	0	SENT_289	[p12l2128t2561r2154b2583],

1	The	DT	O	the	det	5	SENT_290	[p12l6t2593r50b2615],
2	[	CD	NUMBER	[	num	5	SENT_290	[p12l59t2593r104b2620],
3	23	CD	NUMBER	23	num	5	SENT_290	[p12l59t2593r104b2620],
4	]	NNP	O	]	nn	5	SENT_290	[p12l59t2593r104b2620],
5	Bolen	NNP	PERSON	Bolen	_	0	SENT_290	[p12l120t2594r185b2615],
6	S	NN	O	s	dep	5	SENT_290	[p12l198t2595r216b2618],
7	,	,	O	,	_	0	SENT_290	[p12l198t2595r216b2618],
8	Feldman	NNP	PERSON	Feldman	nn	9	SENT_290	[p12l230t2593r331b2615],
9	L	NNP	PERSON	L	appos	6	SENT_290	[p12l344t2595r360b2618],
10	,	,	O	,	_	0	SENT_290	[p12l344t2595r360b2618],
11	Vassy	NNP	PERSON	Vassy	nn	12	SENT_290	[p12l373t2595r440b2620],
12	J	NNP	PERSON	J	appos	6	SENT_290	[p12l449t2595r464b2620],
13	,	,	O	,	_	0	SENT_290	[p12l449t2595r464b2620],
14	Wilson	NNP	PERSON	Wilson	nn	15	SENT_290	[p12l477t2593r560b2615],
15	L	NNP	O	L	appos	6	SENT_290	[p12l573t2595r590b2618],
16	,	,	O	,	_	0	SENT_290	[p12l573t2595r590b2618],
17	Yeh	NNP	O	Yeh	nn	18	SENT_290	[p12l602t2593r647b2615],
18	HC	NNP	O	HC	appos	6	SENT_290	[p12l660t2595r699b2618],
19	,	,	O	,	_	0	SENT_290	[p12l660t2595r699b2618],
20	Marinpoulos	NNP	O	Marinpoulos	nn	21	SENT_290	[p12l713t2594r861b2620],
21	S	NNP	O	S	appos	6	SENT_290	[p12l874t2595r892b2618],
22	,	,	O	,	_	0	SENT_290	[p12l874t2595r892b2618],
23	et	FW	O	et	nn	24	SENT_290	[p12l905t2597r927b2615],
24	al.	FW	O	al.	appos	6	SENT_290	[p12l939t2593r964b2615],
25	.	.	O	.	_	0	SENT_290	[p12l939t2593r964b2615],

1	Systematic	JJ	O	systematic	amod	6	SENT_291	[p12l978t2594r1105b2620],
2	Neonatal	JJ	O	neonatal	amod	6	SENT_291	[p12l1239t2593r1346b2615],
3	Diabetes	NNP	O	Diabetes	nn	6	SENT_291	[p12l1360t2594r1462b2615],
4	International	NNP	O	International	nn	6	SENT_291	[p12l1476t2593r1632b2615],
5	Collaboration	NNP	O	Collaboration	nn	6	SENT_291	[p12l1646t2593r1807b2615],
6	Group	NNP	O	Group	_	0	SENT_291	[p12l1821t2595r1903b2620],
7	:	:	O	:	_	0	SENT_291	[p12l1821t2595r1903b2620],
8	effective	JJ	O	effective	amod	9	SENT_291	[p12l1918t2593r2019b2615],
9	treatment	NN	O	treatment	dep	6	SENT_291	[p12l2033t2597r2154b2615],
10	with	IN	O	with	_	0	SENT_291	[p12l6t2626r61b2648],
11	review	NN	O	review	prep_with	9	SENT_291	[p12l67t2659r154b2681],
12	:	:	O	:	_	0	SENT_291	[p12l67t2659r154b2681],
13	comparative	JJ	O	comparative	amod	14	SENT_291	[p12l164t2659r310b2686],
14	effecﬁveness	NN	O	effecﬁveness	dep	6	SENT_291	[p12l318t2659r468b2681],
15	and	CC	O	and	_	0	SENT_291	[p12l477t2659r520b2681],
16	safety	NN	O	safety	dep	6	SENT_291	[p12l529t2659r598b2686],
17	of	IN	O	of	_	0	SENT_291	[p12l606t2659r631b2681],
18	oral	JJ	O	oral	amod	19	SENT_291	[p12l635t2659r680b2681],
19	medications	NNS	O	medication	nn	23	SENT_291	[p12l688t2659r830b2681],
20	for	IN	O	for	_	0	SENT_291	[p12l839t2659r872b2681],
21	type2diabetes	NNS	O	type2diabete	prep_for	19	SENT_291	[p12l879t2659r1058b2686],
22	oral	JJ	O	oral	amod	23	SENT_291	[p12l1194t2659r1239b2681],
23	sulfonylureas	NNS	O	sulfonylurea	prep_of	14	SENT_291	[p12l1257t2659r1418b2686],
24	in	IN	O	in	_	0	SENT_291	[p12l1437t2659r1459b2680],
25	patients	NNS	O	patient	prep_in	23	SENT_291	[p12l1477t2659r1573b2686],
26	with	IN	O	with	_	0	SENT_291	[p12l1591t2659r1646b2681],
27	diabetes	NN	O	diabetes	prep_with	25	SENT_291	[p12l1664t2659r1763b2681],
28	due	JJ	O	due	_	0	SENT_291	[p12l1782t2659r1825b2681],
29	to	TO	O	to	_	0	SENT_291	[p12l1844t2662r1867b2681],
30	sulfonylurea	NN	O	sulfonylurea	nn	32	SENT_291	[p12l1885t2659r2034b2686],
31	receptor	NN	O	receptor	nn	32	SENT_291	[p12l2053t2662r2154b2686],
32	mellitus	NN	O	mellitus	prep_due_to	23	SENT_291	[p12l67t2726r167b2748],
33	.	.	O	.	_	0	SENT_291	[p12l67t2726r167b2748],

1	Ann	NNP	O	Ann	nn	3	SENT_292	[p12l175t2727r223b2748],
2	Intern	NNP	O	Intern	nn	3	SENT_292	[p12l232t2727r302b2748],
3	Med	NNP	O	Med	_	0	SENT_292	[p12l311t2726r362b2748],
4	2007:147:386	CD	NUMBER	2007:147:386	num	3	SENT_292	[p12l371t2727r586b2751],
5	—	CD	NUMBER	—	number	6	SENT_292	[p12l371t2727r586b2751],
6	99	CD	NUMBER	99	num	3	SENT_292	[p12l371t2727r586b2751],
7	.	.	O	.	_	0	SENT_292	[p12l371t2727r586b2751],

1	(	NN	O	(	nn	2	SENT_293	[p12l1185t2726r1268b2753],
2	SUR1	NN	O	sur1	_	0	SENT_293	[p12l1185t2726r1268b2753],
3	)	NN	O	)	nn	4	SENT_293	[p12l1185t2726r1268b2753],
4	mutations	NNS	O	mutation	dep	2	SENT_293	[p12l1280t2726r1407b2748],
5	.	.	O	.	_	0	SENT_293	[p12l1280t2726r1407b2748],

1	Diabetes	NNP	O	Diabetes	nn	2	SENT_294	[p12l1417t2726r1519b2748],
2	Care	NNP	O	Care	_	0	SENT_294	[p12l1529t2727r1582b2748],
3	2008	CD	DATE	2008	num	2	SENT_294	[p12l1591t2727r1781b2751],
4	;	:	O	;	_	0	SENT_294	[p12l1591t2727r1781b2751],
5	31:204	CD	NUMBER	31:204	number	6	SENT_294	[p12l1591t2727r1781b2751],
6	—	CD	NUMBER	—	dep	2	SENT_294	[p12l1591t2727r1781b2751],
7	9	CD	NUMBER	9	dep	6	SENT_294	[p12l1591t2727r1781b2751],
8	.	.	O	.	_	0	SENT_294	[p12l1591t2727r1781b2751],

1	[	NN	O	[	_	0	SENT_295	[p12l6t2759r51b2786],
2	24	CD	NUMBER	24	num	1	SENT_295	[p12l6t2759r51b2786],
3	]	CD	NUMBER	]	num	5	SENT_295	[p12l6t2759r51b2786],
4	Sherifali	NN	ORGANIZATION	sherifalus	nn	5	SENT_295	[p12l68t2759r163b2781],
5	D	NN	ORGANIZATION	d	dep	1	SENT_295	[p12l173t2760r196b2784],
6	,	,	O	,	_	0	SENT_295	[p12l173t2760r196b2784],
7	Nerenberg	NNP	LOCATION	Nerenberg	nn	8	SENT_295	[p12l206t2759r331b2786],
8	K	NNP	LOCATION	K	appos	5	SENT_295	[p12l340t2760r361b2784],
9	,	,	O	,	_	0	SENT_295	[p12l340t2760r361b2784],
10	Pullenayegum	NNP	O	Pullenayegum	nn	11	SENT_295	[p12l372t2759r538b2786],
11	E	NNP	O	E	appos	5	SENT_295	[p12l549t2760r567b2784],
12	,	,	O	,	_	0	SENT_295	[p12l549t2760r567b2784],
13	Cheng	NNP	ORGANIZATION	Cheng	nn	14	SENT_295	[p12l577t2759r651b2786],
14	JE	NNP	ORGANIZATION	JE	appos	5	SENT_295	[p12l658t2760r687b2786],
15	,	,	O	,	_	0	SENT_295	[p12l658t2760r687b2786],
16	Gerstein	NNP	PERSON	Gerstein	nn	17	SENT_295	[p12l698t2759r796b2781],
17	HC	NNP	O	HC	appos	5	SENT_295	[p12l806t2760r845b2781],
18	.	.	O	.	_	0	SENT_295	[p12l806t2760r845b2781],

1	The	DT	O	the	det	2	SENT_296	[p12l854t2759r898b2781],
2	effect	NN	O	effect	dep	8	SENT_296	[p12l908t2759r973b2781],
3	of	IN	O	of	_	0	SENT_296	[p12l981t2759r1006b2781],
4	oral	JJ	O	oral	amod	5	SENT_296	[p12l1013t2759r1057b2781],
5	[	NN	O	[	prep_of	2	SENT_296	[p12l1132t2759r1177b2786],
6	27	CD	NUMBER	27	number	7	SENT_296	[p12l1132t2759r1177b2786],
7	]	CD	NUMBER	]	num	5	SENT_296	[p12l1132t2759r1177b2786],
8	Stanikj	NNP	O	Stanikj	_	0	SENT_296	[p12l1194t2759r1284b2786],
9	,	,	O	,	_	0	SENT_296	[p12l1194t2759r1284b2786],
10	Gasperikova	NNP	PERSON	Gasperikova	nn	11	SENT_296	[p12l1291t2759r1436b2786],
11	D	NNP	PERSON	D	appos	8	SENT_296	[p12l1443t2760r1466b2784],
12	,	,	O	,	_	0	SENT_296	[p12l1443t2760r1466b2784],
13	Paskova	NNP	O	Paskova	nn	14	SENT_296	[p12l1473t2759r1567b2781],
14	M	NNP	O	M	appos	8	SENT_296	[p12l1574t2760r1602b2784],
15	,	,	O	,	_	0	SENT_296	[p12l1574t2760r1602b2784],
16	Barak	NNP	PERSON	Barak	nn	17	SENT_296	[p12l1609t2759r1675b2781],
17	L	NNP	PERSON	L	appos	8	SENT_296	[p12l1682t2759r1934b2786],
18	,	,	O	,	_	0	SENT_296	[p12l1682t2759r1934b2786],
19	JavorkovaJ	NNP	O	JavorkovaJ	appos	8	SENT_296	[p12l1682t2759r1934b2786],
20	,	,	O	,	_	0	SENT_296	[p12l1682t2759r1934b2786],
21	]	CD	NUMBER	]	num	23	SENT_296	[p12l1682t2759r1934b2786],
22	ancova	NN	O	ancova	nn	23	SENT_296	[p12l1682t2759r1934b2786],
23	E	NN	O	e	appos	8	SENT_296	[p12l1941t2760r1960b2784],
24	,	,	O	,	_	0	SENT_296	[p12l1941t2760r1960b2784],
25	et	FW	O	et	nn	26	SENT_296	[p12l1967t2762r1989b2781],
26	al.	FW	O	al.	appos	8	SENT_296	[p12l1995t2759r2019b2781],
27	.	.	O	.	_	0	SENT_296	[p12l1995t2759r2019b2781],

1	Prevalence	NN	O	prevalence	_	0	SENT_297	[p12l2027t2759r2154b2781],
2	of	IN	O	of	_	0	SENT_297	[p12l6t2792r31b2814],
3	antidiabetic	JJ	O	antidiabetic	amod	4	SENT_297	[p12l67t2824r206b2846],
4	agents	NNS	O	agent	prep_of	1	SENT_297	[p12l216t2827r292b2851],
5	on	IN	O	on	_	0	SENT_297	[p12l303t2830r333b2846],
6	A1C	NN	O	a1c	nn	7	SENT_297	[p12l343t2825r391b2846],
7	levels	NNS	O	level	prep_on	1	SENT_297	[p12l402t2824r473b2846],
8	.	.	O	.	_	0	SENT_297	[p12l402t2824r473b2846],

1	A	DT	O	a	det	3	SENT_298	[p12l484t2825r501b2846],
2	systematic	JJ	O	systematic	amod	3	SENT_298	[p12l512t2825r637b2851],
3	review	NN	O	review	_	0	SENT_298	[p12l649t2825r729b2846],
4	and	CC	O	and	_	0	SENT_298	[p12l740t2824r783b2846],
5	meta	NN	O	meta	nn	6	SENT_298	[p12l795t2824r963b2851],
6	—	NN	O	—	conj_and	3	SENT_298	[p12l795t2824r963b2851],
7	analysis	NN	O	analysis	dep	3	SENT_298	[p12l795t2824r963b2851],
8	.	.	O	.	_	0	SENT_298	[p12l795t2824r963b2851],

1	Diabetes	NNP	O	Diabetes	nn	4	SENT_299	[p12l975t2824r1075b2846],
2	permanent	JJ	O	permanent	amod	4	SENT_299	[p12l1212t2827r1342b2851],
3	neonatal	JJ	O	neonatal	amod	4	SENT_299	[p12l1352t2824r1452b2846],
4	diabetes	NN	O	diabetes	_	0	SENT_299	[p12l1463t2824r1561b2846],
5	in	IN	O	in	_	0	SENT_299	[p12l1571t2825r1593b2846],
6	Slovakia	NNP	LOCATION	Slovakia	prep_in	4	SENT_299	[p12l1603t2824r1700b2846],
7	and	CC	O	and	_	0	SENT_299	[p12l1709t2824r1752b2846],
8	successful	JJ	O	successful	amod	9	SENT_299	[p12l1762t2824r1878b2846],
9	replacement	NN	O	replacement	prep_in	4	SENT_299	[p12l1889t2824r2036b2851],
10	of	IN	O	of	dep	4	SENT_299	[p12l2046t2824r2071b2846],
11	insulin	NN	O	insulin	pobj	10	SENT_299	[p12l2075t2824r2154b2846],
12	with	IN	O	with	dep	4	SENT_299	[p12l6t2857r60b2878],

1	Care	NNP	O	Care	_	0	SENT_300	[p12l67t2890r119b2911],
2	2010	CD	DATE	2010	num	1	SENT_300	[p12l137t2890r352b2914],
3	;	:	O	;	_	0	SENT_300	[p12l137t2890r352b2914],
4	33:1859	CD	NUMBER	33:1859	number	5	SENT_300	[p12l137t2890r352b2914],
5	—	CD	NUMBER	—	dep	1	SENT_300	[p12l137t2890r352b2914],
6	64	CD	NUMBER	64	dep	5	SENT_300	[p12l137t2890r352b2914],
7	.	.	O	.	_	0	SENT_300	[p12l137t2890r352b2914],

1	sulphonylurea	NN	O	sulphonylurea	nn	2	SENT_301	[p12l1205t2889r1373b2916],
2	therapy	NN	O	therapy	_	0	SENT_301	[p12l1395t2889r1486b2916],
3	in	IN	O	in	_	0	SENT_301	[p12l1508t2889r1530b2910],
4	KCNJ1	NN	O	kcnj1	prep_in	2	SENT_301	[p12l1551t2890r1620b2916],
5	1	CD	NUMBER	1	num	4	SENT_301	[p12l1637t2890r1646b2910],
6	and	CC	O	and	_	0	SENT_301	[p12l1671t2889r1714b2911],
7	ABCC8	NN	O	abcc8	nn	9	SENT_301	[p12l1735t2890r1812b2911],
8	mutation	NN	O	mutation	nn	9	SENT_301	[p12l1836t2889r1943b2911],
9	carriers	NNS	O	carrier	prep_in	2	SENT_301	[p12l1965t2889r2058b2911],
10	.	.	O	.	_	0	SENT_301	[p12l1965t2889r2058b2911],

1	J	NNP	O	J	nn	2	SENT_302	[p12l2077t2890r2087b2916],
2	Clin	NNP	O	Clin	_	0	SENT_302	[p12l2109t2889r2154b2911],

1	Endocrinol	JJ	O	endocrinol	amod	2	SENT_303	[p12l6t2921r133b2943],
2	[	NN	O	[	_	0	SENT_303	[p12l142t2921r187b2948],
3	25	CD	NUMBER	25	number	4	SENT_303	[p12l142t2921r187b2948],
4	]	CD	NUMBER	]	dep	2	SENT_303	[p12l142t2921r187b2948],
5	Pearson	NNP	PERSON	Pearson	dep	4	SENT_303	[p12l203t2922r297b2943],
6	ER	NN	O	er	dep	2	SENT_303	[p12l311t2922r346b2946],
7	,	,	O	,	_	0	SENT_303	[p12l311t2922r346b2946],
8	Flechtner	NN	O	flechtner	appos	6	SENT_303	[p12l360t2921r473b2943],
9	I	PRP	O	I	dep	2	SENT_303	[p12l485t2922r497b2946],
10	,	,	O	,	_	0	SENT_303	[p12l485t2922r497b2946],
11	Njolstad	NNP	O	Njolstad	nn	12	SENT_303	[p12l511t2921r610b2948],
12	PR	NNP	O	PR	appos	9	SENT_303	[p12l624t2922r659b2946],
13	,	,	O	,	_	0	SENT_303	[p12l624t2922r659b2946],
14	Malecki	NNP	PERSON	Malecki	nn	15	SENT_303	[p12l673t2921r765b2943],
15	MT	NNP	O	MT	appos	9	SENT_303	[p12l779t2922r822b2946],
16	,	,	O	,	_	0	SENT_303	[p12l779t2922r822b2946],
17	Flanagan	NNP	PERSON	Flanagan	nn	18	SENT_303	[p12l836t2921r943b2948],
18	SE	NN	O	se	appos	9	SENT_303	[p12l956t2922r989b2946],
19	,	,	O	,	_	0	SENT_303	[p12l956t2922r989b2946],
20	Larkin	NN	PERSON	larkin	nn	21	SENT_303	[p12l1003t2921r1077b2943],
21	B	NN	O	b	appos	9	SENT_303	[p12l1090t2922r1110b2946],
22	,	,	O	,	_	0	SENT_303	[p12l1090t2922r1110b2946],
23	et	FW	O	et	nn	24	SENT_303	[p12l1124t2924r1147b2943],
24	al.	FW	O	al.	appos	9	SENT_303	[p12l1159t2921r1185b2943],
25	.	.	O	.	_	0	SENT_303	[p12l1159t2921r1185b2943],

1	Metab	NNP	O	Metab	_	0	SENT_304	[p12l1320t2921r1394b2943],
2	2007	CD	DATE	2007	num	1	SENT_304	[p12l1402t2922r1617b2946],
3	;	:	O	;	_	0	SENT_304	[p12l1402t2922r1617b2946],
4	92:1276	CD	NUMBER	92:1276	number	5	SENT_304	[p12l1402t2922r1617b2946],
5	—	CD	NUMBER	—	dep	1	SENT_304	[p12l1402t2922r1617b2946],
6	82	CD	NUMBER	82	dep	5	SENT_304	[p12l1402t2922r1617b2946],
7	.	.	O	.	_	0	SENT_304	[p12l1402t2922r1617b2946],

1	Neonatal	JJ	O	neonatal	amod	5	SENT_305	[p12l67t2953r174b2975],
2	Diabetes	NNP	O	Diabetes	nn	5	SENT_305	[p12l187t2953r289b2975],
3	International	NNP	O	International	nn	5	SENT_305	[p12l301t2953r457b2975],
4	Collaborative	NNP	O	Collaborative	nn	5	SENT_305	[p12l470t2953r628b2975],
5	Group	NNP	O	Group	_	0	SENT_305	[p12l640t2954r721b2980],
6	:	:	O	:	_	0	SENT_305	[p12l640t2954r721b2980],
7	switching	NN	O	switching	dep	5	SENT_305	[p12l736t2953r853b2980],
8	from	IN	O	from	_	0	SENT_305	[p12l864t2953r921b2975],
9	insulin	NN	O	insulin	prep_from	7	SENT_305	[p12l934t2953r1014b2975],
10	to	TO	O	to	dep	5	SENT_305	[p12l1026t2956r1049b2975],

